FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL disorders Addictions and other Mental Disorders

23 - 26 March, 2017 MADRID - Spain

www.icdd-congress.com

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL disorders Addictions and other Mental Disorders

INDEX

WELCOME LETTER______04

COMMITTEES______06

GENERAL INFORMATION ______08

CONGRESS FLOOR PLAN ______30

PROGRAMME THURSDAY 23, March 33

FRIDAY 24, March 49

SATURDAY 25, March 81

SUNDAY 26, March 129

IV CONGRESSO IBERO-BRASILEIRO DE PATOLOGIA DUAL ______153

FOUNDATION ACTIVITIES ______159

POSTERS ______160 SPONSORS & EXHIBITORS SPONSORS ______208 SATELLITE SYMPOSIA ______210 EXHIBITION FLOOR PLAN ______224

AUTHORS INDEX ______225 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

WELCOME LETTER

Dear Colleagues and Friends,

It is with great pleasure that we welcome you to join us in the World Congress of Dual Disorders to be held from 23-26 March 2017 in Madrid.

The World Association on Dual Disorders will jointly host this meet- ing in conjunction with the Spanish Association on Dual Disorders (SEPD) with the congress theme: “New paradigm in neuroscience to understand mental health”.

This World Congress offers an ideal opportunity to take stock on the state of the art of dual disorders in the early part of this 21st centu- ry and share the vision and future direction of impressive develop- ments in this new field.

In addition to the new developments in research and clinical practice, the congress will focus on neuroscience insights on Dual Disorders.

Leading and major star speakers from all over the world will provide in- sights into their fields of expertise in innovative and attractive formats.

There will also be scheduled sessions working with patient, family and care groups, as well as with other partner organizations such as the psychiatrist and psychologist European residents association.

The World Association on Dual Disorders is committed to improve the health care of mental patients with Dual Disorders wherever they live by raising standards of training, education as well as clinical practice by psychiatrists, psychologists, nurses, social workers and other mental health professionals.

04 23 - 26 March, 2017 Madrid - Spain

This congress is an excellent opportunity to share academic develop- ments, research and clinical practice. It will also provide a forum for better and closer social interactions and support.

Moreover, we are sure that Madrid will be an impressive host. Ma- drid is a special city where the past and present meet and the atmo- sphere is characterized by tradition and modernity.

We look forward to seeing you in Madrid.

Dr. Néstor Szerman Dr. Pedro Ruiz Congress Chairman, Congress Chairman, SEPD Founding President President WADD

Prof. Miguel Casas Dr. Icro Maremmani Congress Chairman, WADD Treasurer President SEPD

05 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

COMMITTEES

HONORARY COMMITTEE

Mr. Francisco de Asís Babín Government Delegation for the National Plan on Drugs.

Mrs. Cristina Cifuentes Presidency of Madrid Community Region.

Mrs. Manuela Carmena Mayor of Madrid

EXECUTIVE COMMITTEE

Dr. Néstor Szerman Dr. José Martínez-Raga Prof. Miguel Casas Dr. Lara Grau-López Dr. Carlos Roncero Dr. Pedro Ruiz Dr. Pablo Vega Dr. Icro Maremmani Dr. Ignacio Basurte

SCIENTIFIC COMMITTEE

Dr. Carlos Roncero Co-President of the Scientific Committee

Dr. Jerónimo Sáiz Co-President of the Scientific Committee

Dr. Néstor Szerman Dr. Lara Grau-López Prof. Miguel Casas Dr. Pedro Ruiz Dr. Icro Maremmani Dr. María Inés López Ibor Dr. Pablo Vega Dr. Marife Bravo Dr. Ignacio Basurte Dr. Gabriel Rubio Dr. José Martínez-Raga

06 23 - 26 March, 2017 Madrid - Spain

CONFERENCE SUPPORT GROUP

Prof. Cecilio Álamo Dr. Carlos Mur de Viu Dr. Francisco Arias Horcajadas Dr. Mercedes Navío Acosta Dr. Dolores Baño Dr. Enriqueta Ochoa Dr. Marife Bravo Dr. Ruth Olmos Dr. Luis Caballero Dr. Carlos Parro Dr. Julia Cambra Dr. Manuel Pereira Dr. Fernando Cañas de Paz Dr. Guillermo Petersen Dr. José Luis Carrasco Dr. Francisco Javier Quintero Dr. Javier Correas Dr. Raquel Rebolledo Dr. Marina Díaz Marsá Dr. Gabriel Rubio Dr. Helena Díaz Moreno Dr. Jerónimo Sáiz Dr. Helen Dolengevich Dr. Diego Urgelés Dr. Francisco Ferre Navarrete Dr. Estíbaliz Munain Dr. María Inés López Ibor Dr. José Manuel Montes Dr. Gregorio Martín Carmona Dr. Álvaro Rivera Dr. Beatriz Mesías Dr. Sabrina Sánchez Dr. Rocío Molina Prado Dr. Juncal Sevilla

ORGANISATION COORDINATORS

Sandra Martínez Francisco J. Gómez Rocío Torralba Marta Gómez Iñigo Alberdi Raquel Grande Germán Montero Sonia Álvarez Lluis Niell Francisco de Pedro Rafael Baena Pablo Feito Christian J. Pardo Rocío Paricio Javier Sánchez Patricia Fernández Héctor de Diego Sara María Cabello de Alba Gonzalo Salazar María García

07 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

GENERAL INFORMATION

APP Navigate through the First World Congress of the World Association of Dual Disorders (WADD) & Fifth International Congress of the Spanish Society of Dual Disorders (SEPD) programme from your iPhone, iPad, and Android. View sessions by day and category, locate exhibitors and create your own itinerary to fully exploit your congress. http://www.icdd-congress.com/scientific-information/app-mobile/ Use this code to unlock the APP if it is required: 85962

CERTIFICATE OF ATTENDANCE Certificates of attendance will be sent to you by e-mail after the congress, please confirm that the congress secretariat has your orrectc email address by checking at the registration desk.

CLOTHING We recommend informal clothing and comfortable shoes during the congress.

CONGRESS ABSTRACTS Will be published online on the ICDD 2017 web site and a USB will be handed to attendees together with the Congress documents.

CONGRESS NAME BADGE On arrival, at the registration counter you will receive your name badge. Please wear your badge at all times at the Congress, during all sessions and events.

08 23 - 26 March, 2017 Madrid - Spain

CURRENCY All official congress prices are indicated in Euro. The official currency in Spain is the Euro €. All major credit cards are accepted in most hotels, restaurants, and shops.

EXHIBITION OPENING HOURS Thursday 23rd March: 16:00 - 20:00 Friday 24th March: 09:00 - 18:30 Saturday 25th March: 09:00 - 17:30

LIABILITY AND INSURANCE The Congress Secretariat and organizers are not and cannot accept liability for personal accidents or loss of or damage to private property of participants. Participants are advised to take their own personal travel and health insurance for their trip.

MOBILE PHONES AND PHOTOGRAPHY Participants are kindly requested to keep their mobile phones switched off at the halls when attending sessions and refrain from taking pictures during sessions.

OFFICIAL LANGUAGE The official language of the congress is English/Spanish and simultaneous translation English-Spanish, Spanish-English will be available in four meeting rooms. Conference language will be indicated outside the meeting rooms.

REFRESHMENTS Coffee will be served on the Exhibition Area from 11:30 to 12:00 on 24th and 25th March and from 18:00 to 18:30 on 24th March. Congress venue has several bars and restaurants where participants will be able to get all sorts of refreshments and snacks.

09 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

REGISTRATION HOURS Thursday 23rd March: 10:00 -19:00 Friday 24th March: 8:00 - 19:30 Saturday 25th March: 8:00 - 18:30 Sunday 26th March: 8:00 -13:00

SAFETY AND SECURITY Please do not leave bags or suitcases unattended at any time, whether inside or outside the session halls. Hotels strongly recommend that you use their safety deposit boxes for your valuables.

SMOKING POLICIES The ICDD 2017 is a non-smoking event and participants are requested to refrain from smoking in the venue.

VENUE Hotel Meliá Castilla C/ Capitán Haya 43 28028 Madrid Tel: +34 91 5675000 www.meliacastilla.com

TECHNICAL SECRETARIAT

C/ Eraso 36, 28028 Madrid Tel: +34 91 361 2600 [email protected] [email protected]

10 23 - 26 March, 2017 Madrid - Spain

CME - CPD ACCREDITATION

EDUCATIONAL OBJECTIVE • Address individual needs in compliance with their Continuous Professional Development (CPD) plan. • Describe a neurobiological link between depression, ADHD, and substance abuse. • Summarise the role of the emergency care in the evaluation and treatment of . • Present the most recent research findings in Dual Disorders, and promote and enhance scientific collaborations around the world. • Review and share recent knowledge and developments about child and adolescent . • Enhance practical knowledge in the medical field of Psychopathology and Dual Disorders. • Enhance dialogue between clinicians, world’s scientific experts and researchers in the field of Dual Disorders and other mental disorders. • Describe clinical and ethical aspects of using coercive strategies in the management of patients with Dual Disorders

ACCREDITATION STATEMENT AND CREDIT DESIGNATION European Accreditation Council for Continuing Medical Education (UEMS/EACCME) The 1st World Congress of the World Association on Dual Disorders (WADD) & 5th International Congress on Dual Disorders: Addictions and other Mental Disorders is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net

The 1st World Congress of the World Association on Dual Disorders (WADD) & 5th International Congress on Dual Disorders: Addictions and other Mental Disorders is designated for a maximum of, or up to, 17 European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

11 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

American Medical Association (AMA) Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/ internationalcme

Royal​ College of Physicians and Surgeons of Canada Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME ​for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca ​ ​

Disclosure and Resolution of Personal Conflicts of Interest In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

Disclosure information is available on the event website and also posted on the notice board in the registration area.

SOCIAL ACTIVITIES

WELCOME COCKTAIL: Thursday 23rd March from 19:00 to 20:00. The Congress Organization would like to invite all attendants in order to exchange opinions and experiences. The Welcome Cocktail will take place in the Poster and Exhibition Area of the Congress Venue.

NETWORKING EVENING: Saturday 25th March from 20:30 “Fundación Patología Dual” invites you to participate in their Networking Evening at Real Café in Santiago Bernabeu Stadium to share with your colleagues all about the Congress in a more relaxed atmosphere. Tickets can be obtained at the Congress Secretariat.

12 23 - 26 March, 2017 Madrid - Spain

INFORMATION FOR PRESENTERS

WORKSHOPS 45 minutes session: Depending on the number of presenters, each can have 15 minutes maximum (2 presenters’ session) for their presentation. We strongly recommend a discussion time of at least one third of the total time of the session taking place at the end of all interventions.

SYMPOSIA 90 minutes session: Each presenter will have 20 minutes maximum (3 presenters’ sessions) for their presentation. (IV Congresso Ibero-Brasileiro de Patologia Dual: symposia of 60 minutes) We strongly recommend a discussion time of at least one third of the total time of the session taking place at the end of all interventions.

ORAL PRESENTATIONS 90 minutes sessions: Depending on the number of presenters, the time allotted to each presenter will be 7 minutes maximum, followed by 2 minutes for discussion.

POSTER PRESENTATION Each author/presenter will be responsible of carrying, placing and removing their poster. The Organization is not responsible for any damages that may occur if the poster is not removed at the times indicated. Dimensions: 0.90 m wide x 1.20 m tall (PORTRAIT) Weight: It is recommended to use light cardboard or consistent paper easy to handle. Design: Free. Text and illustrations should be legible from a 2 meters distance.

13 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

THURSDAY MARCH 23, 2017

ROOM ROOM ROOM ROOM EL ROOM EL ROOM AUDITORIUM CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR ROOM ESCUDO

11:00 - 11:30

11:30 - 12:00 Dual Disorders Course for Psychiatry Residents: 12:00 - 12:30 Integrating Mental Health IV Congresso (Curso de Patología Ibero-Brasileiro de 12:30 - 13:00 Dual para Residentes de Patologia Dual Psiquiatria: Integrando la Salud Mental) 13:00 - 13:30

13:30 - 14:00

Presentation Ceremony of IV Congresso 14:00 - 14:30 Ibero-Brasileiro de Patologia Dual

14:30 - 15:00

15:00 - 15:30 SEPD Assembly SEPD Members only 15:30 - 16:00

ML01 Flashbacks and HPPD (Hallucinogenic SY02 Emerging Persisting Perception SY01 Evolution of SY03 New SY04 Cognitive and 16:00 - 16:45 perspectives for Disorder): Clinical comprehensive technologies in functional impairments SY05 Let´s talk SY06 Anthropology of improved treatments aspects and programs for diagnosis and and Dual Disorders: about chemsex: A drugs: From indigenous of Dual Disorders: pharmacological physicians with treatment of Dual Update. Can we do multidisciplinary approach societies to our days From the bench to the treatment Dual Disorders Disorders something earlier? bedside IV Congresso Ibero- ML02 Culture and Brasileiro de Patologia 16:45 - 17:30 Dual Disorders Dual

WS01 On the origins of Dual Disorders: 17:30 - 18:15 PS01 Focusing on Neuroscience of Dual Disorders: DF01 addiction vulnerability Best Poster Presentations Current outlooks and Multicomponent in mental illness SY08 Drugs for use in future perspectives treatment in conditions different to SY07 Translational adolescent those authorized in Dual OC01 Oral 18:15 - 18:30 neuropsychopharmacology WS02 Female Dual Disorders: Disorders: Consensus of Communications in Dual Disorders impulsivity, internet Integrating different addiction and the SEPD therapeutic hallucinogenic Invitation only strategies persisting perception 18:30 - 19:00 disorder: Different perspectives of Dual Disorders

WELCOME COCKTAIL WELCOME COCKTAIL 19:00 - 20:00 Congress Venue Congress Venue

14 23 - 26 March, 2017 Madrid - Spain

THURSDAY MARCH 23, 2017

ROOM ROOM ROOM ROOM EL ROOM EL ROOM AUDITORIUM CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR ROOM ESCUDO

11:00 - 11:30

11:30 - 12:00 Dual Disorders Course for Psychiatry Residents: 12:00 - 12:30 Integrating Mental Health IV Congresso (Curso de Patología Ibero-Brasileiro de 12:30 - 13:00 Dual para Residentes de Patologia Dual Psiquiatria: Integrando la Salud Mental) 13:00 - 13:30

13:30 - 14:00

Presentation Ceremony of IV Congresso 14:00 - 14:30 Ibero-Brasileiro de Patologia Dual

14:30 - 15:00

15:00 - 15:30 SEPD Assembly SEPD Members only 15:30 - 16:00

ML01 Flashbacks and HPPD (Hallucinogenic SY02 Emerging Persisting Perception SY01 Evolution of SY03 New SY04 Cognitive and 16:00 - 16:45 perspectives for Disorder): Clinical comprehensive technologies in functional impairments SY05 Let´s talk SY06 Anthropology of improved treatments aspects and programs for diagnosis and and Dual Disorders: about chemsex: A drugs: From indigenous of Dual Disorders: pharmacological physicians with treatment of Dual Update. Can we do multidisciplinary approach societies to our days From the bench to the treatment Dual Disorders Disorders something earlier? bedside IV Congresso Ibero- ML02 Culture and Brasileiro de Patologia 16:45 - 17:30 Dual Disorders Dual

WS01 On the origins of Dual Disorders: 17:30 - 18:15 PS01 Focusing on Neuroscience of Dual Disorders: DF01 addiction vulnerability Best Poster Presentations Current outlooks and Multicomponent in mental illness SY08 Drugs for use in future perspectives treatment in conditions different to SY07 Translational adolescent those authorized in Dual OC01 Oral 18:15 - 18:30 neuropsychopharmacology WS02 Female Dual Disorders: Disorders: Consensus of Communications in Dual Disorders impulsivity, internet Integrating different addiction and the SEPD therapeutic hallucinogenic Invitation only strategies persisting perception 18:30 - 19:00 disorder: Different perspectives of Dual Disorders

WELCOME COCKTAIL WELCOME COCKTAIL 19:00 - 20:00 Congress Venue Congress Venue

15 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

FRIDAY MARCH 24, 2017

ROOM ROOM ROOM ROOM EL ROOM ROOM AUDITORIUM CASTILLA HIDALGO DOBLÓN ESCORIAL ROOM EL JARDÍN COMENDADOR ESCUDO

ML03 Schizophrenia and co-occurring WS03 Dealing with new 08:30 - 09:15 substance use SY10 Disentangling designer drugs: The current disorders: Translational DF02 Behavioral concurrent mental SY11 Neurocognition in Dual challenge SY09 Opioid use and OC02 Oral research and reward addictions and Dual health and stimulant Disorders - Implications and SY12 Drug misuse in old age Dual Disorders Communications Disorders use disorders: Clinically assessment in clinical practice WS04 The use of the ML04 Precision relevant research Psychopathy Checklist-Revised 09:15 - 10:00 medicine in psychiatry (PCL-R) in drug abuse research and Dual Disorders and treatment settings

SATELLITE Workshop Industry Session not included 10:00 - 10:45 SATELLITE SATELLITE Symposium Symposium SATELLITE Symposium in official scientific programme Industry Session not Industry Session not Industry Session not included CME/CPD included in official included in official in official scientific programme SATELLITE Symposium scientific programme scientific programme CME/CPD Industry Session not included 10:45 - 11:30 CME/CPD CME/CPD in official scientific programme CME/CPD

11:30 - 12:00 COFFEE BREAK COFFEE BREAK 12:00 - 12:30 SATELLITE SATELLITE SATELLITE SATELLITE Symposium Symposium Symposium Symposium SATELLITE Symposium Industry Session not included 12:30 - 13:00 Industry Session not Industry Session not Industry Session not Industry Session not included in official scientific programme included in official included in official included in official in official scientific programme CME/CPD scientific programme scientific programme scientific programme CME/CPD 13:00 - 13:30 CME/CPD CME/CPD CME/CPD

13:30 - 14:00 OPENING CEREMONY OPENING CEREMONY 14:00 - 15:00 LUNCH BREAK LUNCH BREAK 15:00 - 16:00 PS02 Effects of cannabis use on human behavior and mental disorders(Auditorium) PS02 Effects of cannabis use on human behavior and mental disorders(Auditorium) 16:00 - 16:30 Ask the expert: NIDA Director Dr Volkow (Auditorium) Ask the expert: NIDA Director Dr Volkow (Auditorium)

SY14 Understanding WS05 Relapse: A consequence ML05 Behavioral the importance of of altered executive functions 16:30 - 17:15 addictions in bipolar SY16 Is emotional lability the DF03 Forum of state versus trait due to hypofunctionality of the disorder SY13 Treatment of Dual link between attention deficit European Federation anhedonia: Examining SY15 Gambling and Dual frontal lobe OC03 Oral Disorders in youth: hyperactivity disorder (ADHD) of Psychiatric Trainees a neurobiological link Disorders Communications Updates and substance use disorder ML06 Bipolar disorders (EFPT) between depression, WS06 Learning how to improve 17:15 - 18:00 (SUD)? and cannabis ADHD and substance resilience from mental health abuse

18:00 - 18:30 COFFEE BREAK COFFEE BREAK ML07 Top down and bottom up: Emerging WS07 Housing First for concepts in the homeless population 18:30 - 19:15 treatment of addictions with mental health and other mental issues SY18 New challenges in DF04 Attention deficit the management of Dual SY20 Cognitive and functional disorders SY19 Women who use drugs: SY17 Tools for Dual hyperactivity disorder Disorders within Latin America impairment in patients with OC04 Oral Comorbidities and social WS08 Co-occurrence Disorders and substance use collaboration framework: Fetal Spectrum Communications consequences of substance use disorders Controversies on the use of Disorders (FASD) ML08 Testing the drug and eating disorders: cannabis 19:15 - 20:00 substitution (switching An approach to the addiction) hypothesis adolescent patient in the context of family centered care

16 23 - 26 March, 2017 Madrid - Spain

FRIDAY MARCH 24, 2017

ROOM ROOM ROOM ROOM EL ROOM ROOM AUDITORIUM CASTILLA HIDALGO DOBLÓN ESCORIAL ROOM EL JARDÍN COMENDADOR ESCUDO

ML03 Schizophrenia and co-occurring WS03 Dealing with new 08:30 - 09:15 substance use SY10 Disentangling designer drugs: The current disorders: Translational DF02 Behavioral concurrent mental SY11 Neurocognition in Dual challenge SY09 Opioid use and OC02 Oral research and reward addictions and Dual health and stimulant Disorders - Implications and SY12 Drug misuse in old age Dual Disorders Communications Disorders use disorders: Clinically assessment in clinical practice WS04 The use of the ML04 Precision relevant research Psychopathy Checklist-Revised 09:15 - 10:00 medicine in psychiatry (PCL-R) in drug abuse research and Dual Disorders and treatment settings

SATELLITE Workshop Industry Session not included 10:00 - 10:45 SATELLITE SATELLITE Symposium Symposium SATELLITE Symposium in official scientific programme Industry Session not Industry Session not Industry Session not included CME/CPD included in official included in official in official scientific programme SATELLITE Symposium scientific programme scientific programme CME/CPD Industry Session not included 10:45 - 11:30 CME/CPD CME/CPD in official scientific programme CME/CPD

11:30 - 12:00 COFFEE BREAK COFFEE BREAK 12:00 - 12:30 SATELLITE SATELLITE SATELLITE SATELLITE Symposium Symposium Symposium Symposium SATELLITE Symposium Industry Session not included 12:30 - 13:00 Industry Session not Industry Session not Industry Session not Industry Session not included in official scientific programme included in official included in official included in official in official scientific programme CME/CPD scientific programme scientific programme scientific programme CME/CPD 13:00 - 13:30 CME/CPD CME/CPD CME/CPD

13:30 - 14:00 OPENING CEREMONY OPENING CEREMONY 14:00 - 15:00 LUNCH BREAK LUNCH BREAK 15:00 - 16:00 PS02 Effects of cannabis use on human behavior and mental disorders(Auditorium) PS02 Effects of cannabis use on human behavior and mental disorders(Auditorium) 16:00 - 16:30 Ask the expert: NIDA Director Dr Volkow (Auditorium) Ask the expert: NIDA Director Dr Volkow (Auditorium)

SY14 Understanding WS05 Relapse: A consequence ML05 Behavioral the importance of of altered executive functions 16:30 - 17:15 addictions in bipolar SY16 Is emotional lability the DF03 Forum of state versus trait due to hypofunctionality of the disorder SY13 Treatment of Dual link between attention deficit European Federation anhedonia: Examining SY15 Gambling and Dual frontal lobe OC03 Oral Disorders in youth: hyperactivity disorder (ADHD) of Psychiatric Trainees a neurobiological link Disorders Communications Updates and substance use disorder ML06 Bipolar disorders (EFPT) between depression, WS06 Learning how to improve 17:15 - 18:00 (SUD)? and cannabis ADHD and substance resilience from mental health abuse

18:00 - 18:30 COFFEE BREAK COFFEE BREAK ML07 Top down and bottom up: Emerging WS07 Housing First for concepts in the homeless population 18:30 - 19:15 treatment of addictions with mental health and other mental issues SY18 New challenges in DF04 Attention deficit the management of Dual SY20 Cognitive and functional disorders SY19 Women who use drugs: SY17 Tools for Dual hyperactivity disorder Disorders within Latin America impairment in patients with OC04 Oral Comorbidities and social WS08 Co-occurrence Disorders and substance use collaboration framework: Fetal Alcohol Spectrum Communications consequences of substance use disorders Controversies on the use of Disorders (FASD) ML08 Testing the drug and eating disorders: cannabis 19:15 - 20:00 substitution (switching An approach to the addiction) hypothesis adolescent patient in the context of family centered care

17 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

SATURDAY MARCH 25, 2017

ROOM ROOM ROOM ROOM EL ROOM EL ROOM AUDITORIUM CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR ROOM ESCUDO

WS09 Hypersexual ML09 Dual Disorders 08:30 - 09:15 disorder as Dual Disorder: and SY22 Treatment of SY21 C-Flex - A comorbid substance Diagnosis and treatment cultural game changer. use disorders and SY24 Relevance of the SY25 Perspective of the ML10 Diagnosis SY23 Lifecourse Effects of working bipolar disorder: Time mental disorders among addictive disorder in the OC05 Oral and treatment of epidemiology of Dual assertive outreach to tailor effective cocaine dependent Latin American population Communications attention deficit Disorders WS10 Getting ready for the 09:15 - 10:00 hyperactivity disorder with Dual Disorders interventions based on patients across the lifespan change; stop smoking in and substance use patients clinical epidemiology the severe mental disorder disorder: What does and affective profiles the literature tell us?

ML11 Psychiatric WS11 Update on outcomes of cannabis pathological gambling 10:00 - 10:45 use - why don't we SY27 Does and Dual Disorders have a simple answer methylphenidate DF05 WADD management to a "simple" question? SY26 Dual Disorders: monotherapy increase SY28 Cutting the grass: Forum. Dual SY29 Depressive Is everything risk of mania in Limitations of the current OC06 Oral ML12 Examining the Disorders, a world disorders and co-occurring association between determined during patients with bipolar meassurements of Communications prespectiveWADD substance use disorder WS12 Neurobiological attention deficit childhood? disorder and attention cannabis use Members and public aspects of “non-invasive” 10:45 - 11:30 hyperactivity disorder deficit hyperactivity neuromodulation and and substance use disorder? research in Dual Disorders disorders: A familial risk analysis

11:30 - 12:00 COFFEE BREAK (Best Poster Award Winners) COFFEE BREAK (Best Poster Award Winners)

12:00 - 12:45 SATELLITE SATELLITE SATELLITE Symposium SATELLITE Symposium Symposium Industry Symposium Industry Industry Session not Industry Session not Session not included Session not included included in official scientific included in official scientific 12:45 - 13:30 in official scientific in official scientific programme CME/CPD programme CME/CPD programme CME/CPD programme CME/CPD

13:30 - 14:30 LUNCH BREAK LUNCH BREAK

ML13 Evolutionary WS13 Interdisciplinary psychopathology: An SY30 The 14:30 - 15:15 SY31 Current situation SY32 Dual Disorders SY34 New horizons of work in the HPFBA dual integrative treatment in Epidemiology of Dual SY33 Management of New Psychoactive in Asia: Experience PAIME (Sick doctors clinic Dual Disorders Disorders: Science of patients in daily OC07 Oral Substances (NPS), of drug dependence program): A good practice ML14 Management to inform clinicians clinical practice – Communications psychopharmacology treatment centers in of medical deontology is WS14 Small world and of substance use working in a shifting SOCIDROGALCOHOL 15:15 - 16:00 and psychopathology Vietnam exported scale free networks in Dual and bipolar disorders social landscape Disorders comorbidity

ML15 New findings in SY36 Novel SY37 New 16:00 - 16:45 SY40 Forensic opioid use disorders psychoactive perspectives on the neuropsychiatry and substances and mental treatment of Dual SY38 Dual Disorders SY35 Dual Disorders SY39 Harm reduction and neurocrime applied to the OC08 Oral ML16 Addictive-like health; evidence and Disorders: Integrative as determinants of HIV and neuroscience Dual Disorders study of violent, criminal Communications behavior induced recommendations for care and contingency infection and progression 16:45 - 17:30 and corrupt behavior and by palatable food: research and service management in clinical substance use Neurobiological bases provision practice

SY42 A collaborative WS15 Presentation of PS03 Toward a specific model for persons with the Child and Adolescent 17:30 - 18:15 psychopathology concurrent substance Working Group of the SY41 Substance SY44 Dual Disorders, of substance use use disorders and SEPD SY43 Dual Disorders in consumption and case reports and new OC09 Oral disorders mental illness. patients with diabetes and development of therapeutic experiences: Communications 18:15 - 18:30 Description of the co-morbid viral infections suicidal behavior WS16 Dual Disorders in Mindfulness model and results from prison. Past, present and 18:30 - 19:00 the evaluation of the future model

18 23 - 26 March, 2017 Madrid - Spain

SATURDAY MARCH 25, 2017

ROOM ROOM ROOM ROOM EL ROOM EL ROOM AUDITORIUM CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR ROOM ESCUDO

WS09 Hypersexual ML09 Dual Disorders 08:30 - 09:15 disorder as Dual Disorder: and suicide SY22 Treatment of SY21 C-Flex - A comorbid substance Diagnosis and treatment cultural game changer. use disorders and SY24 Relevance of the SY25 Perspective of the ML10 Diagnosis SY23 Lifecourse Effects of working bipolar disorder: Time mental disorders among addictive disorder in the OC05 Oral and treatment of epidemiology of Dual assertive outreach to tailor effective cocaine dependent Latin American population Communications attention deficit Disorders WS10 Getting ready for the 09:15 - 10:00 hyperactivity disorder with Dual Disorders interventions based on patients across the lifespan change; stop smoking in and substance use patients clinical epidemiology the severe mental disorder disorder: What does and affective profiles the literature tell us?

ML11 Psychiatric WS11 Update on outcomes of cannabis pathological gambling 10:00 - 10:45 use - why don't we SY27 Does and Dual Disorders have a simple answer methylphenidate DF05 WADD management to a "simple" question? SY26 Dual Disorders: monotherapy increase SY28 Cutting the grass: Forum. Dual SY29 Depressive Is everything risk of mania in Limitations of the current OC06 Oral ML12 Examining the Disorders, a world disorders and co-occurring association between determined during patients with bipolar meassurements of Communications prespectiveWADD substance use disorder WS12 Neurobiological attention deficit childhood? disorder and attention cannabis use Members and public aspects of “non-invasive” 10:45 - 11:30 hyperactivity disorder deficit hyperactivity neuromodulation and and substance use disorder? research in Dual Disorders disorders: A familial risk analysis

11:30 - 12:00 COFFEE BREAK (Best Poster Award Winners) COFFEE BREAK (Best Poster Award Winners)

12:00 - 12:45 SATELLITE SATELLITE SATELLITE Symposium SATELLITE Symposium Symposium Industry Symposium Industry Industry Session not Industry Session not Session not included Session not included included in official scientific included in official scientific 12:45 - 13:30 in official scientific in official scientific programme CME/CPD programme CME/CPD programme CME/CPD programme CME/CPD

13:30 - 14:30 LUNCH BREAK LUNCH BREAK

ML13 Evolutionary WS13 Interdisciplinary psychopathology: An SY30 The 14:30 - 15:15 SY31 Current situation SY32 Dual Disorders SY34 New horizons of work in the HPFBA dual integrative treatment in Epidemiology of Dual SY33 Management of New Psychoactive in Asia: Experience PAIME (Sick doctors clinic Dual Disorders Disorders: Science of patients in daily OC07 Oral Substances (NPS), of drug dependence program): A good practice ML14 Management to inform clinicians clinical practice – Communications psychopharmacology treatment centers in of medical deontology is WS14 Small world and of substance use working in a shifting SOCIDROGALCOHOL 15:15 - 16:00 and psychopathology Vietnam exported scale free networks in Dual and bipolar disorders social landscape Disorders comorbidity

ML15 New findings in SY36 Novel SY37 New 16:00 - 16:45 SY40 Forensic opioid use disorders psychoactive perspectives on the neuropsychiatry and substances and mental treatment of Dual SY38 Dual Disorders SY35 Dual Disorders SY39 Harm reduction and neurocrime applied to the OC08 Oral ML16 Addictive-like health; evidence and Disorders: Integrative as determinants of HIV and neuroscience Dual Disorders study of violent, criminal Communications behavior induced recommendations for care and contingency infection and progression 16:45 - 17:30 and corrupt behavior and by palatable food: research and service management in clinical substance use Neurobiological bases provision practice

SY42 A collaborative WS15 Presentation of PS03 Toward a specific model for persons with the Child and Adolescent 17:30 - 18:15 psychopathology concurrent substance Working Group of the SY41 Substance SY44 Dual Disorders, of substance use use disorders and SEPD SY43 Dual Disorders in consumption and case reports and new OC09 Oral disorders mental illness. patients with diabetes and development of therapeutic experiences: Communications 18:15 - 18:30 Description of the co-morbid viral infections suicidal behavior WS16 Dual Disorders in Mindfulness model and results from prison. Past, present and 18:30 - 19:00 the evaluation of the future model

19 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

SUNDAY MARCH 26, 2017

ROOM ROOM ROOM EL ROOM EL ROOM ROOM AUDITORIUM CASTILLA DOBLÓN ESCORIAL JARDÍN COMENDADOR ESCUDO

WS17 Transition to severe mental disorder 08:30 - 09:15 SY47 Clinical and SY46 A better life: and substance misuse in ethical aspects Narratives and research first psychotic episodes SY45 Integrated care of using coercive on recovery in persons DF06 Debate Forum OC10 Oral pathways (ICP) in mental strategies in the living with concurrent of Nurses Communications health and addictions management of substance abuse and WS18 The role of the patients with Dual mental health disorders emergency care in the 09:15 - 10:00 Disorders evaluation and treatment of Dual Disorders

WS19 Analysis of a sample of patients with high dose methadone: 10:00 - 10:45 An aproximation to SY51 Questionnaire interindividual differences SY48 Socio-cultural on spirituality in in methadone doses in aspects of Dual Disorders SY49 Cannabis, SY50 Forensic dual patients in drug OC11 Oral opioid agonist treatments in the diversed Israeli schizophrenia and beyond psychiatry dependence centers. Communications society Design and clinical application ML17 Implementing a low WS20 Drug-induced resource intervention for 10:45 - 11:30 psychosis: A distinct Dual Disorders for Latino entity? immigrant populations

WS21 Attention to institutional impact on long-term inpatient ML18 Cocaine psychosis: 11:30 - 12:15 SY54 Disordered treatment programs What is new? gambling and SY55 Rational use of for Dual Disorders: SY52 International Latino SY53 Dual Disorders in schizophrenia: psychotropic drugs in Example of a therapeutic Research Partnership - OC12 Oral Argentina: Diagnoses and Predictors of relapse, the approach of Dual community Evidence based treatment Communications resources cognitive biases and Disorders in Huelva for Dual Disorders reciprocal associations province ML19 A new way of of Dual Disorders thinking Dual Disorders. 12:15 - 13:00 Book Presentation Opioid system and mental disorders

20 23 - 26 March, 2017 Madrid - Spain

SUNDAY MARCH 26, 2017

ROOM ROOM ROOM EL ROOM EL ROOM ROOM AUDITORIUM CASTILLA DOBLÓN ESCORIAL JARDÍN COMENDADOR ESCUDO

WS17 Transition to severe mental disorder 08:30 - 09:15 SY47 Clinical and SY46 A better life: and substance misuse in ethical aspects Narratives and research first psychotic episodes SY45 Integrated care of using coercive on recovery in persons DF06 Debate Forum OC10 Oral pathways (ICP) in mental strategies in the living with concurrent of Nurses Communications health and addictions management of substance abuse and WS18 The role of the patients with Dual mental health disorders emergency care in the 09:15 - 10:00 Disorders evaluation and treatment of Dual Disorders

WS19 Analysis of a sample of patients with high dose methadone: 10:00 - 10:45 An aproximation to SY51 Questionnaire interindividual differences SY48 Socio-cultural on spirituality in in methadone doses in aspects of Dual Disorders SY49 Cannabis, SY50 Forensic dual patients in drug OC11 Oral opioid agonist treatments in the diversed Israeli schizophrenia and beyond psychiatry dependence centers. Communications society Design and clinical application ML17 Implementing a low WS20 Drug-induced resource intervention for 10:45 - 11:30 psychosis: A distinct Dual Disorders for Latino entity? immigrant populations

WS21 Attention to institutional impact on long-term inpatient ML18 Cocaine psychosis: 11:30 - 12:15 SY54 Disordered treatment programs What is new? gambling and SY55 Rational use of for Dual Disorders: SY52 International Latino SY53 Dual Disorders in schizophrenia: psychotropic drugs in Example of a therapeutic Research Partnership - OC12 Oral Argentina: Diagnoses and Predictors of relapse, the approach of Dual community Evidence based treatment Communications resources cognitive biases and Disorders in Huelva for Dual Disorders reciprocal associations province ML19 A new way of of Dual Disorders thinking Dual Disorders. 12:15 - 13:00 Book Presentation Opioid system and mental disorders

21 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

JUEVES 23 DE MARZO DE 2017

SALA SALA SALA SALA EL SALA EL SALA AUDITORIO SALA ESCUDO CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR

11:00 - 11:30

11:30 - 12:00

Curso de Patología Dual 12:00 - 12:30 IV Congresso para Residentes de Ibero- Brasileiro de Psiquiatria: Integrando la Patologia Dual 12:30 - 13:00 Salud Mental

13:00 - 13:30

13:30 - 14:00

Ceremonia de Presentación del IV 14:00 - 14:30 Congresso Ibero-Brasileiro de Patologia Dual

14:30 - 15:00

15:00 - 15:30 ASAMBLEA SEPD Solo miembros SEPD 15:30 - 16:00

ML01 Flashbacks y HPPD (Trastorno Perceptivo Hallucinogénico SY01 Evolución SY02 Perspectivas 16:00 - 16:45 SY03 Nuevas SY04 Deterioro cognitivo SY06 Antropología de Persistente): de los programas emergentes para SY05 Hablemos de tecnologías en y funcional y Patología las drogas: desde las aspectos clínicos integrales para tratamientos chemsex: un enfoque Patología Dual y su Dual: una realidad. ¿Se sociedades indígenas y tratamiento médicos con mejorados de multidisciplinario tratamiento puede hacer algo antes? hasta nuestros días farmacológico Patología Dual Patología Dual

ML02 Cultura y 16:45 - 17:30 Patología Dual IV Congresso Ibero- Brasileiro de Patologia WS01 Sobre los Dual orígenes de la Patología Dual: Enfoque en 17:30 - 18:15 PS01 neurociencia de la Patología Dual: vulnerabilidad de Presentación de los perspectivas actuales mejores posters DF01 Tratamiento la adicción en la SY08 Medicamentos y futuras multicomponente enfermedad mental para uso en condiciones SY07 en Patología Dual diferentes a las Neuropsicofarmacología OC01 Comunicaciones en adolescentes: autorizadas en Patología 18:15 - 18:30 traslacional en WS02 Impulsividad Orales integración de Dual: consenso de la Patología Dual femenina, adicción a diferentes estrategias Internet y trastorno SEPD terapéuticas persistente de Solo por invitación la percepción 18:30 - 19:00 alucinógena: diferentes perspectivas de la Patología Dual

CÓCTEL DE BIENVENIDA CÓCTEL DE BIENVENIDA 19:00 - 20:00 Sede del Congreso Sede del Congreso

22 23 - 26 March, 2017 Madrid - Spain

JUEVES 23 DE MARZO DE 2017

SALA SALA SALA SALA EL SALA EL SALA AUDITORIO SALA ESCUDO CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR

11:00 - 11:30

11:30 - 12:00

Curso de Patología Dual 12:00 - 12:30 IV Congresso para Residentes de Ibero- Brasileiro de Psiquiatria: Integrando la Patologia Dual 12:30 - 13:00 Salud Mental

13:00 - 13:30

13:30 - 14:00

Ceremonia de Presentación del IV 14:00 - 14:30 Congresso Ibero-Brasileiro de Patologia Dual

14:30 - 15:00

15:00 - 15:30 ASAMBLEA SEPD Solo miembros SEPD 15:30 - 16:00

ML01 Flashbacks y HPPD (Trastorno Perceptivo Hallucinogénico SY01 Evolución SY02 Perspectivas 16:00 - 16:45 SY03 Nuevas SY04 Deterioro cognitivo SY06 Antropología de Persistente): de los programas emergentes para SY05 Hablemos de tecnologías en y funcional y Patología las drogas: desde las aspectos clínicos integrales para tratamientos chemsex: un enfoque Patología Dual y su Dual: una realidad. ¿Se sociedades indígenas y tratamiento médicos con mejorados de multidisciplinario tratamiento puede hacer algo antes? hasta nuestros días farmacológico Patología Dual Patología Dual

ML02 Cultura y 16:45 - 17:30 Patología Dual IV Congresso Ibero- Brasileiro de Patologia WS01 Sobre los Dual orígenes de la Patología Dual: Enfoque en 17:30 - 18:15 PS01 neurociencia de la Patología Dual: vulnerabilidad de Presentación de los perspectivas actuales mejores posters DF01 Tratamiento la adicción en la SY08 Medicamentos y futuras multicomponente enfermedad mental para uso en condiciones SY07 en Patología Dual diferentes a las Neuropsicofarmacología OC01 Comunicaciones en adolescentes: autorizadas en Patología 18:15 - 18:30 traslacional en WS02 Impulsividad Orales integración de Dual: consenso de la Patología Dual femenina, adicción a diferentes estrategias Internet y trastorno SEPD terapéuticas persistente de Solo por invitación la percepción 18:30 - 19:00 alucinógena: diferentes perspectivas de la Patología Dual

CÓCTEL DE BIENVENIDA CÓCTEL DE BIENVENIDA 19:00 - 20:00 Sede del Congreso Sede del Congreso

23 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

VIERNES 24 DE MARZO DE 2017

SALA SALA SALA SALA EL SALA EL SALA AUDITORIO CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR SALA ESCUDO

ML03 Esquizofrenia y trastornos coexistentes por el WS03 ¿Cómo enfrentarse 08:30 - 09:15 uso de sustancias: a las nuevas drogas de investigación SY10 Desccifrando los diseño? Un nuevo desafío trastornos concurrentes SY11 Neurocognición translacional y DF02 Adicciones SY09 Uso de opiáceos de salud mental y del en Patología Dual - SY12 Uso indebido de OC02 Comunicaciones recompensa comportamentales y y Patología Dual uso de estimulantes: Implicaciones y evaluación drogas en personas majores Orales Patología Dual investigación clínica en la práctica clínica WS04 El uso del Psychopathy Checklist- ML04 Medicina de relevante Revised (PCL-R) en la 09:15 - 10:00 precisión en psiquiatría investigación sobre el abuso y Patología Dual de drogas y en los ajustes de tratamiento Taller SATÉLITE Sesión de la industria no 10:00 - 10:45 Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE incluida en el programa Sesión de la industria Sesión de la industria Sesión de la industria no científico oficial CME / CPD no incluida en el no incluida en el incluida en el programa programa científico programa científico científico oficial Simposio SATÉLITE Sesión de la industria no 10:45 - 11:30 oficial CME / CPD oficial CME / CPD CME / CPD incluida en el programa científico oficial CME / CPD 11:30 - 12:00 PAUSA CAFÉ PAUSA CAFÉ 12:00 - 12:30 Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Sesión de la industria Sesión de la industria Sesión de la industria Sesión de la industria no Sesión de la industria no 12:30 - 13:00 no incluida en el no incluida en el no incluida en el incluida en el programa incluida en el programa programa científico programa científico programa científico científico oficial CME / CPD científico oficial CME / CPD 13:00 - 13:30 oficial CME / CPD oficial CME / CPD oficial CME / CPD 13:30 - 14:00 ACTO INSTITUCIONAL ACTO INSTITUCIONAL 14:00 - 15:00 PAUSA ALMUERZO PAUSA ALMUERZO PS02 Efectos del consumo de cannabis en el comportamiento humano y los trastornos mentales 15:00 - 16:00 PS02 Efectos del consumo de cannabis en el comportamiento humano y los trastornos mentales (Auditorio) (Auditorio) 16:00 - 16:30 Pregunte al experto: Directora de NIDA Dra. Volkow (Auditorio) Pregunte al experto: Directora de NIDA Dra. Volkow (Auditorio) SY14 Comprensión de la WS05 Recaída: una SY16 ¿Es labilidad emocional ML05 Adicciones importancia del estado vs. consecuencia de la alteración el vínculo entre el trastorno 16:30 - 17:15 comportamentales en el SY13 Tratamiento de la anhedonia de rasgos: de las funciones ejecutivas DF03 Foro Europeo de por déficit de atención e trastorno bipolar la Patología Dual en examinando un vínculo SY15 Juego y Patología Dual por la hipofuncionalidad del OC03 Comunicaciones Orales Residentes de Psiquiatría hiperactividad (TDAH) y jóvenes: actualizaciones neurobiológico entre la lóbulo frontal el trastorno por uso de ML06 Trastornos depresión, el TDAH y el WS06 Aprender a mejorar la 17:15 - 18:00 sustancias (SUD)? bipolares y cannabis abuso de sustancias resiliencia de la salud mental 18:00 - 18:30 PAUSA CAFÉ PAUSA CAFÉ ML07 Conceptos WS07 Housing First para emergentes en el la población sin hogar 18:30 - 19:15 tratamiento de las con problemas de salud adicciones y otros mental trastornos mentales SY18 Nuevos desafíos en el DF04 Trastorno por SY20 El deterioro cognitivo abordaje de la Patologia Dual, SY19 Mujeres que consumen WS08 Co-ocurrencia de SY17 Herramientas para déficit de atención e y funcional en pacientes en el marco de la cooperación drogas: comorbilidades y OC04 Comunicaciones Orales consumo de sustancias la Patología Dual hiperactividad y trastornos con trastornos del espectro Iberoamericana. Controversias consecuencias sociales ML08 Prueba de la y trastornos de la por uso de sustancias alcohólico fetal (FASD) hipótesis de sustitución alimentación: un enfoque sobre el uso del cannabis 19:15 - 20:00 de fármacos (cambio de al paciente adolescente adicción) en el contexto de la atención centrada en la familia

24 23 - 26 March, 2017 Madrid - Spain

VIERNES 24 DE MARZO DE 2017

SALA SALA SALA SALA EL SALA EL SALA AUDITORIO CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR SALA ESCUDO

ML03 Esquizofrenia y trastornos coexistentes por el WS03 ¿Cómo enfrentarse 08:30 - 09:15 uso de sustancias: a las nuevas drogas de investigación SY10 Desccifrando los diseño? Un nuevo desafío trastornos concurrentes SY11 Neurocognición translacional y DF02 Adicciones SY09 Uso de opiáceos de salud mental y del en Patología Dual - SY12 Uso indebido de OC02 Comunicaciones recompensa comportamentales y y Patología Dual uso de estimulantes: Implicaciones y evaluación drogas en personas majores Orales Patología Dual investigación clínica en la práctica clínica WS04 El uso del Psychopathy Checklist- ML04 Medicina de relevante Revised (PCL-R) en la 09:15 - 10:00 precisión en psiquiatría investigación sobre el abuso y Patología Dual de drogas y en los ajustes de tratamiento Taller SATÉLITE Sesión de la industria no 10:00 - 10:45 Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE incluida en el programa Sesión de la industria Sesión de la industria Sesión de la industria no científico oficial CME / CPD no incluida en el no incluida en el incluida en el programa programa científico programa científico científico oficial Simposio SATÉLITE Sesión de la industria no 10:45 - 11:30 oficial CME / CPD oficial CME / CPD CME / CPD incluida en el programa científico oficial CME / CPD 11:30 - 12:00 PAUSA CAFÉ PAUSA CAFÉ 12:00 - 12:30 Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Sesión de la industria Sesión de la industria Sesión de la industria Sesión de la industria no Sesión de la industria no 12:30 - 13:00 no incluida en el no incluida en el no incluida en el incluida en el programa incluida en el programa programa científico programa científico programa científico científico oficial CME / CPD científico oficial CME / CPD 13:00 - 13:30 oficial CME / CPD oficial CME / CPD oficial CME / CPD 13:30 - 14:00 ACTO INSTITUCIONAL ACTO INSTITUCIONAL 14:00 - 15:00 PAUSA ALMUERZO PAUSA ALMUERZO PS02 Efectos del consumo de cannabis en el comportamiento humano y los trastornos mentales 15:00 - 16:00 PS02 Efectos del consumo de cannabis en el comportamiento humano y los trastornos mentales (Auditorio) (Auditorio) 16:00 - 16:30 Pregunte al experto: Directora de NIDA Dra. Volkow (Auditorio) Pregunte al experto: Directora de NIDA Dra. Volkow (Auditorio) SY14 Comprensión de la WS05 Recaída: una SY16 ¿Es labilidad emocional ML05 Adicciones importancia del estado vs. consecuencia de la alteración el vínculo entre el trastorno 16:30 - 17:15 comportamentales en el SY13 Tratamiento de la anhedonia de rasgos: de las funciones ejecutivas DF03 Foro Europeo de por déficit de atención e trastorno bipolar la Patología Dual en examinando un vínculo SY15 Juego y Patología Dual por la hipofuncionalidad del OC03 Comunicaciones Orales Residentes de Psiquiatría hiperactividad (TDAH) y jóvenes: actualizaciones neurobiológico entre la lóbulo frontal el trastorno por uso de ML06 Trastornos depresión, el TDAH y el WS06 Aprender a mejorar la 17:15 - 18:00 sustancias (SUD)? bipolares y cannabis abuso de sustancias resiliencia de la salud mental 18:00 - 18:30 PAUSA CAFÉ PAUSA CAFÉ ML07 Conceptos WS07 Housing First para emergentes en el la población sin hogar 18:30 - 19:15 tratamiento de las con problemas de salud adicciones y otros mental trastornos mentales SY18 Nuevos desafíos en el DF04 Trastorno por SY20 El deterioro cognitivo abordaje de la Patologia Dual, SY19 Mujeres que consumen WS08 Co-ocurrencia de SY17 Herramientas para déficit de atención e y funcional en pacientes en el marco de la cooperación drogas: comorbilidades y OC04 Comunicaciones Orales consumo de sustancias la Patología Dual hiperactividad y trastornos con trastornos del espectro Iberoamericana. Controversias consecuencias sociales ML08 Prueba de la y trastornos de la por uso de sustancias alcohólico fetal (FASD) hipótesis de sustitución alimentación: un enfoque sobre el uso del cannabis 19:15 - 20:00 de fármacos (cambio de al paciente adolescente adicción) en el contexto de la atención centrada en la familia

25 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

SÁBADO 25 DE MARZO DE 2017

SALA SALA SALA SALA EL SALA EL SALA AUDITORIO CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR SALA ESCUDO

WS09 Trastorno hipersexual ML09 Patología Dual y 08:30 - 09:15 SY22 Tratamiento de como Patología Dual: suicidio trastornos comórbidos SY21 C-Flex - un diagnóstico y tratamiento por uso de sustancias cambiador cultural del SY24 Relevancia de los SY25 Perspectiva del ML10 Diagnóstico y y trastorno bipolar: SY23 Epidemiología juego. Efectos de la trastornos mentales entre trastorno adictivo en la OC05 Comunicaciones tratamiento del trastorno tiempo para adaptar del ciclo de vida de la asertividad en el trabajo los pacientes dependientes población latinoamericana Orales por déficit de atención intervenciones Patología Dual WS10 Preparándonos para con pacientes con de cocaína durante su vida 09:15 - 10:00 e hiperactividad y eficaces basadas en el cambio; dejar de fumar en Patología Dual trastorno por uso de epidemiología clínica y el trastorno mental grave sustancias: ¿qué nos perfiles afectivos dice la literatura? ML11 Resultados psiquiátricos por WS11 Tendencias actuales consumo de cannabis en el manejo integral del 10:00 - 10:45 - ¿por qué no tenemos SY27 ¿Aumenta la juego patológico y Patología una respuesta simple a monoterapia con Dual una pregunta "simple"? metilfenidato el DF05 Foro WADD. SY28 ¿Dónde cortar la SY26 Patología Dual: SY29 Trastornos depresivos riesgo de manía en Patología Dual, una hierba? Limitaciones de las OC06 Comunicaciones ML12 Examinando ¿Está todo determinado y trastornos por uso de la asociación pacientes con trastorno prespectiva mundial actuales mediciones del Orales durante la infancia? sustancias WS12 Aspectos entre trastorno por bipolar y trastorno por Socios WADD y público consumo de cannabis neurobiológicos, de déficit de atención déficit de atención e 10:45 - 11:30 neuromodulación “no e hiperactividad y hiperactividad? invasiva” y de investigación trastornos por uso de en Patología Dual sustancias: un análisis de riesgo familiar 11:30 - 12:00 PAUSA CAFÉ y ENTREGA DE PREMIOS PAUSA CAFÉ y ENTREGA DE PREMIOS 12:00 - 12:45 Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Sesión de la industria Sesión de la industria Sesión de la industria no Sesión de la industria no no incluida en el no incluida en el incluida en el programa incluida en el programa 12:45 - 13:30 programa científico programa científico científico oficial CME / CPD científico oficial CME / CPD oficial CME / CPD oficial CME / CPD 13:30 - 14:30 PAUSA ALMUERZO PAUSA ALMUERZO ML13 Psicopatología WS13 Trabajo evolutiva: un tratamiento SY30 Epidemiología SY31 Situación SY34 Nuevos horizontes 14:30 - 15:15 SY32 Patología Dual interdisciplinario en la integrador en Patología de la Patología Dual: la actual de las SY33 Manejo de del PAIME (Programa en Asia: experiencia de clínica dual HPFBA Dual ciencia para informar nuevas sustancias los pacientes en la de médicos enfermos): OC07 Comunicaciones centros de tratamiento ML14 Gestión del a los médicos que psicoactivas (NPS), práctica clínica diaria – exportación de una buena Orales de drogodependencias WS14 Reducidas redes y uso de sustancias trabajan en un ámbito psicofarmacología y SOCIDROGALCOHOL práctica de deontología 15:15 - 16:00 en Vietnam redes de escala libre en y comorbilidad de social cambiante psicopatología médica Patología Dual trastornos bipolares ML15 Nuevos hallazgos SY36 Nuevas SY37 Nuevas SY40 Neuropsiquiatría 16:00 - 16:45 en trastornos por uso de sustancias psicoactivas perspectivas sobre forense y neurocrimen opiáceos y salud mental; pruebas el tratamiento de la SY38 Patología Dual como SY35 Patología Dual y SY39 Reducción de daños y aplicados al estudio de la OC08 Comunicaciones y recomendaciones Patología Dual: atención determinante de la infección ML16 Comportamiento neurociencia Patología Dual conducta violenta, criminal Orales para la investigación integral y manejo de y progresión del VIH adictivo inducido por y corrupta y el consumo de 16:45 - 17:30 y la prestación de contingencias en la alimentos sabrosos: sustancias bases neurobiológicas servicios práctica clínica PS03 Hacia una SY42 Un modelo WS15 Presentación del 17:30 - 18:15 psicopatología colaborativo para Grupo de Trabajo Infantil y específica de los personas con trastornos Juvenil de la SEPD SY43 Patología Dual en SY44 Patología Dual, trastornos por uso de SY41 Consumo de concurrentes por pacientes con diabetes informes de casos y nuevas OC09 Comunicaciones 18:15 - 18:30 sustancias sustancias y desarrollo uso de sustancias y e infecciones virales experiencias terapéuticas: Orales de conductas suicidas enfermedad mental. WS16 Patología Dual en la comórbidas mindfulness Descripción del modelo cárcel. Pasado, presente 18:30 - 19:00 y resultados de la y futuro evaluación del modelo

26 23 - 26 March, 2017 Madrid - Spain

SÁBADO 25 DE MARZO DE 2017

SALA SALA SALA SALA EL SALA EL SALA AUDITORIO CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR SALA ESCUDO

WS09 Trastorno hipersexual ML09 Patología Dual y 08:30 - 09:15 SY22 Tratamiento de como Patología Dual: suicidio trastornos comórbidos SY21 C-Flex - un diagnóstico y tratamiento por uso de sustancias cambiador cultural del SY24 Relevancia de los SY25 Perspectiva del ML10 Diagnóstico y y trastorno bipolar: SY23 Epidemiología juego. Efectos de la trastornos mentales entre trastorno adictivo en la OC05 Comunicaciones tratamiento del trastorno tiempo para adaptar del ciclo de vida de la asertividad en el trabajo los pacientes dependientes población latinoamericana Orales por déficit de atención intervenciones Patología Dual WS10 Preparándonos para con pacientes con de cocaína durante su vida 09:15 - 10:00 e hiperactividad y eficaces basadas en el cambio; dejar de fumar en Patología Dual trastorno por uso de epidemiología clínica y el trastorno mental grave sustancias: ¿qué nos perfiles afectivos dice la literatura? ML11 Resultados psiquiátricos por WS11 Tendencias actuales consumo de cannabis en el manejo integral del 10:00 - 10:45 - ¿por qué no tenemos SY27 ¿Aumenta la juego patológico y Patología una respuesta simple a monoterapia con Dual una pregunta "simple"? metilfenidato el DF05 Foro WADD. SY28 ¿Dónde cortar la SY26 Patología Dual: SY29 Trastornos depresivos riesgo de manía en Patología Dual, una hierba? Limitaciones de las OC06 Comunicaciones ML12 Examinando ¿Está todo determinado y trastornos por uso de la asociación pacientes con trastorno prespectiva mundial actuales mediciones del Orales durante la infancia? sustancias WS12 Aspectos entre trastorno por bipolar y trastorno por Socios WADD y público consumo de cannabis neurobiológicos, de déficit de atención déficit de atención e 10:45 - 11:30 neuromodulación “no e hiperactividad y hiperactividad? invasiva” y de investigación trastornos por uso de en Patología Dual sustancias: un análisis de riesgo familiar 11:30 - 12:00 PAUSA CAFÉ y ENTREGA DE PREMIOS PAUSA CAFÉ y ENTREGA DE PREMIOS 12:00 - 12:45 Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Simposio SATÉLITE Sesión de la industria Sesión de la industria Sesión de la industria no Sesión de la industria no no incluida en el no incluida en el incluida en el programa incluida en el programa 12:45 - 13:30 programa científico programa científico científico oficial CME / CPD científico oficial CME / CPD oficial CME / CPD oficial CME / CPD 13:30 - 14:30 PAUSA ALMUERZO PAUSA ALMUERZO ML13 Psicopatología WS13 Trabajo evolutiva: un tratamiento SY30 Epidemiología SY31 Situación SY34 Nuevos horizontes 14:30 - 15:15 SY32 Patología Dual interdisciplinario en la integrador en Patología de la Patología Dual: la actual de las SY33 Manejo de del PAIME (Programa en Asia: experiencia de clínica dual HPFBA Dual ciencia para informar nuevas sustancias los pacientes en la de médicos enfermos): OC07 Comunicaciones centros de tratamiento ML14 Gestión del a los médicos que psicoactivas (NPS), práctica clínica diaria – exportación de una buena Orales de drogodependencias WS14 Reducidas redes y uso de sustancias trabajan en un ámbito psicofarmacología y SOCIDROGALCOHOL práctica de deontología 15:15 - 16:00 en Vietnam redes de escala libre en y comorbilidad de social cambiante psicopatología médica Patología Dual trastornos bipolares ML15 Nuevos hallazgos SY36 Nuevas SY37 Nuevas SY40 Neuropsiquiatría 16:00 - 16:45 en trastornos por uso de sustancias psicoactivas perspectivas sobre forense y neurocrimen opiáceos y salud mental; pruebas el tratamiento de la SY38 Patología Dual como SY35 Patología Dual y SY39 Reducción de daños y aplicados al estudio de la OC08 Comunicaciones y recomendaciones Patología Dual: atención determinante de la infección ML16 Comportamiento neurociencia Patología Dual conducta violenta, criminal Orales para la investigación integral y manejo de y progresión del VIH adictivo inducido por y corrupta y el consumo de 16:45 - 17:30 y la prestación de contingencias en la alimentos sabrosos: sustancias bases neurobiológicas servicios práctica clínica PS03 Hacia una SY42 Un modelo WS15 Presentación del 17:30 - 18:15 psicopatología colaborativo para Grupo de Trabajo Infantil y específica de los personas con trastornos Juvenil de la SEPD SY43 Patología Dual en SY44 Patología Dual, trastornos por uso de SY41 Consumo de concurrentes por pacientes con diabetes informes de casos y nuevas OC09 Comunicaciones 18:15 - 18:30 sustancias sustancias y desarrollo uso de sustancias y e infecciones virales experiencias terapéuticas: Orales de conductas suicidas enfermedad mental. WS16 Patología Dual en la comórbidas mindfulness Descripción del modelo cárcel. Pasado, presente 18:30 - 19:00 y resultados de la y futuro evaluación del modelo

27 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

DOMINGO 26 DE MARZO DE 2017

SALA SALA SALA EL SALA EL SALA AUDITORIO CASTILLA DOBLÓN ESCORIAL JARDÍN COMENDADOR SALA ESCUDO

WS17 Transición a trastorno mental grave y consumo 08:30 - 09:15 de sustancias en SY46 Una vida mejor: SY47 Aspectos primeros episodios narrativas e investigación clínicos y éticos del psicóticos SY45 Vías de atención sobre la recuperación en OC10 DF06 Foro de debate uso de estrategias integral en salud mental y personas que viven con Comunicaciones de Enfermeros coercitivas en el adicciones trastornos concurrentes Orales manejo de pacientes WS18 El papel de de abuso de sustancias y con Patología Dual los cuidados de de salud mental emergencia en 09:15 - 10:00 la evaluación y el tratamiento de la Patología Dual

WS19 Análisis de una muestra de pacientes en programa de mantenimiento con dosis altas de metadona: una 10:00 - 10:45 aproximación a las diferencias SY51 Cuestionario interindividuales SY48 Aspectos sobre espiritualidad en las dosis de OC11 socioculturales de la SY49 Cannabis, SY50 Psiquiatría en pacientes duales los tratamientos Comunicaciones Patología Dual en la esquizofrenia y más allá forense en centros de sustitutivos con Orales dispar sociedad israelí toxicomanía. Diseño y metadona aplicación clínica

ML17 Implementación de una intervención de WS20 La psicosis nivel bajo de recursos inducida por drogas: 10:45 - 11:30 para la Patología Dual ¿es una entidad en las poblaciones de distinta? inmigrantes latinos

WS21 Atención al impacto institucional sobre los programas ML18 Psicosis por SY54 Juego de tratamiento 11:30 - 12:15 cocaina: ¿qué hay de patológico y hospitalario a largo nuevo? SY52 Asociación esquizofrenia: SY55 Uso racional plazo de Patología Internacional Latina de SY53 Patología Dual en predictores de de los psicotrópicos OC12 Dual: ejemplo de una Investigación - tratamiento Argentina: diagnósticos y recaída, sesgos en el abordaje de la Comunicaciones comunidad terapéutica de Patología Dual basado recursos cognitivos y Patología Dual en la Orales en la evidencia asociaciones provincia de Huelva recíprocas de ML19 Una nueva forma Patología Dual de pensar en Patología 12:15 - 13:00 Presentación de libros Dual. Sistema opioide y trastornos mentales

28 23 - 26 March, 2017 Madrid - Spain

DOMINGO 26 DE MARZO DE 2017

SALA SALA SALA EL SALA EL SALA AUDITORIO CASTILLA DOBLÓN ESCORIAL JARDÍN COMENDADOR SALA ESCUDO

WS17 Transición a trastorno mental grave y consumo 08:30 - 09:15 de sustancias en SY46 Una vida mejor: SY47 Aspectos primeros episodios narrativas e investigación clínicos y éticos del psicóticos SY45 Vías de atención sobre la recuperación en OC10 DF06 Foro de debate uso de estrategias integral en salud mental y personas que viven con Comunicaciones de Enfermeros coercitivas en el adicciones trastornos concurrentes Orales manejo de pacientes WS18 El papel de de abuso de sustancias y con Patología Dual los cuidados de de salud mental emergencia en 09:15 - 10:00 la evaluación y el tratamiento de la Patología Dual

WS19 Análisis de una muestra de pacientes en programa de mantenimiento con dosis altas de metadona: una 10:00 - 10:45 aproximación a las diferencias SY51 Cuestionario interindividuales SY48 Aspectos sobre espiritualidad en las dosis de OC11 socioculturales de la SY49 Cannabis, SY50 Psiquiatría en pacientes duales los tratamientos Comunicaciones Patología Dual en la esquizofrenia y más allá forense en centros de sustitutivos con Orales dispar sociedad israelí toxicomanía. Diseño y metadona aplicación clínica

ML17 Implementación de una intervención de WS20 La psicosis nivel bajo de recursos inducida por drogas: 10:45 - 11:30 para la Patología Dual ¿es una entidad en las poblaciones de distinta? inmigrantes latinos

WS21 Atención al impacto institucional sobre los programas ML18 Psicosis por SY54 Juego de tratamiento 11:30 - 12:15 cocaina: ¿qué hay de patológico y hospitalario a largo nuevo? SY52 Asociación esquizofrenia: SY55 Uso racional plazo de Patología Internacional Latina de SY53 Patología Dual en predictores de de los psicotrópicos OC12 Dual: ejemplo de una Investigación - tratamiento Argentina: diagnósticos y recaída, sesgos en el abordaje de la Comunicaciones comunidad terapéutica de Patología Dual basado recursos cognitivos y Patología Dual en la Orales en la evidencia asociaciones provincia de Huelva recíprocas de ML19 Una nueva forma Patología Dual de pensar en Patología 12:15 - 13:00 Presentación de libros Dual. Sistema opioide y trastornos mentales

29 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

CONGRESS FLOOR PLAN

GROUND FLOOR (LEFT)

D A B C E

WC

WC N

E

GROUND FLOOR (RIGHT)

WC WC

G N F H I

J

ENTRANCE

30 23 - 26 March, 2017 Madrid - Spain

BASEMENT FLOOR (-1)

WC K L

M

WC ENTRANCE

A DOBLON H HIDALGO

B ESCUDO I VIP ROOM

C COMENDADOR J SPEAKERS PREVIEW ROOM

D TECHNICAL SECRETARIAT K ESCORIAL

E EXHIBITION AREA L JARDÍN

F AUDITORIUM M PRESS ROOM

G CASTILLA N POSTERS AREA

31

PROGRAMME THURSDAY

MARCH 23 THURSDAY 23

CONGRESS APP Navigate through the First World Congress of the World Association of Dual Disorders (WADD) & Fifth International Congress of the Spanish Society of Dual Disorders (SEPD) programme from your iPhone, iPad, and Android. View sessions by day and category, locate exhibitors and create your own itinerary to fully exploit your congress. http://www.icdd-congress.com/ scientific-information/app-mobile/ Use this code to unlock the APP if it is required: 85962

www.icdd-congress.com FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

THURSDAY MARCH 23, 2017

ROOM ROOM ROOM ROOM EL ROOM EL ROOM AUDITORIUM CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR ROOM ESCUDO

11:00 - 11:30

11:30 - 12:00 Dual Disorders Course for Psychiatry Residents:

THURSDAY 23 THURSDAY 12:00 - 12:30 Integrating Mental Health IV Congresso (Curso de Patología Ibero-Brasileiro de 12:30 - 13:00 Dual para Residentes de Patologia Dual Psiquiatria: Integrando la Salud Mental) 13:00 - 13:30

13:30 - 14:00

Presentation Ceremony of IV Congresso 14:00 - 14:30 Ibero-Brasileiro de Patologia Dual

14:30 - 15:00

15:00 - 15:30 SEPD Assembly SEPD Members only 15:30 - 16:00

ML01 Flashbacks and HPPD (Hallucinogenic SY02 Emerging Persisting Perception SY01 Evolution of SY03 New SY04 Cognitive and 16:00 - 16:45 perspectives for Disorder): Clinical comprehensive technologies in functional impairments SY05 Let´s talk SY06 Anthropology of improved treatments aspects and programs for diagnosis and and Dual Disorders: about chemsex: A drugs: From indigenous of Dual Disorders: pharmacological physicians with treatment of Dual Update. Can we do multidisciplinary approach societies to our days From the bench to the treatment Dual Disorders Disorders something earlier? bedside IV Congresso Ibero- ML02 Culture and Brasileiro de Patologia 16:45 - 17:30 Dual Disorders Dual

WS01 On the origins of Dual Disorders: 17:30 - 18:15 PS01 Focusing on Neuroscience of Dual Disorders: DF01 addiction vulnerability Best Poster Presentations Current outlooks and Multicomponent in mental illness SY08 Drugs for use in future perspectives treatment in conditions different to SY07 Translational adolescent those authorized in Dual OC01 Oral 18:15 - 18:30 neuropsychopharmacology WS02 Female Dual Disorders: Disorders: Consensus of Communications in Dual Disorders impulsivity, internet Integrating different addiction and the SEPD therapeutic hallucinogenic Invitation only strategies persisting perception 18:30 - 19:00 disorder: Different perspectives of Dual Disorders

WELCOME COCKTAIL WELCOME COCKTAIL 19:00 - 20:00 Congress Venue Congress Venue

34 23 - 26 March, 2017 Madrid - Spain

THURSDAY MARCH 23, 2017

ROOM ROOM ROOM ROOM EL ROOM EL ROOM AUDITORIUM CASTILLA HIDALGO DOBLÓN ESCORIAL JARDÍN COMENDADOR ROOM ESCUDO

11:00 - 11:30

11:30 - 12:00 Dual Disorders Course for Psychiatry Residents:

12:00 - 12:30 Integrating Mental Health IV Congresso 23 THURSDAY (Curso de Patología Ibero-Brasileiro de 12:30 - 13:00 Dual para Residentes de Patologia Dual Psiquiatria: Integrando la Salud Mental) 13:00 - 13:30

13:30 - 14:00

Presentation Ceremony of IV Congresso 14:00 - 14:30 Ibero-Brasileiro de Patologia Dual

14:30 - 15:00

15:00 - 15:30 SEPD Assembly SEPD Members only 15:30 - 16:00

ML01 Flashbacks and HPPD (Hallucinogenic SY02 Emerging Persisting Perception SY01 Evolution of SY03 New SY04 Cognitive and 16:00 - 16:45 perspectives for Disorder): Clinical comprehensive technologies in functional impairments SY05 Let´s talk SY06 Anthropology of improved treatments aspects and programs for diagnosis and and Dual Disorders: about chemsex: A drugs: From indigenous of Dual Disorders: pharmacological physicians with treatment of Dual Update. Can we do multidisciplinary approach societies to our days From the bench to the treatment Dual Disorders Disorders something earlier? bedside IV Congresso Ibero- ML02 Culture and Brasileiro de Patologia 16:45 - 17:30 Dual Disorders Dual

WS01 On the origins of Dual Disorders: 17:30 - 18:15 PS01 Focusing on Neuroscience of Dual Disorders: DF01 addiction vulnerability Best Poster Presentations Current outlooks and Multicomponent in mental illness SY08 Drugs for use in future perspectives treatment in conditions different to SY07 Translational adolescent those authorized in Dual OC01 Oral 18:15 - 18:30 neuropsychopharmacology WS02 Female Dual Disorders: Disorders: Consensus of Communications in Dual Disorders impulsivity, internet Integrating different addiction and the SEPD therapeutic hallucinogenic Invitation only strategies persisting perception 18:30 - 19:00 disorder: Different perspectives of Dual Disorders

WELCOME COCKTAIL WELCOME COCKTAIL 19:00 - 20:00 Congress Venue Congress Venue

35 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

11:00 - 14:00 Room El Escorial DUAL DISORDERS COURSE FOR PSYCHIATRY RESIDENTS: INTEGRATING MENTAL HEALTH (CURSO DE PATOLOGÍA DUAL PARA RESIDENTES DE PSIQUIATRIA: INTEGRANDO LA SALUD MENTAL)

CHAIRS: Gonzalo Haro, Consorcio Hospital Provincial de Castellón,

THURSDAY 23 THURSDAY España. Francina Fonseca, Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar. Barcelona, España. Helen Dolengevich, Hospital Universitario del Henares. Madrid, España.

SPEAKERS: DEPRESSION AND DUAL DISORDERS Marta Torrens, Institut de Neuropsiquiatria I Addiccions- Parc de Salut Mar, Universitat Autònom. Barcelona, España. PSYCHOSIS AND DUAL DISORDERS Carlos Roncero, Universidad Autónoma de Barcelona, España. ATTENTION DEFICIT HYPERACTIVITY DISORDER/ IMPULSIVITY AND DUAL DISORDERS José Martínez-Raga, Hospital Universitario Dr. Peset, Universitat de Valencia. Valencia, España. RELEVANT PERSONALITY DISORDERS AND DUAL DISORDERS Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España.

11:00 - 19:00 Room El Jardín IV CONGRESSO IBERO-BRASILEIRO DE PATOLOGIA DUAL

(Page 153)

36 23 - 26 March, 2017 Madrid - Spain

15:00 - 16:00 Room Comendador SEPD ASSEMBLY SEPD Members only

16:00 - 16:45 Auditorium Track: Psychopathology and Dual Disorders MAIN LECTURE - ML01

FLASHBACKS AND HPPD (HALLUCINOGENIC 23 THURSDAY PERSISTING PERCEPTION DISORDER): CLINICAL ASPECTS AND PHARMACOLOGICAL TREATMENT

CHAIR: Juan Gibert, Universidad de Cádiz, España.

SPEAKER: Arturo G. Lerner, Lev - Hasharon MHC, Sackler School of Medicine, Tel Aviv University. Tel Aviv, Israel.

16:45 - 17:30 Auditorium Track: Psychotherapeutic Treatments in Dual Disorders MAIN LECTURE - ML02 CULTURE AND DUAL DISORDERS

CHAIR: Francisco Collazos, Hospital Universitari Vall d’Hebron. Barcelona, España.

SPEAKER: Dinesh Bhugra, King’s College London, United Kingdom.

37 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

16:00 - 17:30 Room Castilla Track: Sick Doctors and Dual Disorders SYMPOSIUM - SY01 EVOLUTION OF COMPREHENSIVE PROGRAMS FOR PHYSICIANS WITH DUAL DISORDERS

CHAIR: Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d'Hebron. Barcelona, España. THURSDAY 23 THURSDAY SPEAKERS: CREATION AND EVOLUTION OF PAIMM (SICK DOCTORS PROGRAM) Eugeni Bruguera, Hospital Universitari Vall d’Hebron. Barcelona, España. BARCELONA´S PAIMM IN FIGURES Mª Dolores Braquehais, Universitat Autònoma de Barcelona, Clínica Galatea, Hospital Universitari Vall d’Hebron. Barcelona, España. EXTENSION OF PAIMM TO OTHER HEALTH GROUPS Antoni Calvo, PAIMM Colegio Oficial de Médicos de Barcelona, PAIME. Barcelona, España.,

38 23 - 26 March, 2017 Madrid - Spain

16:00 - 17:30 Room Hidalgo Track: The Present Illegal Drugs as a Future Medication for DDs SYMPOSIUM - SY02 EMERGING PERSPECTIVES FOR IMPROVED TREATMENTS OF DUAL DISORDERS: FROM THE BENCH TO THE BEDSIDE

CHAIR: Umberto Spampinato, University of Bordeaux. France. THURSDAY 23 THURSDAY

SPEAKERS: SEROTONERGIC INVOLVEMENT IN BEHAVIOURAL DEFICITS OBSERVED IN COMORBIDITY OF DEPRESSION AND ADDICTION Malgorzata Filip, Polish Academy of Sciences. Krakow, Poland. GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN DEPRESSION AND ALCOHOL: INSIGHTS FROM ANIMAL MODELS Eva M. Marco, Universidad Complutense de Madrid. España. SUBSTANCE USE IS INDEPENDENTLY INFLUENCED BY SUBSTANCE USE DISORDERS AND ANXIETY/MOOD DISORDERS IN PATIENTS WITH DUAL DISORDERS Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France.

39 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

16:00 - 17:30 Room Doblón Track: Investigation, Development and E-Health Technologies in Dual Disorders SYMPOSIUM - SY03 NEW TECHNOLOGIES IN DIAGNOSIS AND TREATMENT OF DUAL DISORDERS

CHAIR: Álvaro Rivera, Instituto Psiquiátrico Servicios de Salud

THURSDAY 23 THURSDAY Mental José Germain. Madrid, España.

SPEAKERS: VIRTUAL REALITY THERAPY IN ADDICTIVE DISORDERS Joan M. Gelabert, Psious: Virtual Reality Therapy, España. BIG DATA: APPLICATION IN DUAL DISORDERS Diego Urgelés, Clínica Nuestra Señora de la Paz, Orden Hospitalaria San Juan de Dios. Madrid, España. “THE WORDS EXCITE BUT THE EXAMPLE PERSUADES”. AN EXPERIENCE IN NEW TECHNOLOGIES APPLIED IN MENTAL HEALTH SERVICES IN ARABA (SPAIN) Rafael Sánchez, Unidad de Gestión Sanitaria, España. MEDROOM PROJECT: HOW NEW TECHNOLOGIES SUPPORT AN INTEGRATED MODEL OF TREATMENT Ignacio Hernández, Hospital Ramón y Cajal Madrid, España.

40 23 - 26 March, 2017 Madrid - Spain

16:00 - 17:30 Room El Escorial Track: Substance Use Disorders and Dual Disorders SYMPOSIUM - SY04 COGNITIVE AND FUNCTIONAL IMPAIRMENTS AND DUAL DISORDERS: UPDATE. CAN WE DO SOMETHING EARLIER?

CHAIR: José Zarco, Centro Salud Ibiza. Madrid, España. THURSDAY 23 THURSDAY

SPEAKERS: COGNITIVE IMPAIRMENT AND DUAL DISORDERS: DIFFICULTIES IN THE PSYCHOLOGICAL TREATMENT Alfredo Felices, Centre D’Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM. Barcelona, España. NEUROLOGICAL DISORDERS AND DUAL DISORDERS: THE IMPORTANCE OF EARLY DIAGNOSIS AND TREATMENT Laia Grau-López, Hospital Universitari Germans Trías i Pujol. Badalona, España. IS THE INTERSECTION BETWEEN NEUROLOGICAL DAMAGE AND DUAL DISORDER DETECTED EARLY? Begoña Gonzalvo, Centre D’Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM. Barcelona, España.

41 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

16:00 - 17:30 Room Comendador Track: Multidisciplinary Intervention in Dual Disorders SYMPOSIUM - SY05 LET´S TALK ABOUT CHEMSEX: A MULTIDISCIPLINARY APPROACH

CHAIR: Jorge del Romero, Clínica de Enfermedades Infecciosas de la Comunidad de Madrid. España. THURSDAY 23 THURSDAY SPEAKERS: CURRENT SITUATION OF CHEMSEX IN SPAIN Pablo Ryan, Hospital Universitario Infanta Leonor. Madrid, España. PSYCHOPATHOLOGY RELATED TO CHEMSEX USERS Helen Dolengevich, Hospital Universitario del Henares. Madrid, España. PILOT PROGRAM FOR INTERDISCIPLINARY INTERVENTION IN CHEMSEX Alicia Gonzalez Baeza, Hospital Universitario La Paz. Madrid, España.

16:00 - 17:30 Room Escudo Track: Epidemiology and Dual Disorders SYMPOSIUM - SY06 ANTHROPOLOGY OF DRUGS: FROM INDIGENOUS SOCIETIES TO OUR DAYS

CHAIR: Rafael Navarro, Universidad de Granada. España.

SPEAKERS: DRUGS AND CULTURAL SOCIAL MOVEMENTS Lidia Aguado, Clínica del Río. San Pedro de Alcántara, España. AMONG NATIVES: FROM HUNTING TO DRINKING Jesús García, Complejo Hospitalario de Granada. España. SHAMANISM: THE RITUAL AND RELIGIOUS USE OF DRUGS Sabina Zubimendi, Unidad de Salud Mental Comunitaria Huercal-Overa. España.

42 23 - 26 March, 2017 Madrid - Spain

17:30 - 18:30 Auditorium Track: Psychopathology and Dual Disorders PLENARY SESSION - PS01 FOCUSING ON DUAL DISORDERS: CURRENT OUTLOOKS AND FUTURE PERSPECTIVES

CHAIR: Miquel Bernardo, Hospital Clinic, Universitat de Barcelona, España. THURSDAY 23 THURSDAY

SPEAKER: Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine - University of Miami. FL, USA.

17:30 - 19:00 Room Castilla Track: Child and Adolescent Psychiatry DEBATE FORUM - DF01 MULTICOMPONENT TREATMENT IN ADOLESCENT DUAL DISORDERS: INTEGRATING DIFFERENT THERAPEUTIC STRATEGIES

CHAIR: Javier Goti, Hospital Clinic. Barcelona, España.

SPEAKERS: PSYCHIATRIC TREATMENT OF DUAL DISORDERS IN MULTICOMPONENT PROGRAMS FOR ADOLESCENTS Oscar Bukstein, Boston Children’s Hospital. Boston, MA, USA. COGNITIVE BEHAVIOURAL THERAPY AND MOTIVATION ENHANCEMENT THERAPY INTEGRATION IN THE TREATMENT OF ADOLESCENTS WITH DUAL DISORDERS Josep Matalí, Hospital Sant Joan de Deu. Barcelona, España. PSYCHOSOCIAL INTERVENTION IN MULTIDISCIPLINARY TREATMENT PROGRAMS FOR ADOLESCENTS WITH DUAL DISORDERS Javier Goti, Hospital Clinic. Barcelona, España.

43 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

17:30 - 19:00 Room Hidalgo Track: Pharmacology in Dual Disorders SYMPOSIUM - SY07 TRANSLATIONAL NEUROPSYCHOPHARMACOLOGY IN DUAL DISORDERS

CHAIR: Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. THURSDAY 23 THURSDAY SPEAKERS: WHY IS TRANSLATIONAL RESEARCH IMPORTANT IN DUAL DISORDERS? Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. ANIMAL MODELS IN DUAL DISORDERS: STRENGTHS AND WEAKNESSES Mª Salud García, Hospital Universitari Vall d’Hebron. Barcelona, España. FROM PSYCHIATRIC DISORDERS TO ANIMAL MODELS: A BIDIRECTIONAL APPROACH Gabriel Rubio, Universidad Complutense de Madrid, España.

17:30 - 18:15 Room Doblón Track: Substance Use Disorders and Dual Disorders WORKSHOP - WS01 ON THE ORIGINS OF DUAL DISORDERS: NEUROSCIENCE OF ADDICTION VULNERABILITY IN MENTAL ILLNESS

CHAIR/ SPEAKER: R. Andrew Chambers, Indiana University School of Medicine. Indianapolis, IN, USA.

44 23 - 26 March, 2017 Madrid - Spain

18:15 - 19:00 Room Doblón Track: Psychopathology and Dual Disorders WORKSHOP - WS02 FEMALE IMPULSIVITY, INTERNET ADDICTION AND HALLUCINOGENIC PERSISTING PERCEPTION DISORDER: DIFFERENT PERSPECTIVES OF DUAL DISORDERS

CHAIR: THURSDAY 23 THURSDAY Pinhas Dannon, Beer Yaakov-Ness Ziona MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel.

SPEAKERS: IS IMPULSIVITY A MALE TRAIT RATHER THAN FEMALE TRAIT? EXPLORING GENDER DIFFERENCES IN IMPULSIVITY Pinhas Dannon, Beer Yaakov-Ness Ziona MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel. COMORBIDITY OF INTERNET ADDICTION AND COMPULSIVE BUYING WITH OTHER PSYCHIATRIC CONDITIONS Aviv Weinstein, University of Ariel. Ariel, Israel. FLASHBACKS AND HPPD (HALLUCINOGENIC PERSISTING PERCEPTION DISORDER): UNDERSTANDING AND APPROACH OF THIS INTRIGUING PHENOMENA Arturo G. Lerner, Lev - Hasharon MHC, Sackler School of Medicine, Tel Aviv University. Tel Aviv, Israel.

45 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

17:30 - 19:00 Room El Escorial Track: Pharmacology in Dual Disorders SYMPOSIUM - SY08 DRUGS FOR USE IN CONDITIONS DIFFERENT TO THOSE AUTHORIZED IN DUAL DISORDERS: CONSENSUS OF THE SEPD

Invitation only

THURSDAY 23 THURSDAY CHAIR: F. Javier Álvarez, CEIC/CEIm Hospital Clínico Universitario de Valladolid, España.

SPEAKERS: TREATMENT OF COMORBID SUBSTANCE DEPENDENCE ANXIETY DISORDER. PROPOSAL BY THE SEPD WORKING GROUP Marisa Dorado, Unidad de Conductas Adictivas de Gandía. Valencia, España. TREATMENT OF COMORBID ANXIETY DISORDER. PROPOSAL BY THE SEPD WORKING GROUP Carmen Gimeno, Unidad de Conductas Adictivas de Villajoyosa. Valencia, España. DISCUSSION OF THE PROPOSAL BY THE SEPD WORKING GROUP: GUIDELINES OF TREATMENT OF COMORBID ALCOHOL/SUBSTANCE DEPENDENCE ANXIETY DISORDER

17:30 - 18:30 Room Comendador BEST POSTER PRESENTATIONS

46 23 - 26 March, 2017 Madrid - Spain

17:30 - 19:00 Room Escudo ORAL COMMUNICATIONS - OC01 CHAIRS: Saúl Pacurucu, Residencia Medicina Interna Hospital IESS. Cuenca, Ecuador. Maria Robles Martínez, Hospital Universitari Vall d'Hebron. Barcelona, España. THURSDAY 23 THURSDAY

PSYCHOLOGICAL PROBLEM AMONG CHILDREN WHO ARE SEXUALLY ABUSED Md. Masbah Uddin Ahmed Bandhu Social Welfare Society, Bangladesh.

DIFFERENCES ON THE GLOBAL APPRAISAL OF INDIVIDUAL NEEDS-SHORT SCREENER (GAIN-SS) ACCORDING TO GAMBLING AND ALCOHOL SEVERITY AMONG ADOLESCENTS Víctor Martínez-Loredo1, Alba González-Roz1, Sergio Fernández-Artamendi1,2, Aris Grande-Gosende1, Ángel García-Pérez1, José Ramón Fernández-Hermida1 1 Addictive Behaviors Clinical Unit. University of Oviedo, Spain. 2 Universidad Loyola Andalucía, Sevilla, Spain.

CHROMOSOMAL INSTABILITY IN PERIPHERAL BLOOD LYMPHOCYTES IN PATIENTS WITH PHOBIC-ANXIETY DISORDERS T. Proskurina, N. Bagatska, E. Mykhailova Institute for Children and Adolescents Health Care of the NAMS of Ukraine, Ukraine.

CANNABIS ABUSE AND EXTERNALIZING PROBLEM BEHAVIOUR IN ADOLESCENTS - AN UPDATE Rogue Patrick Jean University Hospital Strasbourg; Institution Mertian, Andlau; Fédération de Médecine Translationnelle de Strasbourg; School of Medicine, Strasbourg University; France.

47 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

AUDITORY MISMATCH NEGATIVITY WAS ENHANCED IN ADOLESCENTS WITH MULTIPLE PERSONALITY DISORDERS Jiawei Wang, Bing Pan, Chanchan Shen, Wei Wang Zhejiang University School of Medicine, China.

IMPROVING DUAL DIAGNOSIS CARE IN ACUTE PSYCHIATRIC INPATIENT SETTINGS THROUGH

THURSDAY 23 THURSDAY EDUCATION Kofi Bonnie1,2, Joan Kearney1, Jane Dixon1, Ruth McCorkle1, William MacEwan2 1 Yale University, New Haven, CT, USA. 2 St. Paul’s Hospital, Providence Health Care, Vancouver, BC, Canada.

DELAY DISCOUNTING CHANGES AMONG TREATMENT- SEEKING SMOKERS WITH COMORBID DEPRESSIVE DISORDER Sara Weidberg, Gloria García-Fernández, Aris Grande- Gosende, Victor Martínez-Loredo, Roberto Secades-Villa University of Oviedo, Spain.

DISORGANIZED ATTACHMENT: A RISK FACTOR FOR DUAL DISORDERS DEVELOPMENT Vanesa Simón Martínez, Fátima Vílchez Trigueros, Andrea Erdocia Remacha, Elena Vázquez Ramo, Victoria De Felipe García-Bardón Hospital Universitario de Guadalajara, España.

19:00 - 20:00 Congress Venue WELCOME COCKTAIL

48 PROGRAMME FRIDAY MARCH 24 FRIDAY 24 FRIDAY

CONGRESS APP Navigate through the First World Congress of the World Association of Dual Disorders (WADD) & Fifth International Congress of the Spanish Society of Dual Disorders (SEPD) programme from your iPhone, iPad, and Android. View sessions by day and category, locate exhibitors and create your own itinerary to fully exploit your congress. http://www.icdd-congress.com/ scientific-information/app-mobile/ Use this code to unlock the APP if it is required: 85962

www.icdd-congress.com FRIDAY 24 16:30 -17:15 12:00 -12:30 11:30 -12:00 10:45 -11:30 10:00 -10:45 09:15 -10:00 19:15 -20:00 18:30 -19:15 18:00 -18:30 17:15 -18:00 16:00 -16:30 15:00 -16:00 14:00 -15:00 13:30 -14:00 13:00 -13:30 12:30 -13:00 08:30 -09:15 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & Bipolar disorders ML06 Bipolardisorders disorders: Translationaldisorders: treatment ofaddictions ML08 Testing thedrug medicine in psychiatry medicine inpsychiatry substitution (switching AUDITORIUM addiction) hypothesis bottom up:Emerging ML03 Schizophrenia research andreward ML07 Top down and addictions inbipolar and DualDisorders ML05 Behavioral and other mental and co-occurring DUAL DISORDERS Addictions and other Mental Disorders ML04 Precision concepts inthe substance use and cannabis disorders disorder PS02 Effectsofcannabisuseonhumanbehavior andmentaldisorders FRIDAY MARCH 24,2017 Ask the expert: NIDAAsk theexpert: Director DrVolkow WS07 HousingFirst for of Psychiatric Trainees WS08 Co-occurrence SY09 Opioiduseand European Federation and eating disorders: and eatingdisorders: scientific programme scientific programme adolescent patientin homeless population Industry Sessionnot Industry Sessionnot Industry the context offamily An approach to the with mentalhealth included inofficial included inofficial of substance use CASTILLA DF03 Forum of Dual Disorders centered care Symposium Symposium SATELLITE SATELLITE ROOM CME/CPD CME/CPD (EFPT) issues 50 OPENING CEREMONY OPENING COFFEE BREAK COFFEE BREAK LUNCH BREAK SY13 Treatment ofDual scientific programme scientific programme Industry Sessionnot Industry Sessionnot Industry SY17 Tools for Dual addictions andDual Disorders inyouth:Disorders included inofficial included inofficial DF02 Behavioral HIDALGO Symposium Symposium SATELLITE SATELLITE ROOM CME/CPD CME/CPD Disorders Disorders Updates (Auditorium) use disorders: Clinicallyuse disorders: anhedonia: Examining ADHD andsubstance DF04 Attention deficit hyperactivity disorder (Auditorium) a neurobiological link scientific programme between depression, SY14 Understanding Industry Sessionnot Industry health andstimulant SY10 Disentangling and substance use concurrent mental included inofficial the importance of the importance relevant research state versus trait DOBLÓN Symposium SATELLITE ROOM CME/CPD disorders abuse Disorders withinLatinAmerica Disorders assessment inclinicalpractice in officialscientific programme in officialscientific programme Industry Sessionnot included Industry Sessionnot included Industry SY11 Neurocognition inDual Disorders - Implications and -Implications Disorders Controversies ontheuseof SATELLITE Symposium SATELLITE Symposium SY15 GamblingandDual the management ofDual the management collaboration framework: SY18 New in challenges ESCORIAL ROOM EL CME/CPD CME/CPD Disorders cannabis PS02 Effectsofcannabisuseonhumanbehavior andmentaldisorders Ask the expert: NIDAAsk theexpert: Director DrVolkow in officialscientific programme in officialscientific programme hyperactivity disorder (ADHD) SY19 Women whousedrugs: Industry Sessionnot included Industry Industry Sessionnot included Industry SY12 Drugmisuseinoldage SY16 the Isemotional lability ROOM ELJARDÍN link between attention deficit and substance usedisorder SATELLITE Symposium SATELLITE Symposium Comorbidities andsocial Comorbidities consequences CME/CPD CME/CPD (SUD)? OPENING CEREMONY OPENING COFFEE BREAK COFFEE BREAK LUNCH BREAK WS05 Relapse: A consequence (PCL-R) indrugabuseresearch Psychopathy Checklist-Revised WS06 how Learning to improve in officialscientific programme SY20 Cognitive andfunctional due to ofthe hypofunctionality Industry Sessionnot included Industry of altered executive functions resilience from mentalhealth designer drugs:Thecurrent impairment inpatientswith impairment COMENDADOR WS03 Dealingwithnew SATELLITE Workshop Fetal AlcoholSpectrum and treatment settings WS04 Theuseofthe (Auditorium) Disorders (FASD)Disorders frontal lobe ROOM CME/CPD challenge (Auditorium) Communications Communications Communications ESCUDO OC04 Oral OC03 Oral OC02 Oral ROOM 19:15 -20:00 18:30 -19:15 18:00 -18:30 17:15 -18:00 16:30 -17:15 16:00 -16:30 15:00 -16:00 14:00 -15:00 13:30 -14:00 13:00 -13:30 12:30 -13:00 12:00 -12:30 11:30 -12:00 10:45 -11:30 10:00 -10:45 09:15 -10:00 08:30 -09:15 Bipolar disorders ML06 Bipolardisorders disorders: Translationaldisorders: treatment ofaddictions ML08 Testing thedrug medicine in psychiatry medicine inpsychiatry substitution (switching AUDITORIUM addiction) hypothesis bottom up:Emerging ML03 Schizophrenia research andreward ML07 Top down and addictions inbipolar and DualDisorders ML05 Behavioral and other mental and co-occurring ML04 Precision concepts inthe substance use and cannabis disorders disorder PS02 Effectsofcannabisuseonhumanbehavior andmentaldisorders FRIDAY MARCH 24,2017 Ask the expert: NIDAAsk theexpert: Director DrVolkow WS07 HousingFirst for of Psychiatric Trainees WS08 Co-occurrence SY09 Opioiduseand European Federation and eating disorders: and eatingdisorders: scientific programme scientific programme adolescent patientin homeless population Industry Sessionnot Industry Sessionnot Industry the context offamily An approach to the with mentalhealth included inofficial included inofficial of substance use CASTILLA DF03 Forum of Dual Disorders centered care Symposium Symposium SATELLITE SATELLITE ROOM CME/CPD CME/CPD (EFPT) issues OPENING CEREMONY OPENING COFFEE BREAK COFFEE BREAK LUNCH BREAK SY13 Treatment ofDual scientific programme scientific programme Industry Sessionnot Industry Sessionnot Industry SY17 Tools for Dual addictions andDual Disorders inyouth:Disorders included inofficial included inofficial DF02 Behavioral HIDALGO Symposium Symposium SATELLITE SATELLITE ROOM CME/CPD CME/CPD Disorders Disorders Updates (Auditorium) use disorders: Clinicallyuse disorders: anhedonia: Examining ADHD andsubstance DF04 Attention deficit hyperactivity disorder (Auditorium) a neurobiological link scientific programme between depression, SY14 Understanding Industry Sessionnot Industry health andstimulant SY10 Disentangling and substance use concurrent mental included inofficial the importance of the importance relevant research state versus trait DOBLÓN Symposium SATELLITE ROOM CME/CPD disorders abuse Disorders withinLatinAmerica Disorders assessment inclinicalpractice in officialscientific programme in officialscientific programme Industry Sessionnot included Industry Industry Sessionnot included Industry SY11 Neurocognition inDual Disorders - Implications and -Implications Disorders Controversies ontheuseof SATELLITE Symposium SATELLITE Symposium SY15 GamblingandDual the management ofDual the management collaboration framework: SY18 New in challenges ESCORIAL ROOM EL CME/CPD CME/CPD Disorders cannabis PS02 Effectsofcannabisuseonhumanbehavior andmentaldisorders Ask the expert: NIDAAsk theexpert: Director DrVolkow in officialscientific programme in officialscientific programme hyperactivity disorder (ADHD) SY19 Women whousedrugs: Industry Sessionnot included Industry Industry Sessionnot included Industry SY12 Drugmisuseinoldage SY16 the Isemotional lability ROOM ELJARDÍN link between attention deficit and substance usedisorder SATELLITE Symposium SATELLITE Symposium Comorbidities andsocial Comorbidities consequences CME/CPD CME/CPD (SUD)? OPENING CEREMONY OPENING COFFEE BREAK COFFEE BREAK LUNCH BREAK 51 WS05 Relapse: A consequence (PCL-R) indrugabuseresearch Psychopathy Checklist-Revised WS06 how Learning to improve in officialscientific programme SY20 Cognitive andfunctional due to ofthe hypofunctionality Industry Sessionnot included Industry of altered executive functions resilience from mentalhealth designer drugs:Thecurrent impairment inpatientswith impairment COMENDADOR WS03 Dealingwithnew SATELLITE Workshop Fetal AlcoholSpectrum 23 -26March, and treatment settings WS04 Theuseofthe (Auditorium) Disorders (FASD)Disorders frontal lobe ROOM CME/CPD challenge Madrid -Spain (Auditorium) Communications Communications Communications ESCUDO OC04 Oral OC03 Oral OC02 Oral ROOM 2017

FRIDAY 24 FRIDAY 24 09:15 -10:00 -09:1508:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & REWARD USE DISORDERS:TRANSLATIONAL AND RESEARCH SCHIZOPHRENIA ANDCO-OCCURRING SUBSTANCE Marañón. Madrid, España. Celso Arango,HospitalGeneral UniversitarioGregorio Speaker: Universitario GregorioMarañón. Madrid, España. Néstor Szerman, SaludMentalRetiro, Servicio Hospital General CHAIR: Auditorium School. NH,USA. Alan Green,DepartmentofPsychiatry, DartmouthMedical SPEAKER: Madrid, España. Celso Arango,HospitalGeneral UniversitarioGregorioMarañón. CHAIR: Auditorium DISORDERS PRECISION MEDICINEINPSYCHIATRY ANDDUAL DUAL DISORDERS Addictions and other Mental Disorders

Disorders Track: Investigation, Development andE-HealthTechnologies inDual Track: Psychopathology andDualDisorders MAIN LECTURE-ML03 MAIN LECTURE-ML04 52 08:30 -10:0008:30 -10:0008:30 OPIOID USEANDDUAL DISORDERS Nady El-Guebaly, UniversityofCalgary, Alberta Gambling Cajal Madrid,España. Jerónimo Sáiz,UniversidaddeAlcalá, HospitalRamón y Sebastián/ Donostia,España. Enrique Echeburúa, UniversidaddelPaísVasco. San Marañón. Madrid,España. Francisco Ferre, HospitalGeneral UniversitarioGregorio School ofMedicineTel Aviv University. Tel Aviv, Israel. Pinhas Dannon, BeerYaakov-Ness ZionaMHC,Sackler SPEAKERS: Marañón. Madrid, España. Francisco Ferre, HospitalGeneral UniversitarioGregorio CHAIR: Room Hidalgo Albrecht Ulmer, PrivateConsultation. Germany. Stuttgart, SUBSTANCES ALCOHOL WITHDIFFERENTAGONISTIC DEPENDENCY MORE EFFECTIVENESS INTHETREATMENT OF et deTraitement desAddictions. Paris,France. Amine Benyamina, Centre de Recherche d’Enseignement, COMORBIDITIES THE TREATMENT CLINICFOR OPIATE AND ADDICTION Santa Chiara UniversityHospital,Pisa,Italy. Icro Maremmani,UniversityofPisa,Siena, OPIOIDS ANDDUAL DISORDERS SPEAKERS: Basque, Bayonne,France. Jean-Pierre Daulouede, Centre Hospitalierdela CA’te CHAIR: Room Castilla BEHAVIORAL ANDDUAL DISORDERS ADDICTIONS

Track: Substance andDualDisorders UseDisorders Track: Behavioral Addictions andDualDisorders DEBATE FORUM-DF02 SYMPOSIUM -SY09 53 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 08:30 -10:0008:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & RESEARCH USEDISORDERS: CLINICALLYSTIMULANT RELEVANT DISENTANGLING CONCURRENT MENTAL HEALTH AND Vancouver, Canada. Christian G.Schütz,UniversityofBritishColumbia. PSYCHOTIC USEDISORDERS DISORDERSANDSTIMULANT Parc deSalutMar, UniversitatAutònom. Barcelona, España. Marta Torrens, InstitutdeNeuropsiquiatriaIAddiccions- DISORDERS USE AFFECTIVE DISORDERS ANDSTIMULANT Universitat deValencia. Valencia, España. José Martínez-Raga,HospitalUniversitarioDr. Peset, USEDISORDERS STIMULANT DISORDERAND ATTENTION DEFICITHYPERACTIVITY SPEAKERS: Vancouver, Canada. Christian G.Schütz,UniversityofBritishColumbia. CHAIR: Room Doblón Research Institute.Alberta, Canada. DUAL DISORDERS Addictions and other Mental Disorders

Track: Substance andDualDisorders UseDisorders SYMPOSIUM -SY10 54 08:30 -10:0008:30 Barcelona, España. Elena García-Raboso,HospitalUniversitariVall d'Hebron. DISORDER PATIENTS COGNITIVE PROTOCOL ASSESSMENT INDUAL Carmen Tomás, UniversitatdeValència, España. de València, CIBERSAM.Valencia, España. Vicent Balanzá-Martínez,HospitaldeBétera, Universitat USEDISORDER) CANNABIS DISORDERAND WITH DUAL DISORDERS(BIPOLAR NEUROCOGNITIVE INPATIENTS FUNCTIONING Ana Adan, UniversidaddeBarcelona, España. UniversidaddeBarcelona,Gemma Prat, España. MENTAL ILLNESS DISORDERS. FOCUS ONCO-OCCURRING SEVERE NEUROPSYCHOLOGICAL IMPACT OFDUAL SPEAKERS: de València, CIBERSAM.Valencia, España. Vicent Balanzá-Martínez,HospitaldeBétera, Universitat Ana Adan, UniversidaddeBarcelona, España. CHAIRS: Room ElEscorial PRACTICE IMPLICATIONS INCLINICAL ANDASSESSMENT NEUROCOGNITION INDUAL DISORDERS-

SYMPOSIUM -SY11 Track: InterventioninDualDisorders Multidisciplinary 55 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 08:30 -10:0008:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DRUG MISUSEINOLDAGE Barcelona, España. Cristina Cardona,HospitalUniversitariVall d’Hebron. CHRONIC SUBSTANCE USE COGNITIVE PROGRESS OFPEOPLE OVER 65WITH Universidad Autónoma deBarcelona. España. Elena Ros-Cucurull, HospitalUniversitariVall d’Hebron, DRUG USEINTHEELDERLY España. Girona, Rocío Martinez,Institutd’AssistènciaSanitariaIAS. INTEGRATED APPROACH TO THEELDERLY PATIENT SPEAKERS: Madrid, España. Psicogeriatría, HospitalUniversitario12DeOctubre. Luis F. Agüera, Presidentedela SociedadEspañola de CHAIR: Room ElJardín DUAL DISORDERS Addictions and other Mental Disorders

Track: inDualDisorders GeriatricPsychiatry SYMPOSIUM -SY12 56 09:15 -10:00 -09:1508:30 SETTINGS (PCL-R) ANDTREATMENT INDRUGABUSERESEARCH THE USEOFPSYCHOPATHY CHECKLIST-REVISED CHALLENGE WITHNEWDESIGNERDRUGS:THECURRENT DEALING Israel. David Potik, Tel-Aviv Sourasky Medical Center. Tel-Aviv, SPEAKER: CHAIR/ Room Comendador Parc deSalutMar. Barcelona, España. Álvaro J. Palma, InstitutdeNeuropsiquiatriaIAddiccions- USERS APPROACH, INFORMATION ANDTREATMENT FOR NPS Parc deSalutMar. Barcelona, España. Liliana Galindo,InstitutdeNeuropsiquiatriaIAddiccions- CHALLENGE NEWEST CLINICAL ANDCATHINONES:SYNTHETIC CANNABINOIDS THE de SalutMar. Barcelona, España. Marc Grifell,InstitutdeNeuropsiquiatriaIAddiccions-Parc ONES DIFFERENCES ANDRELEVANCE OFTHEMOST RECENT NEW PSYCHOACTIVE SUBSTANCES (NPS). SPEAKERS: Parc deSalutMar. Barcelona, España. Liliana Galindo,InstitutdeNeuropsiquiatriaIAddiccions- CHAIR: Room Comendador WORKSHOP -WS03 WORKSHOP -WS04

Track: Substance andDualDisorders UseDisorders Track: Psychopathology andDualDisorders 57 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 08:30 -10:0008:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & 1 2 Gail Gilchrist ACROSS-CULTURALAND ENGLAND: COMPARISON MEN RECEIVING SUBSTANCE USETREATMENT INBRAZIL EVER PERPETRATING INTIMATE PARTNER VIOLENCEBY THE PREVALENCE ANDFACTORS ASSOCIATED WITH King’s College London, UnitedKingdom. PollyGail Gilchrist, Radcliffe AMIXEDMETHODS STUDYENGLAND: BY MENRECEIVING SUBSTANCE USETREATMENT IN PERPETRATION OFINTIMATE PARTNER Bangladesh. Training BandhuSocialWelfare Society, Unit, Dhaka, Parker, A.F.M. Iqbal,Shanthi Noriega CatherinePacker,Uddin Ahmed,SultanaAziz, Caleb Masbah UddinAhmed,ChristinaWong, Md.Masbah BANGLADESH IN DHAKA, WHO HAVE PEOPLE SEXWITHMENANDTRANSGENDER TO VIOLENCE AGAINST ADDRESSGENDERBASED MEN STRATEGIES FOR IMPROVING SERVICES ANDPROGRAMS do Sul.PortoAlegre, Brasil. Felix H.Paim Kessler, UniversidadeFederal doRioGrande Universidad Autónoma deBarcelona. España. Lara Grau-López, HospitalUniversitariVall d’Hebron, CHAIRS: Room Escudo 3 Flavia PiresLucasd’Oliviera    DUAL DISORDERS Addictions and other Mental Disorders of PreventiveMedicine,University ofSãoPaulo, Brazil. Gender Violence andHealthResearch Group, Department Brazil. Information onDrugs,UniversidadeFederal de SãoPaulo, Department ofPsychobiology, Centre Brasileiro of King’s College London, UnitedKingdom. ORAL COMMUNICATIONS -OC02 1 , Polly Radcliffe 58 3 1 , AnaReginaNoto 2 , Ana 1 USA. Adelaide, Australia; Virginia Commonwealth University, AIIMS, NewDelhi, King’sCollege London, UK;Universityof Yatan Pal SinghBalhara COUNTRIES (LMICS) INLOWPROFESSIONALS ANDMIDDLEINCOME DISORDERS: IMPLICATIONS OFHEALTH FOR TRAINING MOVING DISORDERS TO FROM ADDICTION DUAL Mexico. National InstituteofPsychiatry Ramón dela FuenteMuñiz, Hugo González-Cantú FOR PSYCHIATRISTS INMEXICO INDUAL DISORDERS PROGRAM OFTRAINING 15 YEARS Veterans’ Administration Medical Center, USA. Icahn School ofMedicineat Mount SinaiandJamesJ.Peters Leo Sher MEN’S MENTAL HEALTH ANDDUAL DISORDERS CNP-Neuchâtel Psychiatry Center, Neuchâtel, Switzerland. Peris Gianina Luca,OrnellaPassoni, Xavier Camarasa,Lola PERCEPTION INDUAL DISORDERSPATIENTS GENDER DIFFERENCESINSLEEPDISTURBANCES 6 5 4 3 2 Gail Gilchrist ILLICIT DRUGUSERS SEX DIFFERENCESINPSYCHIATRIC DISORDERS AMONG Salvany       Barcelona, Barcelona, Spain. Department ofPsychiatry, UniversitatAutònoma de Salut Mar, Barcelona, Spain. Institut deNeuropsiquiatriaIAdiccions (INAD)Parcde del Mar, Parcde Salut MAR,Barcelona, Spain. Substance UseDisorders Research Group;IMIM-Hospital Spain. CIBER inEpidemiology andPublicHealth(CIBERESP), del Mar, Parcde Salut MAR,Barcelona, Spain. Drug AbuseEpidemiology Research Group,IMIM-Hospital King’s College London, UnitedKingdom. 2,3 , MartaTorrens 1 , Yasmina Frem 59 4,5,6 23 -26March, 1 , Antonia Domingo- Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 12:00 -13:30 12:00 -13:30 11:30 -12:00 10:00 -10:45 10:45 -11:30 10:00 -11:30 10:00 -11:30 10:00 -11:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & programme CME/CPD (Page216) Session notincludedinofficialscientific Industry programme CME/CPD (Page215) Sessionnotincludedinofficial scientific Industry programme CME/CPD (Page213) Sessionnotincludedinofficialscientific Industry programme CME/CPD (Page212) Sessionnotincludedinofficialscientific Industry programme CME/CPD (Page211) Sessionnotincludedinofficialscientific Industry programme CME/CPD (Page210) Sessionnotincludedinofficialscientific Industry Room Castilla Room Comendador Room ElJardín Room ElEscorial Room Hidalgo Room Castilla Room Hidalgo programme CME/CPD (Page214) Sessionnotincludedinofficial scientific Industry DUAL DISORDERS Addictions and other Mental Disorders SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM SATELLITE WORKSHOP COFFEE BREAK 60 15:00 -16:00 14:00 -15:00 13:30 -14:00 12:00 -13:00 12:00 -13:30 12:00 -13:30 programme CME/CPD (Page219) Sessionnotincludedinofficialscientific Industry programme CME/CPD (Page218) Sessionnotincludedinofficialscientific Industry programme CME/CPD (Page217) Sessionnotincludedinofficialscientific Industry Bethesda. MD, USA. Nora Volkow , NationalInstituteonDrugAbuse (NIDA), SPEAKER: Universitario GregorioMarañón. Madrid,España. Néstor Szerman, SaludMentalRetiro, Servicio HospitalGeneral CHAIR: Auditorium Auditorium Room ElJardín Room ElEscorial Room Doblón AND MENTAL DISORDERS USEONHUMANBEHAVIOREFFECTS OFCANNABIS

in DualDisorders Track: Investigation, Development andE-Health Technologies PLENARY SESSION-PS02 SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM OPENING CEREMONY LUNCH BREAK 61 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 17:15 -18:00 16:30 -17:15 16:30 - 16:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & BEHAVIORAL ADDICTIONS IN BIPOLAR DISORDER BEHAVIORAL INBIPOLAR ADDICTIONS SPEAKER: Carlos Roncero,UniversidadAutónoma deBarcelona, España. CHAIR: Auditorium Barcelona. España. Eduard Vieta,HospitalClínicdeBarcelona. Universitatde SPEAKER: Madrid, España. Francisco Ferre, HospitalGeneral UniversitarioGregorioMarañón. CHAIR: Auditorium Bethesda. MD, USA. Nora Volkow, NationalInstituteonDrugAbuse(NIDA), SPEAKER: General UniversitarioGregorioMarañón. Madrid,España. Néstor Szerman, SaludMentalRetiro, Servicio Hospital Plan NacionalsobreDrogas,España. Francisco Babín,Delegado delGobiernopara deAsís el CHAIRS: THEEXPERT:ASK NIDA DIRECTOR DRVOLKOW Auditorium España. Ana GonzálezPinto, HospitalSantiagoApóstol.Vitoria, BIPOLAR DISORDERSANDCANNABIS BIPOLAR DUAL DISORDERS Addictions and other Mental Disorders

Track: Behavioral Addictions andDualDisorders Track: Psychopathology andDualDisorders MAIN LECTURE-ML06 MAIN LECTURE-ML05 62 16:30 -18:00 WORK OPPORTUNITIES OFYOUNG PSYCHIATRISTS? INDUAL DISORDERS:IMPROVINGTRAINING THE (EFPT) TRAINEES FORUM OFEUROPEAN FEDERATION OFPSYCHIATRIC DEBATE España. Estíbaliz López deMunain,HospitalRamón yCajal Madrid, NATIONS INTHEDIFFERENT DISORDERS ANDADDICTIONS WORKING OPPORTUNITIES INTHEFIELDOFDUAL DEBATE España. Carlos Gómez,HospitalVirgen DeLa Victoria. Málaga, WORLDWIDE DIFFERENCES INDUAL DISORDERS TRAINING SPEAKERS: España. Estíbaliz López deMunain,HospitalRamón yCajal Madrid, España. Carlos Gómez,HospitalVirgen DeLa Victoria. Málaga, Marañón. Madrid,España. Julia Cambra,HospitalGeneral UniversitarioGregorio CHAIRS: Room Castilla

Track: Training inDualDisorders DEBATE FORUM-DF03 63 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 16:30 -18:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & United Kingdom. Kah Mirza,InstituteofPsychiatry, King´sCollege. London, DISORDER INYOUTH THE TREATMENT OFADHDANDSUBSTANCE USE USA. Oscar Bukstein, BostonChildren’s Hospital.Boston, MA, SUBSTANCE USEDISORDER INYOUTH THE TREATMENT OFCONDUCT DISORDERAND Charleston, SC,USA. Kevin Gray, Medical UniversityofSouthCarolina. AND CO-OCCURRING DEPRESSIONINYOUTH PHARMACOTHERAPIES USE DISORDER FOR CANNABIS Medicine. CT, USA. Yifrah Kaminer, UniversityofConnecticut School of USE DISORDERS OCCURRING DEPRESSION INYOUTH WITHSUBSTANCE PSYCHOSOCIAL FOCUSED INTERVENTIONS FOR CO- SPEAKERS: Medicine. CT, USA. Yifrah Kaminer, UniversityofConnecticut School of CHAIR: Room Hidalgo UPDATES TREATMENT OFDUAL DISORDERSINYOUTH: DUAL DISORDERS Addictions and other Mental Disorders

Track: ChildandAdolescent Psychiatry SYMPOSIUM -SY13 64 16:30 -18:00 ADHD ANDSUBSTANCE ABUSE NEUROBIOLOGICAL DEPRESSION, LINKBETWEEN A ANHEDONIA: EXAMINING VERSUS TRAIT UNDERSTANDING THE IMPORTANCE OFSTATE Disorders. Toronto, ON,Canada. Martin Katzman,START Clinicfor MoodandAnxiety ASSOCIATED TREATMENT IMPLICATIONS SYSTEMANDTHE AND THEENDOCANNABINOID NEUROMODULATION BY THECATECHOLAMINES, THE NEUROBIOLOGY OFTHEPREFRONTAL CORTEX: Toronto, ON,Canada. STARTTia Sternat, Clinicfor MoodandAnxietyDisorders. AND SUBSTANCE USE HEDONIC TONE: ABIOLOGICAL ADHD LINKBETWEEN Toronto, ON,Canada. Epstein, STARTIrvin Clinicfor MoodandAnxietyDisorders. CO-OCCURRING ADHDANDSUBSTANCE USE THE EPIDEMIOLOGY IMPLICATIONS ANDCLINICAL OF SPEAKERS: Disorders. Toronto, ON,Canada. Martin Katzman,START Clinicfor MoodandAnxiety CHAIR: Room Doblón

Track: Psychopathology andDualDisorders SYMPOSIUM -SY14 65 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 16:30 -18:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & Sebastián/ Donostia,España. Enrique Echeburúa, UniversidaddelPaísVasco. San WITHCHRONICIN INDIVIDUALS SCHIZOPHRENIA BEHAVIORAL TREATMENT OFGAMBLINGDISORDER COGNITIVE- AFTER OFRELAPSE PREDICTION Gabriele Fischer, Medical UniversityofVienna.Austria. DISORDER ANDCO-OCCURRING COMORBIDITIES PATHOLOGICAL GAMBLING,SUBSTANCE USE Research Institute.Alberta, Canada. Nady El-Guebaly,UniversityofCalgary, Alberta Gambling OVERVIEW ANDCONSEQUENCES OFCAUSES GAMBLING DISORDERSANDCOMORBIDITIES: SPEAKERS: Gabriele Fischer, Medical UniversityofVienna.Austria. CHAIR: Room ElEscorial GAMBLING ANDDUAL DISORDERS DUAL DISORDERS Addictions and other Mental Disorders

SYMPOSIUM -SY15 Track: Behavioral Addictions andDualDisorders 66 16:30 -18:00 (ADHD) ANDSUBSTANCE USEDISORDER(SUD)? DISORDER ATTENTION DEFICITHYPERACTIVITY THELINKBETWEEN IS EMOTIONAL LABILITY Porto Alegre Clinical Hospital.PortoAlegre, Brasil. Eugenio H.Grevet, Federal UniversityofRioGrande doSul, TREATMENT OFEMOTIONAL LABILITY d’Hebron. Barcelona, España. J. Antoni Ramos-Quiroga,HospitalUniversitariVall INADHDANDSUD EMOTIONAL LABILITY Barcelona,(VHIR). España. IOETAN,Laura Gisbert, Vall d’HebronInstitutdeRecerca FACTOR FOR SUDINADULTHOOD? OVER CHILHOOD:ISITARISK EMOTIONAL LABILITY SPEAKERS: d’Hebron. Barcelona, España. J. Antoni Ramos-Quiroga,HospitalUniversitariVall CHAIR: Room ElJardín

Track: Psychopathology andDualDisorders SYMPOSIUM -SY16 67 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 17:15 -18:00 16:30 -17:15 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & MENTAL HEALTH HOW TOLEARNING IMPROVE RESILIENCEFROM FRONTAL LOBE OFTHE DUETOFUNCTIONS HYPOFUNCTIONALITY ACONSEQUENCERELAPSE: OF ALTERED EXECUTIVE Real. España. Isabel Montoya, GerenciadeAtención Integrada deCiudad Carmen Marroquí,ÁreaSanitariadeCiudadReal. España. Ciudad Real. España. Mª delMarSánchez,GerenciadeAtención Integrada de SPEAKER: Ciudad Real. España. Mª delMarSánchez,GerenciadeAtención Integrada de CHAIR: Room Comendador de Chile, Chile. Diana Kushner, UniversidaddeSantiagoChile. Santiago RELAPSE EXECUTIVE DYSFUNCTIONS PREDICTORS OFA AS Santiago deChile, Chile. Humberto Guajardo,UniversidaddeSantiagoChile. EXECUTIVE FUNCTIONS AFACTORDUAL DISORDERAS FOR RIGIDIZING SPEAKERS: Santiago deChile, Chile. Humberto Guajardo,UniversidaddeSantiagoChile. CHAIR: Room Comendador DUAL DISORDERS Addictions and other Mental Disorders WORKSHOP -WS06 WORKSHOP -WS05

Track: Psychotherapeutic Treatments inDualDisorders Track: Psychotherapeutic Treatments inDualDisorders 68 16:30 -18:00 1 FSBI InstituteofInternalandPreventive Medicine,Russia. Gafarova Vladimir Maximov, DmitriyPanov, IgorGagulin,Almira Valery Gafarov, MikhailVoevoda, ElenaGromova, (NPSR1) POLYMORPHISM SLEEP DISORDERSANDNEUROPEPTIDE RECEPTOR GENE Lev-Hasharon Medical Center, Israel. Daniel Feingold MARIJUANA OPIOIDS ANDMEDICAL CHRONIC PAIN PATIENTS RECEIVING PRESCRIPTION PROBLEMATIC USEOFPAIN MEDICATIONS AMONG CO-OCCURRING AND DEPRESSION,ANXIETY 2 Carmen Coutado TO AFRONTOTEMPORAL DEFICIT AWAY DISORDER, ATTENTION DEFICITHYPERACTIVITY Freelance Professional,Italy. Emanuela Atzori DISORDERS. APRELIMINARY STUDY A CRAVING INSUBSTANCES ABUSEANDEATING ATRIGGERMECHANISMTHE SELFAS DETERMINING THE ALTERATION OFTHESENSORY-COSCIOUSNESS OF Barcelona, España. Laia Rodriguez-Cintas,HospitalUniversitariVall d'Hebron. Florence Vorspan, deParis,France. Publique-Hôpitaux CHAIRS: Room Escudo   Municipalidad SanMartin,BuenosAires,Argentina. ONG Cedisam Argentina, Argentina. ORAL COMMUNICATIONS -OC03 1 , JorgeMorenoHueyo 69 23 -26March, Madrid -Spain 2 2017

FRIDAY 24 FRIDAY 24 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & 1 Kun-Ha Lee AND HEROIN USEAMONGHEROIN ABUSERSINTAIWAN THE RELATIONSHIPS AMONG NEUROTIC, DEPRESSION 3 2 Guillermo Nicolas Jemar DISORDERANDSUBSTANCEPERSONALITY USE EMPATHY ANDSOCIALCOGNITION INBORDERLINE Denmark. Aarhus University, Centre for Alcohol andDrugResearch, Morten Hesse, Birgitte Thylstrup DISORDER PSYCHOEDUCATION FOR ANTISOCIALPERSONALITY COUNSELLING -BRIEF LIFESTYLE IMPULSIVE 3 2 Eliot Gardner PSYCHOSTIMULANT DRUGABUSE RATS: IMPLICATIONS FOR THEETIOLOGY OF CHOICEINLABORATORY ANDIMPULSIVE COCAINE 3 2 Ratika Srivastava 1 1 Ezequiel Mercurio Bartoli         DUAL DISORDERS Addictions and other Mental Disorders Edmonton, Alberta, Canada. Faculty ofMedicineandDentistry, UniversityofAlberta, Baltimore, Maryland, USA. The JohnsHopkinsUniversitySchool ofMedicine, Maryland, USA. U.S. NationalInstituteonDrugAbuse,Baltimore, Medical University, Kaohsiung, Taiwan. Faculty ofMedicine,College ofMedicine,Kaohsiung Kaohsiung Medical UniversityHospital,Kaohsiung, Taiwan. Yuli Hospital, MinistryofHealthandWelfare, Taiwan. PenitenciarioFederalServicio Argentino, Argentina. psicopatías, Argentina. Sociedad Argentina deTrastornos dela personalidady Argentina PenitenciarioFederal - Servicio Argentino. Hospital JoseT. Borda -AsociaciónNeuropsiquiatrica 2 , MartínMazzoglio yNabar 1 , Cheng-Fang Yen 1 , MatthewJohnson 3 2 , MarianaEdith Salech 70 1 , RamiroSantiagoIsla 2,3 2 , NatalieBruner 3 2 , Gastón 2 , 2 , 19:15 -20:00 18:30 -19:15 18:30 - 18:00 Bethesda. MD, USA. Carlos Blanco, NationalInstituteonDrugAbuse(NIDA), SPEAKER: Madrid, España. Jerónimo Sáiz,UniversidaddeAlcalá, Hospital Ramón yCajal CHAIR: Auditorium Washington, USA. Ruben Baler, NationalInstituteonDrugAbuse. SPEAKER: Nervioso (Grupo Cisne).Bogotá,Colombia. Rodrigo Córdoba, Centro deInvestigaciones delSistema CHAIR: Auditorium ADDICTION) HYPOTHESISADDICTION) TESTING THEDRUGSUBSTITUTION(SWITCHING MENTAL DISORDERS IN THETREATMENT ANDOTHER OFADDICTIONS TOP DOWN ANDBOTTOM UP:EMERGING CONCEPTS

in DualDisorders Track: Investigation, Development andE-HealthTechnologies for DualDisorders Track: ThePresent IllegalDrugsasaFuture Medication MAIN LECTURE-ML08 MAIN LECTURE-ML07 COFFEE BREAK 71 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 18:30 -19:15 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & MENTAL HEALTH ISSUES HOUSING FIRSTFOR HOMELESSPOPULATION WITH Fundación. España. Alejandro López, Subdirector General Técnico de RAIS HABITAT PROGRAM IMPLEMENTING HOUSINGFIRSTINSPAIN: THE Portugal. José Ornelas,Responsable delProyecto HousingFirsten INTEGRATIONCOMMUNITY THROUGH HOUSINGFIRST in France. France. Pascale Estecahandy, Responsible for HousingFirstProject RESULTS OFTHEUNCHEZSOID’ABORD PROGRAM SPEAKERS: Fundación. España. Roberto Bernad,HousingFirstresearcher en RAIS CHAIR: Room Castilla DUAL DISORDERS Addictions and other Mental Disorders

Track: Intervention inDualDisorders Multidisciplinary WORKSHOP -WS07 72 19:15 -20:00 University oftheWest Indies.Kingston,Jamaica. Abigail Harrison,UniversityHospitaloftheWest Indies, IN THECONTEXT OFFAMILY CENTEREDCARE EATING DISORDERSANDSUBSTANCE USEDISORDER TREATMENT OFADOLESCENTSWITHCO-OCCURRING Children’s Hospital.Ankara, Turkey. Nuray Kanbur, Hacettepe University, İhsanDoğramacı SUBSTANCE USEDISORDERS OF ASSOCIATIONS EATING BETWEEN DISORDERSAND SUBSTANCE USEDISORDERS, ANDPOTENTIAL CAUSES OFEATINGCOMORBIDITY DISORDERSAND SPEAKERS: Children’s Hospital.Ankara, Turkey. Nuray Kanbur, Hacettepe University, İhsanDoğramacı CHAIR: Room Castilla PATIENT INTHECONTEXT OFFAMILY CENTEREDCARE DISORDERS: ANAPPROACH TO THEADOLESCENT CO-OCCURRENCE OFSUBSTANCE USEANDEATING

Track: Behavioral Addictions andDualDisorders WORKSHOP -WS08 73 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 18:30 -20:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & TOOLS FOR DUAL DISORDERS Málaga, HospitalRegional UniversitariodeMálaga. España. Francisco J. Pavon, InstitutodeInvestigación Biomédica de DUAL DISORDERS IDENTIFICATION OFPOTENTIAL BIOMARKERSFOR Mèdiques. Barcelona, España. Laura I.Furlong, InstitutHospitaldelMard’Investigacions PSYCHIATRIC ANDTHEIRGENES DISEASES PsyGeNET: AKNOWLEDGE PLATFORM ON Columbia University. NY, USA. Deborah Hasin,NewYork StatePsychiatric Institute, PRISM-5 A DIAGNOSTIC INTERVIEW FOR DUAL DIAGNOSIS: THE SPEAKERS: España. Parc deSalutMar, UniversitatAutònom deBarcelona. Marta Torrens, InstitutdeNeuropsiquiatriaIAddiccions- CHAIR: Room Hidalgo DUAL DISORDERS Addictions and other Mental Disorders

Track: Training inDualDisorders SYMPOSIUM -SY17 74 18:30 -20:00 Fundación JimenezDíaz.Madrid,España. Juncal Sevilla,UniversidadAutónoma de Madrid, Barcelona, España. Constanza Daigre, HospitalUniversitarioVall d'Hebron, d’Hebron. Barcelona, España. J. Antoni Ramos-Quiroga,HospitalUniversitariVall Hoth A.C. Mexico. Mª ElenaFrade, Proyectodah, FundaciónCultural Federico Leonor. Madrid,España. Francisco J. Quintero, HospitalUniversitarioInfanta Universitat deValencia. Valencia, España. José Martínez-Raga,HospitalUniversitarioDr. Peset, Psychiatric Institute. NY, USA. Frances Levin, NewYork PresbiterianHospital,NYS España. César Soutullo,Clínica UniversidaddeNavarra. Pamplona, SPEAKERS: Universitat deValencia. Valencia, España. José Martínez-Raga,HospitalUniversitarioDr. Peset, CHAIR: Room Doblón SUBSTANCE USEDISORDERS DISORDERAND ATTENTION DEFICITHYPERACTIVITY

Track: Psychopathology andDualDisorders DEBATE FORUM-DF04 75 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 18:30 -20:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & CANNABIS CONTROVERSIESFRAMEWORK: ONTHEUSEOF DISORDERS WITHINLATIN COLLABORATION AMERICA NEW CHALLENGESINTHEMANAGEMENT OFDUAL La Coruña, España. dePsiquiatría,SERGAS. Mª CarmenGarcía-Mahía,Servicio EVALUATION PROTOCOL THE HEALTH PROPOSAL CORUÑA. OF OFLA AREA DERIVATIVESIN CONSUMERS OFCANNABIS IN ANALYSIS OFPSYCHIATRIC DISORDERSINDICATORS Estado. Montevideo,Uruguay. Vulnerables dela Administración deSaluddel deServicios Gabriel Rossi,Dirección deSaludMentalyPoblaciones THE CURRENTSITUATION INURUGUAY César Pereiro, ACLAD. La Coruña, España. DILEMMAS CANNABIS SPEAKERS: Colombia. Castaño,UniversidadCES.Medellín, Guillermo A. CHAIR: Room ElEscorial DUAL DISORDERS Addictions and other Mental Disorders

SYMPOSIUM -SY18 Track: Substance andDualDisorders UseDisorders 76 18:30 -20:00 Parc deSalutMar. Barcelona, España. Francina Fonseca, InstitutdeNeuropsiquiatriaiAddiccions, WHO USEDRUGSANDTHEIRCHILDREN PSYCHOSOCIAL INTERVENTIONS AMONGWOMEN Parc deSalutMar. Barcelona, España. Adriana Farré, InstitutdeNeuropsiquiatriaiAddiccions, USE DRUGS POSTPARTUM DEPRESSIONAMONGWOMEN WHO Mèdiques. Barcelona, España. Judit Tirado,InstitutHospitaldelMard’Investigacions ASSOCIATED FACTORS WHO INJECT DRUGS INEUROPE: PREVALENCE AND PSYCHIATRIC AMONGWOMEN COMORBIDITY SPEAKERS: Barcelona, España. Biomédica August PiISunyer (IDIBAPS),CIBERSAM. Rocio Martín-Santos, Institutd’Investigació HospitalClínic, CHAIR: Room ElJardín SOCIAL CONSEQUENCES WOMEN WHOUSE DRUGS: COMORBIDITIES AND

Track: GenderandDualDisorders SYMPOSIUM -SY19 77 23 -26March, Madrid -Spain 2017

FRIDAY 24 FRIDAY 24 18:30 -20:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & Barcelona, España. Raquel Vidal,HospitalUniversitariVall d’Hebron. DISORDERS (FASD) ADOLESCENTS WITHFETAL ALCOHOL SPECTRUM PSYCHOLOGICAL INTERVENTION INCHILDRENAND Barcelona, España. Élida Vázquez, HospitalUniversitariVall d’Hebron. ALCOHOL SPECTRUM DISORDERS(FASD) NEUROIMAGING FINDINGSINPATIENTS WITH FETAL Barcelona, España. Nuria Gómez,HospitalUniversitariVall d’Hebron. ALCOHOL SPECTRUM DISORDERS(FASD) IMPAIRMENTFUNCTIONAL INPATIENTS WITHFETAL SPEAKERS: Barcelona, España. Nuria Gómez,HospitalUniversitariVall d’Hebron. CHAIR: Room Comendador DISORDERS (FASD) PATIENTS WITHFETAL ALCOHOL SPECTRUM COGNITIVE IMPAIRMENT ANDFUNCTIONAL IN DUAL DISORDERS Addictions and other Mental Disorders SYMPOSIUM -SY20

Track: ChildandAdolescent Psychiatry 78 18:30 -20:00 Arcos 2 Ana Samico SUBSTANCE ABUSEPATIENTS ADHERENCEIN ANDTHERAPEUTIC IMPULSIVITY Israel. Treatment andResearch, Tel-Aviv Sourasky Medical Center, Dr. MiriamandSheldon G.AdelsonClinic for DrugAbuse David Potik TREATMENT PATIENTS AMONGMETHADONE MAINTENACE TRANSGRESSIONS PSYCHOPATHY ANDBEHAVIORAL DRUGABUSE, LEVELS, THE RELATIONSHIP DIFFERENT BETWEEN 5 4 3 2 Luis AlfonsoNúñezDomínguez SUFFERING ADHWITHCOMORBID DRUGUSE TREATMENT INTHELONG-TERM OUTCOME INPATIENTS THE INFLUENCE OFPSYCHOPHARMACOLOGICAL España. Gonzalo Haro,Consorcio HospitalProvincial deCastellón, América Latina, Guatemala. Enrique Mendoza, PresidenteAsociaciónPsiquiátrica de CHAIRS: Room Escudo Laura Montes Reula 1 1 Portillo Fernández        Equipa deTratamento Oriental,Portugal. Centro Hospitalar Vila Nova deGaiaeEspinho,Portugal. Centro SaludMental,Tudela, España. Centro SaludMental,Tafalla, España. Red deSaludMentalNavarra, España. Hospital deDíaZuría, España. Medical Center Pamplona, España. 2 , NoeliaLópez Olmo ORAL COMMUNICATIONS -OC04 1 , ÂngelaVenâncio 3 , MaríaGarcíaNicolás 3 79 , OlgaArbeoRuiz 3 , Eduardo ManriqueAstiz 23 -26March, 1 , CristinaRecalde 1 , LauraBarradolos Madrid -Spain 2 , Almudena 5 2 2017 4 ,

FRIDAY 24 FRIDAY 24 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & 1 2 Khatuna Todadze OPIOID DEPENDENTPATIENTS DEPRESSION INDIFFERENTINITIALSUBSTANCE USER INFLUENCE OFOPIOIDSUBSTITUTIONTREATMENT ON Biella, Italy. Addiction Treatment Centre Cossato, Local HealthUnit Lorenzo Somaini PSYCHOBIOLOGICAL CORRELATES MAINTENANCE TREATMENT: HISTORY CLINICAL AND SEXUAL DYSFUNCION ANDMETHADONE Foundation,The Bergen Clinics Norway. Skutle Arvid ADHD MAKEADIFFERENCE? DISORDER’ PATIENTS WITHANDWITHOUTADHD. DOES EDUCATIONAL PROBLEMS IN‘SUBSTANCE USE EARLY DEVELOPMENTAL, TEMPERAMENTAL AND of DrugAddiction, Slovenia. University Psychiatric ClinicLjubljana,Center For Treatment AndrejKastelic, KarmenKajdiz Nusa Segrec, AGONIST TREATMENT SEXUAL DYSFUNCTION AMONGPATIENTS INOPIOID   DUAL DISORDERS Addictions and other Mental Disorders Tbilisi, Georgia. Center for Mental HealthandPreventionofAddiction, Tbilisi StateMedical University, Tbilisi,Georgia. 1,2 , Sopiko Mosia 80 2 PROGRAMME SATURDAY MARCH 25

CONGRESS APP Navigate through the First World Congress of the World Association of Dual Disorders (WADD) & Fifth International Congress of the Spanish Society of Dual Disorders (SEPD) programme from your iPhone, iPad, and Android. View sessions by day and category, locate exhibitors and create your own itinerary to fully exploit your congress. SATURDAY 25 SATURDAY http://www.icdd-congress.com/ scientific-information/app-mobile/ Use this code to unlock the APP if it is required: 85962

www.icdd-congress.com SATURDAY 25 18:30 -19:00 18:15 -18:30 17:30 -18:15 16:45 -17:30 16:00 -16:45 15:15 -16:00 10:00 -10:45 09:15 -10:00 08:30 -09:15 14:30 -15:15 13:30 -14:30 12:45 -13:30 12:00 -12:45 11:30 -12:00 10:45 -11:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & PS03 Toward a specific to question? a"simple" integrative treatment in Neurobiological bases outcomes ofcannabis AUDITORIUM have answer asimple ML15 New findingsin Dual Disorders ML09 DualDisorders hyperactivity disorder hyperactivity disorder and bipolar disorders and bipolardisorders psychopathology: An psychopathology: ML12 Examining the association between the literature tell us? disorder: Whatdoes disorder: opioid usedisorders disorders: Afamilialdisorders: Management ML14 Management ML16 Addictive-like and substance use and substance use ML13 Evolutionary use -why don'twe by palatablefood: ML11 Psychiatric behavior induced of substance use of substance use psychopathology DUAL DISORDERS Addictions and other Mental Disorders and treatment of ML10 Diagnosis attention deficit attention deficit Dual Disorders risk analysis comorbidity and suicide disorders SATURDAY MARCH 25,2017 cultural gamechanger. SY26 DualDisorders: Epidemiology ofDual SY35 DualDisorders working in a shifting working inashifting with Dual Disorders with DualDisorders Disorders: Science Disorders: to inform clinicians assertive outreachassertive determined during and neuroscience Effects of working social landscape CASTILLA SY21 C-Flex -A COFFEE BREAK(Best Poster Award Winners) Is everything childhood? ROOM SY30 The patients 82 LUNCH BREAK substances andmental interventions basedon SY31 Current situation programme CME/CPD monotherapy increase bipolar disorder: Time bipolar disorder: disorder andattention Industry Symposium Industry and psychopathology psychopharmacology recommendations for research and service research andservice of New Psychoactive Session not included health; evidence and clinical epidemiology and affective profiles comorbid substancecomorbid patients withbipolar Substances (NPS), deficit hyperactivity SY22 Treatment of in officialscientific use disorders and use disorders consumption and suicidal behavior SY41 Substance methylphenidate to tailoreffective development of HIDALGO risk ofmaniain psychoactive SATELLITE SY36 Novel SY27 Does ROOM disorder? provision management inclinical management model andresults from model for with persons programme CME/CPD concurrent substance Industry Symposium Industry care andcontingency Disorders: IntegrativeDisorders: epidemiology ofDual SY32 DualDisorders SY42 Acollaborative Session not included Members and public and Members the evaluation ofthe of drugdependence treatment centers in perspectives onthe in Asia:Experience prespectiveWADD Disorders, aworldDisorders, in officialscientific use disorders and use disorders Description ofthe treatment ofDual SY23 Lifecourse DOBLÓN mental illness. DF05 WADD Forum. Dual SATELLITE SY37 New ROOM Disorders Vietnam practice model included inofficialscientific SATELLITE Symposium infection andprogression the ChildandAdolescent prison. Past, present and Limitations ofthecurrent mental disorders among mental disorders WS16 in DualDisorders SY28 Cuttingthegrass: SOCIDROGALCOHOL as determinants ofHIV SY24 Relevance ofthe programme CME/CPD WS15 Presentation of Working Group ofthe SY38 DualDisorders Industry Sessionnot Industry SY33 Management cocaine dependent meassurements of of patientsindaily clinical practice – ESCORIAL ROOM EL cannabis use patients SEPD future included inofficialscientific COFFEE BREAK(Best Poster Award Winners) disorders andco-occurringdisorders Latin Americanpopulation program): Agoodpractice patients withdiabetes and SY39 reduction Harm and SATELLITE Symposium co-morbid viral infectionsco-morbid of medicaldeontology is SY25 Perspective ofthe addictive disorder inthe SY43 in DualDisorders substance usedisorder programme CME/CPD SY34 New horizons of PAIME (Sickdoctors Industry Sessionnot Industry across thelifespan SY29 Depressive ROOM EL Dual Disorders JARDÍN exported LUNCH BREAK WS10 Getting ready for the scale free networks inDual research inDualDisorders the severe mentaldisorder disorder as Dual Disorder: disorder asDualDisorder: neurocrime appliedto the and corrupt behavior and aspects of“non-invasive”aspects COMENDADOR therapeutic experiences: Diagnosis andtreatment change; stopchange; smokingin study ofviolent,criminal work intheHPFBA dual WS14 Smallworld and Interdisciplinary WS13 Interdisciplinary WS12 Neurobiological pathological gambling SY44 DualDisorders, case reports andnew case reports neuromodulation and neuropsychiatry and neuropsychiatry and Dual Disorders and DualDisorders WS09 Hypersexual WS11 Update on SY40 Forensic substance use management Mindfulness ROOM Disorders clinic ROOM ESCUDO Communications Communications Communications Communications Communications OC05 Oral OC07 Oral OC08 Oral OC06 Oral OC09 Oral 08:30 -09:15 12:00 -12:45 11:30 -12:00 10:45 -11:30 10:00 -10:45 09:15 -10:00 18:30 -19:00 18:15 -18:30 17:30 -18:15 16:45 -17:30 16:00 -16:45 15:15 -16:00 14:30 -15:15 13:30 -14:30 12:45 -13:30 PS03 Toward a specific to question? a"simple" integrative treatment in Neurobiological bases outcomes ofcannabis AUDITORIUM have answer asimple ML15 New findingsin Dual Disorders ML09 DualDisorders hyperactivity disorder hyperactivity disorder and bipolar disorders and bipolardisorders psychopathology: An psychopathology: ML12 Examining the association between the literature tell us? disorder: Whatdoes disorder: opioid usedisorders disorders: Afamilialdisorders: Management ML14 Management ML16 Addictive-like and substance use and substance use ML13 Evolutionary use -why don'twe by palatablefood: ML11 Psychiatric behavior induced of substance use of substance use psychopathology and treatment of ML10 Diagnosis attention deficit attention deficit Dual Disorders risk analysis comorbidity and suicide disorders SATURDAY MARCH 25,2017 cultural gamechanger. SY26 DualDisorders: Epidemiology ofDual SY35 DualDisorders working in a shifting working inashifting with Dual Disorders with DualDisorders Disorders: Science Disorders: to inform clinicians assertive outreachassertive determined during and neuroscience Effects of working social landscape CASTILLA SY21 C-Flex -A COFFEE BREAK(Best Poster Award Winners) Is everything childhood? ROOM SY30 The patients LUNCH BREAK substances andmental interventions basedon SY31 Current situation programme CME/CPD monotherapy increase bipolar disorder: Time bipolar disorder: disorder andattention Industry Symposium Industry and psychopathology psychopharmacology recommendations for research and service research andservice of New Psychoactive Session not included health; evidence and clinical epidemiology and affective profiles comorbid substancecomorbid patients withbipolar Substances (NPS), deficit hyperactivity SY22 Treatment of in officialscientific use disorders and use disorders consumption and suicidal behavior SY41 Substance methylphenidate to tailoreffective development of HIDALGO risk ofmaniain psychoactive SATELLITE SY36 Novel SY27 Does ROOM disorder? provision management inclinical management model andresults from model for with persons programme CME/CPD concurrent substance Industry Symposium Industry care andcontingency Disorders: IntegrativeDisorders: epidemiology ofDual SY32 DualDisorders SY42 Acollaborative Session not included Members and public and Members the evaluation ofthe of drugdependence treatment centers in perspectives onthe in Asia:Experience prespectiveWADD Disorders, aworldDisorders, in officialscientific use disorders and use disorders Description ofthe treatment ofDual SY23 Lifecourse DOBLÓN mental illness. DF05 WADD Forum. Dual SATELLITE SY37 New ROOM Disorders Vietnam practice model included inofficialscientific SATELLITE Symposium infection andprogression the ChildandAdolescent prison. Past, present and Limitations ofthecurrent mental disorders among mental disorders WS16 in DualDisorders SY28 Cuttingthegrass: SOCIDROGALCOHOL as determinants ofHIV SY24 Relevance ofthe programme CME/CPD WS15 Presentation of Working Group ofthe SY38 DualDisorders Industry Sessionnot Industry SY33 Management cocaine dependent meassurements of of patientsindaily clinical practice – ESCORIAL ROOM EL cannabis use patients SEPD future included inofficialscientific COFFEE BREAK(Best Poster Award Winners) disorders andco-occurringdisorders Latin Americanpopulation program): Agoodpractice patients withdiabetes and SY39 reduction Harm and SATELLITE Symposium co-morbid viral infectionsco-morbid of medicaldeontology is SY25 Perspective ofthe addictive disorder inthe SY43 in DualDisorders substance usedisorder programme CME/CPD SY34 New horizons of PAIME (Sickdoctors Industry Sessionnot Industry across thelifespan SY29 Depressive ROOM EL Dual Disorders JARDÍN exported LUNCH BREAK 83 WS10 Getting ready for the scale free networks inDual research inDualDisorders the severe mentaldisorder disorder as Dual Disorder: disorder asDualDisorder: neurocrime appliedto the and corrupt behavior and aspects of“non-invasive”aspects COMENDADOR therapeutic experiences: Diagnosis andtreatment change; stopchange; smokingin study ofviolent,criminal work intheHPFBA dual WS14 Smallworld and Interdisciplinary WS13 Interdisciplinary WS12 Neurobiological pathological gambling SY44 DualDisorders, case reports andnew case reports neuromodulation and neuropsychiatry and neuropsychiatry and Dual Disorders and DualDisorders WS09 Hypersexual WS11 Update on SY40 Forensic substance use management Mindfulness ROOM Disorders clinic 23 -26March, Madrid -Spain ROOM ESCUDO Communications Communications Communications Communications Communications OC07 Oral OC05 Oral OC06 Oral OC08 Oral OC09 Oral 2017

SATURDAY 25 SATURDAY 25 09:15 -10:00 -09:1508:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders DISORDER: WHAT DOESTHE LITERATURE TELLUS? DISORDERANDSUBSTANCEHYPERACTIVITY USE DIAGNOSIS ANDTREATMENT OFATTENTION DEFICIT DUAL DISORDERSANDSUICIDE Psychiatric Institute.NY, USA. Frances Levin, NewYork PresbiterianHospital,NYS SPEAKER: España. Constanza Daigre, HospitalUniversitarioVall d’Hebron,Barcelona, CHAIR: Auditorium Veterans’ Administration Medical. NY, USA. Leo Sher, MountSinaiSchool of Medicine/James J.Peters SPEAKER: España. Clínica Galatea, HospitalUniversitariVall d’Hebron.Barcelona, Mª DoloresBraquehais,UniversitatAutònoma deBarcelona, CHAIR: Auditorium

Track: Psychopathology andDualDisorders Track: Psychopathology andDualDisorders MAIN LECTURE-ML09 MAIN LECTURE-ML10 84 08:30 -10:0008:30 DISORDERS PATIENTS OF WORKING OUTREACH WITHDUAL ASSERTIVE C-FLEX -ACULTURAL EFFECTS GAMECHANGER. Bror JustAndersen,Vestre Viken HT. Baerum,Norway. MODELTESTING OF RESEARCH -3YEARS EFFECT OFTHE C-FLEX INPRACTICE TEAM Augedal,Aslak Vestre Viken HT. Baerum,Norway. DUAL DISORDERPATIENTS INTERDISCIPLINARY OUTREACH WITH ASSERTIVE OFWORKING 3YEARS EXPERIENCESAFTER PRACTICE Lars Linderoth,Vestre Viken HT. Baerum,Norway. PATIENTS WITHDUAL DISORDERS OUTREACH PRACTICE AGAMECHANGERINASSERTIVE THE C-FLEX AS TEAM SPEAKERS: Bror JustAndersen,Vestre Viken HT. Baerum,Norway. CHAIR: Room Castilla

Track: Intervention inDualDisorders Multidisciplinary SYMPOSIUM -SY21 85 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 08:30 -10:0008:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders France. deParis,FondaMental Foundation,Romain Icick,Hôpitaux GROUPTHERAPEUTIC PRELIMINARY DATA OFAMINDFULNESS-BASED DISORDERS: ALITERATURE REVIEWAND FOR COMORBID SUBSTANCE USEANDBIPOLAR EVIDENCE TO TAILOR EFFECTIVE INTERVENTIONS USING EXISTINGEPIDEMIOLOGICAL ANDCLINICAL Oslo UniversityHospital,ofOslo, Norway. Trine V. Lagerberg,K.G. Jebsen Psychosis Research Centre, ILLNESS WITH BIPOLAR COMORBID ALCOHOL USEDISORDERINOUTPATIENTS ACORE AS FEATUREAFFECTIVE OF LABILITY Montpellier. Montpellier, France. HopitalLapeyronie,Sylvain Thiebaut, Universitéde CHILDHOOD TRAUMA DISORDER:THE ROLE OFGENDERAND BIPOLAR TOBACCO SMOKINGANDSUICIDEATTEMPTS IN SPEAKERS: France. deParis,FondaMental Foundation,Romain Icick,Hôpitaux CHAIR: Room Hidalgo EPIDEMIOLOGY ANDAFFECTIVE PROFILES EFFECTIVE ONCLINICAL INTERVENTIONS BASED DISORDER: TIMETO TAILORDISORDERS ANDBIPOLAR TREATMENT OFCOMORBID SUBSTANCE USE

Track: Psychopathology andDualDisorders SYMPOSIUM -SY22 86 08:30 -10:0008:30 LIFECOURSE EPIDEMIOLOGY OFDUAL DISORDERS Madrid, España. Francisco Arias,HospitalUniversitario12DeOctubre. MISUSE SERVICES MENTALCOMMUNITY HEALTH ANDSUBSTANCE OUTPATIENTS WITHDUAL DISORDERSIN MADRID STUDY ONTHEPREVALENCE OF Ramón dela FuenteMuñiz.CiudaddeMéxico, México. Rodrigo Marín-Navarrete, InstitutoNacionaldePsiquiatría FACILITIES FOR SUBSTANCE USE COMMUNITY-BASED MEXICAN RESIDENTIALCARE CO-OCCURRING DISORDERS:ACHALLENGEFOR Australia. Caroline Salom,UniversityofQueensland. Brisbane, LIFECOURSE EPIDEMIOLOGY OFDUAL DISORDERS SPEAKERS: Health. Brisbane,Australia. Rosa Alati,UniversityofQueensland, School ofPopulation CHAIR: Room Doblón

Track: EpidemiologyandDualDisorders SYMPOSIUM -SY23 87 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 08:30 -10:0008:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Florence Vorspan, deParis,France. Publique-Hôpitaux FRENCH RESEARCH PSYCHOTICCOCAINE-INDUCED SYMPTOMS INTHE España. Carlos Roncero,UniversidadAutónoma deBarcelona, HALLUCINATIONS IS ASSOCIATED WITHTACTILE ANDSOMATIC ADDICTION OFCOCAINE HIGHER SEVERITY Cádiz, España. Francisco González-Saiz,HospitaldeJerez,Universidad PSYCHOSISCOCAINE-INDUCED SYMPTOMS DIAGNOSTIC OF TOOLS ASSESSMENT FOR CLINICAL SPEAKERS: Miguel Gutiérrez,UniversidaddelPaísVasco, España. CHAIR: Room ElEscorial COCAINE DEPENDENTPATIENTSCOCAINE RELEVANCE OFTHEMENTAL DISORDERSAMONG

SYMPOSIUM -SY24 Track: Substance andDualDisorders UseDisorders 88 08:30 -10:0008:30 LIFESPAN THE LATIN POPULATION AMERICAN ACROSS THE DISORDERIN PERSPECTIVE OFTHEADDICTIVE México, México. Alejandro Córdova, SecretaríadeSaludla Ciudad de TO IMPLEMENTSERVICES DUAL DISORDERS INLATIN PERSPECTIVE AMERICA: Enrique González,Cognitive México. &Behabioral Clinic, DISORDER DEFICIT HYPERACTIVITY DUAL DISORDERSINPATIENTS WITHATTENTION Mexicana dePsiquiatríaInfantil.México. Rosa I.Mézquita, Presidentaelecta dela Asociación DISORDER INADOLESCENCE DISORDER:ITS RELATION BIPOLAR WITHADDICTIVE Psiquiátrico deVenezuela. Caracas, Venezuela. Edgard AsociaciónMundialdePsiquiatría,Hospital Belfort, AMERICA SUBSTANCE ABUSEIN CHILDPOPULATION INLATIN CONSIDERATIONSSOCIODEMOGRAPHIC OF SPEAKERS: Iberolatinoamericana dePsiquiatría.México. Enrique Camarena,Presidentedela Asociación CHAIR: Room ElJardín

Track: EpidemiologyandDualDisorders SYMPOSIUM -SY25 89 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 08:30 -09:1508:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders España. María Contreras, Consulta Dr. Carlos Chiclana. Madrid, OF ANOTHER DISEASE? HYPERSEXUAL DISORDER:PATHOLOGY OR SYMPTOM España. Carlos Chiclana,UniversidadSanPablo CEU.Madrid, DISORDER APPROACHTHERAPEUTIC TO HYPERSEXUAL Barcelona, España. Verónica Ferrer, HospitalUniversitarioDexeusQuirón. DISORDER DIAGNOSIS ANDEVALUATION OFHYPERSEXUAL SPEAKERS: España. María Contreras, Consulta Dr. Carlos Chiclana. Madrid, CHAIR: Room Comendador DIAGNOSIS ANDTREATMENT DUALHYPERSEXUAL DISORDER: DISORDERAS WORKSHOP -WS09

Track: Psychopathology andDualDisorders 90 09:15 -10:00 Universidad deCórdoba. España. Fernando Sarramea, HospitalUniversitarioReina Sofía, PHARMACOTHERAPY FOR SMOKINGCESSATION REVIEW OFCURRENTEVIDENCETHE Universidad deCórdoba. España. María J. Jaen,HospitalUniversitarioReina Sofía, TOREADINESS CHANGE INTERVENTION ANDITSRELATION WITHTHE MOTIVATION TOOLS ANDRESULTS OFBRIEF Luis Gutiérrez,Complejo Hospitalario de Granada. España. ANDPSYCHOPATHOLOGYPHYSICAL RISKS SMOKING TOBACCO INSEVEREMENTAL DISORDER. SPEAKERS: Universidad deCórdoba. España. Fernando Sarramea, HospitalUniversitarioReina Sofía, CHAIR: Room Comendador THE SEVEREMENTAL DISORDER READYGETTING FOR THECHANGE;STOP SMOKINGIN WORKSHOP -WS10

Track: Training inDualDisorders 91 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 08:30 -10:0008:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders 1 1 Fernández 2 Hagit Bonny-Noach ACUTE PSYCHOSIS TRAVELERSRESCUING ISRAELI WITHDRUGINDUCED 5 4 3 2 Abel Baquero MENTAL ILLNESSASSOCIATED EVOLUTION OFCONSUMPTION OFSPICEDRUGSAND 3 2 Renju Baby INDIA HOSPITAL INKERALA, TREATMENTDE-ADDICTION FROM ATERTIARY CARE COMORBID PSYCHIATRIC INPATIENT ILLNESSAFTER SUBSTANCE USEDISORDERWITHANDWITHOUT AMONGPATIENTSPREDICTORS OFRELAPSE WITH Barcelona, España. Raul F. Palma, HospitalUniversitariVall d'Hebron. Center For Treatment ofDrugAddiction, Slovenia. Andrej Kastelic, UniversityPsychiatric Clinic Ljubljana, CHAIRS: Room Escudo 1 Delegido   Provincial HospitalConsorcium, Castellón, Spain. General Hospital, Valencia, Spain. ArnaudeVillanova Hospital,Valencia, Spain. AmigóFoundation, Castellón, Spain. UniversityCEU-Cardenal Herrera, Castellón, Spain. MOSCMedical College Hospital,India. AIIMS,NewDelhi,India. MOSCCollege ofNursing,India. Search &Rescue, Israel. Abarbanel MentalHealthCenter &MagnusInternational Israel. (ILSAM), Board Member-Israeli SocietyofAddiction Medicine Ariel University&Israel Anti-DrugAuthority & (IADA) ORAL COMMUNICATIONS -OC05 4 , GonzaloHaroCortes 1 1 , Cesar Mateu Henández , Sandhya Gupta 1,2 , MihaelaDalae 1 , MoranSagivAlayoff 92 2 , JosephVarghese 1 , IsabelAlmodóvar 1,5 3 , AnaBenito 2 3 2 Arne JanHjemsæter PERSONS WITHSUDS LONGITUDINAL STUDY OFTREATMENT SEEKING OF SUBSTANCE USEDISORDER(SUD) -A18YEAR MENTAL LONG-TERM DISTRESSPREDICTS OUTCOME Zentrum FürPsychiatrie Calw, Germany. David GurreaSalas INSPIRATION ORMUST? IN INPATIENT PSYCHIATRIC INGERMANY... SETTINGS SMOKING CESSATION PROGRAMS ANDREDUCTION Clinical UniversityHospitalofLa Coruña, Spain. Mahia, AnaPonte-Novo, CandelaQuiroga-Fernandez Agueda Fernandez-Quintana, MariadelCarmen Garcia- DEPARTMENTEMERGENCY PSYCHOSISCANNABIS-INDUCED ANDTHCUSEINTHE Indiana UniversitySchool of Medicine,USA. AndrewChambers R. THE MODERNBEHAVIORAL HEALTH SYSTEM ANEUROSCIECE-BASED CARE: ADDICTION DESIGNFOR THE 2X4MODELOFINTEGRATED MENTAL HEALTH AND Universidad CES,Colombia. Daniela SanchezAcosta CastañoPerez,Guillermo A. GloriaMariaSierraHincapie, INCOLOMBIADISPLACEMENT DUAL DISORDERSINPOPULATION OFFORCED VICTIM 3 1 Drake DartmouthResearch Centre, USA. SERAF, University ofOslo, Norway.  Innlandet HospitalTrust, Norway. Substance AbuseandMental HealthDisorders, Sykehuset NationalAdvisoryUnitonConcurrentNorwegian 3 , AnneSigneLandheim 1 , JørgenGunnarBramness 93 1 23 -26March, Madrid -Spain 2 , Robert 2017

SATURDAY 25 SATURDAY 25 10:45 -11:30 10:00 -10:45 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders USE DISORDERS:AFAMILIAL RISKANALYSIS DISORDERANDSUBSTANCEDEFICIT HYPERACTIVITY THEASSOCIATIONEXAMINING ATTENTION BETWEEN USA. Joseph Biederman,HarvardUniversity. Cambridge, MA, SPEAKER: de Valencia. Valencia, España. José Martínez-Raga,HospitalUniversitarioDr. Universitat Peset, CHAIR: Auditorium Shaul Lev-Ran, ShebaMedical Center. Tel Hashomer, Israel. SPEAKER: Ana GonzálezPinto, HospitalSantiagoApóstol.Vitoria,España. CHAIR: Auditorium QUESTION? DON’T WEHAVE ASIMPLEANSWERTO A“SIMPLE” PSYCHIATRIC OUTCOMES USE-WHY OFCANNABIS

Track: Psychopathology andDualDisorders Track: Substance andDualDisorders UseDisorders MAIN LECTURE-ML12 MAIN LECTURE-ML11 94 10:00 -11:30 Bruno Etain, HospitalChenevier. Créteil, France. SUBSTANCE PATIENTS MISUSE INBIPOLAR ANDLATER CHILDHOODTRAUMA DISORDER, CHILDHOOD ATTENTION DEFICITHYPERACTIVITY France. deParis,FondaMental Foundation,Romain Icick,Hôpitaux TREATED FOR SUBSTANCE USEDISORDERS? A PREDICTOR OFSUICIDAL BEHAVIOUR INADULTS BY DYSFUNCTIONALBEING RAISED PARENTS: ISIT France. Mohamed El-HadiZerdazi, HopitalHenriMondor. Créteil, ASSOCIATED WITHCOCAINE FACTORS TO PSYCHOTIC PREDICT SYMPTOMS ANDGENETIC OFCHILDHOODTRAUMA INTERACTION SPEAKERS: Florence Vorspan, deParis,France. Publique-Hôpitaux CHAIR: Room Castilla DURING CHILDHOOD? DETERMINED DUAL DISORDERS:ISEVERYTHING

Track: ChildandAdolescent Psychiatry SYMPOSIUM -SY26 95 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 10:00 -11:30 10:00 -11:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders WADD Membersandpublic PERSPECTIVE WADD FORUM. DUAL DISORDERS,AWORLD España. Carlos Roncero, UniversidadAutónoma deBarcelona, Santa Chiara UniversityHospital,Pisa,Italy. Icro Maremmani,UniversityofPisa, Siena, General UniversitarioGregorioMarañón. Madrid,España. Néstor Szerman, SaludMentalRetiro, Servicio Hospital Universitari Vall d'Hebron.Barcelona, España. Miguel Casas,UniversitatAutònoma de Barcelona, Hospital CO-CHAIRS: Miller School ofMedicine-University ofMiami.FL,USA. Pedro Ruiz,DepartmentofPsychiatry &Behavioral Sciences, CHAIR: Room Doblón José M.Goikolea, Barcelona, HospitalClinic. España. DISORDER METHYLPHENIDATE INADULTS WITHBIPOLAR Marañón. Madrid,España. Carmen Moreno,HospitalGeneral UniversitarioGregorio DISORDER WITH BIPOLAR METHYLPHENIDATE INCHILDRENANDADOLESCENTS SPEAKERS: Madrid, España. José M.Montes, HospitalUniversitarioRamón yCajal. CHAIR: Room Hidalgo DISORDER? DISORDER ANDATTENTION DEFICITHYPERACTIVITY RISK OFMANIAINPATIENTS WITHBIPOLAR DOES METHYLPHENIDATE INCREASE MONOTHERAPY

Track: inDualDisorders Pharmacology Track: Behavioral Addictions andDualDisorders DEBATE FORUM-DF05 SYMPOSIUM -SY27 96 10:00 -11:30 Rocío, UniversidaddeSevilla. Sevilla, España. Juan F. Martin-Rodriguez,HospitalUniversitarioVirgen del INYOUNGIMPAIRED ADULTS PLASTICITY CORTICAL THC ANDOTHER COMPOUNDS CANNABIS LINKEDTO Universidad deAlcalá. Madrid,España. Antia Brañas,HospitalUniversitarioPríncipedeAsturias, USERS IN ASNOWBALL SAMPLE OFCANNABIS U-SHAPED CURVE OFPSYCHOTIC-LIKE EXPERIENCES Fundación JimenezDíaz,CIBERSAM.Madrid,España. Barrigon,UniversidadAutónoma deMadrid, Maria L. SYMPTOMS EXPERIENCES: EFFECT OFGENDERANDDEPRESSIVE DISTRESS RELATED TO POSITIVE PSYCHOTIC-LIKE SPEAKERS: Rocío. Sevilla, España. Miguel Ruiz-Veguilla, HospitalUniversitarioVirgen del CHAIR: Room ElEscorial MEASSUREMENTS OF CANNABIS USE OFCANNABIS MEASSUREMENTS LIMITATIONS THEGRASS: CUTTING OFTHECURRENT

SYMPOSIUM -SY28 Track: Psychopathology andDualDisorders 97 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 10:00 -10:45 10:00 -11:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders DISORDERS MANAGEMENT UPDATE ONPATHOLOGICAL GAMBLINGANDDUAL SUBSTANCE USEDISORDER DEPRESSIVE DISORDERSANDCO-OCCURRING Margarita, Venezuela. Venezolano Sociales deServicios Luis Ortegaenla Isla de SánchezBello,HospitalCentralCésar A. delInstituto SPEAKER: CHAIR/ Room Comendador Parc deSalutMar. Barcelona, España. Francina Fonseca, InstitutdeNeuropsiquiatriaiAddiccions, DISORDERS COMORBIDITY MANAGEMENT OFSUBSTANCE USEANDDEPRESSION Universidad Autónoma deBarcelona. España. Lara Grau-López, HospitalUniversitariVall d'Hebron, PATIENTS HOSPITAL DETOXIFICATION INDUAL DEPRESSIVE de BuenosAires,Argentina. Javier Didia,HospitalItalianodeBuenosAiresyUniversidad ADDICTIONS RELATIONSHIP DEPRESSIONAND BETWEEN SPEAKERS: América Latina, Guatemala. Enrique Mendoza, PresidenteAsociaciónPsiquiátrica de CHAIR: Room ElJardín

Track: Psychopathology andDualDisorders WORKSHOP -WS11 SYMPOSIUM -SY29

Track: Behavioral Addictions andDualDisorders 98 10:45 -11:30 España. Gemma Reig,HospitalUniversitariodela Princesa. Madrid, BIOMARKERS NEUROBIOLOGY INDUAL DISORDERSAND Carrión. Palencia, España. Carlos Castañeda,Complejo AsistencialUniversitarioRío ANDNEWPERSPECTIVES BASES CONCEPT, PLASTICITY. BRAIN NEUROPHYSIOLOGICAL Fernando Sanjuan,Neurocavis. Madrid,España. MAGNETIC STIMULATION TRANSCRANIAL DUAL DISORDERSANDDISHABITUATION BY DEEP SPEAKERS: Fernando Sanjuan,Neurocavis. Madrid,España. CHAIR: Room Comendador DISORDERS NEUROMODULATION INDUAL ANDRESEARCH NEUROBIOLOGICAL OF“NON-INVASIVE” ASPECTS WORKSHOP -WS12

in DualDisorders Track: Investigation, Development &E-HealthTechnologies 99 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 10:00 -11:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders 1 2 Jibran Khokhar POTENTIAL WITHSCHIZOPHRENIA INTERACTION EXPOSURE ONREWARD-RELATED BEHAVIORS: LONG-LASTING IMPACT OFADOLESCENTCANNABINOID 2 Jonathan Ipser CONNECTIVITY BRAIN FUNCTIONAL NICOTINE USEONTASK PERFORMANCE ANDINTRINSIC SUBSTANCE USEANDPROSPECTIVE MEMORY: EFFECT OF INVESTIGATING THEASSOCIATION DUAL BETWEEN 4 3 2 Liz Hughes WHO PERPETRATE INTIMATE PARTNER VIOLENCE WITH MENINSUBSTANCE USETREATMENT SETTINGS FORA FRAMEWORK WORKING SAFELY ANDEFFECTIVELY Universitario GregorioMarañón. Madrid,España. Carlos Parro, C.S.MentalRetiro. HospitalGeneral Colombia. Castaño,UniversidadCES.Medellín, Guillermo A. CHAIRS: Room Escudo Bucci 1 1 Gilchrist Freeman    UniversityofCape Town, South Africa. King’sCollege London, UnitedKingdom. RESPECT, UnitedKingdom. SOLACE Women’s AID, UnitedKingdom. UniversityofHuddersfield, UnitedKingdom. Hanover, NewHampshire,USA. Psychological and Brain Sciences, DartmouthCollege, Hampshire, USA. Geisel School ofMedicineatDartmouth,Lebanon, New Research Council ofSouthAfrica. Anxiety andStressDisorders Research Medical Unit, 2 , AlanGreen 4 ORAL COMMUNICATIONS -OC06 1 , JohnJoska 1 , Colin Fitzgerald 1 1 , Dan Stein , Travis Todd 1 100 1 1,2 , HettaGouse 2 2,3 , WilderDoucette , Polly Radcliffe 1 , Carla 4 , Gail 1 , David 1 1 5 4 3 2 Luis AlfonsoNúñezDomínguez N ACETYLCISTEINE DEPENDENCE INCANNABIS 3 2 Evgeniya Markova TREATMENT OFDRUGABUSE INTHE THERAPY PERSPECTIVES OFTHECELLS Instituto deNeurología Cognitiva (INECO), Argentina. Lucia Lizaso,RosarioFigueras RESULTS ANDSOCIALCOGNITION.FUNCTIONING PRELIMINARY CONNECTIVITY, BRAIN EPIGENETICS, FRONTAL LOBES EFFECTS OF“COCAINE PASTE” BASED USEON ARSH, Nova SoutheasternUniversity, USA. Steven Kurtz, ManceButtram ADULT MENWHOUSEDRUGSINTHECLUB SCENE CORRELATES OFSEVEREDEPRESSIONAMONG YOUNG Tamara Shushpanova Laura BarradoLos Arcos Manrique Astiz Centro Salud Mental,Tafalla, España. Centro SaludMental,Tudela, España. HospitaldeDíaZuría, España. Red deSaludMental Navarra, España. Medical Center Pamplona, España.    Russia. Research Medical Center, RussianAcademy ofSciences, Mental HealthResearch Institute,Tomsk National Russian Academy ofSciences, Russia. Molecular Biology Research andBiophysics Institute, Russian Academy ofSciences, Russia. Fundamental andClinical Immunology Research Institute, 5 , OlgaArbeoRuiz 1 , VladimirKozlov 3 101 2 , NoeliaLópez Olmo 23 -26March, 1 , LauraMontes Reula 3 , MaríaGarcíaNicolás 1 , MarinaStarostina Madrid -Spain 2 , Eduardo 2017 2 , 2 4 ,

SATURDAY 25 SATURDAY 25 12:00 -13:30 11:30 -12:00 12:00 -13:30 12:00 -13:30 12:00 -13:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders programme CME/CPD (Page220) Sessionnotincludedinofficialscientific Industry programme CME/CPD (Page223) Session notincludedinofficialscientific Industry programme CME/CPD (Page222) Sessionnotincludedinofficial scientific Industry programme CME/CPD (Page221) Sessionnotincludedinofficial scientific Industry Francisco Javier Montiel Fernando Sarramea Room ElJardín Room ElEscorial Room Doblón Room Hidalgo AreaExhibition 4 3 2 Esperanza Prieto DISORDER FOR SMOKINGCESSATION INPATIENTS WITHBIPOLAR OFMOTIVATION TO“READINESS CHANGE”:MEASURE 1 BEST POSTER AWARD WINNERS Rico delViejo  USMCMontoro,España. HospitalUniversitarioReina Sofía,España. USMCPozoblanco, España. Córdoba UniversidaddeCórdoba, (IMIBIC), España. Instituto MaimónidesdeInvestigación Biomédica de 4 SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM , MaríaJoséSanchez 1 , VirginiaMillán COFFEE BREAK 4 102 4 , JustaRedondo 2 , Francisca Valdivia 4 , MariaJoséJaén 4 , AnaBelén 3 4 , , 15:15 -16:00 14:30 -15:15 14:30 - 13:30 DISORDERS COMORBIDITY MANAGEMENT OFSUBSTANCE USEANDBIPOLAR Medicine. Miami,FL,USA. Ihsan M.Salloum,UniversityofMiami,Miller School of SPEAKER: Julio Bobes,UniversidaddeOviedo,España. CHAIR: Auditorium Julio Sanjuan,UniversidaddeValencia, España. SPEAKER: Universitario GregorioMarañón. Madrid, España. Néstor Szerman, SaludMentalRetiro, Servicio Hospital General CHAIR: Auditorium INTEGRATIVE TREATMENT INDUAL DISORDERS EVOLUTIONARY PSYCHOPATHOLOGY: AN

Track: Psychopathology andDualDisorders Track: Psychopathology andDualDisorders MAIN LECTURE-ML13 MAIN LECTURE-ML14 LUNCH BREAK 103 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 14:30 -16:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders SOCIAL LANDSCAPE TO INFORM CLINICIANSWORKING INASHIFTING THE EPIDEMIOLOGY OFDUAL DISORDERS:SCIENCE Washington, USA. Ruben Baler, NationalInstituteonDrugAbuse. (ABCD) STUDY COGNITIVE DEVELOPMENTTHE ADOLESCENTBRAIN Columbia University. NY, USA. Deborah Hasin,NewYork StatePsychiatric Institute, MENTAL DISORDERS RELATIONSHIP TO MARIJUANA ANDTO LAWS, MARIJUANA OFU.S. USEINRECENT INCREASE YEARS: Shaul Lev-Ran, ShebaMedical Center. Tel Hashomer, Israel. DISORDERS SPECIALIZEDPLANNING SERVICES FOR DUAL THE ROLE OFEPIDEMIOLOGICAL IN RESEARCH SPEAKERS: España. Carlos Roncero,UniversidadAutónoma deBarcelona, CHAIR: Room Castilla

Track: EpidemiologyandDualDisorders SYMPOSIUM -SY30 104 14:30 -16:00 Madrid, España. Helen Dolengevich,HospitalUniversitariodelHenares. AND PSYCHIATRIC IMPLICATIONS SYNTHETIC CATHINONES ANDCHEMSEX:MEDICAL Universitari GermansTrías iPujol. Badalona, España. Magi Farré, UniversitatAutònoma deBarcelona. Hospital NPS PSYCHOPHARMACHOLOGY GENERATION OFLAST Kingdom. Fabrizio Schifano,UniversityofHertfordshire, United CURRENT SITUATION OFNPSINEUROPE SPEAKERS: España. Parc deSalutMar, UniversitatAutònom deBarcelona. Marta Torrens, InstitutdeNeuropsiquiatriaIAddiccions- CHAIR: Room Hidalgo PSYCHOPATHOLOGY SUBSTANCES (NPS), PSYCHOPHARMACOLOGY AND CURRENT SITUATION OFNEWPSYCHOACTIVE

Track: Substance andDualDisorders UseDisorders SYMPOSIUM -SY31 105 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 14:30 -16:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders DEPENDENCE TREATMENT CENTERSINVIETNAM EXPERIENCEOFDRUG DUAL DISORDERSINASIA: CSAPA duMonde.France. BIZIA/Medecins Arkaitz Aguerretxe, Cabinet enLibéral, BIZIA/SETHS, PREVENTION OFRELAPSE OF COGNITIVE BEHAVIORAL INTHE THERAPY DUAL DISORDERSINVIETNAM:CONTRIBUTION Ho ChiMinhCity, Vietnam. Chi Trung Nguyen,UniversityofMedicineandPharmacy, ANDSPECIFICITY IN VIETNAM:GENERALITY CO-OCCURING ANDMENTAL ADDICTION DISORDERS Basque, Bayonne,France. Jean-Pierre Daulouede, Centre Hospitalierdela CA’te SPEAKERS: Basque, Bayonne,France. Jean-Pierre Daulouede, Centre Hospitalierdela CA’te CHAIR: Room Doblón

Track: inDualDisorders Pharmacology SYMPOSIUM -SY32 106 14:30 -16:00 PRACTICE -SOCIDROGALCOHOLPRACTICE MANAGEMENT OFPATIENTS INDAILY CLINICAL Ourense, España. Gerardo Flórez,Complejo Hospitalario Universitario de COMPLEX REALITY COMPULSIVE GAMBLING ANDALCOHOLISM, A Josep Guardia,HospitaldeSantPauBarcelona, España. GRAVITY. RINCA ALCOHOL CONSUMPTION INPATIENTS WITHLOW TREATMENT AIMEDAT PROGRAM REDUCING del PrincipadodeAsturias-SESPA, España. Juan J. Fernández, AGC SaludMental-V-Servicio deSalud MANAGEMENT APPROACHCASE OUTCOMES OFACOMPREHENSIVE TREATMENT WITH SEVERE MENTALLY ILLPEOPLE ANDDRUGUSE: SPEAKERS: Unidad deConductas Adictivas deAlcoi, España. Francisco Pascual, PresidentedeSOCIDROGALCOHOL, CHAIR: Room ElEscorial

SYMPOSIUM -SY33 Track: Substance andDualDisorders UseDisorders 107 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 14:30 -16:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders DEONTOLOGY ISEXPORTED OFMEDICAL AGOODPRACTICE PROGRAM): NEW HORIZONS OFPAIME (SICK DOCTORS España. Protección Socialdela Organización Médica Colegial, Nina Mielgo,Directora Técnica dela Fundaciónde WORK GUIDEINPAIME: FROM PRESENTTO FUTURE Mancha, España. Mª delMarSánchez,Coordinadora delPAIME deCastilla La AREALLPAIME”“WE España. Protección Socialdela Organización Médica Colegial, Juan M.Garrote, SecretarioGeneral dela Fundaciónde PAIME: SICKDOCTORS HIGHSCHOOLPROGRAM SPEAKERS: Colegios Oficiales deMédicos deEspaña,España. Serafín Romero,Vicepresidente delConsejo General de CHAIR: Room ElJardín

Track: SickDoctors andDualDisorders SYMPOSIUM -SY34 108 14:30 -15:15 Juan Rosales,Mexican Academy ofDualPathology, Mexico. RESOURCES OFHUMAN ANDTRAINING CARE MEDICAL Irma Basurto, Mexican Academy ofDualPathology, Mexico. HUMAN RESOURCES REHABILITATION PSYCHOTHERAPY OF ANDTRAINING Mexico. Diego Larios,Mexican Academy ofDualPathology, PUBLIC POLICIESANDPSYCHOSOCIAL ASPECTS SPEAKERS: Mexico. Diego Larios,Mexican Academy ofDualPathology, CHAIR: Room Comendador CLINIC INTERDISCIPLINARY WORK INTHEHPFBADUAL WORKSHOP -WS13

Track: Intervention inDualDisorders Multidisciplinary 109 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 15:15 -16:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders España. Gutiérrez,HospitalPerpetuoSocorro. Badajoz, José R. CONCLUSIONS ANDDISCUSSION Badajoz, España. Francisco J. Pino,UnidaddeSaludMentalMontijo. DISORDERS SMALL WORLD INAFFECTIVE DISORDERSINDUAL IMPORTANCE AND FREENETWORKS OFSCALE Badajoz,España. Drogodependencia. CEDEX. José M.Zoido, Centro ExtremeñodeAtención ala OFDUAL DISORDERS FRAMEWORK ANDSMALLWORLD NETWORKS INTHE FREE SCALE DISORDERIN ATTENTION DEFICITHYPERACTIVITY SPEAKERS: España. Gutiérrez,HospitalPerpetuoSocorro. Badajoz, José R. CHAIR: Room Comendador DISORDERS INDUAL FREENETWORKS SMALL WORLD ANDSCALE WORKSHOP -WS14

Track: Psychopathology andDualDisorders 110 14:30 -16:00 Carretero Paloma SanchezdelaNieta Aragonés ACCELERATEDCANNABIS MY THINKING 3 2 Paola Rosca EXPERIENCE THE ISRAELI TEACHING DUAL DISORDERSTO MENTAL HEALTH STAFF - 4 3 2 María RoblesMartínez A SAMPLEOFPATIENTS WITHALCOHOLIC DEPENDENCE RELATIONSHIP IN CRAVING BETWEEN ANDIMPULSIVITY Marañón. Madrid,España. Mario DeMatteis, HospitalGeneral UniversitarioGregorio Luis Patricio, Casa deSaudeCarnaxide Lisboa,Portugal. CHAIRS: Room Escudo 2 1 1 1 Parta Fernández Sorribes Crous          Servicio deFarmacología.Servicio UniversidaddeCádiz, España. Salud Mental.UniversidaddeCádiz, España. GrupoMultidisciplinarpara elprogresodelaCTS-391 D´Hebron, España. dePsiquiatría.HospitalUniversitarioVallServicio Universitario Vall D´Hebron,España. deAdiccionesServicio yPatología dual.Hospital Universidad deCastilla La Mancha, España. Hospital General UniversitarioCiudadReal, España. Israeli Society ofAddiction Medicine,Israel. Lev Ha SharonMentalHealthCenter, Tel Aviv University, Ministry ofHealthIsrael, Israel. University, Jerusalem, Israel Psychiatric Association,Israel. Ministry ofHealthIsrael, ArielUniversity&Hebrew 1 , MariadelMarSánchezFernández 1,2 ORAL COMMUNICATIONS -OC07 3 , CarlosRoncero , JuanGibertRahola 1 , Keren Goldman 2 111 1,2 , MiguelÁngelGarcía 1,2 2 , ArturoG.Lerner 23 -26March, 4 , AlfonsoAbad 1 , IsabelMontoya Madrid -Spain 1 , MaríaLaura 1,2 3 , Marta 2017

SATURDAY 25 SATURDAY 25 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Raquel Grande Vergara Moragues 1 3 2 Marta GomezMenjibar MADRID STUDY ON DUAL DISORDERSPREVALENCE TOBACCO ANDOTHER PSYCHIATRIC DISORDERS. Benito MenniComplejo AsistencialenSaludMental,España. Alfredo Felices, LauraBlanco, BegoñaGonzalvo, JosepSolé PSYCHOTHERAPY OFADDICTIONS GROUP FACTORS: THERAPEUTIC OFTHE INNERASPECTS 4 3 2 Tania Torres Rincón FOR THEPURPOSEADDICTIONS: OFACASE PSYCHOPATHOLOGICAL INSUBSTANCE COMORBIDITY NEUROPSYCHOLOGICAL ALTERATIONS AND Faculty ofPhilosophy, UniversityofBelgrade, Serbia. Snezana Svetozarevic RELATIONAL DIAGNOSIS DUAL DIAGNOSIS AS 2 Tamara Shushpanova IN TREATING PATIENTS WITHCOMPULSIVE HABITS (M-CHBHU)UREA SHOWN ANTI-GLUCOCORTICOID EFFECT ORIGINAL ANTICONVULSANT META-CHLORO-BENZHYDRYL Tatiana Novozheeva 1 1 Szerman          Unidad AsistencialdeDrogodependenciasCEDRO, España. Instituto deAdicciones, Madrid, España. Hospital General GregorioMarañón, Madrid,España. Hospital Universitario Oporto, Portugal. and Behavioral Neurosciences. UniversidadePortucalense. Portucalense InstituteofNeuropsychology andCognitive Universidad Internacionaldela Rioja, Madrid,España. España. Complejo Hospitalario UniversitariodeVigo,EOXI-CHUVI, Russia. Fundamental andClinical Immunology Research Institute, Russia. Research Medical Center, RussianAcademy ofSciences, Mental HealthResearch Institute,Tomsk National 2 , Pablo Vega 1 , SoniaAlvarez 3,4 1 1,2 112 , Anatoly Solonskii , Francisco Otero Lamas 1 , Nikolai Bokhan , Adolfo PiñónBlanco 3 , BeatrizMesías 12 1 , Francisco Arias DeOctubre, Madrid,España. 1 1 , AnnaMandel 1 3 , Eugenia Markova , IgnacioBasurte 1 , Nestor 1,4 1 , Esperanza 1 , 2 2 , 16:45 -17:30 16:00 -16:45 FOOD: NEUROBIOLOGICAL BASES BEHAVIORADDICTIVE-LIKE INDUCEDBY PALATABLE España. Rafael Maldonado,UniversidadPompeuFabra. Barcelona, SPEAKER: Madrid, España. Ignacio Basurte, HospitalGeneral UniversitarioGregorioMarañón. CHAIR: Auditorium and DrugAbuse,McLean USA. MA, Hospital,Belmont. Roger Weiss, Harvard Medical School/division ofAlcohol SPEAKER: Universitari Vall d'Hebron.Barcelona, España. Miguel Casas,UniversitatAutònoma deBarcelona, Hospital CHAIR: Auditorium NEW FINDINGSINOPIOIDUSEDISORDERS

Track: Behavioral Addictions andDualDisorders Track: Substance andDualDisorders UseDisorders MAIN LECTURE-ML16 MAIN LECTURE-ML15 113 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 16:00 -17:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders DUAL DISORDERSANDNEUROSCIENCE Washington, USA. Ruben Baler, NationalInstituteonDrugAbuse. INITIATIVEBRAIN AND.... Madrid, España. Javier deFelipe, UniversidadPolitécnica eInstitutoCajal. PROJECT BRAIN THE BLUE BRAIN/HUMAN University ofCalifornia, Los Angeles, USA. Thomas Otis,Hoffmann-La Roche. Basel, Switzerland; PRECISION MEDICINE ADVANCES INNEUROSCIENCE AND RESEARCH SPEAKERS: Neuchàctel, Switzerland. Lola Peris, Centre deNeuchâtelois dePsychiatrie. CHAIR: Room Castilla

Disorders Track: Investigation, Development &E-HealthTechnologies inDual SYMPOSIUM -SY35 114 16:00 -17:30 RESEARCH ANDSERVICERESEARCH PROVISION HEALTH; EVIDENCEANDRECOMMENDATIONS FOR NOVEL PSYCHOACTIVE SUBSTANCES ANDMENTAL London, UnitedKingdom. Justine Trippier, NationalHealthService Foundation Trust. Foundation Trust. London, UnitedKingdom. Kipping,Maudsley NationalHealthService Cheryl SETTINGS PSYCHOACTIVE SUBSTANCE USEINMENTAL HEALTH ORGANISATIONAL APPROACHES TO NOVEL Kingdom. Elizabeth Hughes,UniversityofYork. York, United LITERATURE ANDSTAFF SURVEY SUBSTANCES ONMENTAL HEALTH: REVIEWOF WHAT ISTHEIMPACT OFNOVEL PSYCHOACTIVE Ian Hamilton, UniversityofYork. York, UnitedKingdom. BOYSGIRLS, ANDALLTHINGSSPICE SPEAKERS: Kingdom. Elizabeth Hughes,UniversityofYork. York, United CHAIR: Room Hidalgo

Track: Psychopathology andDualDisorders SYMPOSIUM -SY36 115 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 16:00 -17:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders MANAGEMENT IN CLINICAL PRACTICE MANAGEMENT INCLINICAL DISORDERS: INTEGRATIVE ANDCONTINGENCY CARE NEW PERSPECTIVES ONTHETREATMENT OFDUAL Haque, TheNetherlands. Ernst Noordraven, Center For DualDiagnosis(Palier). PSYCHOTIC DISORDERS TO MAINTENANCETREATMENT INPATIENTS WITH FINANCIAL INCENTIVESTO IMPROVE ADHERENCE CONTROLLED TRIALONTHEEFFECTIVENESS OF MONEY FOR MEDICATION: ARANDOMIZED Haque, TheNetherlands. Tony Bloemendaal,Center For DualDiagnosis(Palier). ECONOMY’ TO IMPROVE TREATMENT ENGAGEMENT STUDY ONTHEEFFECTIVENESS OFUSING‘TOKEN- CONTINGENCY MANAGEMENT: ANOBSERVATIONAL The Netherlands. Iris Jongeling,Center For DualDiagnosis(Palier).Haque, IMPROVING OUTCOMES CLINICAL DISORDER TREATMENT (IDDT) ANDITSEFFECT FOR A COMPREHENSIVE OVERVIEW OFINTEGRATED DUAL HOW TO COMBINE THEORY PRACTICE? ANDCLINICAL SPEAKERS: Haque, TheNetherlands. Tony Bloemendaal,Center For DualDiagnosis(Palier). CHAIR: Room Doblón

Track: Intervention inDualDisorders Multidisciplinary SYMPOSIUM -SY37 116 16:00 -17:30 Barcelona, España. Jordi Blanch,UniversidaddeBarcelona, HospitalClinic. TRANSMISSION IMPACT OFNEWPSYCHOACTIVE DRUGSONHIV Daniel Hernández,HospitalRamón yCajal Madrid,España. PROGRESSION COMBINATION AND FOR HIVTRANSMISSION ANDSUBSTANCEPERSONALITY AN IMPORTANT USE, Universitario GregorioMarañón. Madrid,España. Carlos Parro, C.S.MentalRetiro. HospitalGeneral HIV INFECTION CONTROL OFDUAL DISORDERS´TREATMENTSIGNIFICANCE ON SPEAKERS: Barcelona, España. Jordi Blanch,UniversidaddeBarcelona, HospitalClinic. CHAIR: Room ElEscorial INFECTION AND PROGRESSION DETERMINANTSOFHIV DUAL DISORDERSAS

SYMPOSIUM -SY38 Track: andMedicalComorbidities DualDisorders 117 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 16:00 -17:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Madrid, España. Ana Cáceres,InstitutodeAdicciones deMadridSalud. INTERVENTION CONTROLLED ROOMS; ANEWFORM OF INALCOHOL.HARM REDUCTION CONSUMPTION- España. Madrid, Centro NacionaldeEpidemiología Carlos III.Madrid, Luis SordodelCastillo,UniversidadComplutense de REDUCTION HA-REACT: EUROPEAN PROJECT ONHARM Jordi Delás,CruzRoja Barcelona, España. PSYCHIATRIC SYMPTOMATOLOGY MICROOBSERVATORY OFDRUGUSEAND INTERVENTION INSOCIALLY DEPRESSEDAREAS. SPEAKERS: Madrid, España. Beatriz Mesías,InstitutodeAdicciones deMadridSalud. CHAIR: Room ElJardín HARM REDUCTION ANDDUAL DISORDERS HARM REDUCTION

Track: Intervention inDualDisorders Multidisciplinary SYMPOSIUM -SY39 118 16:00 -17:30 Argentino, Argentina. Personalidad yPsicopatías, PenitenciarioFederal Servicio Salech,SociedadArgentina deTrastornosMariana E. dela APPROACH PROPOSALS SOCIAL REPERCUSSION ANDTRANSDISCIPLINARY Argentina. la PersonalidadyPsicopatías, CuerpoMédico Forense, Ramiro S.Isla,SociedadArgentina deTrastornos de OFNEUROCRIMESASSESSMENT -LEGALMEDICAL IMPLICATIONS ANDANALYTICAL Argentino, Argentina. Neuropsiquiátrica Argentina, PenitenciarioFederal Servicio Guillermo N.Jemar, HospitalJoseT. Borda, Asociación CORRUPT BEHAVIOR NEUROBIOLOGY OFVIOLENT, CRIMINALAND SPEAKERS: Argentina, Argentina. Personalidad yPsicopatías, DefensoríaGeneral dela Nación Ezequiel Mercurio,SociedadArgentina deTrastornos dela CHAIR: Room Comendador CORRUPT BEHAVIOR ANDSUBSTANCE USE APPLIED TO THESTUDY OFVIOLENT, CRIMINALAND FORENSIC NEUROPSYCHIATRY ANDNEUROCRIME SYMPOSIUM -SY40

Track: Forensic andDualDisorders 119 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 16:00 -17:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Sousa Psico SaludyTransformación, Colombia. Uriel Escobar, OsvaldoRestrepo,NathalyBravo DURINGTREATMENTDREAMS INDIVIDUALS INADDICTED Faculty ofMedicine -Ain-Shams University, Egypt. Naguib Rehab AbeerEl-Zoheiry, ReemEl-Ghamry, Hanan Azzam, Doha Elserafi,AbdelnasserOmar, Amany El-Rasheed, EGYPTIAN FEMALES RELATION TO AMONGASAMPLEOF FOOD ADDICTION PROFILE AND AFFECT REGULATIONPERSONALITY IN National Autonomous University ofMexico, Mexico. Mexico. National InstituteofPsychiatry Ramón dela FuenteMuñiz, Luis Villalobos-Gallegos DISORDERS CONDOM WITHDUAL USEINASIMPLEOFINDIVIDUALS 3 2 Patrick Alves POPULATIONPORTUGUESE ACADEMIC AUTISTICS FEATURES IN ANDINTERNETADDICTION España. Marta Perea, HospitalUniversitariVall d'Hebron.Barcelona, Ramón dela FuenteMuñiz.CiudaddeMéxico, México. Rodrigo Marín-Navarrete, InstitutoNacionaldePsiquiatría CHAIRS: Room Escudo 1 MinhoUniversity, Portugal. PortoUniversity, Portugal. Alto MinhoLocal VianadoCastelo, HealthUnit, Portugal. 3 ORAL COMMUNICATIONS -OC08 1,2 , Eduardo Palha-Fernandes 120 1 , Cristina Fernandez Foll 1 1 2 Aldebarán Toledo-Fernández CHRONIC SUBSTANCE USE A SAMPLEOFSTUDIESONCOGNITIVE DEFICITSDUETO REVIEW OFCOMPLIANCE WITHDIAGNOSTIC CRITERIAIN NEUROCOGNITIVE ADUAL DISORDER:A DISORDER AS 2 Andriy V. Samokhvalov YEARS OF THEFIRSTTWO DEPRESSIVE ANDALCOHOL USEDISORDERS:OUTCOMES INTEGRATED PATHWAY CARE FOR CONCURRENT MAJOR 2 Maria LauraParra Fernandez ORTHOREXIA NERVOSA SPANISH, AQUESTIONNAIREFOR THEDIAGNOSIS OFTHE TRANSCULTURAL ADAPTATION OFTHE15“ORTHO” IN 2 Paula Jauregui AND COMORBID SYMPTOMS METACOGNITIVE BELIEFSOFPATHOLOGICAL PLAYERS 3 Estibaliz Rodríguez Carlos Roncero Isabel Montoya Crous 1 1 Sescam UCA CiudadReal, Sescam España. UCA UniversidadCastilla La Mancha CiudadReal, España. Ekintza-Aluviz, Spain. UniversityofDeusto,Spain.    DepartmentofPsychiatry, UniversityofToronto, Canada. Centre For Addiction andMentalHealth,Canada. Sociedad Española dePatología Dual,España. Autónoma deBarcelona, España. Hospital UniversitarioVall d’Hebron,Universidad Muñiz, Mexico. National InstituteofPsychiatry Ramón dela Fuente 1,2 , Charlotte Probst 2 , Paloma SanchezdelaNietaAragones 1 2,3 , AnaEstévez , RodrigoMarín-Navarrete 2 , IllargiZarate 2 121 1,2 1 , Peter Voore , SaimaAwan 1 1 1 , MªDelMarSanchez , JaioneOnaindia , AlizaBrzezinski-Rittner 23 -26March, 2 1,2 1 , BernardLe , JürgenRehm Madrid -Spain 1,3 1 , 2 , 2017 1,2 1 ,

SATURDAY 25 SATURDAY 25 17:30 -19:00 17:30 -18:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders SUICIDAL BEHAVIOR SUBSTANCE CONSUMPTION ANDDEVELOPMENT OF Lucas Giner, UniversidaddeSevilla. Sevilla, España. SUBSTANCE MISUSEINCOMPLETED SUICIDE THEPROBLEMS RELATEDIDENTIFYING TO Complutense deMadrid.España. Mercedes Navío, Consejeria deSanidad,Universidad AND ORGANIZATIONAL ASPECTS SUICIDE PREVENTIONINDUAL DISORDERS:CLINICAL d’Hebron. Barcelona, España. Barcelona, Clínica Galatea, HospitalUniversitariVall Mª DoloresBraquehais,UniversitatAutònoma de THE MINDOFSUICIDE:APHENOMENOLOGIC VIEW THE ROLE OF ALCOHOL ANDOTHER SUBSTANCES IN SPEAKERS: Veterans’ Administration Medical. NY, USA. Leo Sher, MountSinaiSchool of Medicine/James J.Peters CHAIR: Room Hidalgo Santa Chiara UniversityHospital,Pisa,Italy. Icro Maremmani,UniversityofPisa,Siena, SPEAKER: School ofMedicine-UniversityMiami.FL,USA. Pedro Ruiz,DepartmentofPsychiatry &Behavioral Sciences, Miller CHAIR: Auditorium SUBSTANCE USEDISORDERS TOWARD ASPECIFIC PSYCHOPATHOLOGY OF

Track: Psychopathology andDualDisorders PLENARY SESSION-PS03

Track: Psychopathology andDualDisorders SYMPOSIUM -SY41 122 17:30 -18:15 17:30 -19:00 Medicine. CT, USA. Yifrah Kaminer, UniversityofConnecticut School of OPPORTUNITIES WITH CO-OCCURRING DEPRESSION: BARRIERSAND (COC) OFCARE CONTINUITY FOR ADOLESCENTSUD Javier Barcelona, Goti,HospitalClinic. España. SPEAKERS: Room ElEscorial Hamar, Norway. Concurrent Substance AbuseandMentalHealthDisorders. NationalAdvisoryUniton Anne Landheim,theNorwegian RESULTS FROM THEEVALUATION Hamar, Norway. Concurrent Substance AbuseandMentalHealthDisorders. NationalAdvisoryUniton Sigrun Odden,theNorwegian RESULTS FROM THEEVALUATION OFROP VESTFOLD Tønsberg, Norway. Bård Grønstøl, Vestfold HospitalHealthAuthority. HEALTH DISORDERSINANORWEGIAN COUNTY WITH CONCURRENT SUBSTANCE ABUSEANDMENTAL COLLABORATIVE TREATMENT MODELFOR PERSONS UNITED WESTAND -DIVIDED WEFALL -A SPEAKERS: Tønsberg, Norway. Bård Grønstøl, Vestfold HospitalHealthAuthority. CHAIR: Room Doblón RESULTS FROM THEEVALUATION OFTHEMODEL MENTAL ILLNESS.DESCRIPTION OFTHEMODELAND CONCURRENT SUBSTANCE USEDISORDERSAND A COLLABORATIVE MODELFOR PERSONSWITH WORKING GROUP OFTHESEPD PRESENTATION OFTHECHILDANDADOLESCENT

Track: Substance andDualDisorders UseDisorders

WORKSHOP -WS15 SYMPOSIUM -SY42 Track: ChildandAdolescent Psychiatry 123 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 18:15 -19:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders España. Martín,CentroJosé A. PenitenciarioTeixeiro La Coruña, AND FUTURE MANAGEMENT OFDUAL DISORDERSINPRISON: PAST España. Delia Gonzalez,Centro PenitenciarioTeixeiro La Coruña, OFDUAL DISORDERSINPRISON EXTRAPENITENTIARY MULTIDISCIPLINAR AND MANAGEMENT INTRA España. José J. Antón, Centro PenitenciariodeAlbolote. Granada, DISORDERS INPRISON CURRENT MANAGEMENT OFPSYCHOTROPES INDUAL SPEAKERS: Villabona, España. Andrés Martinez,Centro PenitenciariodeAsturias. CHAIR: Room ElEscorial FUTURE DUAL DISORDERSINPRISON.PAST, PRESENTAND

Track: Forensic andDualDisorders WORKSHOP -WS16 124 17:30 -19:00 CO-MORBID VIRAL INFECTIONSCO-MORBID VIRAL DUAL DISORDERSINPATIENTS WITHDIABETESAND General deAlmansa. Albacete, España. Antonio Campayo, UniversidaddeZaragoza, Hospital DISORDER PATIENTS DEPRESSION WITHDIABETESANDMAJOR SUBSTANCE ABUSEDISORDERS INHOSPITALIZED Madrid, España. Rodríguez,HospitalUniversitariodeFuenlabrada. José L. MORBID SUBSTANCE ABUSE DISORDER RISK OFSUICIDEINDIABETICPATIENTS WITHCO- Barcelona, España. Jordi Blanch,UniversidaddeBarcelona, HospitalClinic. OR OTHER METABOLIC ILLNESSES DUAL DISORDERSINHIVPATIENTS WITHDIABETES SPEAKERS: Madrid, España. Carlos MurdeVíu,HospitalUniversitarioFuenlabrada. CHAIR: Room ElJardín

Track: Substance andDualDisorders UseDisorders SYMPOSIUM -SY43 125 23 -26March, Madrid -Spain 2017

SATURDAY 25 SATURDAY 25 17:30 -19:00 17:30 -19:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Spain. Clinical UnitofAddictive Behaviors, UniversityofOviedo, Roberto Secades-Villa Fernando Alonso-Pérez, Tania Esperanza-Álvarez, Alba González-Roz, ÁngelGarcía-Pérez, SaraWeidberg, CESSATION TREATMENT SYMPTOMS AMONGPATIENTS RECEIVING ASMOKING LONGITUDINAL CHANGESINDEPRESSIVEANDANXIETY Health. Brisbane,Australia. Rosa Alati,UniversityofQueensland, School ofPopulation Rocío. Sevilla, España. Miguel Ruiz-Veguilla, HospitalUniversitarioVirgen del CHAIRS: Room Escudo Perú. Rafael Navarro, Alad, HospitalHermilioValdizan. Lima, THERAPIES BEHAVIORAL TO THIRDGENERATION THERAPY MINDFULNESS ANDDUAL DISORDERSSINCE Adiccionología Medellín,Colombia. (ALAD). Elvia Velásquez, AsociaciónLatinoamericana de COLOMBIA. ANALYSIS CASE THE FACE OFDUAL DISORDERSINOLDERPEOPLE IN Pathology Section. BuenosAires,Argentina. Javier Didia,PresidenteACAPI, SecretarioWPA Dual ANDLIMITATIONS MODELS CARE PACO, INDUAL DISORDERSINARGENTINA, CASES SPEAKERS: Jorge Jaber, Clínica Jorge Jaber. RiodeJaneiro,Brasil. CHAIR: Room Comendador THERAPEUTIC EXPERIENCES:MINDFULNESS THERAPEUTIC REPORTSANDNEW DUAL DISORDERS,CASE ORAL COMMUNICATIONS -OC09 SYMPOSIUM -SY44

Track: Substance andDualDisorders UseDisorders 126 1 Elliot Stein 2 DISORDER SCHIZOPHRENIA ANDCO-OCCURRING ALCOHOL USE UNDERLIE ALCOHOL DRINKINGINARAT MODELOF IMPAIRED REWARD CIRCUITRY BRAIN MAY 5 4 3 2 Luis AlfonsoNúñezDomínguez OFLONG-ACTINGDISORDERS. THECASE ARIPIPRAZOLE THE USEOFLONG-ACTING ANTYPSYCHOTIC INDUAL 5 4 3 2 Luis AlfonsoNúñezDomínguez FOLLOW-UPYEARS STUDY PALIPERIDONE PALMITATE INDUAL DISORDERS.ATWO Bucaramanga, UniversidaddeSantander, Colombia. Hospital Psiquiátrico SanCamilo, UniversidadAutónoma de Carlos ArturoCassianiMiranda ON DRUGADDICTION HIPOCRETUNERGIC/OREXINERGIC SYSTEMANDITSROLE Jibran Khokhar 1 Barrado Los Arcos Noelia OlmoLópez Almudena Portilla Fernández 1 López Reula Los Arcos   Centro SaludMental,Tafalla, España. España. MentalHealthNet, HospitaldeDíaZuría, España. Centro SaludMental,Tudela, España. Medical Center Pamplona, España. Centro SaludMental,Tudela, España. Medical Center Pamplona, España. Centro SaludMental,Tafalla, España. España. MentalHealthNet, HospitaldeDíaZuría, España. Program, Baltimore,Maryland, USA. National Institute onDrugAbuseIntramural Research Hampshire, USA. Geisel School ofMedicineatDartmouth,Lebanon, New 4 2 , Eduardo ManriqueAstiz , Eduardo ManriqueAstiz 4 , AlmudenaPortillo Fernández 2 , AlanGreen 1 , XiChen 4 , MaríaGarcíaNicolás 2 , OlgaArbeoRuiz 127 1 1 , HanbingLu 4 , OlgaArbeoRuiz 23 -26March, 1 1 5 5 , LauraMontes Reula , MaríaGarcíaNicolás 3 2 , LauraBarrado , BarjorGimi Madrid -Spain 2 4 , NoeliaOlmo , LauraMontes 3 , Laura 1 , 2017 4 2 , ,

SATURDAY 25 SATURDAY 25 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Medical Center, RussianAcademy ofSciences, Russia. Mental HealthResearch Institute,Tomsk NationalResearch Valentina Nikitina,Nikolai Bokhan PROTRACTED COURSE OFORGANIC DISORDERS CLINICAL-IMMUNOLOGICAL CRITERIAOFPROGNOSIS OF 2 Leslie Zun HOSPITAL ADMISSIONS THE RELATIONSHIP DUAL DIAGNOSIS BETWEEN AND Tianjin AnningHospital, China. Chuanjun Zhuo TARGETING SIGNALINGPATHWAY MTOR/VEGF WITHIN RATS´ CCI OF NEUROPATHIC MODELS PAIN BY EFFECTS OFMICRORNA-183 ONAMPA RECEPTORS SinaiHospital,USA. Mt. James Bott WEHELP? CAN POPULATION WHAT INTHEU.S.: DOWEKNOW ANDHOW ALCOHOL/DRUG MENTAL USE, HEALTH ANDTHELGBT 1 Roosevelt University, USA. Chicago Medical School, USA. 1 , Lavonne Downey 128 2 PROGRAMME SUNDAY MARCH 26

CONGRESS APP Navigate through the First World Congress of the World Association of Dual Disorders (WADD) & Fifth International Congress of the Spanish Society of Dual Disorders (SEPD) programme from your iPhone, iPad, and Android. View sessions by day and category, locate exhibitors and create your own itinerary to fully exploit your congress. http://www.icdd-congress.com/ scientific-information/app-mobile/ Use this code to unlock the APP if it is required: 85962 SUNDAY 26 SUNDAY

www.icdd-congress.com SUNDAY 26 12:15 -13:00 10:45 -11:30 10:00 -10:45 09:15 -10:00 08:30 -09:15 11:30 -12:15 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Opioid system andmental Implementing alowML17 Implementing ML18 Cocainepsychosis: Dual Disorders forDual Disorders Latino resource intervention for thinking Dual Disorders. thinking DualDisorders. immigrant populations AUDITORIUM ML19 Anew way of What isnew? disorders SUNDAY MARCH 26,2017 Evidence basedtreatment aspects of Dual Disorders ofDualDisorders aspects 130 SY52 International Latino pathways (ICP)inmental Research - Partnership health andaddictions in thediversed Israeli SY45 Integrated care SY48 Socio-cultural for DualDisorders CASTILLA ROOM society society schizophrenia andbeyond Argentina: Diagnosesand Narratives andresearch mental healthdisorders SY53 in DualDisorders on recovery inpersons substance abuseand living withconcurrent SY46 Abetter life: SY49 Cannabis, DOBLÓN ROOM resources reciprocal associations Predictors ofrelapse, DF06 Debate Forum cognitive biasesand of DualDisorders SY54 Disordered ESCORIAL ROOM EL SY50 Forensic schizophrenia: gambling and psychiatry of Nurses psychotropic drugsin SY55 Rational useof dependence centers. the approach ofDual dual patientsindrug SY51 Questionnaire Disorders inHuelvaDisorders Design andclinical patients withDual SY47 Clinicaland of usingcoercive strategies inthe management of management on spirituality in on spirituality ROOM EL ethical aspects JARDÍN application Disorders Disorders province interindividual differences opioid agonist treatments Example ofatherapeutic and substance misusein evaluation andtreatment COMENDADOR first psychotic episodes sample ofpatientswith sample severe mentaldisorder in methadone dosesin high dosemethadone: emergency care inthe institutional on impact WS18 Therole ofthe WS20 Drug-induced psychosis: Adistinct treatment programs WS19 Analysis ofa WS17 Transition to for DualDisorders: An aproximation to long-term inpatient Book Presentation WS21 Attention to of DualDisorders community ROOM entity? Communications Communications Communications ESCUDO OC10 Oral OC12 Oral OC11 Oral ROOM 12:15 -13:00 11:30 -12:15 10:45 -11:30 10:00 -10:45 09:15 -10:00 08:30 -09:15 Opioid system andmental Implementing alowML17 Implementing ML18 Cocainepsychosis: Dual Disorders forDual Disorders Latino resource intervention for thinking Dual Disorders. thinking DualDisorders. immigrant populations AUDITORIUM ML19 Anew way of What isnew? disorders SUNDAY MARCH 26,2017 Evidence basedtreatment aspects of Dual Disorders ofDualDisorders aspects SY52 International Latino pathways (ICP)inmental Research - Partnership health andaddictions in thediversed Israeli SY45 Integrated care SY48 Socio-cultural for DualDisorders CASTILLA ROOM society society schizophrenia andbeyond Argentina: Diagnosesand Narratives andresearch mental healthdisorders SY53 in DualDisorders on recovery inpersons substance abuseand living withconcurrent SY46 Abetter life: SY49 Cannabis, DOBLÓN ROOM resources reciprocal associations Predictors ofrelapse, DF06 Debate Forum cognitive biasesand of DualDisorders SY54 Disordered ESCORIAL ROOM EL SY50 Forensic schizophrenia: gambling and psychiatry of Nurses psychotropic drugsin SY55 Rational useof dependence centers. the approach ofDual dual patientsindrug SY51 Questionnaire Disorders inHuelvaDisorders Design andclinical patients withDual SY47 Clinicaland of usingcoercive strategies inthe management of management on spirituality in on spirituality ROOM EL ethical aspects JARDÍN application Disorders Disorders province 131 interindividual differences opioid agonist treatments Example ofatherapeutic and substance misusein evaluation andtreatment COMENDADOR first psychotic episodes sample ofpatientswith sample severe mentaldisorder in methadone dosesin high dosemethadone: emergency care inthe institutional on impact WS18 Therole ofthe WS20 Drug-induced psychosis: Adistinct treatment programs WS19 Analysis ofa WS17 Transition to for DualDisorders: An aproximation to long-term inpatient Book Presentation WS21 Attention to of DualDisorders community 23 -26March, ROOM entity? Madrid -Spain Communications Communications Communications ESCUDO OC10 Oral OC11 Oral OC12 Oral ROOM 2017

SUNDAY 26 SUNDAY 26 08:30 -10:0008:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders HEALTH ANDADDICTIONS INTEGRATED PATHWAYS CARE (ICP) INMENTAL Toronto, ON,Canada. Saima Awan, Centre for Addiction andMental Health. ICP THE DA VINCIPROJECT: UPASUCCESSFUL SCALING Health. Toronto, ON,Canada. Andriy V. Samokhvalov, Centre for Addiction andMental ALCOHOL USEDISORDERS ICP FOR DEPRESSIVEAND CONCURRENT MAJOR Deventer, TheNetherlands. Joanneke vanderNagel,Tactus Addiction Treatment. ICP PROCESS AT TACTUS CARE ADDICTION Toronto, ON,Canada. Peter Voore, Centre for Addiction andMentalHealth. MENTAL HEALTH DEVELOPMENT AT AND THECENTREFOR ADDICTION OUTLINE OFTHEICPPARADIGM ANDICP SPEAKERS: Health. Toronto, ON,Canada. Andriy V. Samokhvalov, Centre for Addiction andMental CHAIR: Room Castilla

Track: Intervention inDualDisorders Multidisciplinary SYMPOSIUM -SY45 132 08:30 -10:0008:30 Drammen, Norway. Stian Biong,UniversityCollege ofSoutheast-Norway. RECOVERY -TO BECOME PART OFTHECOMMUNION Morten Brodahl, Author. Hamar, Norway. SOME SEEDS NEEDAWINTERTO SPROUT Silje Mack,Author. Amsterdam, TheNetherlands. A NEWBEGINNING -THEJOURNEYOFDISCOVERY Hamar, Norway. Concurrent Substance AbuseandMentalHealthDisorders. NationalAdvisoryUniton Anne Landheim,theNorwegian ABUSE ANDMENTAL ILLNESS ABOUTRECOVERYRESEARCH FROM SUBSTANCE SPEAKERS: Hamar, Norway. Concurrent Substance AbuseandMentalHealthDisorders. NationalAdvisoryUniton Anne Landheim,theNorwegian CHAIR: Room Doblón SUBSTANCE ABUSEAND MENTAL HEALTH DISORDERS RECOVERY INPERSONSLIVINGWITHCONCURRENT LIFE:NARRATIVESA BETTER ON ANDRESEARCH

Track: Intervention inDualDisorders Multidisciplinary SYMPOSIUM -SY46 133 23 -26March, Madrid -Spain 2017

SUNDAY 26 SUNDAY 26 08:30 -10:0008:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Gregorio Marañón. Madrid,España. Piedad Perez Marin,HospitalGeneral Universitario Barcelona, España. Eduardo Castrillo,HospitalUniversitariVall d’Hebron. Drogodependencias deLatina. Madrid,España. Sonsoles Gutiérrez,Centro deAtención alas SPEAKERS: Pilar Serrano,UniversidadAutónoma deMadrid.Madrid,España. CHAIR: Room ElEscorial NEW PATIENT CHALLENGES PROFILES, NEWCARE DEBATE FORUM OFNURSES DEBATE FORUM-DF06

Track: InterventioninDualDisorders Multidisciplinary 134 08:30 -10:0008:30 Emanuel Valenti, UniversidadEuropea.Madrid,España. QUALITATIVE STUDY INTENCOUNTRIES COACTION WITHAMBULATORY PATIENTS. A OFTHEUSEINFORMAL ASPECTS ETHICAL Marañón. Madrid,España. Ignacio García,HospitalGeneral UniversitarioGregorio DISORDERS EFFECTIVENESS INTHETREATMENT OFDUAL FORMS OFINFORMAL COACTION ANDITS Marañón. Madrid,España. Alfredo Calcedo,HospitalGeneral UniversitarioGregorio COERTION INPATIENTS WITHDUAL DISORDERS LEGAL OFTHEUSE ASPECTS ANDCLINICAL SPEAKERS: Marañón. Madrid,España. Ignacio García,HospitalGeneral UniversitarioGregorio CHAIR: Room ElJardín DUAL DISORDERS STRATEGIES INTHEMANAGEMENT OFPATIENTS WITH OFUSINGCOERCIVE ASPECTS ANDETHICAL CLINICAL

Track: Intervention inDualDisorders Multidisciplinary SYMPOSIUM -SY47 135 23 -26March, Madrid -Spain 2017

SUNDAY 26 SUNDAY 26 09:15 -10:00 -09:1508:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders EVALUATION ANDTREATMENT OFDUAL DISORDERS INTHE THE ROLE CARE OFTHEEMERGENCY Chicago, IL,USA. Leslie Zun, Chicago Medical SinaiHospital. School/Mount SPEAKER: CHAIR/ Room Comendador Negrín. Las Palmas,España. Adrián Neyra,HospitalUniversitariodeGran Canaria Dr. SPEAKER: CHAIR/ Room Comendador SUBSTANCE MISUSE INFIRSTPSYCHOTIC EPISODES TO SEVEREMENTALTRANSITION DISORDERAND WORKSHOP -WS18 WORKSHOP -WS17

Track: Intervention inDualDisorders Multidisciplinary Track: Psychopathology andDualDisorders 136 08:30 -10:0008:30 AND PERCEPTION QUALITATIVE STUDY OFPATIENT ANDSTAFF EXPERIENCE INDENMARK(PARTMECHANICAL RESTRAINT 2)-A PATIENTS WITHDUAL DISORDERSANDTHEUSEOF 4 3 2 Eva Brekke PERSPECTIVES AND SUBSTANCE USEDISORDERS:FIRST-PERSON RECOVERY INCO-OCCURRING MENTAL HEALTH Tianjin AnningHospital, China. Chuanjun Zhuo EPILEPSY: META-ANALYSIS ANETWORK EPILEPTIC MEDICATIONS FOR PARTIAL SEIZURES OF EVALUATE OFANTI- ANDSAFETY THEEFFICACY Nottingham University, UnitedKingdom. Nottinghamshire Healthcare NHSFoundation Trust/ David Manley RECOVERY NARRATIVES INDUAL DISORDERS Barcelona, España. Abderraman Esojo,HospitalUniversitariVall d'Hebron. Jorge Jaber, Clínica Jorge Jaber. RiodeJaneiro,Brasil. CHAIRS: Room Escudo Competence Centre for DualDiagnosis, Denmark. Sidsel Busch,AmalieRasmussen, KatrineJohansen 1 Yale University, NewHaven,Connecticut, USA.   Innlandet Hospital Trust, Stange,Hedmark,Norway. Norway. Community College ofHedmark,Elverum, Hedmark, Buskerud, Norway. Community College ofSoutheastNorway, Drammen, ORAL COMMUNICATIONS -OC10 1,2 , LarsLien 137 1,3 , Larry Davidson, Larry 23 -26March, Madrid -Spain 4 , StianBiong 2017 2

SUNDAY 26 SUNDAY 26 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Abuse andMentalHealthDisorders, Hamar, Norway. NationalAdvisoryUnitonConcurrentNorwegian Substance Lars Lien STORIES DOCTORS ANDPSYCHOLOGISTS FROM THESE LEARN MENTAL HEALTH DISORDERSINNORWAY: WHAT CAN LIVING WITHCONCURRENT SUBSTANCE ABUSEAND NARRATIVES ONRECOVERY ANDRESEARCH INPERSONS Proyectodah, Mexico. Mª ElenaFrade ABUSE PREVENTION RESULTS TO IMPROVE SOCIALIMPACT ANDSUBSTANCE ADHD INTERVENTION MODELINMEXICO, IT’SRESEARCH Madrid, España. Instituto Psiquiátrico JoséGermain,Leganés, Comunidad de Pablo Feito Fernández, Francisco dePedro Melgarejo DUAL DISORDER APPLICATIONCLINICAL OFTHENEUROPSYCHOLOGY IN The Banyan Academy ofLeadership inMentalHealth,India. J. HariniChristopher JEOPARDY CAREGIVERS’ EMOTIONAL WELL-BEING: ADOUBLE SCHIZOPHRENIA ANDSUBSTANCE USEONKINSMEN 138 10:00 -11:30 10:45 -11:30 POPULATIONS FOR DUAL DISORDERSFOR LATINO IMMIGRANT IMPLEMENTING ALOW RESOURCE INTERVENTION Magnus InternationalSearch &Rescue. Tel Aviv, Israel. Moran Sagiv-Alayoff, AbarbanelMentalHealthCenter, A FOREIGNER DUAL FIELD PSYCHIATRY DISORDERSEMERGENCY AS Authority. Jerusalem, Israel. Hagit Bonny-Noach, ArielUniversity, Israel Anti-Drug STUDY INISRAEL’S OPEN DRUGSCENE LARGEST HARD TO REACH POPULATION: ETHNOGRAPHIC MULTICULTURALISM AND DUAL DISORDERSAMONG School ofMedicine,Tel Aviv University. Tel Aviv, Israel. Yael Delayahu, AbarbanelMentalHealthCenter, Sackler DISORDERS PSYCHIATRIC UNIT PATIENTSIMMIGRANT DUAL INANISRAELI ANDNON- OFIMMIGRANT CHARACTERISTICS SPEAKERS: Medicine, Tel Aviv University. Tel Aviv, Israel. Arturo G.Lerner, Lev -HasharonMHC,Sackler School of CHAIR: Room Castilla USA. School, Somerville. MA, Research, Cambridge HealthAlliance &Harvard Medical Margarita Alegría,Center for Multicultural MentalHealth SPEAKER: España. Beatriz Mesías,InstitutodeAdicciones deMadridSalud.Madrid, CHAIR: Auditorium THE DIVERSED ISRAELI SOCIETY THE DIVERSEDISRAELI SOCIO-CULTURAL OFDUAL ASPECTS DISORDERSIN

Track: InterventioninDualDisorders Multidisciplinary

Track: Substance andDualDisorders UseDisorders MAIN LECTURE-ML17 SYMPOSIUM -SY48 139 23 -26March, Madrid -Spain 2017

SUNDAY 26 SUNDAY 26 10:00 -11:30 10:00 -11:30 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders FORENSIC PSYCHIATRY CANNABIS, SCHIZOPHRENIACANNABIS, ANDBEYOND Humanos delPerú. Edwin M.Alvarado,MinisteriodeJusticiayDerechos ANDADDICTIONS DELINQUENCY PREVENTION OFYOUNG PEOPLE AT RISKOFYOUTH Marañón. Madrid,España. Alfredo Calcedo,HospitalGeneral UniversitarioGregorio BEHAVIORADDICTIVE ANDITSCONSEQUENCES VOLUNTARINESS INTHE ANDRESPONSIBILITY Lorenzo, Paraguay. Julio Torales, UniversidadNacionaldeAsunción.San EMPLOYMENT FOR PERSONS WITHDUAL DISORDERS LEGAL PROTECTION OFTHERIGHT TO WORK AND SPEAKERS: Marañón. Madrid, España. Leticia Camarillo,HospitalGeneral UniversitarioGregorio CHAIR: Room ElEscorial Sciences (AIIMS) NewDelhi,India. Yatan Pal SinghBalhara,All IndiaInstituteofMedical DISORDERS: EXPERIENCESANDEVIDENCEFROM INDIA CO-OCCURRING PSYCHOSIS USE ANDCANNABIS Madrid, España. Francisco Arias,HospitalUniversitario12DeOctubre. PSYCHOSIS, ANDCANNABIDIOL CANNABIS SPEAKERS: Adicciones deHuelva, España. ProvincialJuan Ramírez,Servicio Drogodependenciasy CHAIR: Room Doblón

Track: Psychopathology andDualDisorders

SYMPOSIUM -SY50 SYMPOSIUM -SY49 Track: Forensic andDual Disorders 140 10:00 -11:30 Barcelona, España. Marta Sorribes,HospitalUniversitariVall d’Hebron. APPLIEDINVALLSPIRITUALITY D’ HEBRON HOSPITAL EXPERIENCEONTHEQUESTIONNAIRE CLINICAL Barcelona, España. Nieves Martínez-Luna, HospitalUniversitariVall d’Hebron. SCIENTIFIC EVIDENCETO DATE PATIENTS WITHDUAL DISORDERS.REVIEWOF STUDIES ONTHEAPPROACH TO IN SPIRITUALITY DeltaBadalona. España. Jaume Roig,CAS BASIS PRACTICAL IN PATIENTS WITHDUAL DISORDERS.THEORETICAL- TOOL ATHERAPEUTIC SPIRITUAL INTELLIGENCEAS SPEAKERS: Barcelona, España. Nieves Martínez-Luna, HospitalUniversitariVall d’Hebron. CHAIR: Room ElJardín CLINICAL APPLICATIONCLINICAL IN DRUGDEPENDENCECENTERS.DESIGNAND INDUAL PATIENTSQUESTIONNAIRE ONSPIRITUALITY

Track: Psychotherapeutic Treatments inDualDisorders SYMPOSIUM -SY51 141 23 -26March, Madrid -Spain 2017

SUNDAY 26 SUNDAY 26 10:45 -11:30 10:00 -10:45 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders DRUG-INDUCED PSYCHOSIS: ENTITY? ADISTINCT DOSES INOPIOIDAGONIST TREATMENTS INTERINDIVIDUAL DIFFERENCESINMETHADONE DOSE METHADONE:ANAPROXIMATION TO ANALYSIS OFASAMPLEPATIENTS WITHHIGH Mental Health Net. Pamplona,Laura Montes, España. MentalHealthNet. PSYCHOSISCOCAINE Almudena Portilla, Pamplona, España. MentalHealthNet. AMPHETAMINE PSYCHOSIS Pamplona,Noelia López, España. MentalHealthNet. PSYCHOSISCANNABIS-INDUCED SPEAKERS: Núñez,CentroLuis A. Médico. Pamplona, España. CHAIR: Room Comendador Andrea Taboada, Complejo AsistencialdeZamora. España. MAINTENANCE WITHMETHADONE PSYCHOLOGICAL VARIABLES ANDDOSES OF Carlos Llanes,Complejo AsistencialdeZamora. España. METHADONE MEGADOSES? OF PHARMACOGENETICS THE“WHY” CAN EXPLAIN Amaya Caldero,Complejo AsistencialdeZamora. España. WITH METHADONE SAMPLE OFPATIENTS INMAINTENANCEPROGRAM ANALYSIS VARIABLES OFSOCIODEMOGRAPHIC INA SPEAKERS: Amaya Caldero,Complejo AsistencialdeZamora. España. CHAIR: Room Comendador WORKSHOP -WS20 WORKSHOP -WS19

Track: Psychopathology andDualDisorders Track: Substance andDualDisorders UseDisorders 142 10:00 -11:30 1 1 CAPACITY ANDDUAL DISORDERSAT THECOURTS 5 4 3 2 Michael Schaub CONTROLLEDRANDOMISED TRIAL PRELIMINARY RESULTS FROM ATHREEARM MISUSE ANDDEPRESSIONSYMPTOMS INADULTS: INTERVENTION TO REDUCECO-OCCURING ALCOHOL OFANINTERNET-BASED EFFICACY SELF-HELP Cima Health,Spain. Josep MariaFabregas Pedrell COMPLETE ONLINECONSULTATION CITA.IO TECHNOLOGY PLATFORM THAT OFFERSA Parc deSalutMar. Barcelona, España. Francina Fonseca, InstitutdeNeuropsiquiatriaiAddiccions, Estado. Montevideo,Uruguay. Vulnerables dela Administración deSaluddel deServicios Gabriel Rossi,Dirección deSaludMentalyPoblaciones CHAIRS: Room Escudo 3 2 Marta Navas Tejedor Severin Haug Boss García-Albea HospitalClínico SanCarlos, España. HospitalUniversitarioPuerta de Hierro,España. HospitalUniversitarioInfanta Leonor, España.      Germany. Friedrich-Alexander-Universität, Erlangen-Nürnberg, Netherlands. Vrije UniversiteitAmsterdam, Amsterdam, The Leuphana University, Lueneburg, Germany. Amsterdam, TheNetherlands. Academic Medical Centre, UniversityofAmsterdam, ISGF, UniversityofZurich, Switzerland. Swiss Research InstituteFor Public HealthAndAddiction 3 , HeleenRiper ORAL COMMUNICATIONS -OC11 3 1 , AndreasWenger 1 , MatthijsBlankers 3,4 1 , JackDekker , Pedro GarcíaParajuá 143 23 -26March, 1 , David Ebert 4 2 , AnnaGoudriaan , DirkLehr Madrid -Spain 2 , Julia 5 3 , Leif 2017 4 ,

SUNDAY 26 SUNDAY 26 11:30 -12:15 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders COCAINE PSYCHOSIS:COCAINE WHAT ISNEW? España. Carlos Roncero, UniversidadAutónoma deBarcelona, SPEAKER: Hassan Rahioui,HôpitalHenriEy. Paris,France. CHAIR: Auditorium Veterans’ Administration Medical Center, USA. Icahn School ofMedicineat Mount SinaiandJamesJ.Peters Leo Sher AND DISCUSSION ATESTOSTERONEAFTER REPORT INJECTION: ACASE POLYSUBSTANCE USEDISORDERSCOMMITS HOMICIDE AN INDIVIDUAL AND WITHCOMORBID BIPOLAR Kharkiv, Ukraine. Kharkiv Medical Academy ofPostgraduate Education, Burmaka Chuev,Ivan Sosin,Jury OlenaGoncharova, Nadiya SOMATIZATION AND NICOTINE WITHHEPATHOPATHY ADDICTION DETOXIFICATION AT THERAPY DUAL ALCOHOL ADJUVANT NANOTECHNOLOGY FOR INTEGRATED Proyectodah, Mexico. Juan CarlosPerez Castro STRATEGY FOR SUBSTANCE ABUSEPREVENTION A FOR PHYSICIAN,AS PRIMARYADHD TRAINING CARE 2 Sharon Rabinovitz NON-USERS COMPARISON OFHYPERSEXUAL SUBSTANCE USERSAND CRIMINAL PROFILE OFCONVICTED SEXUAL OFFENDERS: 1  UniversityofHaifa,Israel. Center for MentalHealth,Israel. Ashkelon Academic College, Ashkelon &Be’er Ya’akov

Track: Substance andDualDisorders UseDisorders MAIN LECTURE-ML18 1 , JudithAbulafia 144 2 11:30 -13:00 12:15 -13:00 EVIDENCE BASED TREATMENTEVIDENCE BASED FOR DUAL DISORDERS INTERNATIONAL LATINO PARTNERSHIP RESEARCH - Barcelona, España. Francisco Collazos, HospitalUniversitari Vall d’Hebron. PROJECTRESEARCH TRIAL CLINICAL AND IIDEA FINDINGS FROM THEINTERNATIONAL LATINO ADDRESSING LATINO DUAL DISORDERS: IMMIGRANT España. Rodrigo Carmona,FundaciónJiménezDiaz.Madrid, PREVENTION FOR LATINO MIGRANTS TRIALFOR DUALCLINICAL DISORDERSANDHIV RESULTS OFANINTERNATIONAL RANDOMIZED USA. School, Somerville. MA, Research, Cambridge HealthAlliance &Harvard Medical Margarita Alegría,Center for Multicultural MentalHealth ADULTSMIGRANT SUBSTANCE ANDHIVPREVENTIONFOR USE, LATINO BEHAVIORAL FOR MENTAL THERAPY HEALTH, DEVELOPMENT ANINTEGRATED OFIIDEA: COGNITIVE SPEAKERS: Barcelona, España. Francisco Collazos, HospitalUniversitariVall d’Hebron. CHAIR: Room Castilla General UniversitarioGregorioMarañón. Madrid,España. Néstor Szerman, SaludMentalRetiro, Servicio Hospital SPEAKER: de Adicciones. Madrid,España. Pablo Vega, SociedadEspañola dePatología Dual(SEPD);Instituto CHAIR: Auditorium SYSTEM ANDMENTAL DISORDERS A NEWWAY OFTHINKINGDUAL DISORDERS.OPIOID

Track: Substance andDualDisorders UseDisorders

Track: Intervention inDualDisorders Multidisciplinary MAIN LECTURE-ML19 SYMPOSIUM -SY52 145 23 -26March, Madrid -Spain 2017

SUNDAY 26 SUNDAY 26 11:30 -13:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders RESOURCES DUAL DISORDERSINARGENTINA: DIAGNOSES AND Argentinos. Argentina. Yaraví ArceScott, Vicepresidenta AsociacióndePsiquiatras DISORDERSANDDUAL DISORDERS ANXIETY Argentina. Fernández, MiembroCapítuloJosé L. Patología DualAPSA. RESIDENTIAL TREATMENT INDUAL DISORDERS Aires, Argentina. Hospital ItalianodeBuenosAiresyUniversidad Javier Didia,PresidenteCapítulo Patología DualAPSA, DISORDERS ANDOTHER ADDICTIONS ANDSYSTEMSOFREGISTRATIONNETWORKS INDUAL SPEAKERS: Uruguay. Presidentedel2ºCongreso(MUCAM), deAILANCYP, Freedy Pagnussat, Integrante dela Médica Uruguaya CHAIR: Room Doblón

Track: Intervention inDualDisorders Multidisciplinary SYMPOSIUM -SY53 146 11:30 -13:00 RECIPROCAL ASSOCIATIONS OFDUAL DISORDERS COGNITIVE AND BIASES PREDICTORS OFRELAPSE, DISORDERED GAMBLINGANDSCHIZOPHRENIA: Diagnostico Psicológico. Barcelona, España. Barcelonesa deLudopatía yAdicciones/ Institutode Montserrat Gómez,UniversidaddeBarcelona, Asociación SCHIZOPHRENIA OF SLOT-MACHINES GAMBLERSWITHDUAL COGNITIVE ANDIRRATIONAL BIASES BELIEFS Igor Yakovenko, UniversityofCalgary, Canada. FEATURES OFDUAL DISORDERS PATTERNS ANDUNIQUECLINICAL OFINTERACTION SCHIZOPHRENIA ANDDISORDEREDGAMBLING: Sebastián/ Donostia,España. Enrique Echeburúa, UniversidaddelPaísVasco. San DISORDER DISORDERED GAMBLERSWITHSEVEREMENTAL PREDICTORS FAILURE OFTHERAPEUTIC IN SPEAKERS: Diagnostico Psicológico. Barcelona, España. Barcelonesa deLudopatía yAdicciones/ Institutode Montserrat Gómez,UniversidaddeBarcelona, Asociación CHAIR: Room ElEscorial

SYMPOSIUM -SY54 Track: Behavioral Addictions andDualDisorders 147 23 -26March, Madrid -Spain 2017

SUNDAY 26 SUNDAY 26 11:30 -13:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders PROVINCE THE APPROACH OFDUAL DISORDERSINHUELVA RATIONAL USEOFPSYCHOTROPIC DRUGSIN Jiménez. Huelva, España. Gutiérrez,ComplejoMaría L. Hospitalario JuanRamón ANTIPSYCHOTICS INADHERENCEANDRECOVERY THE ROLE OFLONG-TERM INJECTABLE Adicciones deHuelva, España. ProvincialJuan Ramírez,Servicio Drogodependenciasy OFHUELVA ANDADDICTIONS ADDICTIONS PATHOLOGY INTHEPROVINCIAL SERVICE OFDRUG ANTIPSYCHOTICS INPATIENTS WITHDUAL THE ROLE OFLONG-TERM INJECTABLE Jiménez. Huelva, España. Mercedes Guzmán,Complejo Hospitalario JuanRamón UNIT. RATIONAL USEOFPSYCHOTROPIC DRUGS MANAGEMENT OFDUAL DISORDERSIN AN ACUTE SPEAKERS: Jiménez. Huelva, España. Juan J. Mancheño, Complejo Hospitalario Juan Ramón CHAIR: Room ElJardín

Track: inDualDisorders Pharmacology SYMPOSIUM -SY55 148 11:30 -12:15 Drogodependientes "ElAlba". Toledo, España. Alberto Jiménez,Centro deTratamiento de DUAL PATIENT RECOVERY THE SUBJECT CONDITION ANDITSRELATION TO Drogodependientes “ElAlba”. Toledo, España. Ignacio Fuerte, Centro deTratamiento de ADMINISTRATION OFPRIVILEGES THE USER:COMMUNICATION, REGULATION AND THE DIALOGUE THEINSTITUTIONAND BETWEEN "El Alba". Toledo, España. Lucas García,Centro deTratamiento deDrogodependientes STARTED ITALL APPROACH: TURNAROUND THECOPERNICAN THAT FROM INDIVIDUAL ATTENTION TO GROUP SPEAKERS: "El Alba". Toledo, España. Lucas García,Centro deTratamiento deDrogodependientes CHAIR: Room Comendador COMMUNITY OFATHERAPEUTIC DUAL DISORDERS:EXAMPLE TERM INPATIENT TREATMENT FOR PROGRAMS ATTENTION TO INSTITUTIONALIMPACT ONLONG- WORKSHOP -WS21

Track: Psychotherapeutic Treatments inDualDisorders 149 23 -26March, Madrid -Spain 2017

SUNDAY 26 SUNDAY 26 12:15 -13:00 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders Room Comendador (Organización Médica Colegial) Fundación para la Protección Socialdela OMC GUÍA PAIME (Organización Médica Colegial) Fundación para la Protección Socialdela OMC ENFERMO (PAIME) DEATENCIÓNMANUAL DELPROGRAMA ALMÉDICO Iberolatinoamericana dePsiquiatría.México. Enrique Camarena,Presidentedela Asociación YSALUD,CANNABIS EVIDENCIA DELMITO ALA Argentina. Argentina. Hilda Tevez AsociacióndePsiquiatría Lombardo, INAPBA, Argentina. Argentina. Católica deCuyo-San Juan,AsociacióndePsiquiatría Guillermo Fernández D’Adam, Universidad INAPBA, DAÑO...SIEMPRE !!! CEREBROS CHATARRA??? HACEN DROGAS” “LAS BOOK PRESENTATION 150 11:30 -13:00 1 Centre Hans, Capital Sct. regionofDenmark,Denmark. Competence Centre for DualDiagnosis, MentalHealth Solvej Mårtensson, KatrineJohansen REGISTERBASED STUDY INDENMARK-(PARTMECHANICAL RESTRAINT 1)A PATIENTS WITHDUAL DISORDERSANDTHEUSEOF Instituto Psiquiátrico JoséGermain, España. Francisco DePedro Melgarejo,Pablo Feito Fernández DUAL DISORDERSINAREHABILITATION UNIT 3 2 Yatan Pal SinghBalhara WITHOUT CO-OCCURRING PSYCHIATRIC DISORDERS PATIENTS WITHSUBSTANCE USEDISORDERSWITHAND A COMPARATIVE STUDY OFPATHWAYS TO AMONG CARE Investigación Hospital12deOctubre (i+12),España. Hospital Universitario12DeOctubre, Institutode Grande Sonia Alvarez,David Rentero, MartaGómez,Raquel AN ACUTE PSYCHIATRIC INPATIENT UNIT ANDPSYCHOSIS.CANNABIS DIFFERENCESIN CLINICAL CSAPA duMonde.France. BIZIA/Medecins Arkaitz Aguerretxe, Cabinet enLibéral, BIZIA/SETHS, Barcelona, España. Nieves Martínez-Luna, HospitalUniversitariVall d’Hebron. CHAIRS: Room Escudo Tripathi NDDTC, AIIMS,NewDelhi.  NDDTC andDepartmentofPsychiatry, AIIMS,NewDelhi. Australia; Virginia Commonwealth University, USA. King’s College London, UK;UniversityofAdelaide, 3 , S.Shalini ORAL COMMUNICATIONS -OC12 3 151 1,2 , SiddharthSarkar 23 -26March, Madrid -Spain 1 , Richa 2017

SUNDAY 26 SUNDAY 26 FIFTH INTERNATIONAL CONGRESSOF THESPANISH SOCIETYONDUAL DISORDERS(SEPD)

FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & DUAL DISORDERS Addictions and other Mental Disorders 1 UNED, España. Araceli GarciaPardo STABILITY INDUAL DISORDERS EVALUATION AND DEVELOPMENT OFEMOTIONAL Tenerife, España. Máster enGestiónyDerecho Sanitario,SantaCruzde Isabel Aguilar Dorta SPANISH LAW THE IMPORTANCE OFTHETERM“DUAL DISORDER”IN 2 Gonzalo Martinez-Ales PROSPECTIVE STUDY SUICIDE ATTEMPT. RESULTS FROM AHOSPITAL-BASED PSYCHIATRIC ARISK MARKEROF DISORDERSAS TOXIC BETWEEN INTERACTION CONSUMPTION AND Rubio Eduardo Jimenez Bravo UniversidadAutónoma deMadrid,España. HospitalUniversitarioLa Paz,España. 1,2 1 , AndresFraga 1 , Victor Baena 152 1 , BeatrizRodriguez 1,2 , Eva Roman 1 , Iker Louzao 1 , PilarSanchez 1,2 , MariaFe 1 , Iñigo 1 , 23 - 26 March, 2017 Madrid - Spain

IV CONGRESSO IBERO-BRASILEIRO DE PATOLOGIA DUAL

Thursday, March 23rd

11:00 - 12:00 Room El Jardín Track: Multidisciplinary Intervention in Dual Disorders SYMPOSIUM - IB01 TREATING DUAL PATIENTS ACCORDING TO A NEW PARADIGM

CHAIR: Célia Franco, President of APPD, Unidade Patologia Dual. C.H.U. Coimbra, Portugal.

SPEAKERS: IMPLICATIONS OF THE CHANGING OF PARADIGM IN THE TREATMENT OF DUAL DISORDERS PATIENTS Célia Franco, President of APPD, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. OUTPATIENT MANAGEMENT OF DUAL DISORDERS PATIENT: THE DUAL DISORDERS UNIT EXPERIENCE Elisabete Albuquerque, Centro Hospitalar Universitário de Coimbra, Portugal. RECOVERY IN DUAL DISORDERS PATIENT Tânia Silva, Centro Hospitalar Universitário de Coimbra, Portugal.

153 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

12:00 - 13:00 Room El Jardín Track: Multidisciplinary Intervention in Dual Disorders SYMPOSIUM - IB02 MULTIDISCIPLINARY TEAMS IN THE MANAGEMENT OF DUAL DISORDERS PATIENTS

CHAIR: Vera Martins, Unidade Patologia Dual. C.H.U. Coimbra, Portugal.

SPEAKERS: NURSING INVOLVEMENT IN THE MANAGEMENT OF DUAL DISORDERS PATIENTS Vladimiro Andrade, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. DAY-CARE UNIT IN DUAL DISORDERS PATIENTS TREATMENT Filomena Neto, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. CONJUGALITY AND ALCOHOL: LACES OF (MISS) VENTURE Sofia Trigo,Unidade Patologia Dual. C.H.U. Coimbra, Portugal.

13:00 - 14:00 Room El Jardín Track: Investigation, Development and E-Health Technologies in Dual Disorders SYMPOSIUM - IB03 MENTAL HEALTH IN LATIN AMERICA; ITS CHALLENGES

CHAIR: Enrique Mendoza, Presidente Asociación Psiquiátrica de América Latina, Guatemala. Speakers:

SPEAKERS: STIGMA AND ADDICTION: DOUBLE STIGMA Antonio G. da Silva, Vicepresidente Asociación Psiquiátrica de América Latina, Brasil. MENTAL HEALTH CARE POLICIES IN LATIN AMERICA Enrique Mendoza, Presidente Asociación Psiquiátrica de América Latina, Guatemala. DUAL DISORDERS IN DRUG USERS ATTENDED AT YOUTH INTEGRATION CENTERS Carmen Fernández, Directora General Centros De Integración Juvenil A.C., Mexico.

154 23 - 26 March, 2017 Madrid - Spain

14:00 - 14:30 Room El Jardín PRESENTATION CEREMONY OF IV CONGRESSO IBERO- BRASILEIRO DE PATOLOGIA DUAL

Célia Franco, President of APPD, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. Antonio G. da Silva, Vicepresidente Asociación Psiquiátrica de América Latina, Brasil. Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España.

14:30 - 15:30 Room El Jardín Track: Forensic and Dual Disorders SYMPOSIUM - IB04 IMPACT OF DUAL DISORDERS IN THE PRACTICE OF FORENSIC SCIENCES

CHAIR: João Pinheiro, Instituto Nacional de Medicina Legal e Ciências Forenses, IP. Coimbra, Portugal. Rafael Bañou, Consejo de Medicina Forense de España. Murcia, España.

SPEAKERS: SUICIDE AND DUAL DISORDERS Benito López de Abajo, Instituto de Medicina Legal de Galicia. Santiago de Compostela, España. COERCIVE TREATMENTS IN MENTAL HEALTH Máximo Colón, Instituto Nacional de Medicina Legal e Ciencias Forenses. Coimbra, Portugal. ANALYSIS OF PREMATURE MORTALITY IN USERS OF THE ADDICTION CARE CENTERS OF THE CARE NETWORKS OF GALICIA AND NORTH OF PORTUGAL Andrés Fontenla, Plan de Trastornos Adictivos de Galicia, (CHUVI), SERGAS. Vigo, España.

155 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

15:30 - 16:30 Room El Jardín Track: Investigation, Development and E-Health Technologies in Dual Disorders SYMPOSIUM - IB05 INTELECTUAL DEVELOPMENT DISORDER AND SUBSTANCE USE DISORDERS

CHAIR: Antonio G. da Silva, Vicepresidente Asociación Psiquiátrica de América Latina, Brasil.

SPEAKERS: OVERVIEW, DIAGNOSIS, RISK FACTORS AND AETIOLOGY Elisabete Albuquerque, Centro Hospitalar Universitário de Coimbra, Portugal. THE EXPERIENCE OF COIMBRA DUAL DISORDER UNIT Pedro Esteves, Centro Hospitalar Universitário de Coimbra, Portugal. TREATMENT APPROACHES Adriana Santos, Centro Hospitalar Universitário de Coimbra, Portugal.

156 23 - 26 March, 2017 Madrid - Spain

16:30 - 17:30 Room El Jardín Track: Pharmacology in Dual Disorders SYMPOSIUM - IB06 LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN DUAL DISORDERS

CHAIRS: Fátima Pessoa, Divisão de Intervenção nos Comportamentos Aditivos e nas Dependências (DICAD), Portugal. Indalecio Carrera, Universidad de Santiago de Compostela, ACLAD. La Coruña, España.

SPEAKERS: RECOMMENDATIONS FOR THE USE OF INJECTABLE ANTIPSYCHOTICS IN DUAL DISORDERS José A. Santos, Divisão de Intervenção nos Comportamentos Aditivos e nas Dependências (DICAD), Portugal. NURSING ACTION IN DUAL DISORDERS: TREATMENTS WITH LONG-TERM INJECTABLE ANTIPSYCHOTICS Mª José Álvarez, Plan de Trastornos Adictivos de Galicia, CHUVI, SERGAS. Vigo, España. STUDY OF THE PATIENTS TREATED WITH NILD IN THE ASSISTANCE NETWORKS OF GALICIA AND THE NORTH OF PORTUGAL. PRELIMINARY RESULTS Manuel Conde, Plan de Trastornos Adictivos de Galicia, CHUVI, SERGAS. Vigo, España.

157 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

17:30 - 18:30 Room El Jardín Track: Investigation, Development and E-Health Technologies in Dual Disorders SYMPOSIUM - IB07 NEW CHALLENGES IN DUAL DISORDERS

CHAIR: João Romildo Bueno, Consultorio Dr João Romildo Bueno. Rio de Janeiro, Brasil.

SPEAKERS: PSYCHOPATHOLOGY IN THE PATIENT WITH TOBACCO DEPENDENCE Tânia Silva, Centro Hospitalar Universitário de Coimbra, Portugal. ADDICTIONS WITHOUT SUBSTANCES - STATE OF ART Vera Martins, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. ALCOHOL AND OTHER SUBSTANCES IN PATIENTS WITH EATING DISORDERS Teresa Carvalhão, Centro Hospitalar Universitário de Coimbra, Portugal. ALCOHOL CONSUMPTION AND ENTERTAINMENT IN COLLEGE STUDENTS Teresa Medeiros, Universidade dos Açores, Portugal.

158 23 - 26 March, 2017 Madrid - Spain

FOUNDATION ACTIVITIES

Friday, March 24th

16:30 - 19:30 Room El Prado FUNDACIÓN DE PATOLOGÍA DUAL FEAFES JORNADAS DE PUERTAS ABIERTAS PARA FAMILIARES Y PACIENTES CON PATOLOGÍA DUAL

16:30 - 17:00 ACTO INSTITUCIONAL Representante Ayuntamiento de Madrid, Fundación de Patología Dual, UNAD, Confederación Salud Mental, FERMAD

17:00 - 17:30 PREGUNTE A LA DRA. NORA VOLKOW MODERA: Néstor Szerman, Presidente de la Fundación de Patología Dual

17:30 - 19:30 COLOQUIO CON LOS FAMILIARES, PACIENTES Y EXPERTOS MODERA: Antonio Prieto, Gerente de Madrid Salud

EXPERTOS: Néstor Szerman, Miguel Casas, Marta Torrens, Ruth Olmos, María Perez, Rocío Molina e Inés González

ORGANIZA: COORDINA:

COLABORAN:

159 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

POSTERS

POSTER SESSION 1 4 A REVIEW: THE INFLUENCE THURSDAY-FRIDAY OF NICOTINE ADDICTION IN MOTHERS OF PATIENTS WITH ADHD 1 INFLUENCE OF CANNABIS EFFECT ON WORK MEMORY Maria-Encarnacion Dominguez- PERFORMANCE DUE TO FIRST Ballesteros, Maria Jose Marquez DEGREE RELATIVES HISTORY. Marquez, Miguel Perez Sosa, RESULTS OF A 51-INDIVIDUALS Cristina Garcia Román, Paloma SAMPLE WHO SUFFERED A FIRST Aguilar Valseca PSYCHOTIC EPISODE Hospital Virgen Macarena, Sevilla, Nieves Gomez-Coronado Suárez De España. Venegas, Patricia Blanco Ramón, Miguel Ruiz Veguilla 5 THE ROLE OF DEVELOPMENTAL PSYCHIATRY IN ADDICTION FROM Hospital Universitario Virgen del ADHD TO FIRST DRUGS ABUSE Rocío, Sevilla, España. Elias Garcia1, Rocio Moreno2, Blanca 2 2 DOES THE CANNABIS Tarjuelo CONSUMPTION INCREASE THE 1 Sescam, Area de Gestión Integrada PERCENTAGE OF ALTERATIONS de Toledo, Toledo, España. IN THE NEURODEVELOPMENT 2 Sermas, USM de Vallecas, Hospital OF CANNABIS CONSUMERS WHO de San Sebastian de los Reyes, SUFFERED FIRST PSYCHOTIC Madrid, España. EPISODES BEFORE BEING OVER EIGHTEEN YEARS OLD? EVIDENCE 6 FROM ADOLESCENCE TO PRESENTED IN A 60- INDIVIDUALS ADULTHOOD; THE IDENTITY SAMPLE CONSTRUCTION AND ITS IMPACT Patricia Blanco Ramón, Nieves IN DRUGS ABUSE Gomez-Coronado Suárez de Elias Garcia1, Rocio Moreno2, Blanca Venegas, Miguel Ruíz Veguilla Tarjuelo2 Hospital Universitario Virgen del 1 Sescam, Area de Gestión Integrada Rocío, Sevilla, España. de Toledo, Toledo, España. 2 Sermas, USM de Vallecas, Hospital 3 ADDICTION TO NEW TECHNOLOGIES IN FIRST EPISODE de San Sebastian de los Reyes, OF PSYCHOSIS Madrid, España. Maria Encarnacion Dominguez 7 DEPRESSION AFTER SPINAL CORD Ballesteros, Cristina Garcia Román, INJURY AND IT'S ASSOCIATION Paloma Aguilar Valseca, Maria Jose WITH INJURY CHARACTERISTICS Marquez Marquez AND SOCIO-ECONOMIC Hospital Virgen Macarena, Sevilla, INDICATORS IN IRAN España. Zahra Khazaeipour, Seyedeh- Hospital Virgen Rocio, Sevilla, Mohadeseh Taheri-Otaghsara, España. Maryam Naghdi Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Iran.

160 23 - 26 March, 2017 Madrid - Spain

8 DUALLY DIAGNOSED 12 "BINGE ": ADOLESCENTS: OUR EXPERIENCE TREATMENT AND DUAL IN DIAGNOSING AND TREATMENT DISORDERS Jelena Kostic, Ljubiša Milosavljevic, Mercedes Lopez-Rico1, Jimena Miodrag Stankovic Lopez-Sanchez Lopez1, Jose Luis 2 Department of Child and Adolescent Jimenez Hernandez Psychiatry, Clinic for Mental Health 1 University of Salamanca, Spain. Protection, Serbia. 2 "Doce de Octubre" Hospital, Spain.

9 PREVALENCE OF MENTAL 13 POSTRAUMATIC STRESS DISORDERS ACCORDING TO DSM5 DISORDER IN PEDIATRIC PATIENT IN A CLINICAL SAMPLE FROM A BY LIGHT STRESSORS. A CASE CHILD AND YOUTH MENTAL UNIT REPORT 1 Isabel Laporta Herrero , Mª Pilar Jhonny Alejandro Muñoz Valencia, 2 Delgado Miguel , Javier Navarro Jose Ricardo Muñoz Zuñiga Aznar3 Universidad Tecnológica de Pereira, 1  Centro de Salud Mental Infanto- España. Juvenil, Servicio Navarro de Salud, España. 14 THE MOTHERS WITH DUAL 2 Hospital Royo Villanova, Servicio DISORDERS: ATTACHED Aragonés de Salud, Zaragoza, PROBLEMS España. Laura Nuevo1, Victoria Muñoz1, 3 Hospital Universitario Miguel Beatriz Mata1, Leonor Asensio1, Servet, Servicio Aragonés de Salud, Estefania Segura1, Maria Antonia Zaragoza, España. Font2, Mercedes Novo2, Laura Mella1 10 PSYCHIATRIC COMORBIDITY IN 1 Hospital General Ciudad Real, HOSPITAL UNITS OF CENTROS DE España. INTEGRACIÓN JUVENIL A.C. (CIJ) 2 Hospital Perpetuo Socorro, Laura Margarita Leon Leon Albacete, España. Centros de Integración Juvenil, A.C., Mexico. 15 ATTACHMENT THEORY AND ADDICTION – THE INFLUENCE OF 11 AGE OF ONSET FOR CO-MORBID MATERNAL DRUG ABUSE DISORDERS IN EARLY AND LATE João Perestrelo, Georgina Lapa ONSET BIPOLAR DISORDER Centro Hospitalar Vila Nova de Gaia/ 1 2 Josephine Loftus , Bruno Etain , Espinho Healthcare Centre, Portugal. Frank Bellivier2, Chantal Henry3, Jan 4 Scott 16 CONTRIBUTION OF HEREDITY TO 1 Centre Hospitalier Princesse Grace, FORMATION OF PHOBIC ANXIETY Monaco. DISORDERS IN CHILDREN 2 Hôpital Fernand Widal, Paris, T. Proskurina, N. Bagatska, E. France. Mykhailova, N. Reshetovska, L 3 Université Paris-Est, Créteil, France. Glotka 4 Newcastle University, & Centre for Institute for Children and Affective Disorders, IPPN, King's Adolescents Health Care of The College, London. United Kingdom. NAMS of Ukraine, Ukraine.

161 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

17 ATTITUDE AND RISK OF 22 RELATION BETWEEN SUBSTANCE USE IN ADOLESCENTS DISSOCIATION, DRUG ABUSE DIAGNOSED WITH ASPERGER AND SUICIDE ATTEMPS IN SYNDROME ADOLESCENT: A CASE REPORT M. Ramos, L. Boada, C. Moreno, C. Estefania Segura Escobar, Victoria Llorente, J. Romo, M. Parellada Muñoz Martinez, Germán Jimenez Hospital General Universitario Londoño, Carlos Rodriguez Gómez Gregorio Marañón, Madrid, España. Carreño, Laura Nuevo Fernández, Luis Beato Fernández 18 TOBACCO CONSUMPTION IN Hospital General Universitario de FIRST PSYCHOTIC EPISODES: Ciudad Real, España. CAUSALITY OR VULNERABILITY TO ADDICTION? 23 LIVE ME ALONE: STYLE OF Ana Rubio Garcia, Rubén Catalán ATTACHMENT PREDICTS Barragan, Rocío Gutierrez THE COMMITMENT IN A Rodriguez, Iván Martínez Molina, DESINTOXICATION TREATMENT Manuel Canal, Miguel Ruiz-Veguilla Estefania Segura Escobar, Victoria Hospital Virgen del Rocío, Sevilla, Muñoz Martinez, Germán Jimenez España. Londoño, Carlos Rodriguez Gómez Carreño, Laura Nuevo Fernández, 19 FETAL ALCOHOLIC SYNDROME: Luis Beato Fernández “CUIDAR CUIDANDO” PROGRAM Hospital General Universitario de Eduardo Sacristán1,2, Ester Pla2, Ciudad Real, España. Carme Cunillera1, Mireia Sala2 THE IMPORTANCE OF DUALITY IN 1  24 CAS Garrotxa, España. SCHIZOPHRENIA 2  CDIAP INTEGRA Garrotxa, España. Marta Soto Laguna, Joaquina Prados Gómez, Manuel Fernández- KLINEFELTER SYNDROME AND 20 Torija Daza, Gema Belmonte García, PSYCHIATRIC MANIFESTATIONS. Beatrzi Herrejon Teodoro, Francisco PALIPERIDONE USE José González Eduardo Sacristán1, Dolores Hospital Provincial de La Robles2, Carme Cunillera1, Xavier Misericordia, Toledo, España. Tolaguera1, Rosa Serrat1, Anna 1 Calvet 25 THE EFFECTIVENESS OF PLAY 1 CAS Garrotxa, España. THERAPY BASED ON COGNITIVE- 2 CSMA Garrotxa, España. BEHAVIORAL ASPECT (PTBCB) IN POPULATION OF ADHD 21 TRAUMA IN PSYCHIATRIC CHILDREN: A PRELIMINARY STUDY SUICIDAL ATTEMPTERS WITH Hsin I Wu, Yi Hsien Wu AND WITHOUT SUBSTANCE USE Jianan Mental Hospital, Taiwan. DISORDERS Rosa Patrizia Sant'Angelo1, Roberta 26 EFFECTIVENESS FOR COGNITIVE Raggini1, Monica Pacetti1, Marisa BEHAVIORAL GROUP THERAPY IN Bolondi2, Laura Bisi2, Viviana A POPULATION OF ADHD BOYS Storbini3, Raffaele Fiorillo3, Federica FROM PARENTS´ VIEW 3 Ambrosini Yi Hsien Wu, Tung-Chia Chen 1  Mental Health Department, AUSL Yuli Hospital, Ministry of Health and Romagna, Italy. Welfare, Taiwan. 2 University of Modena, Italy. 3 University of Bologna, Italy.

162 23 - 26 March, 2017 Madrid - Spain

27 SELF-INJURIOUS BEHAVIOR IN 31 TREATING ADDICTION WITH WOMEN WITH DUAL DISORDERS SCHEMA THERAPY AND EMDR Ana De La Fuente Martín, Rodrigo IN A SAMPLE OF FEMALES WITH Marín Navarrete CO-OCCURRING SUBSTANCE USE DISORDER AND POST-TRAUMATIC Universidad La Salle, Hospital STRESS DISORDER Ángeles del Pedregal, Instituto 1 Nacional de psiquiatría Ramón de la Geraldine Tapia , Beatrice Perez- 2 3 Fuente, Mexico. Dandieu , Florin Oprescu , Lenoir Hugo1, Othily Erika1, Jean-Michel 2 28 VOLUNTARY SUBSTANCE ABUSE Delile AND CHEMICAL SUBMISSION: NOT 1 University of Bordeaux, France. SO FAR AWAY...CASE REPORT 2 CEID Bordeaux, France. 1 Marta Navas Tejedor , Julia García 3 University of the Sunshine Coast, 2 Albea Martín , Pedro García Australia. Parajuá3 1 Hospital Universitario Infanta 32 CLINICAL DIFFERENCES BY Leonor. España. GENDER IN PATIENTS WITH 2 Hospital Clínico San Carlos, España. BIPOLAR DISORDERS AND HARMFUL CONSUMPTION OF 3  Hospital Universitario Puerta de ALCOHOL Hierro, España. Francisco Manuel Vallejo Auñón, 29 HOMOSEXUALITY AND DRUGS Lucia González Cordero SOCIOCULTURAL RISK FACTORS, Hospital Universitario de Ceuta, COMPARATIVE CONSUMPTION España. AMONG LGB AND HETEROSEXUAL POPULATION AND SOCIAL 33 GENDER DIFFERENCES IN PERCEPTION OF TOXIC DECISION-MAKING PROCESSES CONSUMPTION LINKED TO VENTROMEDIAL Beatriz Rodriguez Paz, Markel PREFRONTAL CORTEX IN Mahillo Gutierrez PATIENTS ADDICTED TO SUBSTANCES Red de Salud Mental de Bizkaia, 1 España. Esperanza Vergara Moragues , Adolfo Piñón Blanco2,3, Maria 4 30 MENTAL DISORDERS IN Casanueva Fernández , Francisco 2 PATIENTS BREAST CANCER: Otero Lamas DIFFERENTIATED APPROACH 1 Universidad Internacional de La TO THE STUDY NOZOGENY Rioja, Logroño, España. DISORDERS 2 Unidad Asistencial de Olga Shushpanova Drogodependencias (UAD) CEDRO, Scientific Center of Mental Health, Vigo, España. Russia. 3 Portucalense Institute of Neuropsychology and Cognitive and Behavioral Neurosciences (INPP). Universidade Portucalense, Oporto, Portugal. 4 Complejo Hospitalario Universitario de Vigo, EOXI-CHUVI, Vigo, España.

163 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

34 CHEMICAL SUBMISSION: A CASE 39 SUICIDALITY INFLUENCE ON THE REPORT EXECUTIVE FUNCTIONING OF MEN Idoia Astigarraga, Andoni WITH DUAL SCHIZOPHRENIA Aramburu, Jessica Lorena Talavera, Ana Adan1, Maria del Mar Capella1, Mikel Arranz, Jessica Heemskerk, Gemma Prat1, Diego A. Forero2, Elisabet Vincent, Maria Soledad José Francisco Navarro3 Mondragon, Gixane Garcia Belen 1 University of Barcelona, España. Berjano 2 Universidad Antonio Nariño, Osakidetza, España. Colombia. 3  35 A CASE OF PARANOID University of Málaga, España. SCHIZOPHRENIA WITH HEROIN AND CANNABINOIDS 40 DANGEROUS CONSEQUENCES CONSUMPTION – THE EVOLUTION Trinitario Ballesta Casanova OVER THE YEARS CAS Fontsanta. CAS Garbivent, Teresa Carvalhao, Elisabete España. Albuquerque, Tânia Silva, Célia Franco 41 CANNABIS AS A LEADING FACTOR AND PSYCHOSIS MAINTAINER Coimbra University Hospitals, Portugal. Martha Cancino Botello, María de los Ángeles Canseco Navarro, 36 "HEY THERE! I AM USING Juan Miguel Hernández Sánchez, WHATSAPP®!” Marta Machado Vera, Sofía Alonso Alicia Gomez Peinado1, Araceli Gutiérrez, María Amparo Descalzo Martínez Carrascosa1, Carmen Cabadés García Moreno1, Paloma Cano Consorcio Hospital General Ruiz1,2, Marta Lucas Pérez-Romero1, Universitario De Valencia, España. Patricia Romero Rodenas1, María Teresa Tolosa Pérez1 42 EVALUATION OF POSITIVE AND NEGATIVE SYMPTOMS IN 1 Complejo Hospitalario Universitario PATIENTS WITH SCHIZOPHRENIA de Albacete, España. AND ITS RELATIONSHIP WITH 2  Unidad de Conductas Adictivas de THE SUBSTANCE DEPENDENCE IN Almansa, España. THE PSYCHIATRIC HOSPITAL FRAY BERNARDINO ÁLVAREZ 37 DUAL DISORDERS BY HEALTH PROFESSIONALS IN TRAINING Edgar Casillas Guzmán, Eva Alicia García Armendáriz J. Brotons López, J. Cervera Martínez, R. Genovés Muñoz, V. Hospital Psiquiátrico Fray Bernardino Avellón Juárez, J. Martínez Raga, R. Álvarez, Mexico. Calabuig Crespo 43 ANIMAL MODELING Hospital Universitario Dr. Peset de POLYSUBSTANCE ADDICTION Valencia, España. VULNERABILITY IN MENTAL ILLNESS: CONCURRENT NICOTINE 38 YOU NEVER KNOW WHAT´S AND ALCOHOL USE IN A AROUND THE NEST CORNER: NEURODEVELOPMENTAL RAT EXPLORING PRACTITIONERS MODEL OF SCHIZOPHRENIA HOPE INSPIRING PRACTICES R. Andrew Chambers, Alena Sentir, Knut Tore Sælør, Ottar Ness, Marit Rick Bell, Eric Engleman Borg, Stian Biong Indiana University School of University College of Southeast Medicine, USA. Norway, Norway.

164 23 - 26 March, 2017 Madrid - Spain

44 INTEGRATIVE MODEL IN THE 47 DRUG CONSUMPTION DURING TREATMENT OF PSYCHOSIS AND PRODROMAL PHASE OF TOXIC DEPENDENCE: A CASE PSYCHOSIS: AN EMERGENCY REPORT SERVICES APPROACH María Pilar Delgado Miguel1, Isabel José Luis Escobar Fernández1, Laporta Herrero2, Javier Navarro Margarita Guerrero Jiménez2, Aznar3 Carmen Maura Carrillo de Albornoz 2 1 Hospital Royo Villanova. Servicio Calahorro , José Antonio Rodríguez 2 Aragonés de Salud, España. Manzano 1  2 Unidad Salud Mental Infanto- Caravaca de La Cruz Mental Health Juvenil. Servicio Navarro de Salud, Center. Murcia, Spain. España. 2 Granada Sur Mental Health Service. 3 Hospital Miguel Servet. Zaragoza, Granada, Spain. España. 48 CLINICAL AND FUNCTIONAL 45 DELUSIONAL THINKING IMPROVEMENT OF PATIENTS REDUCTION DURING PROLONGED WITH SEVERE SCHIZOPHRENIA ABSTINENCE IN PATIENTS WITH AND SUBSTANCE ABUSE SEVERE ALCOHOL USE DISORDERS UNDERGOING LONG COMPREHENSIVE TREATMENT Alexandra Dereux1,2, Camille Lefebvre-Durel1, Geoffroy Juan J. Fernandez-Miranda, Silvia Dupeyron1, Aurore Girard1, Camille Diaz Fernández, Danny F. Frías Ortiz Rollat1, Frank Bellivier1,2, Eric Agc-S Mental-V-Sespa Asturian Hispard1, Bruno Etain1,2, Florence Mental Health Service, Spain. Vorspan1,2 1 Département de Psychiatrie et de 49 CANNABIS AND SCHIZOPHRENIA. Médecine Addictologique, Hôpital INDIVIDUAL VULNERABILITY OR Fernand Widal, APHP, France. CAUSALITY? 2 Inserm Umr-S 1144. Paris, France. Carmen García Moreno, Araceli Martínez Carrascosa, Alicia Gómez 46 DRUG USE DURING A FIRST Peinado, Patricia Romero Ródenas, PSYCHOTIC EPISODE: THE Marta Lucas Pérez-Romero, Maria MIGRATION PROCESS Teresa Tolosa Pérez José Luis Escobar Fernández1, Complejo Hospitalario Universitario Margarita Guerrero Jiménez2, de Albacete. Servicio de Salud Carmen Maura Carrillo de Albornoz Mental. Albacete, España. Calahorro2, José Antonio Rodríguez Manzano2 50 CONSCIOUSNESS OF DISEASE IN PSYCHOTIC PATIENTS 1  Caravaca de La Cruz Mental Health CONSUMERS OF CANNABIS Center. Murcia, Spain. Maria Angelica Garcia-Encinas1, 2  Granada Sur Mental Health Service. Carmen Massons1, Jesus Vicente Granada, Spain. Cobo1, Lourdes Nieto2, Inmaculada Ruiz3, Esther Pousa3, Olga Chapinal1 1 Hospital Universitari Parc Tauli, Barcelona, España. 2 Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. San Lorenzo Huipulco, Tlalpan, Mexico. 3 Institut de Neuropsiquiatria i Addiccions. Parc de Salut Mar, Barcelona, España.

165 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

51 CHEM-SEX: A CASE BEYOND DUAL 54 COMORBIDITIES IN DISORDERS SCHIZOPHRENIA AND Zelma González2, Itziar Ezquiaga1, RELATIONSHIP WITH Paola Rossi1,3, Claudio Tamarit1,3, DEPERSONALIZATION SYMPTOMS Francina Fonseca1,3,4, Marta Rocío Gutiérrez Rodríguez, Ana Torrens1,3,4 Rubio García, Rubén Catalán 1 Instituto de Neuropsiquiatría i Barragán, Iván Martínez Molina, Adicciones, Parc de Salud Mar, Manuel Canal Rivero, Miguel Ruiz Barcelona, España. Veguilla 2 Hospital Obispo Polanco,Teruel, Hospital Universitario Virgen del España. Rocío, España. 3  Hospital del Mar d´Investigaciones 55 COCAINE AND TACTILE Médicas-IMIM, Parc de Salud Mar, HALLUCINATIONS: A CASE Barcelona, España. REPORT 4  Universidad Autónoma de Daniel Hernandez-Huerta1, Cecilia Barcelona, Barcelona, España. Juan-Perez1, Jose Luis Gomez- Cano1, Enriqueta Ochoa-Magado1,2 52 TREATMENT WITH PALIPERIDONE 1  PALMITATE DLP IN PATIENTS WITH Ramon Y Cajal University Hospital, DUAL DISORDERS ENTERING THE Madrid, Spain. UNIT OF ACUTE PSYCHIATRICS 2 Alcala de Henares University, WITH ACTIVE PSYCHOTIC CLINIC Madrid, Spain. González Galdamez Ana Luisa, Belmar Simó Alejandro, Rodríguez 56 DUAL DISORDERS AND Hernández Alicia, Piqueras Acevedo TREATMENT: THE EXPERIENCE OF Maria Dolores, Martínez Perez A MULTIPROFESSIONAL TEAM IN Isabel, Campos Navarro Pilar, Gil MENTAL HEALTH Sanchez Alfonso, Bravo Gómez Jorge Jaber Filho, Jose Verissimo Silvia, Robles Martinez Ricardo, Junior, Janine Mendonça, Marcus García Briñol Carlos Schwartz, Simone Leite, Simone Hospital Universitario Santa Lucía Humel, Allan Moravia, Lucas Di Cartagena, España. Piero, Angela Hollanda, Bruno Reys Clínica Jorge Jaber, Brazil. 53 PARANOID SCHIZOPHRENIA WITH PRECIPITATING TOXIC: A CASE 57 HALF WAY BETWEEN PSYCHOSIS REPORT AND CANNABIS Aida González Suárez1, Laura Lago Araceli Martínez Carrascosa, García2, Isabel Barrera Salas3, Sergio Carmen García Moreno, Alicia Ocio León1, Mario Javier Hernández Gómez Peinado, Maria Teresa González1, Adela Alonso Alonso1, Tolosa Pérez, Patricia Romero Manuel Gómez Simón1, Omar W. Rodenas, Marta Lucas Pérez- Muquebil Ali Al Shaban Rodriguez4, Romero, Paloma Cano Ruiz 2 María Covandonga Huergo Lora , Complejo Hospitalario Universitario 1 Jaime Ramón López Fernández de Albacete, Servicio de Salud 1 Centro de Salud Mental de Mieres, Mental. Albacete, España. Mieres, Asturias, España. LATE ONSET CANNABIS INDUCED 2 Hospital Vital Alvarez Buylla, 58 PSYCHOSIS: A CASE REPORT Mieres, Asturias, España. Juan Jose Mora Mesa, Isabel 3 Policlínico Salud 4, Gijón, Asturias, Sánchez Lorenzo España. Servicio Extremeño de Salud, España. 4 Centro de Salud Mental de Luarca, Luarca, Asturias, España.

166 23 - 26 March, 2017 Madrid - Spain

59 CONTAINMENT AND 62 DO COCAINE-PSYCHOTIC INTERVENTION IN A PSYCHOTIC SYMPTOMS AND COCAINE- PATIENT AFTER PROLONGED INDUCED TACTILE/SOMATIC EPISODE OF SUBSTANCE ABUSE. A HALLUCINATIONS AFFECT CASE REPORT TREATMENT ADHERENCE AND Javier Navarro Aznar1, María Pilar COCAINE CONSUMPTION AMONG Delgado Miguel2, Isabel Laporta COCAINE-DEPENDENT PATIENTS?: Herrero3, María Burillo Gonzalvo1, A ONE-YEAR FOLLOW UP STUDY Paloma Gotor Reula4 Raul Felipe Palma Alvarez1, 1 1 Hospital Universitario Miguel Constanza Daigre , Elena Ros- 1,2 1,2 Servet, España. Cucurull , Lara Grau-López , Laia Rodriguez-Cintas1,2, Abderraman 2  Hospital Psiquiátrico Nuestra Esojo1, Eduardo Castrillo1, Claudia Señora del Carmen, España. Gutierrez-Guarín3, Cindy Olivieri- 3 Centro de Salud Mental infanto- Nobmann3, Carlos Roncero1,2 juvenil. Servicio Navarro de Salud, 1 Vall Hebron University Hospital. España. CIBERSAM. Barcelona, Spain. 4  Hospital Universitario Lozano Blesa, 2 Autonomous University of España. Barcelona. Barcelona, Spain. 3  60 CANNABIS USE AND EARLY Universidad del Norte. Barranquilla, INTERVENTION PROGRAMS FOR Colombia. ACUTE PSYCHOSIS 63 PSYCHOTICS SYMPTOM AND Patricia Ortega Gutiérrez, Stefano SUBSTANCE ABUSE Goretti, Melania Rodriguez Lara Maria Desamparados Perez U.G.C Salud Mental Almeria, España. Lopez1, Beatriz Herrejon Teodoro1, Nuria Berenguer Elias2, Nilushi FEATURES OF NICOTINE 61 Ratnayaka2, Roberto Perez Asenjo1, ADDICTION IN SCHIZOPHRENIA Elida Castro Arias1, Joaquina Prados Svetlana Pakhomova, Julia Barylnik, Gomez1, Marta Soto Laguna1, Julia Abrosimova Manuel Fernandez Torija1, Gema GBOU ''Saratov Medical University Belmonte1 n.a. Razumovsky V.I.", Russia. 1 Complejo Hospitalario de Toledo, España. 2 North Early Intervention in Psychosis Team Birmingham, United Kingdom.

64 PSYCHOSIS INDUCED BY DESIGNER DRUGS. A REPORT OF 3 CASES Baena Mures Rafael Angel, Niell Galmes Lluis, Alberdi Paramo Iñigo, Montero Hernandez German, Tenorio Guadalupe Miriam, Rodríguez Quijano José Hospital Universitario Clínico San Carlos, España.

167 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

65 LESS OBJECTIVES CAN PRODUCE 70 DESVENLAFAXINE IN THE WIDER RESULTS TREATMENT OF MAJOR Laura Rubio, Iciad Abad, Danny DEPRESSIVE DISORDER AND Frías, Félix Jacobo, Arantxa COMORBID ALCOHOL USE Sánchez, Concepción Pedrero DISORDERS 1 Servicio Público de Salud del Edmundo Cartagena Lopez , 2 Principado de Asturias, España. Samuel Leopoldo Romero Guillena , Arancha Lopez Mariano1, Maria 1 66 IS CANNABIS CONSUMPTION Evangelina Claro Torres , Maria 1 RELATED TO BETTER INSIGHT? Angeles Rodriguez Cejas , Juan Carlos Hornillo Castro1, Beatriz Oda Juan Seron, Ivan Martinez, Miguel Plasencia Garcia de Diego3 Ruiz 1 C.P.D. Sevilla, España. Hospital Universitario Virgen del 2  Rocío, España. U.G.C. Salud Mental. Area Hospitalaria Virgen Macarena. 67 EFFECT OF ECT ELECTRODE Sevilla, España. PLACEMENT AND SEIZURE 3 Hospital de la Merced, Osuna, TITRATION FOR SCHIZOPHRENIA: Sevilla, España. A REPORT FROM A LARGE PUBLIC PSYCHIATRIC INSTITUTION 71 DEPRESSION AND COMORBID Jiangbo Ying, Phern Chern Tor, Chai ALCOHOL USE DISORDER: Pin Ang, Ramya Radivel, Vincent Lu, BENEFITS FROM NALMEFENE Chunzhen Tan, Lee Shen Yap, Yee IN THE REDUCTION OF Ming Mok CONSUMPTION AND DEPRESSIVE SYMPTOMS Institute of Mental Health, Singapore. Santiago Duran-Sindreu, Javier de Diego-Adeliño, Juan Carlos Pascual, 68 THE BECK SCALE FOR SUICIDE Joan Trujols, Aina Fernández-Vidal, IDEATION (BSSI), RELIABILITY, Thaïs Tiana, Mar Carceller-Sindreu, AND VALIDITY OF ITS ARABIC Dolors Puigdemont, Maria J. TRANSLATION IN KUWAIT Portella, Enric Álvarez Bader Alansari Hospital de La Santa Creu I Sant Pau. Instituto de Investigación Biomédica Kuwait University, Kuwait. Sant Pau (IIB-Sant Pau), Universidad Autónoma de Barcelona (UAB). 69 SEVERITY OF ALCOHOL USE Centro de Investigación Biomédica, DISORDER IN PATIENTS WITH Barcelona, España. ASSOCIATED DEPRESSIVE SYMPTOMS 72 BENZODIACEPINE PROLONGED Julia Cambra, Mario Madroñal, USE: EFECTS ON RECOVERY OF Carlos Parro MAJOR DEPRESION Hospital General Universitario Danny Francisco Frias Ortiz, Gregorio Marañón, España. Juan José Fernandez Miranda, Maria Isabel Barrera Salas, José Manuel León Alegria, Omar Walid Muquebil, Ali Al Shaban Rodriguez SESPA, Servicio de Salud del Principado de Asturias, España.

168 23 - 26 March, 2017 Madrid - Spain

73 DUAL DISORDERS OF DEPRESSION 76 DO WE PREFER TO TALK ABOUT HOME SUICIDE INSTEAD OF ASSESSING Laura Lago García1, Aida González ADDICTION?: A CASE REPORT OF Suárez2, Adrián Azanza Balmori3, MISDIAGNOSED BENZODIAZEPINE Sergio Ocio León2, Mario Javier WITHDRAWAL Hernández González2, Adela Alonso Clara Oliveras Salvà, Susana Gomes Alonso2, Manuel Gómez Simón2, Da Costa, Mireia Solerdelcoll Omar W. Muquebil Ali Al Shaban Arimany, Anna Lligoña Garreta, Luis Rodriguez4, María Covandonga Pintor Pérez 1 Huergo Lora , Jaime Ramón López Hospital Clínic i Universitari de 2 Fernández Barcelona, Barcelona, Spain. 1 Hospital Vital Alvarez Buylla, España. 77 DEPRESSION AND ADDICTION 2 Centro de Salud Mental de Mieres, ALONG THE PATHWAY TOWARD España. SUICIDE 1 1 3 Hospital San Agustín, España. Jalessa Perez , James Overholser , Alison Athey1, Jennifer Lehmann1, 4  Centro de Salud Mental de Luarca, Lesa Dieter1, Craig Stockmeier2 España. 1 Case Western Reserve University, 74 DUAL PATIENTS WITH MAJOR USA. DEPRESSION EXHIBIT HIGHER 2 University of Mississippi Medical NEUROTICISM-ANXIETY AND Center, USA. IMPULSIVITY THAN SUBSTANCE USE DISORDER PATIENTS 78 BIPOLAR DISORDER AND WITHOUT COMORBIDITY SUBSTANCE USE DISORDERS IN A José Francisco Navarro1, Juan TUNISIAN SAMPLE Manuel Antunez1, Maria Del Mar Seifeddine Ben Mustapha, Wided Capella2, Ana Adan2 Homri, Raja Labbane 1 University of Málaga, Málaga, Razi Hospital, University of Tunis El Spain. Manar, Tunisia. 2 University of Barcelona, Barcelona, BIPOLAR DISORDER AND CO- Spain. 79 OCCURRING CANNABIS USE DISORDERS 75 DUAL PATIENTS WITH MAJOR DEPRESSION SHOW WORSE Seifeddine Ben Mustapha, Wided COPING STRATEGIES THAN Homri, Raja Labbane SUBSTANCE USE DISORDER Razi Hospital, University of Tunis El PATIENTS WITHOUT Manar, Tunisia. COMORBIDITY José Francisco Navarro1, Maria 80 COMPARISON OF INSIGHT del Mar Capella2, Juan Manuel IN BIPOLAR DISORDER WITH Antunez1, Ana Adan2 AND WITHOUT CO-MORBID SUBSTANCE USE DISORDERS 1 University of Málaga, Málaga, Spain. Seifeddine Ben Mustapha, Wided Homri, Raja Labbane 2 University of Barcelona, Barcelona, Spain. Razi Hospital, University of Tunis El Manar, Tunisia.

169 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

81 THE DURATION OF UNDIAGNOSED 85 INFLUENCE OF SUBSTANCE USE BIPOLAR DISORDER: IMPACT OF DISORDER IN BIPOLAR AND SUBSTANCE USE DISORDERS CO- SCHIZOAFFECTIVE DISORDER IN MORBIDITY A COMMUNITY MENTAL HEALTH Seifeddine Ben Mustapha, Wided CENTER Homri, Raja Labbane Silvia Gasque, Itziar Ezquiaga, Razi Hospital, University of Tunis El Álvaro José Palma, Xavier Estrada, Manar, Tunisia. Maria África Cruz, Sandra Castillo, Montserrat Forner, Miguel Gárriz 82 ATTEMPTED SUICIDE IN PEOPLE Institut de Neuropsiquiatria I WITH CO-OCCURING BIPOLAR Addiccions. Parc de Salut Mar. AND SUBSTANCE USE DISORDERS Barcelona, España. Seifeddine Ben Mustapha, Wided Homri, Raja Labbane 86 BIPOLAR DISORDER AND SUBSTANCE ABUSE: FACING THE Razi Hospital, University of Tunis El DIAGNOSTIC CHALLENGE Manar, Tunisia. Celia González Soria, Laila Al Chaal 83 METHAMPHETAMINE ABUSE AND Marcos, Lucía Sánchez Marcos, BIPOLAR DISORDER: THE “SHABÚ” Isabel Valriberas Herrero, Rafaela CASE ON A PATIENT WITH De la Mata Hidalgo, Rubén De PSYCHOSIS SYMPTOMS Alarcón Gómez, Nerea Casado Espada, Javier De la Iglesia Larrad, Danny Francisco Frias Ortiz1, Juan Laura Alonso León José Fernandez Miranda1, Laura Rubio1, Maria Francina Fonseca Complejo Asistencial Universitario Casals2, Gerad Mateu Codina2, Rosa de Salamanca. IBSAL. Salamanca, Blanca Sauras Quetcuti2, José Luis España. Pérez-Heredia2 STABILITAZION OF PATIENT 1  87 SESPA, Servicio de Salud del WITH BIPOLAR DISORDER AND Principado de Asturias. AGC-V- DEPENDENCE ON ALCOHOL AND Salud Mental, Asturias, España. CANNABIS IN TREATMENT WITH 2 Parc Sanitaria Mar " Centre Emeli NALMEFENO Mira", Barcelona, España. Alfredo Guerrero Morcillo1, Joan Aviñó Isern2, Pedro Martínez SUBSTANCE USE DISORDER 84 Mollá3, María Serna Torrijos1, Sergio AMONG BIPOLAR AND Salmerón Ríos1 SCHIZOAFFECTIVE PATIENTS 1 Hospital General de Villarrobledo, Silvia Gasque, Itziar Ezquiaga, Albacete, España. Álvaro José Palma, Xavier Estrada, 2  Maria África Cruz, Sandra Castillo, Hospital Universitario Sant Joan de Montserrat Forner, Miguel Gárriz Alacant, Alicante, España. 3  Institut de Neuropsiquiatria I Unidad de Salud Mental del Addiccions. Parc de Salut Mar. Departamento de Salud Xátiva- Barcelona, España. Ontinyent, Valencia, España.

170 23 - 26 March, 2017 Madrid - Spain

88 BIPOLAR DISORDER 91 SOCIAL FUNCTIONING IN AND CONSUMPTION OF OUTPATIENTS WITH BIPOLAR PSYCHOSTIMULANTS, INFLUENCE DISORDER AND ALCOHOL ON PROGNOSIS CONSUMPTION Edurne Losa Mujika, Belén Berjano Mihail Cristian Pirlog1,2, Dragos Noya, Estela Saez Fuentes, Maria Ovidiu Alexandru2, Anca Livia Soledad Mondragón Egaña, Laura Chirita1,2, Livia Alexandru2, Mihai Ramos Calvo, Jessica Lorena Mutica3, Anamaria Ciubara3 Talavera Palacios, Idoia Astigarraga 1 Clinic Neuropsychiatry Hospital of Iriondo, Andoni Aramburu Sanz, Craiova, Romania. Elisabet Vincent Tur, Jessica 2  Heemskerk University of Pharmacy and Medicine of Craiova, Craiova, Hospital Galdakao - Usansolo, Romania. Galdakao, Bizkaia, España. 3 Elisabeta Doamna Psychiatric 89 MOTIVATIONAL PROFILE IN Hospital, Galati, Romania. BIPOLAR ILLNESS STRATIFIED ACCORDING TO SMOKING 92 ANALYSIS ABOUT A NEW INTENSITY DIAGNOSIS IN DSM 5: OBSESSIVE COMPULSIVE DISORDER 1 Virginia Millan Aguilar , Miriam SUBSTANCE-INDUCED Ayora Rodríguez2, Esperanza Prieto 1 1 Bonilla3 Miriam Ayora , Mireia Barrios , Daniel Falla2 1 Hospital Reina Sofia, Córdoba, 1  España. Unidad de Salud Mental Comunitaria Peñarroya- 2  Unidad de Salud Mental Pueblonuevo, España. Comunitaria Peñarroya- 2  Pueblonuevo, Córdoba, España. Fundación Grupo Develop, Madrid, España. 3 Unidad de Salud Mental Comunitaria Pozoblanco, Córdoba, 93 TRANSDIAGNOSTIC APPROACH España. FOR EMOTIONAL DISTORTIONS: A CASE REPORT RELAPSE IN COCAINE ADDICTION 90 1 IN PATIENT WITH BIPOLAR María Pilar Delgado Miguel , Isabel 2 DISORDER I. A CASE REPORT Laporta Herrero , Javier Navarro Aznar3 Javier Navarro Aznar1, María Pilar 1  Delgado Miguel2, Isabel Laporta Hospital Royo Villanova. Servicio Herrero3, Ana González Gil4, Ioritze Aragonés de Salud, España. Yetano Larrazabal2 2 Unidad Salud Mental Infanto- 1 Hospital Universitario Miguel Juvenil. Servicio Navarro de Salud, Servet, España. España. 3  2 Hospital Psiquiátrico Nuestra Hospital Miguel Servet. Zaragoza, Señora del Carmen, España. España. 3 Centro de Salud Mental infanto- juvenil. Servicio Navarro de Salud, España. 4 Hospital Royo Villanova, España.

171 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

94 ADVERTISING INFLUENCE ON 98 ANXIETY ASSESSMENT IN DUAL SPORTS BETTING BEHAVIOUR DISORDERS PATIENTS AMONG ADOLESCENTS Maria Varela1, Jesús Ballesteros2, Ana Estévez1, Hibai Lopez- Jaime Del Corral3, Raquel Gonzalez1,2, Susana Jiménez- Rebolledo3 3 Murcia 1 Hospital Universitario de La 1 Universidad Deusto, España. Princesa, Madrid, España. 2 Nottingham Trent University, 2 Hospital Universitario de Getafe, United Kingdom. Madrid, España. 3 Hospital Universitari de Bellvitge, 3 Clínica Nuestra Señora de La Paz, Barcelona, España. Madrid, España.

95 OBSESSION TO CONSUME. A CASE 99 THE CONNECTION BETWEEN REPORT PERSONALITY DISORDERS AND Mª José Jaén Moreno1, Elisa SUBSTANCE ABUSE Magistrati Jiménez2, Rocío Julia Abrosimova, Svetlana Torrecilla Olavarrieta2 Pakhomova, Julia Barylnik 1 Instituto Maimónides de Saratov State Medical University n.a. Investigación Biomédica de Razumovskii, Russia. Córdoba. Universidad de Córdoba. Hospital Universitario Reina Sofia, 100 PERSONALITY DISORDERS España. AND TOXIC CONSUMPTION. 2 Unidad de Salud Mental TRANSVERSE DESCRIPTIVE STUDY Comunitaria Jerez. Jerez de la IN THE PERSONALITY DISORDER Frontera, Cádiz. España. UNIT OF ROMÁN ALBERCA HOSPITAL 96 GHB USE DISORDER AND Alejandro Belmar Simó1, Ana Luisa POSTTRAUMATIC STRESS González Galdámez1, Ricardo DISORDER Robles Martínez1, Maria Dolores 1 Cecilia Paloma Juan Pérez1, Daniel Piqueras Acevedo , Isabel Martínez 2 Hernández Huerta1, Enriqueta Pérez , Maria Dolores Ortega 3 4 Ochoa Mangado1,2, José Luis García , Alicia Jaén Hernández , 4 Gómez Cano1, Laura Maraña Pedro Alfonso Rosique Díaz , Alicia 1 Garceo1, Luciana Sánchez Flores1 Rodríguez Hernández , Angel Sánchez Bahillo3 1 Hospital Ramón y Cajal, Madrid, 1  España. Hospital General Universitario Santa Lucia Cartagena, Murcia, 2  Universidad Alcalá de Henares, España. Madrid, España. 2 Hospital Psicogeriátrico Virgen del 97 PAPER ADDICTION: A CASE Valle. Murcia, España. REPORT 3 CSM Cartagena, Murcia, España. Gonzalo Salazar, Alvaro Andreu, 4 Hospital Román Alberca, España. Sandra Gómez, Javier Sánchez, Juan San Martín 101 SUBSTANCE ABUSE IN Hospital General Universitario BORDERLINE PERSONALITY Gregorio Marañón, Madrid, España. DISORDER: IMPULSIVITY AND SENSATION SEEKING María García, Alvaro Andreu, Isabel Vicente, Mario De Matteis CSM Retiro. Hospital General Universitario Gregorio Marañón, Madrid, España.

172 23 - 26 March, 2017 Madrid - Spain

102 EFFECTIVE PERSONALITY IN 105 THE BERMUDA TRIANGLE: TOXICS THE POPULATION WITH DUAL ABUSE, PERSONALITY DISORDER DISORDERS: FIRST APPROACHES OR BIPOLAR DISORDER? Lucia Gonzalez Cadelo Germán Montero Hernández, Fundación Acorde, España. Iñigo Alberdi Páramo, Rafael Ángel Baena Mures, Lluis Niell 103 DUAL DISORDERS IN BORDERLINE Gálvez, Miriam Manuela Tenorio PERSONALITY DISORDER: A CASE Guadalupe, Jesús Ibáñez Vizoso, REPORT Manuel Villanueva Gallego, Jesús Pemán Rodríguez, Javier Gómez Aida González Suárez1, Laura Lago Beteta, María Dolores Saiz González García2, Danny Frias Ortiz3, Sergio Ocio León1, Mario Javier Hernández Instituto de Psiquiatría y Salud González1, Adela Alonso Alonso1, Mental. Hospital Clinico San Carlos. Manuel Gómez Simón1, Omar W. Madrid, España. Muquebil Ali Al Shaban Rodriguez4, María Covandonga Huergo Lora2, 106 ORGANIC DISORDER OF Jaime Ramón López Fernández1 PERSONALITY AND SUBSTANCE ABUSE 1 Centro de Salud Mental de Mieres, 1 Mieres, Asturias, España. Patricia Ortega Gutiérrez , Stefano Goretti1, Yaiza Rojo Vallejo2 2 Hospital Vital Alvarez Buylla, 1  Mieres, Asturias, España. U.G.C. Salud Mental Almeria, España. 3 Centro de Salud Mental El Coto, 2  Gijón, Asturias, España. Hospital de Poniente, USMC El Ejido, El Ejido, Almeria, España. 4 Centro de Salud Mental de Luarca, Luarca, Asturias, España. 107 DYSFUNCTION OF THE ENDOGENOUS OPIOID SYSTEM, 104 PATHOLOGICAL PERSONALITY BORDERLINE PERSONALITY DIMENSIONS AND DRUG OF DISORDER AND SUICIDE. A CHOICE IN DUAL DISORDERS NARRATIVE REVIEW 1 Maria Gema Hurtado Ruíz , Gerard Hector Saiz Garcia1, Victor Pereira2, 1 Mateu Codina , Maite Campillo Olga Arbeo1 Sanz1, Adriana Farré Martínez1, 1  Liliana Galindo Guarin2, Josep Complejo Hospitalario Navarra, Martí Bonany1, Roberto Sánchez España. González2, Rosa Sauras Quetcuti1, 2 Clínica Universidad de Navarra, Laura Diaz Digón1 España. 1 Parc de Salut Mar Barcelona, España. 108 ARIPIPRAZOLE IN THE TREATMENT OF PATIENTS WITH 2  Instituto de Salud Carlos III, Rio BORDERLINE PERSONALITY Hortega, España. DISORDER AND SUBSTANCE USE, A CASE REPORT Julia Vendrell1, Christian Fadeuilhe1, Joan Marc Vidal1, Julia Dualde1, Marian Pozuelo1, Jose Salavert2 1 Hospital Universitario Vall d’Hebron, CIBERSAM, Barcelona, España. 2 UIPA Hospital de Sant Rafael, Barcelona, España.

173 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

109 STORIES ABOUT ADULT PATIENTS 113 IMPACT OF CANNABIS WITH ATTENTION DEFICIT AND AND ALCOHOL USE ON HIPERACTIVITY DISORDER METHYLPHENIDATE RESPONSE AND THE USE AND ABUSE OF IN A SAMPLE OF CHILDREN AND SUBSTANCES ADOLESCENTS WITH ATTENTION- Laura Juliana Acosta Mariño DEFICIT/HYPERACTIVITY DISORDER Universidad Del Rosario, Colombia. Marta Santos-Burguete, María 110 LINKS BETWEEN ATTENTION- Vallejo-Valdivielso, Azucena Díez- DEFICIT/HYPERACTIVITY Suárez, Pilar de Castro-Manglano, DISORDER AND SMOKING César Soutullo-Esperón Patrick Alves1,2, Eduardo Palha Clínica Universidad de Navarra. Fernandes1 Pamplona, España. 1  Alto Minho Local Health Unit, Viana 114 IMPULSIVITY IN ADULT- Do Castelo, Portugal. ADHD PATIENTS ACROSS 2 Porto University, Portugal. SCHIZOPHRENIA AND SUBSTANCE USE DISORDER GROUPS: A CROSS- 111 LINKED: SYMPTOMATIC SECTIONAL ANALYSIS CONTAMINATION IN “THREE-AL” Srinivas Kandrakonda PATHOLOGY, ADHD & SUD & MDD. SYM_CON SAMPLE Maxcure Corporate Hospitals, India.

1 Pino Calderon Francisco Javier , A BINGE EATING LIKE A SHOT OF 2 115 Zoido Ramos Jose MIguel , HEROIN: A CASE REPORT Gutierrez Casares Jose Ramon3, Valades Santos Antonio4 Mario Madroñal Morales, Julia Cambra Almerge 1 Servicio Extremeño de Salud. ESM Montijo, España. Hospital General Universitario Gregorio Marañón, Madrid, España. 2 Servicio Extremeño de Salud. CEDEX Badajoz, España. 116 NALMEFENE USE IN REWARD 3 Servicio Extremeño de Salud. SYSTEM DISORDERS Hospital Perpetuo Socorro, España. Hector Saiz Garcia1, Victor Pereira2, 4 Transfer Extremadura, España. Olga Arbeo1, Almudena Portilla1, Laura Montes1 112 HEALTH-RELATED QUALITY OF 1 Complejo Hospitalario Navarra, LIFE AND WORK PRODUCTIVITY España. OF ADULTS WITH ADHD 2 Clínica Universidad de Navarra, 3 Antonio Muñoz Ruiz , Charlotte España. E. Kosmas2, Chloe Patel2, Philip 4 1 Asherson , Alain Joseph 117 EFFECTS OF COCAINE ON SEXUAL 1 Shire, Zug, Switzerland. RESPONSE 2 ICON Clinical Research UK Ltd, Celia González Soria, Lucía Sánchez Abingdon, United Kingdom. Pernas, Laila Al Chaal Marcos, Laura 3 Shire, Madrid, Spain. Alonso León, Isabel Valriberas Herrero, Rafaela De la Mata 4  Institute of Psychiatry, Psychology Hidalgo, Javier De la Iglesia Larrad, and Neuroscience, King’s College Rubén De Alarcón Gómez, Nerea London, London, United Kingdom. Casado Espada Complejo Asistencial Universitario de Salamanca. IBSAL. Salamanca, España.

174 23 - 26 March, 2017 Madrid - Spain

118 SLEEPING DISORDERS IN DUAL 123 BROWN ADD SCALE AND ASRS AS DISORDERS PATIENTS PREDICTORS OF INTOLERANCE OF Jesus Ballesteros1, Maria Varela2, UNCERTAINTY IN GENERALIZED Jaime del Corral3, Raquel ANXIETY DISORDER PATIENTS Rebolledo3 WITH OR WITHOUT COMORBID ADHD 1 Hospital Universitario de Getafe, 1 1 Madrid, España. Alexa Fine , Kathryn Fotinos , Khalidha Nasiri1, Munira Mohamed1, 2  Hospital de La Princesa, Madrid, Irvin Epstein1, Isaac Szpindel1, España. Catherine Cameron1, Sarah Cook1, 3 Clínica Nuestra Señora de La Paz, Tia Sternat1,4, Martin Katzman1,2,3,4 Madrid, España. 1 START Clinic For Mood And Anxiety Disorders, Toronto, Canada. 119 INFLUENCE OF COMORBID 2  MENTAL DISORDER IN THE Northern Ontario School of PERSONALITY PROFILE OF DUAL Medicine, Thunder Bay, Canada. DISORDERS PATIENTS 3 Lakehead University, Thunder Bay, Ana Adan, Julia Elena Marquez- Canada. Arrico 4 Adler School of Professional University of Barcelona, Spain. Studies, Toronto, Canada.

120 FACTORS ASSOCIATED WITH THE 124 INTOLERANCE OF UNCERTAINTY, USE OF ALCOHOL IN PERSONS PERFECTIONISM, AND COPING AS WITH BIPOLAR AFFECTIVE PREDICTORS OF AN OBSESSIVE- DISORDERS AMONG THE ADULT COMPULSIVE DISORDER COLOMBIAN POPULATION DIAGNOSIS AMONG A CLINICAL POPULATION Alejandro Castillo1,2, Camila Rincon2, 1 1 Sonia Bersh1,2 Kathryn Fotinos , Alexa Fine , Khalidha Nasiri1, Munira Mohamed1, 1 Fundación Clínica Valle De Lili, Irvin Epstein1, Isaac Szpindel1, Colombia. Catherine Cameron1, Sarah 2 Universidad ICESI, Colombia. Cook1, Tia Sternat1,4, Martin A. Katzman1,2,3,4 121 COMORBIDITY OF DANDY- 1 START Clinic For Mood And Anxiety WALKER SYNDROME AND DUAL Disorders, Toronto, Canada. DISORDERS: A CASE STUDY 2 Northern Ontario School of Héctor De Diego Ruiz1, Gonzalo Medicine, Thunder Bay, Canada. Salazar de Pablo1, Javier Sánchez Cerezo1, Manuel González 3 Lakehead University, Thunder Bay, González1, Mario De Matteis1,2 Canada. 1 Hospital General Universitario 4 Adler School of Professional Gregorio Marañón, Madrid, España. Studies, Toronto, Canada. 2 Centro de Salud Mental de Retiro, 125 CANNABIS WITHDRAWAL Madrid, España. SYNDROME AND MIXED EPISODES IN BIPOLAR DISORDER 122 DUAL DISORDERS: FREQUENCY IN A PSYCHIATRY SERVICE Isaac González-González, Alejandro Hernández-Dorta Annia Duany Navarro, Gloria Hernandez Marin Complejo Hospitalario Universitario de Canarias, España. Hospital Dr. Salvador Allende, Cuba.

175 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

126 IS TOXIC CONSUMPTION A 131 PSYCHOGENIC POLYDIPSIA AND RELEVANT ELEMENT FOR SCHIZOPHRENIA: THREE CASE- INVOLUNTARY ENTRY IN A REPORTS PSYCHIATRIC SUBACUTE UNIT? Cristina Macias1, Olivia Orejas2, L. González-Vallespí1, M. Ferré1, E. Esther Boix2, Sara García1, Jordi Boix-Quintana1, E. Giné1, C. Palma1, Pagerols1, Alicia Casals1, Marta A. Frías1, A. Salvador1, E. Aluco1, O. Vallvé1, Montse Pérez1, Elisenda Orejas2 Carrió1, Joan Ramón Fortuny1 1 Hospital de Mataró. Consorci 1 CAEM-INAD-Parc de Salut Mar. Sta. Sanitari del Maresme, España. Coloma de Gramenet, Barcelona, 2 Institut de Neuropsiquiatría I España. Addiccions (INAD). Parc de Salut 2 Centre Forum-INAD-Parc de Salut Mar, España. Mar, Barcelona, España.

127 STIGMATIZING ATTITUDES ABOUT 132 ASSESSMENT OF PSYCHOPATHY DEPRESSION, BIPOLAR DISORDER, AND IMPULSIVITY IN COCAINE SCHIZOPHRENIA AND POST- ADDICTS AS THEY PRESENT TRAUMATIC STRESS DISORDER SCHIZOPHRENIA OR ANTISOCIAL Marietta Kékes Szabó PERSONALITY DISORDER 1,2 2 University of Szeged, Gyula Juhász Cesar Mateu , Elena López , Isabel 2 3 Teacher Training Faculty, Hungary. Guzman , Irene Pérez , María Luis Graña3, Gerardo Sabater4, Adela 2,3 2,3 128 VERBAL AND VISUAL- Ferrando , Gonzalo Haro SPATIAL WORKING 1 Hospital Arnau de Vilanova, España. MEMORY PERFORMANCE 2 Universidad CEU-Cardenal-Herrera, IN SCHIZOPHRENIC WITH Castellón, España. SUBSTANCE USERS VS. 3  SUBSTANCE USERS Hospital Provincial de Castellón, España. Fadel Khashawi, Bader AlAnsari 4 Universidad Jaume I, Castellón, Kuwait University, Kuwait. España. THE PRINCESS AND THE DEVIL: 129 133 CONSEQUENCES OF CHRONIC VIOLENCE, MULTIADDICTION TO POLYCONSUMPTION: DRUGS AND CANCER RESISTANT XEROSTOMY OR Rodrigo Leal HYPOCHONDRIAC DELIRIUM? Cosam Estacion Central, SENDA, Germán Montero Hernández, Santiago, Chile. Iñigo Alberdi Páramo, Rafael Ángel Baena Mures, Lluis Niel 130 PROFILE OF DUAL PATIENTS IN Gálvez, Cristina Pérez Sobrino, Ana ADDICTIVE BEHAVIOR UNIT OF Carabias Contreras, Lucía Gallego ALBACETE Deike Marta Lucas Pérez-Romero1, Instituto de Psiquiatría y Salud Patricia Romero Rodenas1, Mª Mental. Hospital Clínico San Carlos. Teresa Tolosa Pérez1, Mar Domato Madrid, España. Lluch1, María Luisa Celorrio Bustillo1, Rocío Giménez Mateo1, 134 AUTISM SPECTRUM DISORDER Francisco Javier Lucas Pérez- AND SUBSTANCE USE DISORDER 2 Romero Lluis Niell Galmés, Rafael Ángel 1 Complejo Hospitalario Universitario Baena Mures, Iñigo Alberdi Paramo, de Albacete. Servicio de Salud German Montero Hernandez, Mental. Albacete, España. Miriam Manuela Tenorio Guadalupe 2 GAI Albacete, España. Hospital Clínico San Carlos, España.

176 23 - 26 March, 2017 Madrid - Spain

135 FUNCTIONALITY AND HEALTH: 140 DEVELOPMENT OF MEASURING 2-YEARS FOLLOW-UP OF INSTRUMENTS FOR DIAGNOSING OUTPATIENTS WITH MENTAL THE SEVERITY OF NEUROTIC DISORDER TREATED WITH PERSONALITY TRAITS IN RUSSIA PALIPERIDONE PALMITATE Piotr Krystian Trabczynski, Gailna Maria Desamparados Perez Lopez, Isurina Ignacio Zarrans Herrera Oria, Saint Petersburg State University, Roberto Perez Asenjo Russia. Hospital Provincial de Toledo, España. 141 EFFECTS OF NALMEFENE ON CRAVING 136 POLYTHERAPY IN DUAL PATIENTS Laila Al Chaal Marcos1, Celia Patricia Romero Rodenas1, Marta González Soria1, Lucía Sánchez Lucas Pérez-Romero1, Mª Teresa Pernas1, Laura Alonso León1, Isabel Tolosa Pérez1, Mar Domato Lluch1, Valribera Herrero1, Rafaela de la María Luisa Celorrio Bustillo1, Rocío Mata Hidalgo1, Javier de la Iglesia Giménez Mateo1, Francisco Javier Larrad1, Nerea María Casado Lucas Pérez-Romero2 Espada1, Rubén de Alarcón Gómez1, 2 1 Complejo Hospitalario Universitario Nieves de Uribe Viloria de Albacete. Servicio de Salud 1 Hospital Clínico Universitario Mental. Albacete, España. Salamanca, IBSAL, España. 2 GAI Albacete, España. 2 Hospital Clínico Universitario Valladolid, España. 137 ATTENTION DEFICIT HYPERACTIVITY DISORDER, 142 PREGABALIN: BETWEEN ANXIETY AND EMERGING DRUGS AND Mikel Ruiz Feliu, María Carmen SUBSTITUTIVE OPPORTUNITY Campos Mangas Nadir Bourbon, Abderrahmane Osakidetza - Servicio Vasco de Salud, Belaid España. Mahfoud Boucebci Psychiatric Hospital, Algeria. 138 SUBSTANCE USE DISORDER AND SUICIDAL BEHAVIOUR IN GETAFE 143 PSYCHIATRIC ASPECTS OF THE UNIVERSITY HOSPITAL TREATMENT OF HCV INFECTION Laura Sevilla, Jesus Ballesteros, Daniela Bundalo, Daniela Vojnović Alicia Picazo, Mar Rivas Clinical Hospital Centre Sestre Hospital Universitario de Getafe, Milosrdnice, Zagreb, Croatia. España. 144 MORFINOMANIA IN SANTA 139 DUAL DISORDERS IN A HALF STAY ISABEL PSYCHIATRIC HOSPITAL UNIT OF ALBACETE (LEGANÉS): 1900-1931 Mariá Teresa Tolosa Pérez1, Patricia Ruth Candela 1 Romero Rodenas , Marta Lucas Hospital Universitario de 1 1 Pérez-Romero , Mar Domato Lluch , Fuenlabrada. Madrid, España. María Luisa Celorrio Bustillo1, Rocío Giménez Mateo1, Francisco Javier Lucas Pérez-Romero2 1 Complejo Hospitalario Universitario de Albacete. Servicio de Salud Mental. Albacete, España. 2 GAI Albacete, España.

177 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

145 METHADONE INTERRUPTION AND 149 LONGITUDINAL ASSOCIATION PSYCHOTIC SYMPTOMS. A CASE BETWEEN PAIN SEVERITY REPORT AND SUBSEQUENT OPIOID María Amparo Descalzo, Sofía USE IN PRESCRIPTION OPIOID Alonso, Marta Margarita Machado, DEPENDENT PATIENTS WITH María Angeles Canseco, Juan CHRONIC PAIN Miguel Hernández, Marta Cristina Margaret Griffin Cancino, Marta Corral, María McLean Hospital/Harvard Medical Pacheco School, USA. Hospital General Universitario de Valencia, España. 150 THE INTERACTION BETWEEN CHRONIC PAIN AND THE ABUSE 146 REMISSION OF CENTRAL SLEEP POTENTIAL OF PRESCRIPTION APNEA AFTER METHADONE OPIOIDS AS MEASURED IN THE WITHDRAWAL IN AN OPIATE CLINICAL LABORATORY ADDICT PATIENT: A CASE REPORT Jermaine Jones, Sandra Comer 1 José Luis Escobar Fernández , New York Psychiatric Institute and Carmen Maura Carrillo de Albornoz Department of Psychiatry, College of 2 Calahorro , Margarita Guerrero Physicians and Surgeons of Columbia 2 1 Jiménez , Anna Maria Boszczyk University, USA. 1 Caravaca de La Cruz Mental Health Center. Murcia, Spain. 151 HEPATITIS C TREATMENT IN 2 Granada Sur Mental Health Service. PEOPLE WITH A HISTORY OF Granada, Spain. INJECTING DRUGS: POPULATION CHARACTERISTICS, BARRIERS 147 COMORBIDITY AND RETENTION TO TREATMENT, OPTIONS FOR IN A METHADONE MAINTENANCE CHANGE IN ITALY TREATMENT Richard Littlewood1, Lorenzo 2 Francina Fonseca1,2,3, Claudio Somaini Castillo1,2, Paola Rossi1,2, Gabriel 1 Applied Strategic, London, United Vallecillo1,2, Diana Martínez- Kingdom. 1,2 1,2 Sanvisens , Claudio Tamarit , Pilar 2 Addiction Treatment Center, Local 1 1,2,3 Samos , Marta Torrens Health Service, Biella, Italy. 1 Institut de Neuropsiquiatria i Addicions– Parc de Salut Mar, 152 THE EFFECTIVENESS Barcelona, España. OF BUPRENORPHINE/ 2 Institut Hospital del Mar NALOXONE ON MISUSE AND d’Investigacions Mèdiques, DIVERSION BEHAVIOURS AND Barcelona, España. PSYCHOPATOLOGY IN DETAINED DUAL DIAGNOSED PATIENTS: 3  Universitat Autònoma de THE ROLE OF THE LENGTH OF Barcelona, España. TREATMENT AND DOSAGE

1 1 148 TRANSFERRING METHADONE Felice Alfonso Nava , D Lageder , 1 1 PATIENTS TO SUBOXONE L Marcolongo , E Dinelli , G 1,2 (BUPRENORPHINE/NALOXONE) Padovan IN TWO OUTPATIENT CLINICS 1 Penitentiary Medicine and DURING 2013-2016. CLINICAL Addiction Unit, Health District of REPORT Padua, Italy. Igor Gorjaltsan 2 University of Padua, Italy. Mental Health Center. Beer-Sheva, Israel.

178 23 - 26 March, 2017 Madrid - Spain

153 OPIOID USE DISORDER AND 156 INTEGRAL TREATMENT OF PERIPHERAL BRAIN-DERIVED OPIATES DEPENDENT PATIENTS NEUROTHROPHIC FACTOR: A AND DUAL DISORDERS REVIEW IN TREATMENT WITH Raul Felipe Palma-Alvarez1, BUPRENORPHINE/NALOXONE Kristpher Amaro-Hosey1, Elena Ros- Maria Del Mar Sanchez Fernandez1, Cucurull1,2, Laia Rodriguez-Cintas1,2, Isabel Montoya Crous1, Paloma Abderraman Esojo1, Alfonso Abad1, Sanchez de la Nieta Aragones1, Nieves Martínez-Luna1, Margarida Laura Parra Fernandez2 1 Corominas-Roso , Lara Grau- 1 Sescam UCA Ciudad Real, España. López1,2, Carlos Roncero1,2 2 Universidad de Castilla la Mancha 1  Vall d’Hebron University Hospital- Ciudad Real, España. Public Health Agency, Barcelona (ASPB), CIBERSAM. Barcelona, 157 OPIOID RELATED PSYCHOSIS Spain. Catalina Suárez Viñas, Laura Rubio 2  Universidad Autónoma de Rodríguez Barcelona, Barcelona, Spain. UHP Gijón, España. 154 DUAL DISORDERS IN PATIENTS CANCELLED IN METHADONE MAINTENANCE 158 PROGRAM, DEPENDING ON 159 BILATERAL PALLIDAL ISCHAEMIC WHETHER THEY ARE OR NOT LESION AFTER OPIOID DRUG CONSUMPTION ROOM OVERDOSE. CASE SERIES USERS Patricia Vaquero Casado1, Ana Romaguera1, Roser Martínez1, Abderraman Esojo Jimenez2, Celia Laura Bádenas1, Isabel Novell1, Mareca Viladrich1, Raúl Felipe Claudio Castillo1, Marta Torrens1,2 Palma Álvarez2, Jesús Miguel Ruiz 1 Institut de Neuropsiquiatria i Idiago1, Carlos Roncero Alonso2,3,4 Addiccions, Parc de Salut Mar, 1 Mare de Déu de la Mercè Hospital, Barcelona, Spain. Hermanas Hospitalarias, Barcelona, 2 Universitat Autònoma de Spain. Barcelona, Barcelona, Spain. 2 Vall d'Hebron University Hospital- Public Health Agency of Barcelona 155 SOCIOCULTURAL VARIABLES (ASPB), Barcelona, Spain. IN PATIENTS TREATED WITH BUPRENORPHINE/NALOXONE 3 Vall d'Hebron University Hospital, AND DIAGNOSIS OF DUAL CIBERSAM, Spain. DISORDERS 4 Universitat Autònoma de Paloma Sanchez De La Nieta Barcelona, Barcelona, Spain. Aragonez1, Mª del Mar Sanchez Fernandez1, Isabel Montoya Crous1, 160 SCHIZOPHRENIA AND HARMFUL Laura Parra Fernandez2 ALCOHOL CONSUMPTION 1 Sescam UCA Ciudad Real, España. Sofía Alonso Gutiérrez, María Amparo Descalzo Cabadés, Marta 2 Universidad Castilla la Mancha Margarita Machado Vera, María Ciudad Real, España. de los Ángeles Canseco Navarro, Martha Cristina Cancino Botello, Juan Miguel Hernández Sánchez, María Desamparados Peña Serrano, Marta Corral Galarreta, María Constanza Pacheco Santander Consorcio Hospital General Universitario de Valencia, España.

179 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

161 EFFECTS OF ALCOHOL 167 DUAL DISORDERS AND TYPE OF CONSUMPTION ON FUNCTIONAL DRINKERS IMPAIRMENT IN PSYCHOTIC Tania Abad Costoya1, Niceto DISORDERS González Valerio1, Mª del Carmen Helena Becerra Darriba1, Ainhoa García Mahía2, Águeda Fernández Irune Ojeda Martínez1, Marta Pilar Quintana2 1 Jiménez Cortés , Alfredo Gurrea 1 Unidad de Alcoholismo A Coruña, 2 Escajedo España. 1  Hospital San Jorge. Huesca, España. 2 Complejo Hospitalario Universitario 2 Unidad de Atención y Seguimiento A Coruña, España. de Adicciones. Huesca, España. 168 SEXUAL DYSFUNCION WITH THE 162 ALCOHOLISM IN THE LEGANES USE OF NALMEFENE IN A COHORT NATIONAL ASYLUM (1900-1931) OF 50 PATIENTS Ruth Candela Carlos Gomez Sanchez-Lafuente1, 2 Hospital Universitario de Rocio Reina Gonzalez , Juan Ignacio 1 Fuenlabrada. Madrid, España. Duran Nieto 1 Hospital Virgen de La Victoria 163 DUAL ADDICTION Málaga, España. Silvia Cañas Fraile 2 Hospital Regional Universitario Complejo Hospitalario Universitario Málaga, España. de Albacete, España. 169 REDUCTION OF ALCOHOL 164 ABOUT A CASE OF ALCOHOL CONSUMPTION IN A PATIENT IN DEPENDENCE AND MENTAL NALMEFENE TREATMENT RETARDATION Beatriz Herrejon Teodoro, Maria Maria Gloria Cordeiro-Crespo de Los Desamparados Pérez López, Cabral-Campell1, Maria Dolores Federico Caño Salomón Ortega Garcia2, Maria de los Hospital Provincial de Toledo, Angeles Diaz-Maroto Tello1, Maria España. Teresa Camuñas Sevilla1, Raquel Fernandez Auñon1, Alicia Fuentes 170  IN Garcia1 A PATIENT WITH MADELUNG´S 1 Hospital General La Mancha-Centro, DISEASE España. Cecilia Paloma Juan Pérez1, Daniel 1 2 CSM Cartagena, Murcia, España. Hernández Huerta , Enriqueta Ochoa Mangado1,2, José Luis 1 165 ALCOHOL AND DISSOTIATION Gómez Cano , Laura Maraña Garceo1, Luciana Sánchez Flores1, Jaime Del Corral, Emilia González, Irene Milagros Domínguez Belén Fernández, Raquel Rebolledo Zabaleta2 Centro de Patología Dual, Clínica 1 Hospital Ramón y Cajal. Madrid, Nuestra Señora de La Paz. San Juan España. De Dios, España. 2 Universidad Alcalá de Henares. 166 ALCOHOLIC, TABAQUIC Madrid, España. DEPENDENCE: IN SEARCH OF THEIR RELATIONSHIP Annia Duany Navarro1, Erislandy Duran Perez2 1 Hospital Dr. Salvador Allende, Cuba. 2 Hospital Psiquiátrica de la Habana Dr Bernabe Ordaz, Cuba.

180 23 - 26 March, 2017 Madrid - Spain

171 APPLICATION OF THE 176 PREVALENCE OF SUICIDAL MULTIDIMENSIONAL SCALE BEHAVIOURS IN PATIENTS AT OF ALCOHOL CRAVING (EMCA) FOLLOW UP IN ADDICTION TO ASSESS THE EFFICACY TREATMENT CENTERS OF NALMEFENE IN THE Lara Cabanillas Carrillo1, Ana REDUCTION OF ALCOHOL Domínguez Cejudo2, Elisa Llamas CRAVING IN A SAMPLE OF López3 PATIENTS INTEGRATED FOR 1  DETOXIFICATION Hospital General Universitario de Ciudad Real, España. Carlos Llanes Álvarez1, Ana 2  Isabel Álvarez Navares2, Maria Hospital Universitario Virgen del Ángeles Garzón de Paz2, Jesus Rocío, España. Ángel Monforte Porto1, Alberto 3 Clínica ABA Salud, España. San Román Uría1, Patricia López Landeiro1, Bianca Renau Minguez1, 177 FEMALE ALCOHOLISM AT WORK Manuel Ángel Franco Martín1 AND GRIP THE TREATMENT PROGRAMS IN MUNICIPALITIES OF 1 Complejo Asistencial de Zamora, THE STATE OF SÃO PAULO España. Ana Lúcia Oliveira Marin 2 Hospital Clínico Universitario de Salamanca, España. Instituto de Pesos e Medidas do Estado de São Paulo, Brazil. 172 PREVALENCE OF CLINICALLY RELEVANT ALCOHOL USE AMONG 178 DUAL DISORDERS PREVALENCE NEW REFERALS TO A PSYCHIATRIC AMONG PATIENTS REFERRED OUTPATIENT CLINIC FOR A BECAUSE OF ALCOHOL USE REASON OTHER THAN ALCOHOL DISORDER USE DISORDER Carlos Parro-Torres, Isabel Vicente David Lopez Gomez HGU Gregorio Marañón. Madrid, CSM Alcobendas. Madrid, España. España.

173 CANCELLED 179 COMORBIDITY OF ALCOHOL USE DISORDER AND OTHER MENTAL 174 MARCHIAFAVA-BIGNAMI DISEASE: DISORDERS A CASE REPORT Bojan Pavkovic1, Mirjana Markovic1, Ana Luzia Melo1, Filipe Godinho1, Ivan Markovic2, Jelena Tovarovic2, Sofia Marques1, Camila Nóbrega2, Ivan Dimitrijevic3,4 1 1 Luís Bento , Daniel Barrocas , 1 Community Health Center “Dr Simo 1 Madalena Serra Milosevic”. Belgrade, Serbia. 1  Hospital do Espírito Santo de Évora, 2 Community Health Center "Dr Portugal. Milenko Marin". Loznica, Serbia. 2  Centro Hospitalar Psiquiátrico de 3 Clinic for Psychiatry, Clinical Center Lisboa, Portugal. of Serbia. Belgrade, Serbia. 4  175 A PHASE 3, MULTICENTER University of Belgrade, School of RANDOMIZED DOUBLE BLIND Medicine. Belgrade, Serbia. PLACEBO CONTROLLED STUDY OF THE OPIOID RECEPTOR ANTAGONIST – ODELEPRAN THE TREATMENT OF ALCOHOL ADDICTION Elvira Mukhametshina R-Pharm, Russia.

181 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

180 DECISION-MAKING AND RELAPSE 5 TREATMENT OF ALCOHOL IN ALCOHOLICS: A 12 MONTHS DEPENDENCE. A CASE REPORT FOLLOW-UP STUDY Lucía Sánchez Pernas, Laila Al Bartolomé Pérez Gálvez1,2, Carlos Chaal Marcos, Celia González Soria, Cuesta Moreno2, Juan Manuel Rafaela De la Mata Hidalgo, Isabel Molina López2 Valriberas Herrero, Nerea Casado 1 Hospital Universitario de San Juan. Espada, Javier De la Iglesia Larrad, Alicante, España. Rubén De Alarcón Gómez, Laura Alonso León, Ana Álvarez 2 Universidad Miguel Hernández. Alicante, España. Complejo Asistencial Universitario Salamanca. Ibsal, España.

6 ALCOHOL CONSUMPTION IN PATIENTS WITH SUICIDAL POSTER SESSION 2 BEHAVIOR IN PUBLIC PLACES SATURDAY-SUNDAY Alba Sedano Capdevila, Fanny Cegla Schvartzman, Marta Migoya Borja, 1 ASSOCIATION OF ALEXITHYMIA Elsa Arrua Duarte, Silvia Vallejo WITH TYPE A/B ALCOHOLISM Oñate, Constanza Vera Varela, Lucía Villoria Borrego, Maria Luisa 1 Antonio Ortuño Pérez , Bartolomé Barrigón, Enrique Baca García Pérez Gálvez1,2 Hospital Universitario Fundación 1  Universidad Miguel Hernández. Jiménez Díaz. Madrid, España. Alicante, España. 2 Hospital Universitario de San Juan. 7 JEALOUSY IN THE DEFICIT OF Alicante, España. VITAMIN B12. AN ALCOHOLISM CASE REPORT 2 ADHERENCE TO José Torroba1, María Isabel Osuna PSYCHOPHARMACOLOGICAL Carmona2, Carmen Barrionuevo TREATMENT IN DUAL DEPRESSION Baeza2, Antonella Garrido Beltrán1 1 Samuel Leopoldo Romero Guillena , 1 Alternativa 2, España. Beatriz Oda Plasencia García De 2  Diego2, María García Salguero1, Hospital Universitario Virgen de la Estrella Serrano Guerrero1 Victoria. Málaga, España. 1  U.G.C Salud Mental Virgen 8 PREVALENCE OF ACCIDENT RATE Macarena. Sevilla, España. IN COCAIN-DEPENDENT PATIENTS 2 Hospital de La Merced, Osuna. AND ITS RELATION WITH COCAINE Sevilla, España. INDUCED PSYCHOSIS (CIP) Alfonso Carlos Abad1, Carlos 3 FROM ALCOHOL TO DELUSIONAL Roncero1, Laia Rodríguez-Cintas1, JEALOUSY Elena Ros-Cucurull1, Constanza Melania Rodríguez1, Yaiza Rojas2 Daigre1, Lara Grau-López1, María 1 1 1 Hospital Torrecárdenas, España. Robles-Martínez , Manuel Peláez , Abel Morales1, Javier Álvarez2 2 Hospital de Poniente, España. 1 Hospital Vall D'Hebron. SAPD, 4 NALMEFENE AS A STRATEGY IN España. THE PRECONTEMPLATIVE STAGE 2 Universidad de Valladolid, España. OF ALCOHOL PROBLEMS Eduardo Sacristán, Carme Cunillera, Rosa Serrat, Xavier Tolaguera, Anna Calvet CAS Garrotxa, España.

182 23 - 26 March, 2017 Madrid - Spain

9 DRESS SYNDROME DISSEMINATED 14 THE EFFECTS OF HORMONAL BY PSYCHOTROPIC DRUGS OR LEVELS ON KETAMINE- PRODUCED BY THE HARMFUL INDUCED PREPULSE INHIBITION CONSUMPTION OF TOXICS? DISRUPTION IN FEMALE RATS Iñigo Alberdi Paramo, German Renata Ferreira-Sgobbi1,2, Manoel Montero Hernandez, Rafael Baena Jorge Nobre1,2,3 Mures, Lluis Niell Galmez, Miriam 1 University of São Paulo, Brazil. Tenorio Guadalupe 2 INeC – Neuroscience and Behavior Hospital Clinico San Carlos, España. Institute, Brazil. 3  10 METHYLPHENIDATE MISUSE. CASE Uni-FACEF, Brazil. REPORT AND REVIEW OF THE LITERATURE 15 COCAINE-INDUCED PSYCHOSIS: IS THERE A ROLE FOR LONG-ACTING Roberto Pérez Asenjo, Mª INJECTABLE ANTIPSYCHOTICS? Desamparados Pérez López, Abel Hidalgo Borreguero, Beatriz Filipe Godinho, Sofia Marques, Ana Herrejón Teodoro, Marta Soto Melo, Madalena Serra, Luis Bento, Laguna, Manuel Torija Daza, Gema Daniel Barrocas Belmonte Hospital Espirito Santo de Évora, Hospital Provincial de Toledo, Portugal. España. 16 CASE REPORTS OF PSYCHOPATHOLOGY RELATED TO 11 KEYS TO SUCCESS ENERGY DRINKS Trinitario Ballesta Casanova Daniel Hernandez-Huerta1, Maria CAS Fontsanta/CAS Garbivent, Martin-Larregola2, Jorge Gomez- España. Arnau2, Javier Correas-Lauffer2,3, Helen Dolengevich-Segal2,3 12 CAFFEINE CONSUMPTION AND 1  SEVERE MENTAL DISORDER: A Ramón y Cajal University Hospital. DESCRIPTIVE STUDY Madrid, Spain. 2  José Luis Escobar Fernández1, Henares University Hospital. Carmen Maura Carrillo de Albornoz Madrid, Spain. Calahorro2, Margarita Guerrero 3 Francisco de Vitoria University, Jiménez2 Spain. 1 Caravaca de La Cruz Mental Health Center. Murcia, Spain. 17 SCHIZOAFFECTIVE DISORDER AND POLYDRUG USE: A CASE REPORT 2 Granada Sur Mental Health Service. 1 Granada, Spain. Ainhoa I. Ojeda Martínez , Helena Becerra Darriba1, Marta Sánchez 1 13 COKE DEPENDENCE: AN UNUSUAL Enamorado , Marta P. Jiménez 2 HYPERTYROIDISM CASE Cortés 1  José Luis Escobar Fernández1, Hospital General San Jorge, Huesca, Carmen Maura Carrillo de Albornoz España. Calahorro2, Margarita Guerrero 2 Centro de Salud Mental "Pirineos". Jiménez2 Huesca, España. 1 Caravaca de La Cruz Mental Health Center. Murcia, Spain. 2 Granada Sur Mental Health Service. Granada, Spain.

183 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

18 PSYCHOSIS INDUCED BY 23 CANNABIS INDUCED PSYCHOTIC MEPHEDRONE (THE NEW DISORDER; A CASE REPORT “RECREATIONAL" DRUG): Edurne Losa Mújica, Belén Berjano A REVIEW OF SCIENTIFIC Noya, Estela Saez Fuentes, Laura LITERATURE FROM A CASE Ramos Calvo, Elisabet Vincent Tur, REPORT Andoni Aramburu Sanz, Jessica Miriam Manuela Tenorio Heemskerk, Idoia Astigarraga Guadalupe, Rafael Angel Baena Iriondo, Mikel Arranz Diez, Jessica Mures, Iñigo Alberdi, Lluís Niell Lorena Talavera Palacios Galmes Hospital Galdakao - Usansolo, Hospital Clínico San Carlos, España. Galdakao. Bizkaia, España.

19 CANNABIS AND METABOLIC RISK 24 IS DEPERSONALIZATION IN PSYCHOSIS ASSOCIATED WITH CONSUMPTION Helena Becerra Darriba1, Ainhoa OF CANNABIS? Irune Ojeda Martínez1, Marta Pilar Iván Martínez Molina, Juan Manuel Jiménez Cortés1, Alfredo Gurrea Serón Luna, Miguel Ruiz Veguilla 2 Escajedo Hospital Universitario Virgen del 1 Hospital San Jorge. Huesca, España. Rocío. Sevilla, España. 2 Unidad de Atención y Seguimiento de Adicciones. Huesca, España. 25 "FALSE MEMORY" AND CANNABIS USE: A CASE REPORT 20 CANNABIS VULNERABILITY Ainhoa I. Ojeda Martínez1, Helena 1 Silvia Cañas Fraile Becerra Darriba , Marta Sánchez Enamorado1, Marta P. Jiménez Complejo Hospitalario Universitario Cortés2 de Albacete, España. 1 Hospital General San Jorge, Huesca, 21 CATATONIA AND INADVERTENT España. CANNABIS DISCONTINUATION: A 2 Centro de Salud Mental "Pirineos", CASE REPORT Huesca, España. José Luis Escobar Fernández1, Carmen Maura Carrillo de Albornoz 26 SMOKING AND SEVERAL MENTAL Calahorro2, Margarita Guerrero DISORDERS Jiménez2 Francina Fonseca Casals, Maria 1 Caravaca de La Cruz Mental Health Rosario Valera Fernández, Cristina Center. Murcia, Spain. Perez Carrasco, Albert Pratdesava Villanueva, Rosa Aceña Dominguez, 2  Granada Sur Mental Health Service. Marta Torrens Melich Granada, Spain. Institut de Neuropsiquiatria y 22 CANNABINOID HYPEREMESIS Addiccions (INAD). Parc de Salut Mar, SYNDROME: THE BIG SIMULATOR España. João Fonseca1, Daniela Vilaverde2, Rosa Rodrigues1 1 Hospital Senhora da Oliveira, Portugal. 2 Hospital de Braga, Portugal.

184 23 - 26 March, 2017 Madrid - Spain

27 DEPRESSIVE SYMPTOMATOLOGY 31 DOES A RELATIONSHIP BETWEEN IN INDIVIDUALS SEEKING PSYCHOPATHOLOGY AND LEVEL SMOKING CESSATION TREATMENT OF SEVERITY OF TOBACCO USE Raul Sansores1, Leonor Garcia- DISORDER EXIST? Gomez1, Luis Villalobos-Gallegos2, Carmela Martínez-Vispo1, Elena Valeri Noe-Díaz1, Alejandra Fernandez del Rio2, Ana Lopez- Ramirez-Venegas1, Rodrigo Marin- Durán1, Ursula Martinez1, Elisardo Navarrete2 Becoña1 1 National Institute of Respiratory 1 University of Santiago de Diseases Ismael Cosio Villegas, Compostela, España. España. 2 University of Zaragoza, España. 2 National Institute of Psychiatry Ramon de la Fuente Muñiz, España. 32 TOBACCO AND MENTAL HEALTH: A STUDY IN THE PROVINCE OF 28 DESCRIPTIVE STUDY ON HUELVA DUAL DISORDERS, TOBACCO María Cinta Ramírez Domínguez1, CONSUMPTION AND MEDICAL Ana María Carrasco Sánchez1, COMORBIDITIES Lourdes Hernandez Gonzalez1, Juan María José Jaén Moreno1, Rocío Francisco Ramírez López2 2 Torrecilla Olavarrieta , Elisa 1 Complejo Hospitalario de Huelva, 2 Magistrati Jiménez España. 1  Instituo Maimónides de 2 Centro Provincial de Investigación Biomédica de Drogodependecia de Huelva, Córdoba, Universidad de Córdoba, España. Hospital Universitario Reina Sofía, España. 33 REASONS TO QUIT TOBACCO IN 2 Unidad de Salud Mental PATIENTS WITH SCHIZOPHRENIA Comunitaria de Jerez. Jerez de la AND NICOTINE DEPENDENCE: Frontera, España. STATE OF THE ART REVIEW Sabrina Sanchez Quintero, Carlos 29 RELATIONSHIP BETWEEN Harkous Peña, Luis Caballero SUICIDAL BEHAVIOUR AND Martinez TOBACCO DEPENDENCE Hospital HM Puerta del Sur, España. María Vidal Millares1, María Lado 2 Codesido , María del Carmen García 34 UTILISING RECENT ALCOHOL 2 Mahía BIOMARKERS ETHYL 1 Hospital Virxe da Xunqueira, GLUCURONIDE AND ETHYL España. SULPHATE TO MONITOR ALCOHOL 2 Hospital Universitario de A Coruña, USE IN PATIENTS RECEIVING España. METHADONE MAINTENANCE TREATMENT 30 SEVERITY OF TOBACCO USE Basma Alharthy, Kim Wolff, Jane DISORDER AND LIFETIME Marshall TREATMENT FOR DEPRESSION IN King's College London, United A CLINICAL SAMPLE Kingdom. Carmela Martínez-Vispo1, Ana Lopez-Duran1, Elena Fernandez del Rio2, Ruben Rodriguez-Cano1, Elisardo Becoña1 1 University of Santiago de Compostela, España. 2 University of Zaragoza, España.

185 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

35 TREATMENT OF ZOLPIDEM 39 DUAL DISORDERS. SUBSTANCE DEPENDENCE AND PSYCHIATRIC USE DISORDER IN A SPECIFIC DISORDERS: SYSTEMATIC REVIEW OUTPATIENT PROGRAM FOR OF CLINICAL CASES PATIENTS WITH BORDERLINE Maria Celia Brangioni, Jorge Lessa, PERSONALITY DISORDER Thiago Correa M. De Matteis1, M. García1, C. 1 2 1 Universidade de Brasília – UNB, Rubio , P. Sánchez , I. Vicente Brazil. 1 Hospital General Universitario Gregorio Marañón, Madrid, España. 36 PROFILE OF WOMEN WITH 2 Hospital Universitario La Paz, ALCOHOL DEPENDENCE IN Madrid, España. SEEKING TREATMENT UNIT OF ADDICTIVE BEHAVIOR OF 40 “CHEMSEX” ADDICTION: (UN) ALBACETE DURING 2015 JUSTIFIED ALARMISM? Mª Luisa Celorrio, Rocío Giménez, Belén Fernández Calatrava, Raquel Araceli Martínez, Patricia Romero, Rebolledo Carmona, Jaime del Marta Lucas, Mª Teresa Tolosa Corral Serrano, Emilia González Complejo Hospitalario de Albacete, Sánchez España. Centro de Patología Dual (Clínica Nuestra Señora de La Paz). Instituto 37 ASSISTANCE ATTENTION TO DUAL de Adicciones. Ayuntamiento de DISORDERS IN A COMMUNITY Madrid, España. MENTAL HEALTH UNIT Maria Conde Rivas1, Jorge Luis 41 RETENTION, DISABILITY, Garcia Egea1, Marcos Gomez RELAPSES AND Revuelta2, Ana Rubio Garcia1, PSYCHOPATHOLOGICAL STATUS Maria Juncal Ruiz3, Nieves Gomez IN SEVERE DUAL PATIENTS Coronado1, Oriol Porta Olivares1, UNDERGOING COMPREHENSIVE Rocio Gutierrez Sanchez1 TREATMENT. A SIX-YEAR FOLLOW- 1 Hospital Universitario Virgen del UP Rocio, Sevilla, España. Juan J. Fernández Miranda, Silvia 2 Hospital Universitario de Álava - Diaz Fernández, Danny F. Frías Ortiz Sede Santiago, Vitoria, España. Agc-S Mental-V-Sespa Asturian 3 Hospital Universitario Marqués de Mental Health Service, Spain. Valdecilla, Santander, España. 42 SUICIDE, ALCOHOL AND DUAL 38 TOXIC CONSUMPTION PATTERN DISORDERS IN A SAMPLE OF PATIENTS Paula Fuertes WITH DUAL DISORDERS IN AN Gabinete de Psicología, Astorga, AREA OF HIGH PREVALENCE OF España. CONSUMPTION Maria Conde Rivas1, Jorge Luis Garcia Egea1, Maria Juncal Ruiz3, Ana Rubio Garcia1, Marcos Gomez Revuelta2, Nieves Gomez Coronado1, Oriol Porta Olivares3, Rocio Gutierrez Rodriguez1 1 Hospital Universitario Virgen Del Rocio, Sevilla, España. 2 Hospital Universitario de Álava - Sede Santiago, Vitoria, España. 3 Hospital Universitario Marqués de Valdecilla, Santander, España.

186 23 - 26 March, 2017 Madrid - Spain

43 DESCRIPTION OF TOXIC 46 HYPOXIC-ISCHEMIC BRAIN INJURY CONSUMPTION PATTERNS RELATED TO DUAL DISORDERS: DEPENDING ON TYPOLOGIES IN WITHIN SIGHT OF A DRONE DUAL DISORDER PATIENTS Begoña Gonzalvo1, Alfredo Felices1, Jorge Luis Garcia Egea1, Oriol Irene Targa2, Jordi Bordas1, Porta Olivares3, Rocio Gutierrez MªJesús Sotelo1, Silvia Serrano1, Rodriguez1, Maria Conde Rivas1, Lidia Salvador1, Laura Galán1, Maria Juncal Ruiz3, Nieves Gomez Maribel López3, Josep Solé3 1 Coronado , Marcos Gomez 1 CAS Benito Menni CASM. Sant boi 2 1 Revuelta , Manuel Canal Rivero Llobregat, Barcelona, España. 1  Hospital Universitario Virgen del 2 Benito Menni CASm. Granollers, Rocio, Sevilla, España. Barcelona, España. 2  Hospital Universitario de Álava - 3 Unitat Patologia Dual. Benito Sede Santiago, Vitoria, España. Menni CASM. Sant Boi Llobregat, 3 Hospital Universitario Marqués de Barcelona, España. Valdecilla, Santander, España. 47 MORBIDITY RISK FOR 44 DLK1 GENE DELETION INCREASED PSYCHIATRIC DISORDERS IN FIRST ANXIETY-LIKE BEHAVIOURS AND DEGREE RELATIVES OF PATIENTS CONSUMPTION IN MICE WITH ALCOHOL DEPENDENCE Maria S Garcia-Gutierrez1,3, SYNDROME: AN INDIAN STUDY Francisco Navarrete1,3, Jorge Arun Kandasamy, Mrunal Bandawar, Laborda2, Jorge Manzanares1,3 Vivek Benegal 1 Instituto de Neurociencias, Centre For , Universidad Miguel Hernández- National Institute of Mental Health CSIC, Alicante, España. And NeuroScience, India. 2 Red Temática de Investigación Cooperativa en Salud (RETICS), Red 48 EXPECTATION OF FAMILY FRONT de Trastornos Adictivos, Instituto de TO DRUG ADDICTS Salud Carlos III, MICINN and FEDER, Marta Kolhs1, Agnes Olschowky2, Madrid, España. Tania Ascari1 3 Centro Regional de Investigaciones 1 UDESC - Universidade do Estado de Biomédicas (CRIB), Unidad de Santa Catarina, Brazil. Biomedicina UCLM-CSIC, Albacete, 2 UFRGS - Universidade Federal do España. Rio Grande do Sul, Brazil.

45 PROFILE OF WOMEN IN SEEKING 49 THE PROFILE OF NURSING TREATMENT UNIT OF ADDICTIVE STUDENTS AND THE USE OF BEHAVIOR OF ALBACETE DURING PSYCHOACTIVE SUBSTANCES 2015 Marta Kolhs1, Tania Ascari1, Agnes Rocío Giménez, M. Luisa Celorrio, Olschowky2, Robson Lovison1, Sara Araceli Martínez, Marta Lucas, Mª Piccoli1, Raquel Nogueira1, Taina Teresa Tolosa, Patricia Romero Vendrusculo1 Complejo Hospitalario de Albacete, 1 UDESC - Universidade do Estado de España. Santa Catarina, Brazil. 2 UFRGS - Universidade Federal do Rio Grande do SUL, Brazil.

187 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

50 STUDY OF PERSONALITY AND 53 DISCPACITY IN PATIENTS WITH COMSUMPTION OF ALCOHOL SERIOUS MENTAL DISORDERS AND OTHER DRUGS IN AN AND CONSUMPTION OF INPATIENT SAMPLE SUBSTANCES María Vidal Millares1, María Lado Juan José Mancheño Barba1, Maria Codesido2, María del Carmen García Luisa Gutierrez López1, Jesus Mahía2 Villahoz González2, Alfonso Gomez 1 3 1 Hospital Virxe da Xunqueira, Rebollo , Sara Domínguez Salas , 3 España. Fermín Fernández Calderón 1  2 Hospital Universitario de A Coruña, Unidad de Salud Mental España. Comunitaria de Huelva, España. 2 Servicio Provincial de 51 EVOLUTION OF CONSUMPTION Drogodependencias de Huelva, DURING ONE YEAR'S TIME España. FOLLOWING DISCHARGE FROM 3 Universidad de Huelva, España. AN IN-HOUSE PROGRAM FOR ADDICTION DISORDERS 54 SUBSTANCE ABUSE AND SECURITY Miguel Angel Lopez, Francisco MEASURES FOR INTERNMENT IN A Arias, Maria Fernandez, Gema PSYCHIATRIC CENTER Jeronimo, Rebeca Sanabria Tiscar Méndez1, Ana Trujillo1, Elena Centro Terapéutico Valle del Tietar, Dutilh1, Agapito Herrero2 España. 1 Hospital Virgen del Puerto. Plasencia, España. 52 PSYCHOLOGICAL DISTRES IN 2  DUAL DISORDERS: ANALYSIS OF Centro Sociosanitario. Plasencia, THE MODALITY OF INTERVENTION España. AND RELATIONSHIP WITH THE SEVERITY OF THE DEPENDENCY 55 25I-NBOME: A RECENT PSYCHEDELIC SUBSTANCE WITH 1 Juan José Mancheño Barba , DANGEROUS IMPLICATIONS Maria Luisa Gutierrez López1, Irene Rodríguez Martín2, Francisco O.W. Muquebil Ali Al Shaban 1 Márquez Ligero3, Sara Domínguez Rodrígz , M.M. Fernández 1 Salas4, Carmen Díaz Batanero4 Fernández , M.A. Fernández Menéndez2 1 Unidad de Salud Mental 1  Comunitaria de Huelva, España. Centro de Salud Mental de Luarca, Asturias, España. 2 Servicio Provincial de 2  Drogodependencias de Huelva, Monash University, Australia. España. 56 ASSESSMENT OF THE SUICIDE 3  Unidad de Salud Mental PREVENTION PROGRAM IN Comunitaria de Valverde del PEOPLE WITH DUAL DISORDERS Camino, España. OF A COMMUNITY MENTAL 4 Universidad de Huelva, España. HEALTH UNIT IN SOUTHERN SPAIN (RURAL AREA) Samuel Leopoldo Romero Guillena1, Beatriz Oda Plasencia García De Diego2, Estrella Serrano Guerrero1, Evelio de Ingunza Barreiro1, María García Salguero1, Vicente Asensio Cabrera1 1 U.G.C Salud Mental Virgen Macarena, Sevilla, España. 2 Hospital de La Merced, Osuna Sevilla, España.

188 23 - 26 March, 2017 Madrid - Spain

57 PREVALENCES OF SUBSTANCE 61 USE OF BUPRENORFIN/ USE DISORDERS ACCORDING TO NALOXONE IN SCHIZOPHRENIA DSM-IV AND DSM-5 CRITERIA IN WITH HIGH ABUSE COCAINE PATIENTS WITH DUAL DISORDERS CONSUMPTION Juan Ramírez López1, Guadalupe Eduardo Sacristán1, Dolores de la Villa Márquez1, Luis Javier Robles2, Carme Cunillera1, Rosa Fernández García2, Elena Delgado Serrat1, Xavier Tolaguera1, Anna Rico3, Bella María González Ponce4, Calvet1 4 Oscar M. Lozano Rojas 1 CAS Garrotxa, España. 1  Servicio Provincial de 2 CSMA Garrotxa, España. Drogodependencias de Huelva, España. 62 INHALANT-INDUCED ORGANIC 2 Unidad de Salud Mental BRAIN SYNDROME Comunitaria de Huelva, España. Lucía Sánchez Pernas, Celia 3 Fundación Andaluza Beturia para la González Soria, Laila Al Chaal Investigación en Salud, España. Marcos, Isabel Valriberas Herrero, 4 Universidad de Huelva, España. Rafaela De la Mata Hidalgo, Rubén De Alarcón Gómez, Javier De 58 STUDY OF RELIABILITY OF la Iglesia Larrad, Nerea Casado THE REDUCED VERSION OF Espada, Laura Alonso León, Ana PERSONALITY INVENTORY FOR Álvarez THE DSM-5 (PID-5) IN PATIENTS Complejo Asistencial Universitario WITH DUAL DISORDERS Salamanca. Ibsal, España. Juan Ramírez López1, Manuel Fernández Molina1, Juan José 63 TOXICS IN PRISON Mancheño Barba2, Elena Delgado Javier Valdés Valdazo1, Miguel Rico3, Carmen Díaz Batanero4, Ángel Heredero Sanz1, Francisco Oscar Lozano Rojas4 Luis Rodríguez Fernández1, Javier 1 1 1 Servicio Provincial de Min Kim , Antonio Serrano García , 1 Drogodependencias de Huelva, Carmen Manso Bazús , Carlos 2 España. Llanes Álvarez 1  2 Unidad de Salud Mental Complejo Asistencial Universitario Comunitaria de Huelva, España. León, España. 2  3 Fundación Andaluza Beturia para la Complejo Asistencial Universitario Investigación en Salud, España. Zamora, España. 4  Universidad de Huelva, España. 64 REMISSION OF CLINICAL SYMPTOMS IN PATIENTS WITH 59 FAMILY DUAL DISORDER AND WITHOUT DUAL DISORDERS Laura Rubio1, Iciad Abad2, Félix TREATED IN THERAPEUTIC Jacobo1, Danny Frías1, L. Pérez1, COMMUNITY 1 Carlos M. Rodríguez , Concepción Esperanza Vergara Moragues1, 1 1 Pedrero , Arantxa Sánchez Francisco González Saiz2 1  Área V, Asturias, España. 1 Universidad Internacional de La 2 Área IV, Asturias, España. Rioja, España. 2 Unidad de Salud Mental de la 60 DOES BECOMING A FATHER Comunidad de Villamartín, Hospital INCREASE THE RISK OF RE- de Jerez (Cádiz), Servicio Andaluz de LAPSE IN SUBSTANCES ADDICT Salud, España. PATIENTS? Yenny Saad Sociedad Médica Universal, Uruguay.

189 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

65 INTENSIVE AMBULATORY 69 DRUNKOREXIA TREATMENT IN PATIENTS WITH Mercedes Valverde Barea1, Antonio DIAGNOSIS OF BORDERLINE España Osuna1, Francisca Cartas PERSONALITY DISORDER AND Moreno2, Miguel E. Ortigosa Luque1 SUBSTANCE USE DISORDER 1 Complejo Hospitalario Jaén, España. I. Vicente1, M. García1, C. Rubio1, P. 2  Sánchez2, M. De Matteis1 USMC Úbeda, España. 1  Hospital General Universitario 70 METHOXPHENIDINE USE IN A Gregorio Marañón, Madrid, España. PATIENT WITH MULTISUBSTANCE- 2 Hospital Universitario La Paz, INDUCED PSYCHOTIC DISORDER Madrid, España. Matteo Caloro1, Giuseppa Calabrò1, Eleonora De Pisa1, Georgios D. 66 LISDEXAMFETAMINE IN PATIENTS Kotzalidis1, Fabrizio Schifano2, Paolo WITH OBESITY AND BINGE EATING Schifano1 DISORDER (DSM-5) 1 Sapienza University of Rome, Italy. Cristina Banzo-Arguis, Miriam 2  Patricia Félix-Alcántara, Belen School of Life and Medical Sciences, Rodriguez-Borlado, Fernando Mora University of Hertfordshire, Minguez, Sonia Fernández Rojo, Hatfield, United Kingdom. Francisco Javier Quintero Gutiérrez AMANTADINE PLUS NALMEFENE del Álamo 71 FOR PATHOLOGICAL GAMBLING: Hospital Infanta Leonor, España. AN USEFUL COMBINED TREATMENT? RELATIONSHIP BETWEEN EATING 67 1 DISORDERS AND ALCOHOL- José Luis Escobar Fernández , RELATED DISORDERS: A Carmen Maura Carrillo de Albornoz 2 SYSTEMATIC REVIEW Calahorro , Margarita Guerrero Jiménez2, Anna Maria Boszczyk1 Enrique Guerra Gomez1, Belen 1  Unzeta Conde1, Irene Baños Caravaca de La Cruz Mental Health Martin1, Pilar Vilariño Besteiro1, Center. Murcia, Spain. Karen Eaton Iturbide1, Cesar Perez 2 Granada Sur Mental Health Service. Franco1, Cristina Pages Rivero2, Iraia Granada, Spain. Zabaleta Andreu3, Andres Suarez Velazquez4 72 GAMBLING: CONSEQUENCES ON GAMBLERS' RELATIVES 1 Santa Cristina Hospital, Spain. Ana Estévez, Paula Jauregui, Jaione 2 La Princesa Hospital, Spain. Onaindia 3 Fuenlabrada Hospital, Spain. University of Deusto, Spain. 4 Jose Germain Hospital, Spain. 73 EMOTIONAL DISREGULATION 68 EVERYTHING CAN GET AS A COMMON PREDICTOR OF COMPLICATED PATHOLOGICAL GAME AND Marta Soto Laguna, Gema COMORBID SYMPTOMS Belmonte García, Manuel Paula Jauregui1, Ana Estévez1, Fernández-Torija Daza, Joaquina Jaione Onaindia1, Estibaliz Prados Gómez, Roberto Pérez Rodríguez2, Illargi Zarate2 Asenjo, Adolfo Benito Ruiz, Abel 1 University of Deusto, Spain. Hidalgo Borreguero 2 Ekintza-Aluviz, Spain. Hospital Provincial de La Misericordia, Toledo, España.

190 23 - 26 March, 2017 Madrid - Spain

74 PSYCHOLOGICAL PREDICTORS OF 79 FAMILY HISTORY AND SMARTPHONE USE IN MEDICAL IMPULSIVITY IN GAMBLING STUDENTS: A STUDY WITH A DISORDER NOVEL TELEMETRIC APPROACH Patricia Sánchez Páez1, Josefa Devavrat Harshe, Saras Prasad, Pérez-Templado1, Diego de la Shabbiullah Syed, Yogesh Kulkarni, Vega2, Ángela Ibáñez1, Jerónimo Gurudas Harshe Saiz Ruiz1 Dr D Y Patil Medical College, 1 Hospital Universitario Ramón y Kolhapur, India. Cajal, Madrid, España. 2 Hospital Universitario Virgen 75 SEX ADDICTION, MYTH OR Macarena, Sevilla, España. REALITY? Dennis Lin 80 LETHALITY IN SUICIDAL Wine Country Sex And Relationship BEHAVIORS OF PSYCHIATRIC Therapy, USA. PATIENTS WITH AND WITHOUT SUBSTANCE ABUSE 76 IS NALMEFENE “USEFUL” IN Rosa Patrizia Sant'Angelo1, Roberta PATHOLOGICAL GAMBLING? Raggini1, Marisa Bolondi2, Laura THE USE OF NALMEFENE IN THE Bisi2, Monica Pacetti1, Federica TREATMENT OF PATHOLOGICAL Ambrosini3 GAMBLING. A CASE REPORT 1 Mental Health Department, AUSL Sonia Pedrosa Armenteros1, Anna ROMAGNA, Italy. 1 Salas Martínez , Daniel Vicente 2 University of Modena, Italy. Rivera1, Manuel Yzuel Sanz2 3 University of Bologna, Italy. 1 Hospital Clínico Universitario Lozano Blesa, España. 81 A STUDY OF GAMBLING PROBLEM 2 Centro Solidaridad Zaragoza, AMONG TREATMENT SEEKING España. SUBSTANCE USERS IN INDIA Siddharth Sarkar, Yatan Balhara, 77 USE OF ZIPRASIDONE IN A Arpit Parmar, Pallavi Rajhans PATIENT WITH DIFFICULTY IN THE CONTROL OF IMPULSES AIIMS, New Delhi, India. AND ALCOHOL ABUSIVE CONSUMPTION 82 RESPONSE TO INJECTABLE ARIPIPRAZOLE (MAINTENA®) IN 1 Eduardo Sacristán , Dolores THE CONTROL OF SYMPTOMS 2 1 Robles , Carme Cunillera , Rosa OF A PATIENT WITH BIPOLAR 1 1 Serrat , Xavier Tolaguera , Anna DISORDER AND ALCOHOL AND 1 Calvet STIMULANT DEPENDENCE. A CASE 1 CAS Garrotxa, España. REPORT OF DUAL DISORDERS 2 CSMA Garrotxa, España. Olga Arbeo1, Héctor Sáiz1, Víctor Pereira2 78 CONSUMPTION PATTERNS 1 Complejo Hospitalario de Navarra, EVALUATION OF A SUBSTANCE España. ABUSE POPULATION 2 Clínica Universitaria de Navarra, 1 1 Ana Samico , Ângela Venâncio , España. Cristina Recalde2 1 Centro Hospitalar Vila Nova de Gaia e Espinho, Vila Nova de Gaia, Portugal. 2 Equipa de Tratamento Oriental, Porto, Portugal.

191 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

83 COMPARATIVE STUDY OF 86 BENEFITS OF LONG-ACTING METHADONE/BUPRENORPHINE- INJECTABLE ANTIPSYCHOTICS IN NALOXONE TREATMENT IN PATIENTS WITH DUAL DISORDERS PATIENTS DIAGNOSED WITH Ivan Celic, Marko Curkovic, Andrea OPIOID USE DISORDER IN THE Tomic, Petrana Brecic, Vlado Jukic PROVINCE OF CORDOBA University Psychiatric Hospital 1 María Nuria Ferrer Chinchilla , Ana Vrapce, Croatia. Martínez Domingo2, Francisco 3 Ignacio Mata Cala 87 EFFECTIVENESS OF INHALED 1 Clínica Universidad de Navarra, LOXAPINE IN THE DUAL- España. DIAGNOSIS PATIENTS: A CASE 2 Hospital Universitario Reina Sofía, REPORT España. Christian Fadeuilhe Grau1, Júlia 1 3 Instituto Provincial de Bienestar Vendrell Serres , Edgar Fadeuilhe 3 1 Social, España. Grau , Miguel Sandonis Vicente , M. Concepción Martínez Sánchez1, Pol 1 1,2 84 NALMEFENE AND DUAL Ibáñez Jiménez , Lara Grau-López , 1,2 DISORDERS IN OUTPATIENT Carlos Roncero Alonso SETTING: A NATURALISTIC STUDY 1 Hospital Universitario Vall Isabel Menéndez-Miranda1, María d’Hebron, CIBERSAM, Barcelona, González-Martínez2, Maria Jesús España. Antuña-Díaz2, Rocío Villa-Diez2, 2 Hospital Universitario Vall Gemma Isabel San Narciso- d’Hebron. Agencia de Salud Pública Izquierdo2, Maria Jesús Castelao- de Barcelona, España. 3 Lorenzo , Pilar Alejandra Sáiz- 3 Hospital Universitario Germans 4 Martínez Trias I Pujol, Badalona, Barcelona, 1 Hospital Universitario San Agustín, España. Avilés, Spain. 2 Mental Health Services (área V), 88 LONG-ACTING INJECTABLE Gijón, Spain. ARIPIPRAZOLE IN THE TREATMENT OF PATIENTS WITH 3  Mental Health Centre of Arriondas, DUAL DISORDERS: A CASE Spain. REPORT 4  University of Oviedo, Spain. Christian Fadeuilhe Grau1, Júlia Vendrell Serres1, Edgar Fadeuilhe 85 USE OF NALMEFENE IN ALCOHOL Grau3, Elena Ros-Cucurull1,2, Lara USE DISORDER IN COMORBIDITY Grau-López1,2 WITH PATHOLOGICAL GAMBLING. 1  CLINICAL SERIES Hospital Universitario Vall d’Hebron, CIBERSAM, Barcelona, 1 Samuel Leopoldo Romero Guillena , España. Beatriz Oda Plasencia García De 2  Diego2, Alicia Quirós López2 Hospital Universitario Vall d’Hebron. Agencia de Salud Pública 1  U.G.C Salud Mental Virgen de Barcelona, España. Macarena, Sevilla, España. 3 Hospital Universitario Germans 2  Hospital de La Merced, Osuna Trias I Pujol, Badalona, Barcelona, Sevilla, España. España.

192 23 - 26 March, 2017 Madrid - Spain

89 PSYCHOPHARMACOLOGICAL 92 INHIBITION RESPONSE FOR TREATMENT OF DUAL DISORDERS: ALCOHOLISM. RESULTS WITH “DO WE KNOW WHAT WE ARE NALMEFENE DOING?” Beatriz Oda Plasencia García De Jorge Luis Garcia Egea1, Rocio Diego1, Samuel Leopoldo Romero Gutierrez Rodriguez1, Maria Conde Guillena2, Edmundo Cartagena Rivas1, Oriol Porta Olivares3, López3 3 Maria Juncal Ruiz , Nieves Gomez 1 Hospital de la Merced, Osuna, 1 Coronado , Marcos Gomez Sevilla, España. Revuelta2, Manuel Canal Rivero1 2 U.G.C Salud Mental Virgen 1  Hospital Universitario Virgen del Macarena, Sevilla, España. Rocio, Sevilla, España. 3 Centro de Tratamiento de 2  Hospital Universitario de Álava - Adicciones, Mairena del Alcor, Sede Santiago, Vitoria, España. Sevilla, España. 3 Hospital Universitario Marqués de Valdecilla, Santander, España. 93 EFFECT OF ANTI-CRAVING AGENTS ON IMMEDIATE POSTDISCHARGE 90 DESCRIPTION OF A SAMPLE COURSE OF ALCOHOL OF PATIENTS WITH DUAL DEPENDENCE SYNDROME DISORDERS IN TREATMENT COMORBID WITH SCHIZOPHRENIA WITH ARIPIPRAZOL INJECTABLE Lekhansh Shukla, Venkata Lakshmi SUSPENSION OF EXTENDED Narasimha, Arun Kandasamy, RELEASE Prabhat Chand, Vivek Benegal, Carlos Llanes Álvarez1, Jesús Ángel Pratima Murthy 1 Monforte Porto , Ana Isabel Álvarez National Institute of Mental Health 2 Navares , Maria Ángeles Garzón and Neurosciences, Bangalore, India. de Paz2, Amaya Caldero Alonso1, 1 Manuel Ángel Franco Martín 94 EFFICACY AND TOLERANCE 1 Complejo Asistencial de Zamora, OF VORTIOXETIN FOR THE España. TREATMENT OF DEPRESSIVE 2 Hospital Clínico Universitario de SYMPTOMS IN ALCOHOL Salamanca, España. DEPENDENT PATIENTS IN ABSTINENCE SITUATION 91 PALIPERIDONE PALMITATE Alfonso Carlos Abad1,2, Abderramán VERSUS CONVENTIONAL DEPOTS Esojo1,2, Elena Ros-Cucurull1,2, Lara FOR DUAL DISORDERS. A 4 YEAR Grau-López1,2, Raul Felipe Palma- FOLLOW-UP STUDY (EXTENSION Álvarez1,2, Laia Rodríguez-Cintas1,2, STUDY) Marta Sorribes1, Carlos Roncero1,2 Samuel Leopoldo Romero Guillena1, 1 Hospital Universitari Vall d’Hebron. Beatriz Oda Plasencia García De Agencia de Salud Pública de Diego2, Alicia Quirós López2 Barcelona. CIBERSAM. Barcelona, 1 U.G.C Salud Mental Virgen España. Macarena, Sevilla, España. 2 Universitat Autònoma de 2 Hospital de La Merced, Osuna Barcelona. Barcelona, España. Sevilla, España.

193 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

95 GLOBAL FUNCTIONING IN 100 IMPROVING DEMENTIA WITH PATIENTS UNDER TREATMENT NALMEFENE? WITH NALMEFENE: DRUG Jose María Mongil San Juan1, EFFICACY AND TOLERABILITY Francisco Jose Jimenez Barea2 1 Lidia Aguado Bailón , Alejandro 1 Servicio Andaluz de Salud (SAS), 2 2 Porras Segovia , Pilar Calvo Rivera , España. Caridad López Callejas3, Manuel 2  Ruiz3 Diputación de Cádiz, España. 1  Clínica Del Río, San Pedro de 101 KETAMINE AND BIPOLAR Alcántara, Málaga, España. DISORDER 2  Complejo Hospitalario Granada, Gonzalo Salazar1, Javier Sánchez1, España. Mario de Matteis1,2 3  Centro Provincial de 1 Hospital General Universitario Drogodependencias, Granada, Gregorio Marañón, España. España. 2 Centro de Salud Mental Retiro, 96 BZD CONSUMPTION IN PATIENTS Hospital General Universitario WITH ALCOHOL USE DISORDERS Gregorio Marañón, España. Laila Al Chaal Marcos, Lucía Sánchez 102 ELECTION OF Pernas, Celia González Soria, PSYCHOPHARMACEUTICAL IN A Rafaela de la Mata Hidalgo, Isabel PATIENT WITH Valriberas Herrero, Laura Alonso AND CANNABIS CONSUMPTION León, Javier de la Iglesia Larrad, José Torroba1, María Isabel Osuna Nerea María Casado Espada, Rubén Carmona2, Carmen Barrionuevo de Alarcón Gómez Baeza2, Antonella Garrido Beltrán1 Hospital Clínico Universitario 1 Alternativa 2, España. Salamanca. IBSAL, España. 2 Hospital Universitario Virgen de la 97 METHADONE MAINTENANCE Victoria, Málaga, España. PROGRAMME AND POTENTIAL INTERACTIONS WITH CANNABIS 103 INJECTABLE LONG-TERM DEPENDENCE ANTIPSICOTICS (ILD) AND DUAL DISORDERS. Lidia Fernández Mayo, Elena EVOLUTIONARY DESCRIPTION Barbero García, Dolores Baño FROM THE NURSING EVIDENCE OF Rodrigo, Margarita Agujetas THE CSM RETIRO Rodriguez, Valentín de Antonio Pérez, Aurora García Sánchez Arturo Alonso Sedano, José Sánchez Hernández, Juan C. CAID Majadahonda, España. Fernández Morales, Ana Quispe 98 EFFECTIVENESS OF Vilches, Alicia Cunillera Llorente, ANTICONVULSANTS IN COCAINE Néstor Szerman Bolotner DEPENDENCE CSM de Retiro, Madrid, España. Gabriel García, Adrian Azanza, NEW PARADIGMS IN THE Isabel Menéndez 104 IDENTIFICATION OF PATIENTS Hospital San Agustin, España. WITH DUAL DISORDERS. A CASE REPORT TREATMENT OF COCAINE 99 1 1 DEPENDENCE WITH NALMEFENE Olga Arbeo , Héctor Sáiz , Víctor Pereira2 Gabriel García, Adrian Azanza, 1  Isabel Menéndez Complejo Hospitalario de Navarra, España. Hospital San Agustin, España. 2 Clínica Universitaria de Navarra, España.

194 23 - 26 March, 2017 Madrid - Spain

105 “WHEN THE MANIA IS OVER AND 109 EMERGENT DRUGS: A CASE THE DESIRE APPEARS” REPORT Martha Cancino Botello, Juan A. López De Haedo, J. Brotons Miguel Hernández Sánchez, María López, V. Avellón Júarez de los Ángeles Canseco Navarro, Hospital Universitario Dr. Peset, Marta Machado Vera, Sofía Alonso Valencia, España. Gutiérrez, María Amparo Descalzo Cabadés 110 WRITING PHOBIA AND CHRONIC Consorcio Hospital General USE OF ALCOHOL Universitario de Valencia, España. Maria Celia Brangioni, Ana Karla Carvalho Leite Andrade, Ivan 106 SELF-MEDICATION AMONG Ranulfo Vaz SEVERE MENTAL DISORDER PATIENTS University of Brasília, Brazil.

1 José Luis Escobar Fernández , 111 THE THERAPEUTIC PROCESS Carmen Maura Carrillo de Albornoz IN A COGNITIVE BEHAVIORAL 2 Calahorro , Margarita Guerrero TREATMENT IN PATIENTS WITH 2 Jiménez DUAL DISORDERS 1  Caravaca de La Cruz Mental Health Mercedes Delgado Arroyo1, Neus Center. Murcia, Spain. Estelrich1, Marta Perea1,2,3, Marta 2 Granada Sur Mental Health Sorribes1,2, Constanza Daigre1,2,, Services. Granada, Spain. Laia Rodríguez1,2, Diana Romero1,2, Carlos Roncero1,2 107 PSYCHOPATHOLOGY, MULTIPLE 1 SAPD Hospital Universitari Vall SUBSTANCE ABUSE AND CHRONIC d´Hebron-ASPB, Barcelona, España. PAIN IN A COMPLEX DUAL 2  DISORDER. CASE REPORT Universitat Autónoma de Barcelona, España. Victor Pereira1, Hector Saiz2, Olga 3  Arbeo2 Corporació Sanitària Parc Taulí, Sabadell, España. 1 Clínica Universidad de Navarra, España. 112 CANCELLED 2 Complejo Hospitalario de Navarra, España. 113 MENTALIZING FAILURES IN DUAL PATIENTS TREATED AT A DUAL 108 PHARMACOFIESTA OR DISORDERS UNIT AUTOMEDICATION? INTEGRAL Emilia Gonzalez Sanchez, Belén TREATMENT OF 3 FENTANIL Pilar Fernández Calatrava, Raquel ADDICTED PATIENTS IN A CENTER Rebolledo Carmona, Jaime Del OF INTEGRAL CARE FOR DRUG- Corral Serrano TREATMENT Centro de Patología Dual. Clínica 1 Iraia Zabaleta Andreu , Sara Arias Nuestra Señora de La Paz, España. Rubio1, Clara Sanahuja Muñoz2 1 Hospital Universitario de Fuenlabrada, Madrid, España. 2 Centro Hospitalario de Tratamiento de Drogodependientes. Asociación Proyecto Hombre, Madrid, España.

195 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

114 PSYCHOEDUCATIONAL AND 118 PSYCHOGENETIC POLYDIPSIA? A PSYCHOLOGICAL TREATMENT MULTIFACTORIAL CASE FOR PATIENTS WITH MEDICATION César Cagigal, Carla Silva OVERUSE HEADACHE Centro Hospitalar e Universitário de 1,2 1,2,3 Diana Romero , Marta Perea , Coimbra, Portugal. Patricia Pozo-Rosich1, Elena Ros1,2, 1 Marta Torres-Ferrus , Carlos 119 CALCIFICATIONS OF THE PALE 1,2 Roncero GLOBE IN PATIENTS WITH DUAL 1 Hospital Universitario Vall DISORDERS. THE DIAGNOSTIC D'Hebron, España. CHALLENGE OF FAHR SYNDROME 2 Universidad Autónoma de César Cagigal, Carla Silva Barcelona, España. Centro Hospitalar e Universitário de 3 Corporación Sanitaria Parc Taulí, Coimbra, Portugal. España. 120 USING PARTICIPATORY VIDEO FOR 115 CASE REPORT: PEOPLE WITH SEVERE MENTAL PSYCHOTHERAPEUTIC ILLNESS AND DUAL DIAGNOSIS: A INTERVENTIONS IN SUBSTANCE FEASIBILITY STUDY USE DISORDER WITH PROLONGED Victoria Carmichael1, Robert GRIEF AND ATTENTION DEFICIT Whitley1,2 DISORDER, RESIDUAL TYPE 1 Douglas Mental Health University 1 Parmeet Kaur Soni , Jai Ranjan Institute, Montreal, Quebec, 2 Ram Canada. 1  Mental Health Foundation, Kolkata, 2 McGill University, Montreal, India. Quebec, Canada. 2 Apollo Gleneagles Hospital, Kolkata, India. 121 CONTRIBUTIONS OF NEUROPSYCHOLOGY TO 116 THE IMPORTANCE OF TACKLING DUAL DISORDERS COORDINATIONS OF DUAL Francisco De Pedro Melgarejo DISORDERS Instituto Psiquiátrico José Germain, Carmen Simón Rodríguez, Lola España. Rodríguez Martos, Laia Rodríguez Cintas, Marta Sorribes Puertas, 122 CANCELLED Alfonso Carlos Abad González, Carlos Roncero Alonso 123 INTERVENTION PROGRAM ON Agencia de Salud Pública, Hospital SEVERE ALCOHOL DEPENDENCE Universitari Vall d'hebron, Universitat SYNDROME IN A DAY HOSPITAL: A Autónoma de Barcelona, CIBERSAM, ONE-YEAR FOLLOW-UP STUDY Barcelona, España. Elsa Gomez Ruiz1, Juan Francisco Bejarano Ramírez1,2, Javier 117 DECENTRALIZED ALCOHOL Vázquez-Bourgon1,2,3, Fernando TREATMENT: CHARACTERIZATION Hoyuela Zatón1, Elena Cortazar OF A NEWLY CREATED López1, Begoña Agüeros Pérez1, OUTPATIENT CONSULTATION Benedicto Crespo-Facorro1,3 Eduardo Palha Fernandes1,3, Patrick 1 University Hospital Marqués de Alves1,2, Carlos Vasconcelos3 Valdecilla-IDIVAL, Santander, Spain. 1 Alto Minho Local Health Unit, Viana 2 University of Cantabria, Spain. do Castelo, Portugal. 3 CIBERSAM, Spain. 2 Porto University, Portugal. 3 Center for Integrated Responses, Oriental Porto, Portugal.

196 23 - 26 March, 2017 Madrid - Spain

124 ATTENTION TO EMERGENCIES 128 SUICIDE AND ALCOHOL USE IN IN DUAL DISORDERS IN THE CHILDREN EMERGENCY DEPARTMENT OF Lluis Niell Galmés, Miriam Manuela GENERAL HOSPITALS Tenorio Guadalupe, Rafael Ángel Aitana M. González Álvarez1, Baena Mures, Germán Montero Esther Torío Ojea2, María González Hernández, Iñigo Alberdi Páramo 3 Martínez Hospital Clínico San Carlos, España. 1 Centro de Salud Mental. Langreo, España. 129 REPORT OF SUPPORT GROUPS 2 Hospital Universitario Central de FOR PARENTS WITH CHILDREN Asturias. Oviedo, España. WITH ADHD: A COMMUNITY BASED PROGRAM. THEIR 3  Centro de Salud Mental El Coto. SOCIAL IMPACT AND THEIR Gijón, España. OPPORTUNITY FOR SUBSTANCE ABUSE PREVENTION 125 THE BENEFITS OF PHYSICAL ACTIVITIES IN PATIENTS WITH Juan Carlos Pérez Castro, Iván DUAL DISORDERS Serrano, María E. Frade Jorge Jaber Filho, Jose Verissimo Proyectodah, México. Junior, Jussara Cardozo, Alessandro Halabi, Sergio Carvalho, Angela 130 COORDINATION OF METHADONE Hollanda, Bruno Reys DISPENSING IN CASE OF A 3 MONTHS TREKKING Clínica Jorge Jaber, Brazil. Javier Pita De La Vega-Garcia1,2, 3 126 MULTI DIAGNOSES AMONG Juanjo Garcia-Orozco , Cristian 1 WAR AFFECTED POPULATION IN Perez-Massip , Anna Vallmitjana- 1 1 GEORGIA Soler , Joana Jimenez-Serrano , Lara Moreno-Sancho1,2, Vanessa 1,2 Mariam Jishkariani , Teimuraz Vilella-Carbonell1,2, Cristina 1 1,2 Bokuchava , George Berulava , Seco-Casares1,2, Bárbara Martinez- 1 Kakhaber Mikadze , Ekaterine Cirera1,2, Miriam Gregorio-Elcoso2 Kikvadze1 1 Centro de Atención a 1  Psycho - Rehabilitation Centre Drogodependencias de Mataró, "EMPATHY" (RCT/EMPATHY), Tbilisi, Barcelona, España. Georgia. 2 Centro de Salud Mental 2  State Medical University, Tbilisi, Ambulatorio de Mataró, Barcelona, Georgia. España 3  127 CHANGES IN Hospital Clínico Universitario de PSYCHOPHYSIOLOGICAL ACTIVITY Valencia, España. AFTER APPROACH/AVOIDANCE TRAINING Andres Martínez Maldonado1, Ana Sion1, Rosa Jurado Barba1, Gabriel Rubio Valladolid1, 2, 3 1 Research Institute I + 12, Madrid, Spain. 2 Hospital Universitario 12 de Octubre, Madrid, Spain. 3 Addictive Disorders Network, Spain.

197 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

131 MULTIDISCIPLINARY 134 MEDIUM-STAY TREATMENT AND INTERVENTION IN A PREGNANT REHABILITATION UNITS FOR WOMAN ON TREATMENT SEVERE MENTAL DISORDERS: WITH METHADONE AND DUAL TOWARDS AN OPTIMAL CARE FOR DISORDER DUAL PATHOLOGY PATIENTS Javier Pita De La Vega1,2, Juanjo Alvaro Rivera Villaverde, Jose Garcia-Orozco3, Cristian Perez- Manuel Carrascosa Bernaldez, Massip1, Anna Vallmitjana-Soler1, Lorenzo Chamorro Garcia 1 Joana Jimenez-Serrano , Lara Instituto Psiquiátrico Jose Germain 1,2 Moreno-Sancho , Vanessa Vilella- de Leganés, España. Carbonell1,2, Eva Garcia-de la Plaza1, 1,2 Denise Jacobowitz , Miriam 135 AN INNOVATIVE SERVICE 2 Gregorio-Elcoso MODEL OF DRUG AND ALCOHOL 1 Centro de Atención a SERVICES INTEGRATING ACROSS Drogodependencias de Mataró, A HOSPITAL AND COMMUNITY Barcelona, España. MENTAL HEALTH SERVICES – 2 Centro de Salud Mental TRUE PARTNERSHIP FOR BETTER Ambulatorio de Mataró, Barcelona, ACCESS IN WESTERN AUSTRALIA España Raj Tanna1,3, Greg Gordon2, Richard 2,3 2 3 Hospital Clínico Universitario de O'Regan , Suzanne Helfgott Valencia, España. 1 Joondalup Catchment Area Mental Health, North Metro Health Service, 132 DUAL DISORDERS: IS THERE Australia. A DISCRIMINATION IN THESE 2 Next Step Drug & Alcohol Services, PATIENTS? Perth, Western Australia. 1 María Cinta Ramírez Domínguez , 3 University of Western Australia, 1 Ana María Carrasco Sánchez , Australia. Miguel Graciani Pérez de 1 Regadera , Juan Francisco Ramírez 136 PSYCHIATRIC HOSPITAL: A SERIES 2 López OF CASES 1  Complejo Hospitalario de Huelva, V. Espinola, J. Aguilar España. Hospital Psiquiátrico, Asunción, 2  Centro Provincial de Paraguay. Drogodependecia de Huelva, España. 137 ARE WE TAKING FULLY ADVANTAGE OF SOCIAL MEDIA TO 133 CONTRIBUTIONS AND COMBAT ADDICTIONS? METHODOLOGY FOR Miguel Álvarez de Mon, Marta OCCUPATIONAL THERAPY IN Santos, María Arrieta, Patricio ACUTE DUAL PATHOLOGY UNIT Molero Natàlia Ribas Muñoz, Zaida Cañadas Clínica Universidad de Navarra, Aceña, Esperanza González Pamplona, España. Ruano, Marta Nayach José, Víctor Jornet Jimón, Albert Pratdesava Villanueva Parc de Salut Mar, Barcelona, España.

198 23 - 26 March, 2017 Madrid - Spain

138 EFFECTS OF CLASSICAL 140 DIFFERENCES IN PATIENTS WITH CONDITIONING AND AT SUBSTANCE USE DISORDER AND DIFFERENT TIMES OF THE SUBSTANCE USE DISORDER AND ADMINISTRATION OF THE PERSONALITY DISORDER IN UNCONDITIONED STIMULUS TREATMENT IN HEALTH CARE ON PURKINJE CELLS OF THE CENTERS WITH ALTERNATIVE CEREBELLUM IN ADULT RATS LEGAL MEASURES Hector Rodriguez1, Sara Largacha1, Natàlia Ribas Muñoz1, Lola Constanza Simunovic1, Omar Rodríguez Martos2, Raquel De Espinoza-Navarro2, Camilo Arriaza1, la Cruz Planas3, Carme Padrós María Eugenia Castro1 Susanna4, María Jesús Sotelo 5 6 1 Universidad de Chile, Chile. Borjas , Pilar Mas Sanfiz , Lola Sánchez Sánchez1, Irene Infante4, 2  Universidad de Tarapacá, Arica, Zaida Cañadas Aceña1 Chile. 1 Parc De Salut Mar, España. 139 SOCIODEMOGRAPHIC 2 Hospital Universitari Vall d'Hebron, CHARACTERISTICS AND MENTAL España. COMORBIDITY IN PATIENTS 3 Althaia, Xarxa Assistencial TAKING TREATMENT IN AN Universitària Manresa, España. ADDICTIVE BEHAVIOUR UNIT 4  (UCA) DERIVED BY COURT ORDER Hospital Universitari Mutua de Terrassa, España. Maria Gloria Cordeiro-Crespo 5  Cabral-Campello1, Maria Dolores Germanes hospitalàries Benito Ortega Garcia2, Maria Teresa Menni, España. Camuñas Sevilla1, Maria de los 6 Consorci Hospitalari de Vic., España. Angeles Diaz-Maroto Tello1, Alicia Fuentes Garcia1, Raquel Fernández 141 CASE REPORT: ATTEMPTED Auñon1 DOUBLE MURDER FOLLOWING 1 Hospital General La Mancha-Centro, PERIOD OF DAILY USE OF CRACK España. COCAINE 2 CSM. Cartagena. Murcia, España. Foteini Papouli, Ravi Lingam, Mourad Wahba, Rachel Woodward Bamburgh Clinic, Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

199 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

142 TREATMENT NEEDS OF 145 CONSUMPTION OF PHYSICIANS WITH SELF- PSYCHOACTIVE SUBSTANCES REPORTED DUAL DISORDERS: A IN SHOW BUSINESS WORKERS. RETROSPECTIVE COHORT STUDY SITUATION IN SPAIN DURING THEIR FIRST TREATMENT Isabel Almodóvar Fernández1, Paula EPISODE AT A PHYSICIANS’ Sánchez Thevenet1 , Ana Benito2, HEALTH PROGRAM Abel Baquero3, Mihaela Dalae4, María Dolores Braquehais1, Miquel Gonzalo Haro1 1 2 Jordi Bel , Sergi Valero , Xulián 1 Universidad CEU Cardenal Herrera, 1 1 1 Mozo , Enric Llavayol , Tània Pujol , España. Meritxell Heredia1, Albert Díaz1, 2  Eugeni Bruguera1,2, Miquel Casas1,2 Unidad de Salud Mental Torrente, Valencia, España. 1 Integral Care Program For Sick 3  Health Professionals, Galatea Fundación Amigó Castellón, España. Clinic, Barcelona, Spain. 4 Consorcio Hospitalario Provincial de 2 Hospital Universitari Vall d’Hebron, Castellón, España. CIBERSAM, Universitat Autònoma PREVALENCE OF ALCOHOL AND de Barcelona, Barcelona, Spain. 146 TOBACCO IN BASIC EDUCATION STUDENTS IN PUBLIC SCHOOLS 143 HOW CAN THE PAIME PROGRAM CONTRIBUTE TO DUAL PATIENT Fabio Bautista-Pérez CARE? A CASE REPORT Universidad Evangélica de El Arantza Yubero1, Enriqueta Ochoa2, Salvador, El Salvador. Francisco Arias3 DESCRIPTIVE STUDY OF A SAMPLE 1 Proyecto Hombre, España. 147 OF PATIENTS ADMITTED TO INAD 2  Hospital Ramón y Cajal, España. PSYCHIATRY SUBACUTE UNIT 3  Hospital Doce de Octubre, España. Ester Boix Quintana1, Miquel Ferré1, Laura González-Vallespí1, Eloi Giné1, 144 PROSPECTIVE STUDY ON Laura Martínez2, Eva Daví1, Roberto PATIENTS DIAGNOSED OF DUAL Esteban1, Carme Masferrer3, Paz DISORDERS IN A MENTAL HEALTH Flores3, Olivia Orejas3 CENTER AND DERIVED FROM 1  PRIMARY CARE CENTERS Hospital de Mataró - Consorci Sanitari del Maresme, España. Iñigo Alberdi Paramo1, German 2  Montero Hernández1, Miriam Hospital del Mar. Parc de Salut Mar, Tenorio Guadalupe1, Lluis Niell España. Galmez1, Rafael Baena Mures1, 3 Institut de neuropsiquiatría i Cristina Perez Sobrino1, Javier addiccions (INAD). Parc de Salut Gomez Beteta1, Paula Fabero Cruz2, Mar, España. Carmen Carrascosa Carrascosa2 FACTORS RELATED TO 1 Hospital Clínico San Carlos, Madrid, 148 PSYCHOACTIVE SUBSTANCE USE España. IN AN EDUCATIONAL INSTITUTION 2  Centro de Salud Las Aguilas, IN JAMUNDÍ VALLE, COLOMBIA Madrid, España. Carlos Arturo Cassiani Miranda Hospital Psiquiatrico San Camilo Bucaramanga, Colombia.

200 23 - 26 March, 2017 Madrid - Spain

149 DUAL DISORDERS TREATMENT 152 PREVALENCE OF CONSUMPTION SYSTEMS: WHAT WE DO? PATTERNS AND THE Iciar Ezquiaga Bravo1, Zelma PSYCHOPATHOLOGICAL PROFILE González Vega2, Paola Rossi1, OF SPANISH PATIENTS WITH DUAL Francina Fonseca1,3, Claudio DISORDERS IN EACH ASSISTANCE Tamarit1,3, Joan Mestre3, Antonia MODALITY Domingo3, Marta Torrens1,3,4 Maria Luisa Gutiérrez López1, 2 1 Institut de Neuropsiquiatria I Juan Ramírez , Javier Adriaenses 1 3 Addiccions (INAD), Parc Salut Mar, Lázaro , Elena Delgado Rico , 4 Barcelona, España. Daniel Dacosta Sánchez , Fermín Fernández Calderón4 2 Hospital Obispo Polanco, Teruel, 1  España. Unidad de Salud Mental Comunitaria de Huelva, España. 3 Hospital del Mar d'Investigacions 2  Mèdiques-IMIM, Parc de Salut Mar, Servicio Provincial de Barcelona, España. Drogodependencias de Huelva, España. 4 Universitat Autònoma de 3  Barcelona, Barcelona, España. Fundación Andaluza Beturia para la investigación en Salud, España. 150 STUDY OF DUAL DISORDERS IN 4 Universidad de Huelva, España. A COMMUNITY MENTAL HEALTH SETTING 153 PREVALENCE AND Mª Del Carmen García Mahía, CHARACTERISTICS OF DUAL Águeda Fernández Quintana DISORDERS AMONG CLINIC ATTENDING PATIENTS IN GENERAL Hospital Abente y Lago, España. PSYCHIATRY AND DE-ADDICTION CENTRE OF TERTIARY CARE DUAL DISORDERS IN A 151 HOSPITAL SPECIALIZED ADDICTION CENTER 1 2 IN BOGOTA-COLOMBIA Khagendra Kafle , Debasish Basu , Subodh B. N.2 Jeffrey Gonzalez Giraldo1,2, Jaime 1  Valero Carvajal1, Alexie Vallejo Chitwan Medical College, Chitwan, Silva1,2, Rodrigo Nel Cordoba Nepal. Rojas1,2 2 Postgraduate Institute of 1 CISNE (centro de investigaciones del Medical Education and Research, sistema nervioso), Colombia. Chandigarh, India. 2 Universidad del Rorasio, Colombia.

201 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

154 PREVALENCE OF DUAL 157 SOME CHARACTERISTICS OF DISORDERS IN A CENSUS OF PATIENTS IN TREATMENT FOR PATIENTS WITH SEVERE MENTAL ADDICTION PROBLEMS IN THE DISORDERS DEPARTMENT OF MENTAL HEALTH Laura Lago García1, Aida González AND ADDICTION PREVENTION Suárez2, Adrián Azanza Balmori3, DURING 2015 IN ZAGREB, Sergio Ocio León2, Mario Javier CROATIA AND COMPARISON WITH Hernández González2, Adela Alonso NATIONAL DATA Alonso2, Manuel Gómez Simón2, Mirjana Orban1, Danica Romac1, Omar W. Muquebil Ali Al Shaban Boris Gracin1, Lea Maricic1, Zrinka Rodriguez4, María Covandonga Cavar1, Kristina Terzic2 1 Huergo Lora , Jaime Ramón López 1 Teaching Institute For Public Health 2 Fernández Andrija Stampar MD, Zagreb, 1 Hospital Vital Alvarez Buylla, Croatia. España. 2 General Hospital „Josip Benèeviæ 2 Centro de Salud Mental de Mieres, MD“, Nova Gradiška, Croatia. España. 3 Hospital San Agustín, España. 158 OUR EXPERIENCE WITH DUAL DISORDER ADMISSIONS IN 4  Centro de Salud Mental de Luarca, PRIVATE PRACTICE España. Mónica Brenda Ortega Pacheco, 155 DRUG INGESTION AND Silvia Parra Bru, Cristina Del Canto ECONOMIC, SOCIAL, Jiménez EMPLOYMENT, FAMILY AND Policlínica Miramar, España. MARITAL ISSUES FROM A CLINICAL SAMPLE IN A MENTAL HEALTH 159 PREVALENCE OF DUAL CENTER DISORDERS IN PRIMARY CARE Isabel Laporta Herrero1, Mª Pilar REFERRALS. ANALYSIS OF 2015 Delgado Miguel2, Javier Navarro Samuel Leopoldo Romero Guillena1, Aznar3 Beatriz Oda Plasencia García De 2 1 1 Centro de Salud Mental Infanto- Diego , Evelio de Ingunza Barreiro , 1 Juvenil, Servicio Navarro de Salud, Estrella Serrano Guerrero , María 1 Pamplona, España. Jose Candon Gamez , Manolo Guillen Benítez1 2 Hospital Royo Villanova, Servicio 1  Aragonés de Salud, Zaragoza, U.G.C Salud Mental Virgen España. Macarena, Sevilla, España. 2  3 Hospital Universitario Miguel Hospital de La Merced, Osuna Servet, Servicio Aragonés de Salud, Sevilla, España. Zaragoza, España. 160 TOXICS CONSUMPTION IN SUICIDAL ATTEMPTS ATTENDED 156 DUAL DISORDERS PATIENTS IN A DAY HOSPITAL BY THE INTERCONSULTATION UNIT AND THE LINK OF PSYCHIATRY IN Marta Niubo, Maria Francisca A GENERAL HOSPITAL Hollenstein, Yolanda Manzano, Eva Daví, Roberto Esteban, Esther Boix, Baena Mures Rafael Angel, Niell Denis Daniela Jacobowitz, Bárbara Galmes Lluis, Alberdi Paramo Iñigo, Martinez, Eloi Giné, Josep Cañete Montero Hernández Germán, Lázaro Pascual Yolanda, Olivares Hospital de Mataro. Consorci Sanitari Gerechter Luis, Rodríguez Quijano del Maresme, España. José Hospital Universitario Clínico San Carlos, España.

202 23 - 26 March, 2017 Madrid - Spain

161 PROFILE OF WOMEN WITH DUAL 164 PSYCHOSTIMULANTS USE AND DISORDERS ADDMITED TO A PREDICTION OF THE LONG TERM SPECIFIC TREATMENT CENTER SURVIVAL AMONG SUBJECTS Ana María Recio Vivas1, Cecilia WITH SCHIZOPHRENIA AND CO- Peñacoba Puente2, Mónica Díaz OCCURRING MULTISUBSTANCE de Neira Hernando3, Laura Visiers USE DISORDERS Jiménez1, David Peña Otero1, Aviva Wolf1, Yuri Gimelfarb2, Mashit Raquel Rebolledo Carmona4 Ben-Tzarfati2 1 Centro de Ciencias de La Salud San 1 Ness Ziona Mental Health Center Rafael. Universidad Antonio de affiliated to Sackler Faculty of Nebrija, España. Medicine, Tel Aviv University, Israel. 2 Universidad Rey Juan Carlos, 2 Abarbanel Mental Health Center España. affiliated to Sackler Faculty of 3 Universidad Complutense de Medicine, Tel Aviv University, Israel. Madrid, España. 165 PREVALENCE OF ALCOHOL 4  Clínica Nuestra Señora de la Paz, CONSUMPTION BY APPLYING España. THE CAGE QUESTIONNAIRE CAMOUFLAGED IN A SAMPLE OF 162 PROFILE OF MEN WITH DUAL PSYCHIATRIC PATIENTS, DRUG DISORDERS ADDMITED TO A ADDICTS AND HEALTHY PATIENTS SPECIFIC TREATMENT CENTER Francisco Javier Zamora 1 Ana María Recio Vivas , Cecilia Rodríguez1, Idilio González 2 Peñacoba Puente , Mónica Díaz Martínez1, Leticia Tolosa Gutiérrez1, 3 de Neira Hernando , Laura Visiers Monica Sánchez-Autet2, Belén 1 1 Jiménez , David Peña Otero , Arranz3, Marina Garriga4 Raquel Rebolledo Carmona4 1 Servicio Extremeño de Salud, 1  Centro de Ciencias de La Salud San España. Rafael. Universidad Antonio de 2  Nebrija, España. Hospital Universitari Mutua Terrassa, Barcelona, España. 2 Universidad Rey Juan Carlos, 3  España. Parc Sanitari Sant Joan de Déu, CIBERSAM, Barcelona, España. 3 Universidad Complutense de 4  Madrid, España. Institut de Neurociènces, Hospital Clínic de Barcelona, IDIBAPS, 4  Clínica Nuestra Señora de la Paz, CIBERSAM, Universitat de España. Barcelona, Barcelona, España. METHADONE-MAINTAINED 163 166 THE HEALTH STIGMA TOWARDS TREATMENT. ANALYSIS OF PATIENTS WITH ALCOHOL ABUSE PHARMACOLOGICAL ADHERENCE PROBLEM 1 Anna Salas Martinez , Sonia Carlos Gómez Sanchez-Lafuente1, 1 Pedrosa Armenteros , Daniel Rocio Reina Gonzalez2, Juan Ignacio 1 Vicente Rivera , Salvador Bello Duran Nieto1 Franco1, Manuel Yzuel Sanz2 1 Hospital Virgen de La Victoria 1  Hospital Clínico Universitario Málaga, España. Lozano Blesa, España. 2 Hospital Regional Universitario, 2  Fundación Centro de Solidaridad Málaga, España. de Zaragoza – Proyecto Hombre, España.

203 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

167 PERSONALITY DISORDERS AND 172 REFERRAL TO A HEPATOLOGY SUBSTANCE ABUSE DISORDERS UNIT FROM A DUAL DIAGNOSIS Stefano Goretti, Maria Del Carmen UNIT OF PATIENTS WITH Sánchez Sánchez, Anselmo HEPATITIS C: PRELIMINARY Cañabate Prados, Juan Carlos RESULTS Ibañez Salmerón Raul Felipe Palma Alvarez1, 1 U.G.C Salud Mental Almería, España. Abderraman Esojo , Nieves Martínez-Luna1, Laia Rodriguez- 1 1 168 ATTENTION-DEFICIT/ Cintas , Maria Robles , Elisabeth 1 HYPERACTIVITY DISORDER AND Monterde-Ochoa , Thais Ballabriga- 1 1,2 SUBSTANCE USE DISORDERS. A Córdoba , Lara Grau-López , Maria 3 1,2 CLINICAL CASE Buti , Carlos Roncero 1  Stefano Goretti, Maria Del Carmen Hospital Vall d’Hebron- Agencia Sanchéz Sanchéz, Patricia Ortega de Salud Pública. CIBERSAM. Gutiérrez Barcelona, España. 2  U.G.C. Salud Mental Almería, España. Universidad Autónoma de Barcelona. Barcelona, España. 169 OPIOID OVERUSE PAIN 3 Hospital Vall d’Hebron. Barcelona, SYNDROME (OPPS) IN PATIENTS España. WITH CHRONIC NONTERMINAL PAIN. PREVENTION AND 173 DUAL DISORDERS AMONG LIVER TREATMENT TRANSPLANTATION CANDIDATES: Ana Isabel Henche, Rosa ARE THEY PROPERLY ADDRESSED Fernandez-Marcote IN THE SCIENTIFIC LITERATURE? 1 2 Unidad Conductas Adictivas de Victor Pereira , Hector Saiz , Olga 2 Toledo, España. Arbeo 1 Clínica Universidad de Navarra, 170 PAIN MANAGEMENT IN OPIOID- España. TOLERANT PATIENT 2 Complejo Hospitalario de Navarra, Denise Jacobowitz, Marta Niubó, España. Eva Daví, Roberto Esteban, Ester Boix, Lara Moreno, Vanesa Vilella, 174 SEVERITY OF Nuria Planet, Teresa Fernandez, PSYCHOPATHOLOGICAL Enric Batlle SYMPTOMS IN PATIENTS WITH Hospital de Mataró, Consorci del PRIMARY HYPOTHYROIDISM Maresme. Barcelona, España. Olena Pityk1, Iryna Kuzhda2, Mykola Pityk1 THE ASSOCIATION BETWEEN 171 1 Ivano-Frankivsk National Medical POST-STROKE DEPRESSION AND University, Ukraine. THE ACTIVITIES OF DAILY LIVING/ 2  GAIT BALANCE IN PATIENTS WITH Ivano-Frankivsk Regional Children FIRST-ONSET STROKE PATIENTS Hospital, Ukraine. Chi-Un Pae Catholic University, Republic of Korea.

204 23 - 26 March, 2017 Madrid - Spain

175 COGNITIVE ASSESSMENT IN DUAL 177 TRIPLE DIAGNOSIS: COMORBIDITY DIAGNOSED PATIENTS OF DUAL DISORDERS AND HIV Raquel Rebolledo1, Belen Javier Sánchez Cerezo1, Gonzalo Fernandez1, Emilia González1, Jaime Salazar De Pablo1, Héctor De Del Corral1, Cecilia Peñacoba2, Ana Diego1, Manuel Gonzalez1, Mario De Mª Recio3 Matteis1,2 1 Centro de Patología Dual. Clínica 1 Hospital General Universitario Nuestra Señora de la Paz. Madrid, Gregorio Marañón, Madrid, España. España. 2 Centro de Salud Mental de Retiro, 2 Universidad Rey Juan Carlos. Hospital General Universitario Madrid, España. Gregorio Marañón, Madrid, España. 3 Universidad A. de Nebrija. Madrid, España. 178  AND DUAL DISORDERS: A CASE REPORT 176 IRREVERSIBLE URINARY DAMAGE Javier Sánchez Cerezo1, Gonzalo ASSOCIATED TO CHRONIC USE OF Salazar De Pablo1, Héctor De KETAMINE, A CASE REPORT Diego1, Manuel Gonzalez1, Mario De 1,2 María Robles Martínez1, Raul Felipe Matteis Palma-Álvarez1, Alfonso Abad1, Lara 1 Hospital General Universitario Grau-López1,2, Nieves Martínez- Gregorio Marañón, Madrid, España. 1 1 Luna , Marta Sorribes , Carlos 2 Centro de Salud Mental de Retiro, 1,2 Roncero Hospital General Universitario 1 Hospital Universitario Vall Gregorio Marañón, Madrid, España. d´Hebron. Barcelona, España. 2 Universidad Autónoma de 179 DIFFERENTIAL DIAGNOSIS Barcelona, Barcelona, España. BETWEEN AND ANTICHOLINERGIC DELIRIUM Ana Cristina Trujillo Moreno, María Tiscar Méndez Magaña, Elena Dutilh Fernández, Ángel Luis Blanco González Hospital Virgen del Puerto, Plasencia, Cáceres, España.

205 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

NOTES

206 23 - 26 March, 2017 Madrid - Spain

NOTES

207 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

SPONSORS & EXHIBITORS

PLATINUM

SILVER

"Supported by Gilead sciences Europe Ltd who provided funding. Gilead Sciences has had no input into the content of the materials and presentations used at this event, other than the Gilead Satellite Symposium”

BRONZE

208 23 - 26 March, 2017 Madrid - Spain

GENERAL

209 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

SATELLITE SYMPOSIA

Friday, March 24th SYMPOSIUM JANSSEN

10:00 - 11:30 Room Castilla Language: Spanish (Idioma: Español) NUEVAS RESPUESTAS TERAPÉUTICAS PARA EL PACIENTE DUAL: TRATAMIENTO INTEGRAL PARA LA RECUPERACIÓN

MODERADOR: Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d'Hebron. Barcelona, España.

PONENTES: NUEVAS RESPUESTAS TERAPÉUTICAS EN EL ABORDAJE FARMACOLÓGICO Luis San, Salud Mental Parc Sanitari de Sant Joan de Déu. Barcelona, España. NUEVAS RESPUESTAS TERAPÉUTICAS EN EL ABORDAJE INTEGRAL José Mª Vázquez, CAS de Sants, Barcelona, España.

210 23 - 26 March, 2017 Madrid - Spain

Friday, March 24th SYMPOSIUM LUNDBECK

10:00 - 11:30 Room Hidalgo DUAL DEPRESSION. HOW DO WE ASSESS AND TREAT IT?

CHAIR: Jerónimo Sáiz, Universidad de Alcalá, Hospital Ramón y Cajal Madrid, España.

SPEAKERS: COGNITIVE SYMPTOMATOLOGY: HOW PRESENT IS IN THE PATIENT WITH DUAL DEPRESSION? José M. Montes, Hospital Universitario Ramón y Cajal. Madrid, España. BAD SYNERGIES: 1+1=3. AFFECTATION OF COGNITIVE SYMPTOMOLOGY IN DUAL DISORDERS WITH DEPRESSION Luis Gutiérrez, Complejo Hospitalario de Granada. España. WHAT SHOULD WE TAKE INTO ACCOUNT TO PROPERLY DIAGNOSE AND TREAT COGNITIVE SYMPTOMS IN THE PATIENT WITH DEPRESSION AND ADDICTIONS? Beatriz Rodríguez, Hospital Universitario Ramón y Cajal. Madrid, España.

211 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Friday, March 24th SYMPOSIUM PFIZER

10:00 - 11:30 Room El Escorial THERAPEUTIC APPROACH OF THE PSYCHIATRIC PATIENT: SMOKING CESSATION A PENDING SUBJECT

CHAIR: Eugeni Bruguera, Hospital Universitari Vall d’Hebron. Barcelona, España.

SPEAKERS: TOBACCO AND PSYCHIATRY: DANGEROUS LIAISONS Gemma Nieva, Hospital Universitari Vall d’Hebron. Barcelona, España. WHAT TO BEAR IN MIND WHEN A PSYCHIATRIC PATIENT IS CEASING SMOKING Pepe Navarro, Hospital Universitari Vall d’Hebron. Barcelona, España. TOBACCO USE DISORDER APPROACH ON THE PSYCHIATRIC PATIENT: NEW DATA Eugeni Bruguera, Hospital Universitari Vall d’Hebron. Barcelona, España.

212 23 - 26 March, 2017 Madrid - Spain

Friday, March 24th SESSION MUNDIPHARMA

10:45 - 11:30 Room El Jardín TAKE-HOME NALOXONE PROGRAMMES: SHOULD UNIVERSAL ACCESS BE OUR GOAL?

CHAIR: Joan Colom, Agència de Salut Pública de Catalunya. Barcelona, España.

SPEAKERS: OPIOID OVERDOSE IN CLINICAL SETTING: BARRIERS TO USE NALOXONE FROM PATIENTS’ VIEW Raul F. Palma, Hospital Universitari Vall d’Hebron. Barcelona, España. OVERDOSE PREVENTION. A SUCCESSFUL PROGRAMME AMONG HARM REDUCTION POLICIES. THE EXPERIENCE OF CATALONIA Joan Colom, Agència de Salut Pública de Catalunya. Barcelona, España.

213 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Friday, March 24th WORKSHOP FERRER

10:00 - 10:45 Room Comendador SEPD EDUCATIONAL PROGRAMME Dual Disorders protocols: 10.000 students trained in the last decade. New modules 2016

SPEAKERS: CONCEPTUALIZATION OF DUAL DISORDERS Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. DUAL DISORDERS AND BEHAVIORAL ADDICTIONS Francisco Ferre, Hospital General Universitario Gregorio Marañón. Madrid, España. Ignacio Basurte, Hospital General Universitario Gregorio Marañón. Madrid, España.

214 23 - 26 March, 2017 Madrid - Spain

Friday, March 24th SYMPOSIUM INDIVIOR

12:00 - 13:30 Room Castilla TURNING THE PAGES: CHALLENGES AND COMPLEXITIES IN OPIOID DEPENDENCE

CHAIR: Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France.

SPEAKERS: OVERDOSE: THE EUROPEAN STORY Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France. RELAPSE AND RE-TREAT: RE-WRITE YOUR PATIENTS JOURNEY Lorenzo Somaini, Addiction Treatment Centre. Biella, Italy. CASE CLINIC: OPTIMISING PATIENTS’ CARE Case 1: A PATIENT ON METHADONE WHO WANTS IMPROVE HIS RECOVERY Jan Melichar, Spire Bristol Hospital, United Kingdom. Case 2: A PATIENT ON SUBOXONE WHO IS USING HEROIN ON TOP DUE TO SUBOPTIMAL DOSING Maurice Dematteis, University Hospital of Grenoble, France.

215 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Friday, March 24th SYMPOSIUM OTSUKA-LUNDBECK

12:00 - 13:30 Room Hidalgo THE CHALLENGE OF ADHERENCE IN DUAL DISORDERS

CHAIR: Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. José Martínez-Raga, Hospital Universitario Dr. Peset, Universitat de Valencia. Valencia, España.

SPEAKERS: “FAST TALKS” WHY IS THE ADHERENCE IN DUAL DISORDERS CRUCIAL? Antonio Terán, Centro Asistencial San Juan de Dios. Palencia, España. WHAT IS THE PATIENT’S CARE PATHWAY IN DUAL DISORDERS? IMPACT ON ADHERENCE Adrian Neyra, Hospital Universitario de Gran Canaria Doctor Negrín. Las Palmas de Gran Canaria, España. HOW DO WE USE ANTIPSYCHOTICS IN DUAL DISORDERS? USE OF ARIPIPRAZOLE ONCE- MONTHLY IN THE TREATMENT OF PATIENTS WITH PSYCHOSIS AND DUAL DISORDERS Adriana Farré, Centre-Forum Barcelona, España. DISCUSSION: HOW TO FACILITATE THE TREATMENT TO THE PATIENTS WITH PSICOSIS AND DUAL DISORDERS?

216 23 - 26 March, 2017 Madrid - Spain

Friday, March 24th SESSION MSD

12:00 - 13:30 Room Doblón ADDICTIONS AND DUAL DISORDERS SPECIALISTS INTEGRATION INTO THE HEPATITIS C ELIMINATION PARADIGM: NO PATIENT LEFT BEHIND

CHAIR: Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat Autònom. Barcelona, España.

SPEAKERS: HEPATITIS C SIGNIFICANCE IN PATIENTS WITH ADDICTIONS Ashley Brown, Imperial College London, St. Mary’s and Hammersmith Hospitals in London. London, United Kingdom. KEY ROLE OF ADDICTIONS CLINICS IN THE HEPATITIS C CLINICAL MANAGEMENT Brian Conway, University of British Columbia Vancouver, Vancouver Infectious Diseases Centre. Vancouver, Canada. DISCUSSION AND CLOSING REMARKS All panel

217 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Friday, March 24th SYMPOSIUM LUNDBECK

12:00 - 13:30 Room El Escorial BIPOLAR DISORDER UNDER DEBATE

CHAIR: Eduard Vieta, Hospital Clínic de Barcelona. Universitat de Barcelona. España.

SPEAKERS: Consuelo de Dios, Hospital Universitario La Paz. Madrid, España. Vicent Balanzá-Martínez, Hospital de Bétera, Universitat de València, CIBERSAM. Valencia, España. Ángela Ibáñez, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, CIBERSAM, España.

SUBJECTS: Is bipolar disorder an epigenetic disease? How do you distinguish yourself from adult TDAH? Can neuroimaging help diagnosis? How to identify symptoms such as anxiety or irritability during mania? How to separate substance-induced mania from primary mania?

218 23 - 26 March, 2017 Madrid - Spain

Friday, March 24th SYMPOSIUM SERVIER

12:00 - 13:00 Room El Jardín NEW ADVANCES IN THE TREATMENT OF PATIENTS WITH DEPRESSION AND DUAL DISORDER

SPEAKERS: Cecilio Álamo, Universidad de Alcalá, Hospital de la Paz, España. José M. Montes, Hospital Universitario Ramón y Cajal. Madrid, España.

219 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Saturday, March 25th SYMPOSIUM LUNDBECK

12:00 - 13:30 Room Hidalgo CONTROVERSIES AND DUAL DISORDERS IN ALCOHOL CONSUMPTION DISORDERS

CHAIR: José Martínez-Raga, Hospital Universitario Dr. Peset, Universitat de Valencia. Valencia, España.

SPEAKERS: BIPOLAR DISORDER AND ALCOHOL CONSUMPTION DISORDER José M. Goikolea, Hospital Clinic. Barcelona, España. BPD AND ALCOHOL CONSUMPTION DISORDER Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. SCHIZOPHRENIA AND ALCOHOL CONSUMPTION DISORDER Lara Grau-López, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona. España. DEBATE

220 23 - 26 March, 2017 Madrid - Spain

Saturday, March 25th SYMPOSIUM PHILIP MORRIS INTERNATIONAL

12:00 - 13:30 Room Doblón TOBACCO HARM REDUCTION

SPEAKER: Nuno Fazenda, El Cubo, Neuchâtel, Switzerland.

221 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Saturday, March 25th SYMPOSIUM EXELTIS

12:00 - 13:30 Room El Escorial HOW, WHEN, AND WHY DEPRESSIVE SYMPTOMS APPEAR IN RECOVERY OF ALCOHOL-DEPENDENT PATIENTS

CHAIR: Ignacio Basurte, Hospital General Universitario Gregorio Marañón. Madrid, España.

SPEAKERS: Gabriel Rubio, Universidad Complutense de Madrid, España. Cecilio Álamo, Universidad de Alcalá, Hospital de la Paz, España.

222 23 - 26 March, 2017 Madrid - Spain

Saturday, March 25th SYMPOSIUM GILEAD

12:00 - 13:30 Room El Jardín KEEPING HCV IN MIND: FROM DETECTION TO ACTION

CHAIR: Carlos Roncero, Universidad Autónoma de Barcelona, España.

SPEAKERS: THE IMPACT OF HCV INFECTION IN DUAL DISORDER PATIENTS Carlos Roncero, Universidad Autónoma de Barcelona, España. THE NEED FOR HOLISTIC CARE OF DUAL DISORDER PATIENTS - PERSPECTIVES FROM THE UK AND ITALY Oscar D’Agnone, University of Manchester, United Kingdom. Lorenzo Somaini, Addiction Treatment Centre. Biella, Italy. THE JOURNEY TO HCV CURE - A PRACTICAL APPROACH TO TREATING PATIENTS WITH DUAL DISORDERS Carlos Roncero, Universidad Autónoma de Barcelona, España. Maria Buti, Hospital Universitari Vall d’Hebron. Barcelona, España. TAKING HCV OUT OF THE EQUATION - BENEFITS BEYOND CURE (PANEL DISCUSSION/Q&A) All

IMPROVING OUTCOMES IN OUR DUAL DISORDER PATIENTS (MEETING SUMMARY) Carlos Roncero, Universidad Autónoma de Barcelona, España.

Supported by Gilead Sciences Europe Ltd who provided funding. Gilead Sciences has had no input into the content of the materials and presentations used at this event, other that the Gilead Satellite Symposium.

223 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

EXHIBITION FLOOR PLAN

13 23 14 24

POSTERS

1-2 16

3 17-18 4 19 15 20 21 22 5

7 8 9 10 11 12

1-2 INDIVIOR 13 PREMISA 3 ROVI 14 VINCILAB 4 15 GILEAD 5 INSTITUTO DE 16 SERVIER ADICCIONES 17-18 LUNDBECK 7 SANOFI 19-20 OTSUKA - LUNDBECK 8 SHIRE 21 WCP 2017 9 FERRER 22 PFIZER 10 EXELTIS 23 WISEPRESS 11 NUTRICIÓN MEDICA 24 SEPD/WADD/ 12 JANSSEN FUNDACIÓN PATOLOGÍA DUAL

224 23 - 26 March, 2017 Madrid - Spain

AUTHORS INDEX

A. Castaño, Guillermo______76, 100 Álamo, Cecilio______219, 222

A. Forero, Diego______164 Alansari, Bader______168, 176

A. Katzman, Martin______175 Alati, Rosa______87, 126

A. Martín, José______124 Alberdi, Iñigo______184

A. Núñez, Luis______142 Alberdi Páramo, Iñigo______167, 173, 176, 183, 197, 200 A. Sánchez Bello, César______98 Albuquerque, Elisabete______153, 156, 164 A. Santos, José______157 Alegría, Margarita______139, 145 Abad, Alfonso Carlos______111, 179, 183, 194, 196, 205 Alejandra Sáiz-Martínez, Pilar______192

Abad, Iciad______168, 189 Alejandro Muñoz Valencia, Jhonny______161

Abad Costoya, Tania______180 Alexandru, Livia______172

Abrosimova, Julia______167, 172 Alfonso Nava, Felice______179

Abulafia, Judith______144 Alharthy, Basma______185

Aceña Dominguez, Rosa______184 Almodóvar Fernández, Isabel______92, 200

Acosta Mariño, Laura Juliana______174 Alonso, Sofía______178

Adan, Ana______55, 164, 169, 175 Alonso Alonso, Adela______166, 169, 173, 202

Adriaenses Lázaro, Javier______202 Alonso Gutiérrez, Sofía______164, 179, 195

África Cruz, María______170 Alonso León, Laura______170, 174, 177, 182, 189, 194 Aguado, Lidia______42 Alonso Sedano, Arturo______194 Aguado Bailón, Lidia______194 Alonso-Pérez, Fernando______126 Agüeros Pérez, Begoña______197 Aluco, E.______176 Aguerretxe, Arkaitz______106, 151 Álvarez, Sonia______112, 151 Aguilar, J.______198 Álvarez, Ana______182, 189 Aguilar Valseca, Paloma______160 Álvarez, Enric______168 Agujetas Rodríguez, Margarita______194 Álvarez, Javier______183 Al, Bader______176 Álvarez, Mª José______157 Al Chaal Marcos, Laila______170, 174, 177, 182, 189, 194 Álvarez de Mon, Miguel______198

Al Shaban Rodríguez, Ali______168 Álvarez Navares, Ana Isabel______181, 193

225 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Alves, Patrick______120, 174, 196 Atzori, Emanuela______69

Amaro-Hosey, Kristpher______179 Augedal, Aslak______85

Ambrosini, Federica______162, 191 Auriacombe, Marc______39, 215

Andrade, Vladimiro______154 Avellón Juárez, V.______164, 195

Andreu, Alvaro______172 Aviñó Isern, Joan______171

Andrew Chambers, R.______44, 93, 164 Awan, Saima______121, 132

Antonia Font, María______161 Ayora Rodríguez, Miriam______172

Antunez, Juan Manuel______169 Azanza, Adrian______194

Antuña-Díaz, María Jesús______192 Azanza Balmori, Adrián______169, 194, 202

Aramburu, Andoni______164 Aziz, Sultana______58

Aramburu Sanz, Andoni______171, 184 Azzam, Hanan______120

Arango, Celso______52 B. N. Laura Lago García, Subodh______202

Arbeo, Olga______174, 192, 195, 205 Baby, Renju______92

Arbeo Ruiz, Olga______79, 101, 127 Baca García, Enrique______182

Arce Scott, Yaraví______146 Bádenas, Laura______179

Arias, Francisco______87, 112, 140, 188, 200 Baena, Victor______152

Arias Rubio, Sara______195 Baena Mures, Rafael Ángel______167, 173, 176, 183, 184, Arranz, Belén______203 197, 200

Arranz, Mikel______164 Bagatska, N.______47, 161

Arranz Diez, Mikel______184 Balanzá-Martínez, Vicent______55, 218

Arriaza, Camilo______199 Baler, Ruben______71, 104, 114

Arrieta, María______198 Balhara, Yatan______191

Arrua Duarte, Elsa______182 Ballabriga-Córdoba, Thais______205

Arturo Cassiani Miranda, Carlos______127, 200 Ballesta Casanova, Trinitario______164, 183

Ascari, Tania______188 Ballesteros, Jesús______172, 175, 177

Asensio, Leonor______161 Bandawar, Mrunal______187

Asensio Cabrera, Vicente______189 Banzo-Arguis, Cristina______190

Asherson, Philip______174 Baño Rodrigo, Dolores______194

Astigarraga, Idoia______164 Baños Martin, Irene______190

Astigarraga Iriondo, Idoia______171, 184 Bañou, Rafael______155

Athey, Alison______169 Baquero, Abel______92, 200

226 23 - 26 March, 2017 Madrid - Spain

Barbero García, Elena______194 Bento, Luis______181, 183

Barrado los Arcos, Laura______79, 101, 127 Benyamina, Amine______53

Barrera Salas, María Isabel______166, 168 Berenguer Elias, Nuria______167

Barrigón, María Luisa______182 Berjano Noya, Belén______171, 184

Barrionuevo Baeza, Carmen______183, 194 Bernad, Roberto______72

Barrios, Mireia______172 Bernardo, Miquel______43

Barrocas, Daniel______181, 183 Bersh, Sonia______175

Bartoli, Gastón______70 Berulava, George______197

Barylnik, Julia______167, 172 Bhugra, Dinesh______37

Basu, Debasish______202 Biederman, Joseph______94

Basurte, Ignacio______112, 113, 214, 222 Biong, Stian______133, 137, 164

Basurto, Irma______109 Bisi, Laura______162, 191

Batlle, Enric______204 Blanch, Jordi______117, 125

Bautista-Pérez, Fabio______200 Blanco, Carlos______71

Beato Fernández, Luis______162 Blanco, Laura______112

Becerra Darriba, Helena______180, 184 Blanco González, Ángel Luis______205

Becoña, Elisardo______185 Blanco Ramón, Patricia______160

Bejarano Ramírez, Juan Francisco______197 Blankers, Matthijs______143

Belaid, Abderrahmane______177 Bloemendaal, Tony______116

Belén Rico del Viejo, Ana______102 Boada, L.______162

Belfort, Edgard______89 Bobes, Julio______103

Bell, Rick______164 Boix, Ester______204

Bellivier, Frank______161, 165 Boix, Esther______176, 202

Bello Franco, Salvador______203 Boix Quintana, Ester______200

Belmar Simó, Alejandro______166, 172 Boix-Quintana, E.______176

Belmonte García, Gema____162, 167, 183, 190 Bokhan, Nikolai______112, 128

Ben Mustapha, Seifeddine______169, 170 Bokuchava, Teimuraz______197

Ben-Tzarfati, Mashit______203 Bolondi, Marisa______162, 191

Benegal, Vivek______187, 193 Bonnie, Kofi______48

Benito Delegido, Ana______92, 200 Bonny-Noach, Hagit______92, 139

Benito Ruiz, Adolfo______190 Bordas, Jordi______187

227 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Borg, Marit______164 Calcedo, Alfredo______135, 140

Boss, Leif______143 Caldero Alonso, Amaya______142, 193

Boszczyk, Anna María______178, 190 Caloro, Matteo______190

Bott, James______128 Calvet, Anna______162, 182, 189, 191

Bourbon, Nadir______177 Calvo, Antoni______38

Brañas, Antia______97 Calvo Rivera, Pilar______194

Braquehais, Mª Dolores______38, 84, 122, 200 Camarasa, Xavier______59

Bravo, Nathaly______120 Camarena, Enrique______89, 150

Bravo Gómez, Silvia______166 Camarillo, Leticia______140

Brecic, Petrana______192 Cambra, Julia______63, 168

Brekke, Eva______137 Cambra Almerge, Julia______174 Cameron, Catherine______Brodahl, Morten______133 175 Campayo, Antonio______125 Brotons López, J.______164, 195 Campillo Sanz, Maite______173 Brown, Ashley______217 Campos Mangas, María Carmen______177 Bruguera, Eugeni______38, 200, 212 Campos Navarro, Pilar______166 Bruner, Natalie______70 Camuñas Sevilla, María Teresa______180, 199 Brzezinski-Rittner, Aliza______121 Canal, Manuel______162 Bucci, David______100 Canal Rivero, Manuel______166, 187, 193 Bukstein, Oscar______43, 64 Cancino, Marta Cristina______178 Bundalo, Daniela______177 Cancino Botello, Martha______164, 195 Burillo Gonzalvo, María______167 Candela, Ruth______177, 180 Burmaka, Nadiya______144 Candon Gamez, María Jose______202 Busch, Sidsel______137 Cano Ruiz, Paloma______164, 166 Buti, María______205, 223 Canseco, María Ángeles______178 Buttram, Mance______101 Canseco Navarro, María Caballero Martinez, Luis______185 de los Ángeles______164, 179, 195

Cabanillas Carrillo, Lara______181 Cañabate Prados, Anselmo______204

Cáceres, Ana______118 Cañadas Aceña, Zaida______198, 199

Cagigal, César______196 Cañas Fraile, Silvia______180, 184

Calabrò, Giuseppa______190 Cañete, Josep______202

Calabuig Crespo, R.______164 Caño Salomón, Federico______180

228 23 - 26 March, 2017 Madrid - Spain

Capella, María del Mar______164, 169 Cavar, Zrinka______202

Carabias Contreras, Ana______176 Cegla Schvartzman, Fanny______182

Carceller-Sindreu, Mar______168 Celia Brangioni, María______186, 195

Cardona, Cristina______56 Celic, Ivan______192

Cardozo, Jussara______197 Celorrio Bustillo, María Luisa______176, 177, 186, 187 Carmichael, Victoria______196 Cervera Martínez, J.______164 Carmona, Rodrigo______145 Chamorro García, Lorenzo______198 Carrasco Sánchez, Ana María______185, 198 Chand, Prabhat______193 Carrascosa Bernaldez, Jose Manuel______198 Chapinal, Olga______166 Carrascosa Carrascosa, Carmen______200 Chen, Tung-Chia______Carrera, Indalecio______157 162 Chen, Xi______Carrió, Elisenda______176 127

Cartagena López, Edmundo______168, 193 Chern Tor, Phern______168

Cartas Moreno, Francisca______190 Chiclana, Carlos______90

Carvalhão, Teresa______158, 164 Chuev, Jury______144

Carvalho, Sergio______197 Cinta Ramírez Domínguez, María____ 185, 198

Casado Espada, Nerea______170, 174, 177, Ciubara, AnaMaría______172 182, 189, 194 Claro Torres, María Evangelina______168

Casals, Alicia______176 Collazos, Francisco______37, 145 Casanueva Fernández, María______164 Colom, Joan______213 Casas, Miguel______38, 96, 113, 159, 200, 210 Colón, Máximo______155 Casillas Guzmán, Edgar______164 Comer, Sandra______178 Castañeda, Carlos______99 Concepción Martínez Sánchez, M.______193 Castaño Perez, Guillermo A.______93 Conde, Manuel______157 Castelao-Lorenzo, María Jesús______192 Conde Rivas, María______186, 187, 193 Castillo, Alejandro______175 Constanza Pacheco Santander, María_____ 179 Castillo, Claudio______178, 179 Contreras, María______90 Castillo, Sandra______170 Conway, Brian______217 Castrillo, Eduardo______134, 167 Cook, Sarah______175 Castro, María Eugenia______199 Cordeiro-Crespo Cabral-Campell, Castro Arias, Elida______167 María Gloria______180, 199

Catalán Barragán, Rubén______162, 166 Córdoba, Rodrigo______71

229 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Córdova, Alejandro______89 de Dios, Consuelo______218

Corominas-Roso, Margarida______179 de Felipe, Javier______114

Corral, Marta______178 de Felipe García-Bardón, Victoria______48

Corral Galarreta, Marta______179 de Ingunza Barreiro, Evelio______189, 202

Correa, Thiago______186 de la Cruz Planas, Raquel______199

Correas-Lauffer, Javier______184 de la Fuente Martín, Ana______162

Cortazar López, Elena______197 de la Iglesia Larrad, Javier______170, 174, 177, 182, 189, 194 Coutado, Carmen______69 de la Mata Hidalgo, Rafaela____ 170, 174, 177, Crespo-Facorro, Benedicto______197 182, 189, 194

Cristian Pirlog, Mihail______172 de la Vega, Diego______191

Cristina Cancino Botello, Martha______179 de la Villa Márquez, Guadalupe______189 Cuesta Moreno, Carlos______182 de los Desamparados Pérez Cunillera, Carme______162, 182, 189, 191 López, María______180

Cunillera Llorente, Alicia______194 de Matteis, Mario______111, 172, 175, 186, 190, 194, 205 Curkovic, Marko______192 de Pedro Melgarejo, D. Kotzalidis, Georgios______190 Francisco______138, 151, 196

D’Agnone, Oscar______223 de Pisa, Eleonora______190

Dacosta Sánchez, Daniel______202 de Uribe Viloria, Nieves______177

Daigre, Constanza______75, 84, 167, Dekker, Jack______143 183, 195 del Canto Jiménez, Cristina______202 Dalae, Mihaela______92, 200 del Corral, Jaime______172, 175, Dannon, Pinhas______45, 53 180, 205

Daulouede, Jean-Pierre______53, 106 del Corral Serrano, Jaime______186, 195

Daví, Eva______200, 202, 204 del Romero, Jorge______42

Davidson, Larry______137 Delás, Jordi______118 de Alarcón Gómez, Rubén_____ 170, 174, 177, Delayahu, Yael______139 182, 189, 194 Delgado Arroyo, Mercedes______195 de Antonio Pérez, Valentín______194 Delgado Miguel, María Pilar______161, 165, de Asís Babín, Francisco______62 167, 172, 202 de Castro-Manglano, Pilar______174 Delgado Rico, Elena______189, 202 de Diego Ruiz, Héctor______175, 205 Delile, Jean-Michel______163 de Diego-Adeliño, Javier______168 Dematteis, Maurice______215

230 23 - 26 March, 2017 Madrid - Spain

Dereux, Alexandra______165 Duran Nieto, Juan Ignacio______180, 203 Descalzo Cabadés, Duran Perez, Erislandy______180 María Amparo______164, 178, 179, 195 Duran-Sindreu, Santiago______168 Di Piero, Lucas______166 Dutilh, Elena______189 Díaz, Albert______200 Dutilh Fernández, Elena______205 Díaz Batanero, Carmen______189 E. Frade, María______197 Díaz de Neira Hernando, Mónica______203 E. Kosmas, Charlotte______174 Diaz Digón, Laura______173 E. Salech, Maríana______119 Diaz Fernández, Silvia______165, 186 Eaton Iturbide, Karen______190 Diaz-Maroto Tello, María Ebert, David______143 de los Ángeles______180, 199 Echeburúa, Enrique______53, 66, 147 Didia, Javier______98, 126, 146 Edith Salech, Maríana______70 Dieter, Lesa______169 El-Ghamry, Reem______120 Díez-Suárez, Azucena______174 El-Guebaly, Nady______53, 66 Dimitrijevic, Ivan______182 El-Hadi Zerdazi, Mohamed______95 Dinelli, E.______179 El-Rasheed, Amany______120 Dixon, Jane______48 El-Zoheiry, Abeer______120 Dolengevich-Segal, Helen______36, 42, 105, 184 Elserafi, Doha______120

Domato Lluch, Mar______176, 177 Engleman, Eric______164

Domingo, Antonia______201 Epstein, Irvin______65, 175

Domingo-Salvany, Antonia______59 Erdocia Remacha, Andrea______48 Dominguez Ballesteros, Escobar, Uriel______120 María Encarnacion______160 Escobar Fernández, José Luis______165, 178, Domínguez Cejudo, Ana______181 183, 184, 190, 195 Domínguez Salas, Sara______189 Esojo, Abderramán______137, 167, 179, Dorado, Marisa______46 194, 205 Doucette, Wilder______100 Esojo Jiménez, Abderraman______179 Downey, Lavonne______128 España Osuna, Antonio______190 Drake, Robert______93 Esperanza-Álvarez, Tania______126 Dualde, Julia______174 Espinola, V.______198 Duany Navarro, Annia______175, 180 Espinoza-Navarro, Omar______199

Dupeyron, Geoffroy______165 Esteban, Roberto______200, 202, 204

231 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Estecahandy, Pascale______72 Fernández Calatrava, Belén______186

Estelrich, Neus______195 Fernández Calderón, Fermín______189, 202

Esteves, Pedro______156 Fernández D’Adam, Guillermo______150

Estévez, Ana______121, 172, 190, 191 Fernández del Rio, Elena______185

Estrada, Xavier______170 Fernández Fernández, M.M.______189

Etain, Bruno______95, 161, 165 Fernández García, Luis Javier______189

Ezquiaga, Itziar______166, 170 Fernández Mayo, Lidia______194

Ezquiaga Bravo, Iciar______201 Fernández Menéndez, M.A.______189

F. Agüera, Luis______56 Fernández Miranda, Juan José______168, 170, 186 F. Martin-Rodríguez, Juan______97 Fernández Molina, Manuel______189 F. Palma, Raul______92, 213 Fernández Morales, Juan C.______194 Fabero Cruz, Paula______200 Fernández Quintana, Águeda______180, 201 Fabregas Pedrell, Josep María______143 Fernández Rojo, Sonia______190 Fadeuilhe Grau, Christian______174, 193 Fernández Torija, Manuel______167 Fadeuilhe Grau, Edgar______193 Fernández-Artamendi, Sergio______47 Falla, Daniel______172 Fernández-Hermida, José Ramón______47 Farré, Adriana______77, 216 Fernández-Marcote, Rosa______204 Farré, Magi______105 Fernández-Miranda, Juan J.______165 Farré Martínez, Adriana______173 Fernández-Quintana, Agueda______93 Fazenda, Nuno______221 Fernández-Torija Daza, Manuel______162, 190

Fe Bravo, María______152 Fernández-Vidal, Aina______168

Feingold, Daniel______69 Ferrando, Adela______176

Feito Fernández, Pablo______138, 151 Ferre, Francisco______53, 62, 214

Felices, Alfredo______41, 112, 187 Ferré, M.______176

Félix-Alcántara, Miriam Patricia______190 Ferré, Miquel______200

Fernández, Belén______180, 205 Ferreira-Sgobbi, Renata______183

Fernández, Carmen______154 Ferrer, Verónica______90

Fernández, Juan J.______107 Ferrer Chinchilla, María Nuria______192

Fernández, María______188 Figueras, Rosario______101

Fernández, Teresa______204 Filip, Malgorzata______39

Fernández Auñon, Raquel______180, 199 Fine, Alexa______175

232 23 - 26 March, 2017 Madrid - Spain

Fiorillo, Raffaele______162 Gagulin, Igor______69

Fischer, Gabriele______66 Galán, Laura______187

Fitzgerald, Colin______100 Galindo, Liliana______57, 173

Flavia Pires Lucas d’Oliviera, Ana______58 Gallego Deike, Lucía______176

Flores, Paz______200 Galmes Lluis, Niell______202

Flórez, Gerardo______107 García, Elias______160

Fonseca, Francina______36, 77, 98, 143, García, Gabriel______194 166, 178, 201 García, Ignacio______135 Fonseca, João______184 García, Jesús______42 Fonseca Casals, María Francina_____ 170, 184 García, Lucas______149 Fontenla, Andrés______155 García, M.______186, 190 Forner, Montserrat______170 García, María______172 Fortuny, Joan Ramón______176 García, Sara______176

Fotinos, Kathryn______175 García Albea Martín, Julia______163

Frade, Mª Elena______75, 138 García Armendáriz, Eva Alicia______164

Fraga, Andres______152 García Belen Berjano, Gixane______164

Franco, Célia______153, 155, 164 García Briñol, Carlos______166

Franco Martín, Manuel Ángel______181, 193 García Carretero, Miguel Ángel______111

Freeman, Carla______100 García Egea, Jorge Luis______186, 187, 193 Frem, Yasmina______59 García Mahía, María del Carmen______Frías, A.______176 180, 185, 188, 201 García Moreno, Carmen______Frías, Danny______168, 189 164, 165, 166 García Nicolás, María______79, 101, 127 Frias Ortiz, Danny Francisco______165, 168, 170, 173, 186 García Parajuá, Pedro______143, 163

Fuentes García, Alicia______180, 199 García Pardo, Araceli______152

Fuerte, Ignacio______149 García Román, Cristina______160

Fuertes, Paula______186 García Salguero, María______182, 189

G. da Silva, Antonio______154, 155, 156 García Sánchez, Aurora______194

G. Lerner, Arturo______37, 45, 111, 139 García-Albea, Julia______143

G. Schütz, Christian______54 García-de la Plaza, Eva______198

Gafarov, Valery______69 García-Encinas, María Ángelica______166

Gafarova, Almira______69 García-Fernández, Gloria______48

233 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

García-Gómez, Leonor______185 Goldman, Keren______111

García-Gutierrez, María S.______187 Gomes da Costa, Susana______169

García-Mahia, María del Carmen______76, 93 Gómez, Carlos______63

García-Orozco, Juanjo______198 Gómez, Marta______151

García-Pérez, Ángel______47, 126 Gómez, Montserrat______147

García-Raboso, Elena______55 Gómez, Nuria______78

Gardner, Eliot______70 Gómez, Sandra______172

Garrido Beltrán, Antonella______183, 194 Gómez Beteta, Javier______173, 200

Garriga, Marina______203 Gómez Cano, José Luis______172, 181

Gárriz, Miguel______170 Gómez Coronado, Nieves______186, 187, 193

Garzón de Paz, María Ángeles______181, 193 Gómez Menjibar, Marta______112

Gasque, Silvia______170 Gómez Peinado, Alicia______164, 165, 166

Gelabert, Joan M.______40 Gómez Rebollo, Alfonso______189

Gema Hurtado Ruíz, María______173 Gómez Revuelta, Marcos______186, 187, 193

Genovés Muñoz, R.______164 Gómez Ruiz, Elsa______197

Gerechter Luis, Olivares______202 Gómez Sánchez-Lafuente, Carlos______180, 203 Gibert Rahola, Juan______37, 111 Gómez Simón, Manuel______166, 169, Gil Sánchez, Alfonso______166 173, 202 Gilchrist, Gail______58, 59, 100 Gómez-Arnau, Jorge______184 Gimelfarb, Yuri______203 Gómez-Cano, Jose Luis______166 Giménez, Rocío______176, 177, Gómez-Coronado Suárez 186, 187 de Venegas, Nieves______160 Gimeno, Carmen______46 Goncharova, Olena______144 Gimi, Barjor______127 González, Delia______124 Giné, E.______176 González, Emilia______180, 205 Giné, Eloi______200, 202 González, Enrique______89 Giner, Lucas______122 González, Francisco José______162 Girard, Aurore______165 González, Inés______159 Gisbert, Laura______67 González, Manuel______205 Glotka, L______161 González, Zelma______166 Godinho, Filipe______181, 183 González Álvarez, Aitana M.______197

Goikolea, José M.______96, 220 González Baeza, Alicia______42

234 23 - 26 March, 2017 Madrid - Spain

González Cadelo, Lucia______173 Gouse, Hetta______100

González Cordero, Lucia______163 Graciani Pérez de Regadera, Miguel______198 González Galdamez, Ana Luisa______166, 172 Gracin, Boris______202 González Gil, Ana______172 Grande, Raquel______112, 151 González Giraldo, Jeffrey______202 Grande-Gosende, Aris______47, 48 González González, Manuel______175 Grau-López, Laia______41 González Martínez, Idilio______203 Grau-López, Lara______58, 98, 167, González Martínez, María______197 179, 183, 193, González Pinto, Ana______62, 94 194, 205, 220

González Ponce, Bella María______189 Gray, Kevin______64

González Ruano, Esperanza______198 Green, Alan______52, 100, 127

González Saiz, Francisco______190 Gregorio-Elcoso, Miriam______198

González Sánchez, Emilia______186, 195 Grifell, Marc______57

González Soria, Celia______170, 174, 177, Griffin, Margaret______178 182, 189, 194 Gromova, Elena______69 González Suárez, Aida______166, 169, Grønstøl, Bård______123 173, 202 Guajardo, Humberto______68 González Valerio, Niceto______180 Guardia, Josep______107 González Vega, Zelma______201 Guerra Gómez, Enrique______190 González-Cantú, Hugo______59 Guerrero Jiménez, Margarita___ 165, 178, 183, González-González, Isaac______175 184, 190, 195 González-Martínez, María______192 Guerrero Morcillo, Alfredo______171 González-Roz, Alba______47, 126 Guillen Benítez, Manolo______202 González-Saiz, Francisco______88 Gunnar Bramness, Jørgen______93 González-Vallespí, Laura______176, 200 Gupta, Sandhya______92 Gonzalvo, Begoña______41, 112, 187 Gurrea Escajedo, Alfredo______180, 184 Gordon, Greg______198 Gurrea Salas, David______93 Goretti, Stefano______167, 174, 204 Gutiérrez, Luis______91, 211 Gorjaltsan, Igor______178 Gutiérrez, Miguel______88 Goti, Javier______43, 123 Gutiérrez, Sonsoles______134 Gotor Reula, Paloma______167 Gutierrez Casares, Goudriaan, Anna______143 José Ramon______174

235 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Gutierrez López, María Luisa______189, 202 Hernández Huerta, Daniel______172, 181 Gutiérrez Rodríguez, Rocío______162, 166, Hernandez Marin, Gloria______175 186, 187, 193 Hernández Sánchez, Gutierrez Sánchez, Rocío______186 Juan Miguel______164, 179, 195 Gutierrez-Guarín, Claudia______167 Hernández-Dorta, Alejandro______175 Guzman, Isabel______176 Hernandez-Huerta, Daniel______166, 184 Guzmán, Mercedes______148 Herrejón Teodoro, Beatriz______162, 167, 180, 183 H. Grevet, Eugenio______67 Herrero, Agapito______189 H. Paim Kessler, Felix______58 Hesse, Morten______70 Halabi, Alessandro______197 Hidalgo Borreguero, Abel______183, 190 Hamilton, Ian______115 Hispard, Eric______165 Harini Christopher, J.______138 Hollanda, Ángela______166, 197 Harkous Peña, Carlos______185 Hollenstein, María Francisca______202 Haro, Gonzalo______36, 79, 92, 176, 200 Homri, Wided______169, 170 Harrison, Abigail______73 Hornillo Castro, Juan Carlos______168 Harshe, Devavrat______191 Hoyuela Zatón, Fernando______197 Harshe, Gurudas______191 Hsien Wu, Yi______162 Hasin, Deborah______74, 104 Huergo Lora, María Covandonga______166, 169, 173, 202 Haug, Severin______143 Hughes, Elizabeth______115 Heemskerk, Jessica______164, 171, 184 Hughes, Liz______100 Helfgott, Suzanne______198 Humel, Simone______166 Henche, Ana Isabel______204 I Wu, Hsin______162 Henry, Chantal______161 I. Furlong, Laura______74 Heredero Sanz, Miguel Ángel______190 I. Mézquita, Rosa______89 Heredia, Meritxell______200 Ibáñez, Ángela______191, 218 Hernández, Daniel______117 Ibáñez Jiménez, Pol______193 Hernández, Ignacio______40 Ibañez Salmerón, Juan Carlos______204 Hernández, Juan Miguel______178 Ibáñez Vizoso, Jesús______173 Hernández Germán, Montero______202 Icick, Romain______86, 95 Hernandez González, Lourdes______185 Infante, Irene______199 Hernández González, Mario Javier______166, 169, 173, 202 Ipser, Jonathan______100

236 23 - 26 March, 2017 Madrid - Spain

Iqbal, A. F. M.______58 Jishkariani, Maríam______197

Irune Ojeda Martínez, Ainhoa______180, 184 Johansen, Katrine______137, 151

Isurina, Gailna______177 Johnson, Matthew______70

J. Antón, José______124 Jones, Jermaine______178

J. Jaen, María______91 Jongeling, Iris______116

J. Palma, Álvaro______57 Jordi Bel, Miquel______200

J. Pavon, Francisco______74 Jorge Nobre, Manoel______183

J. Pino, Francisco______110 Jornet Jimón, Víctor______198

J. Portella, María______168 Joseph, Alain______174

J. Quintero, Francisco______75 Joska, John______100

Jaber, Jorge______126, 137 Juan Pérez, Cecilia Paloma______172, 181 Juan-Perez, Cecilia______Jaber Filho, Jorge______166, 197 166 Jukic, Vlado______192 Jacobo, Félix______168, 189 Juncal Ruiz, María______186, 187, 193 Jacobowitz, Denis Daniela______202 Jurado Barba, Rosa______197 Jacobowitz, Denise______198, 204 Just Andersen, Bror______85 Jaén, María José______102 Kafle, Khagendra______202 Jaén Hernández, Alicia______172 Kajdiz, Karmen______80 Jaén Moreno, María José______172, 185 Kaminer, Yifrah______64, 123 Jan Hjemsæter, Arne______93 Kanbur, Nuray______73 Jauregui, Paula______121, 190, 191 Kandasamy, Arun______187, 193 Javier Álvarez, F.______46 Kandrakonda, Srinivas______174 Jeronimo, Gema______188 Karla Carvalho Leite Jesús Sotelo, Mª______187 Andrade, Ana______195

Jiménez, Alberto______149 Kastelic, Andrej______80, 92

Jiménez, Eduardo______152 Katzman, Martin______65, 175

Jiménez Barea, Francisco José______194 Kaur Soni, Parmeet______196

Jiménez Cortés, Marta Pilar______180, 184 Kearney, Joan______48

Jiménez Hernandez, Jose Luis______161 Kékes Szabó, Marietta______176

Jiménez Londoño, Germán______162 Khashawi, Fadel______176

Jiménez-Murcia, Susana______172 Khazaeipour, Zahra______160

Jiménez-Serrano, Joana______198 Khokhar, Jibran______100, 127

237 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Kikvadze, Ekaterine______197 Lehr, Dirk______143

Kipping, Cheryl______115 Leite, Simone______166

Kolhs, Marta______188 Lenoir, Hugo______163

Kostic, Jelena______161 León Alegria, José Manuel______168

Kozlov, Vladimir______101 Leon Leon, Laura Margarita______161

Krystian Trabczynski, Piotr______177 Lessa, Jorge______186

Kulkarni, Yogesh______191 Lev-Ran, Shaul______94, 104

Kurtz, Steven______101 Levin, Frances______75, 84

Kushner, Diana______68 Lien, Lars______137, 138

Kuzhda, Iryna______205 Lin, Dennis______191

L. Barrigon, María______97 Linderoth, Lars______85 L. Fernández, José______146 Lingam, Ravi______199 L. Gutiérrez, María______148 Littlewood, Richard______179 L. Rodríguez, José______125 Livia Chirita, Anca______172 Labbane, Raja______169, 170 Lizaso, Lucia______101 Laborda, Jorge______187 Llamas López, Elisa______181 Lado Codesido, María______185, 188 Llanes Álvarez, Carlos______142, 181, Lageder, D.______179 190, 193

Lago García, Laura______166, 169, 173 Llavayol, Enric______200

Lakshmi Narasimha, Lligoña Garreta, Anna______169 Venkata______193 Llorente, C.______162 Landheim, Anne______123, 133 Loftus, Josephine______161 Lapa, Georgina______161 López, Alejandro______72 Laporta Herrero, Isabel______161, 165, 167, 172, 202 López, Elena______176

Largacha, Sara______199 López, Maribel______187

Larios, Diego______109 López, Miguel Ángel______188

Le Foll, Bernard______121 López, Noelia______142

Leal, Rodrigo______176 López Callejas, Caridad______194

Lee, Kun-Ha______70 López de Abajo, Benito______155

Lefebvre-Durel, Camille______165 López de Haedo, A.______195

Lehmann, Jennifer______169 López de Munain, Estíbaliz______63

238 23 - 26 March, 2017 Madrid - Spain

López Fernández, Mack, Silje______133 Jaime Ramón______166, 169, 173, 202 Madroñal, Mario______168 López Gómez, David______181 Madroñal Morales, Mario______174 López Landeiro, Patricia______181 Magistrati Jiménez, Elisa______172, 185 López Maríano, Arancha______168 Mahillo Gutierrez, Markel______163 López Olmo, Noelia______79, 101 Maldonado, Rafael______113 López-Durán, Ana______185 Mancheño, Juan J.______148 López-González, Hibai______172 Mancheño Barba, Juan José______189 López-Rico, Mercedes______161 Mandel, Anna______112 López-Sánchez López, Jimena______161 Manley, David______137 Losa Mújica, Edurne______171, 184 Manrique Astiz, Eduardo______79, 101, 127 Louzao, Iker______152 Manso Bazús, Carmen______190 Lovison, Robson______188 Manzanares, Jorge______44, 187 Lozano Rojas, Oscar M.______189 Manzano, Yolanda______202 Lu, Hanbing______127 Maraña Garceo, Laura______172, 181 Lu, Vincent______168 Marc Vidal, Joan______174 Luca, Gianina______59 Marco, Eva M.______39 Lucas, Marta______186, 187 Marcolongo, L.______179 Lucas Pérez-Romero, Mareca Viladrich, Celia______179 Francisco Javier______176, 177 Maremmani, Icro______53, 96, 122 Lucas Pérez-Romero, Marta______164, 165, 166, 176, 177 Maricic, Lea______202

Luis Graña, María______176 Marín-Navarrete, Rodrigo______87, 120, 121, 163, 185 Luzia Melo, Ana______181 Markova, Eugenia______112 M. Alvarado, Edwin______140 Markova, Evgeniya______101 M. Garrote, Juan______108 Markovic, Ivan______182 M. Rodríguez, Carlos______189 Markovic, Mirjana______182 M. Salloum, Ihsan______103 Marques, Sofia______181, 183 MacEwan, William______48 Márquez Ligero, Francisco______189 Machado, Marta Margarita______178 Marquez Marquez, María Jose______160 Machado Vera, Marta Margarita______164, 179, 195 Marquez-Arrico, Julia Elena______175

Macias, Cristina______176 Marroquí, Carmen______68

239 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Marshall, Jane______185 Massons, Carmen______166 Mårtensson, Solvej______151 Mata, Beatriz______161 Martí Bonany, Josep______173 Mata Cala, Francisco Ignacio______192 Martin-Larregola, María______184 Matalí, Josep______43 Martín-Santos, Rocio______77 Mateu, Cesar______176 Martinez, Andrés______124 Mateu Codina, Gerard______170, 173 Martinez, Bárbara______202 Mateu Henández, Cesar______92 Martinez, Ivan______168 Maura Carrillo de Albornoz Calahorro, Carmen______165, 178, 183, Martinez, Rocío______56 184, 190, 195 Martinez, Ursula______185 Maximov, Vladimir______69 Martínez, Araceli______186, 187 Mazzoglio y Nabar, Martín______70 Martínez, Laura______200 McCorkle, Ruth______48 Martínez, Roser______179 Medeiros, Teresa______158 Martínez Carrascosa, Melichar, Jan______215 Araceli______164, 165, 166 Mella, Laura______161 Martínez Domingo, Ana______192 Melo, Ana______183 Martínez Maldonado, Andres______197 Méndez, Tiscar______189 Martínez Molina, Iván______162, 166, 184 Mendonça, Janine______166 Martínez Mollá, Pedro______171 Mendoza, Enrique______79, 98, 154 Martínez Pérez, Isabel______166, 172 Menéndez, Isabel______194 Martinez-Ales, Gonzalo______152 Menéndez-Miranda, Isabel______192 Martinez-Cirera, Bárbara______198 Menni, Benito______187 Martínez-Loredo, Víctor______47, 48 Mercurio, Ezequiel______70, 119 Martínez-Luna, Nieves______141, 151, 179, 205 Mesías, Beatriz______112, 118, 139 Martínez-Raga, José______36, 54, 75, 94, Mestre, Joan______201 164, 216, 220 Mielgo, Nina______108 Martínez-Sanvisens, Diana______178 Migoya Borja, Marta______182 Martínez-Vispo, Carmela______185 Mikadze, Kakhaber______197 Martins, Vera______154, 158 Milagros Domínguez Mas Sanfiz, Pilar______199 Zabaleta, Irene______181 Masbah Uddin Ahmed, Md.______47, 58 Millán Aguilar, Virginia______102, 172 Masferrer, Carme______200 Milosavljevic, Ljubiša______161

240 23 - 26 March, 2017 Madrid - Spain

Min Kim, Javier______190 Muñoz Martinez, Victoria______161, 162

Ming Mok, Yee______168 Muñoz Ruiz, Antonio______174

Mirza, Kah______64 Muñoz Zuñiga, Jose Ricardo______161 Mohamed, Munira______175 Muquebil Ali Al Shaban Rodrígz, O.W.______189 Molero, Patricio______198 Mur de Víu, Carlos______125 Molina, Rocío______159 Mures Rafael Ángel, Baena______202 Molina López, Juan Manuel______182 Murthy, Pratima______Mondragon, María Soledad______164 193 Mondragón Egaña, Mutica, Mihai______172 María Soledad______171 Mykhailova, E.______47, 161

Monforte Porto, Jesús Ángel______181, 193 N. Jemar, Guillermo______119

Mongil San Juan, Jose María______194 Naghdi, Maryam______160 Monterde-Ochoa, Elisabeth______205 Naguib, Rehab______120 Montero Hernández, Germán___ 167, 173, 176, Nasiri, Khalidha______175 183, 197, 200 Navarrete, Francisco______187 Montes, José M.______96, 211, 219 Navarro, José Francisco______164, 169 Montes Reula, Laura______79, 101, 127, 142, 174 Navarro, Pepe______212

Montiel, Francisco Javier______102 Navarro, Rafael______42, 126

Montoya Crous, Isabel______68, 111, 121, 179 Navarro Aznar, Javier______161, 165, 167,

Mora Mesa, Juan José______166 172, 202 Mora Minguez, Fernando______190 Navas Tejedor, Marta______143, 163 Morales, Abel______183 Navío, Mercedes______122 Moravia, Allan______166 Nayach José, Marta______198 Moreno, C.______162 Nel Cordoba Rojas, Rodrigo______202 Moreno, Carmen______96 Ness, Ottar______164 Moreno, Lara______204 Neto, Filomena______154 Moreno, Rocio______160 Neyra, Adrián______136, 216 Moreno Hueyo, Jorge______69 Nicolas Jemar, Guillermo______70 Moreno-Sancho, Lara______198 Niel Gálvez, Lluis______173, 176 Mosia, Sopiko______80 Niell Galmes, Lluis______167, 176, 184, 197 Mozo, Xulián______200 Niell Galmez, Lluis______183, 200

Mukhametshina, Elvira______181 Nieto, Lourdes______166

241 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Nieva, Gemma______212 Orban, Mirjana______202

Nikitina, Valentina______128 Orejas, Olivia______176, 200

Niubó, Marta______202, 204 Ornelas, José______72

Nóbrega, Camila______181 Ortega García, María Dolores______172, 180, 199 Noe-Díaz, Valeri______185 Ortega Gutiérrez, Patricia______167, 174, 204 Nogueira, Raquel______188 Ortega Pacheco, Mónica Noordraven, Ernst______116 Brenda______202 Noriega, Shanthi______58 Ortigosa Luque, Miguel E.______190 Novell, Isabel______179 Ortuño Pérez, Antonio______182 Novo, Mercedes______161 Osuna Carmona, María Novozheeva, Tatiana______112 Isabel______183, 194

Nuevo Fernández, Laura______161, 162 Otero Lamas, Francisco______112, 164 Núñez Domínguez, Othily, Erika______163 Luis Alfonso______79, 101, 127 Otis, Thomas______114 O’Regan, Richard______198 Overholser, James______169 Ochoa, Enriqueta______200 Ovidiu Alexandru, Dragos______172 Ochoa Mangado, Enriqueta_____166, 172, 181 Pacetti, Monica______162, 191 Ocio León, Sergio______166, 169, Pacheco, María______178 173, 202 Packer, Catherine______58 Oda Plasencia García de Diego, Beatriz______168, 182, 189, Pacurucu, Saúl______47 192, 193, 202 Padovan, G______179 Odden, Sigrun______123 Padrós Susanna, Carme______199 Ojeda Martínez, Ainhoa I.______184 Pae, Chi-Un______204 Oliveira Marin, Ana Lúcia______181 Pagerols, Jordi______176 Oliveras Salvà, Clara______169 Pages Rivero, Cristina______190 Olivieri-Nobmann, Cindy______167 Pagnussat, Freedy______146 Olmo López, Noelia______127 Pakhomova, Svetlana______167, 172 Olmos, Ruth______159 Pal Singh Balhara, Yatan______59, 140, 151 Olschowky, Agnes______188 Palha Fernandes, Omar, Abdelnasser______120 Eduardo______120, 174, 196

Onaindia, Jaione______121, 190, 191 Palma, Álvaro José______170

Oprescu, Florin______163 Palma, C.______176

242 23 - 26 March, 2017 Madrid - Spain

Palma Álvarez, Pereiro, César______76 Raúl Felipe______167, 179, 194, 205 Perestrelo, João______161 Pan, Bing______48 Perez, Jalessa______169 Panov, Dmitriy______69 Perez, María______159 Papouli, Foteini______199 Pérez, Irene______176 Paramo Iñigo, Alberdi______202 Pérez, L.______189 Parellada, M.______162 Pérez, Montse______176 Parker, Caleb______58 Pérez Asenjo, Roberto______167, 177, Parmar, Arpit______191 183, 190

Parra Bru, Silvia______202 Perez Carrasco, Cristina______184

Parra Fernández, Pérez Castro, Juan Carlos______144, 197 María Laura______111, 121, 179 Perez Franco, Cesar______190 Parro, Carlos______100, 117, 168 Pérez Gálvez, Bartolomé______182 Parro-Torres, Carlos______181 Perez López, María Pascual, Francisco______107 Desamparados______167, 177, 183

Pascual, Juan Carlos______168 Perez Marin, Piedad______134

Pascual Yolanda, Lázaro______202 Pérez Sobrino, Cristina______176, 200

Passoni, Ornella______59 Perez Sosa, Miguel______160

Patel, Chloe______174 Perez-Dandieu, Beatrice______163

Patricio, Luis______111 Pérez-Heredia, José Luis______170

Patrick Jean, Rogue______47 Perez-Massip, Cristian______198

Pavkovic, Bojan______182 Pérez-Templado, Josefa______191

Pedrero, Concepción______168, 189 Peris, Lola______59, 114

Pedrosa Armenteros, Sonia______191, 203 Pessoa, Fátima______157

Peláez, Manuel______183 Picazo, Alicia______177

Pemán Rodríguez, Jesús______173 Piccoli, Sara______188

Peña Otero, David______203 Pilar Fernández Calatrava, Belén______195 Peña Serrano, María Desamparados______179 Pin Ang, Chai______168

Peñacoba Puente, Cecilia______203, 205 Pinheiro, João______155

Perea, Marta______120, 195, 196 Pino Calderon, Francisco Javier______174 Pereira, Victor______174, 192, 195, 205 Pintor Pérez, Luis______169

243 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Piñón Blanco, Adolfo______112, 164 Quispe Vilches, Ana______194

Piqueras Acevedo, María R. Gutiérrez, José______110 Dolores______166, 172 Rabinovitz, Sharon______144 Pita de La Vega-García, Javier______198 Radcliffe, Polly______58, 100 Pityk, Mykola______205 Radivel, Ramya______168 Pityk, Olena______205 Raggini, Roberta______162, 191 Pla, Ester______162 Rahioui, Hassan______144 Planet, Nuria______204 Rajhans, Pallavi______191 Ponte-Novo, Ana______93 Ramírez, Juan______140, 148, 189, 202 Porras Segovia, Alejandro______194 Ramírez López, Juan Francisco______185, 198 Porta Olivares, Oriol______186, 187, 193 Ramirez-Venegas, Alejandra______185 Portilla, Almudena______142, 174 Ramos, M.______162 Portillo Fernández, Almudena______79, 127 Ramos Calvo, Laura______171, 184

Potik, David______57, 79 Ramos-Quiroga, J. Antoni______67, 75

Pousa, Esther______166 Ranjan Ram, Jai______196

Pozo-Rosich, Patricia______196 Ranulfo Vaz, Ivan______195

Pozuelo, Marían______174 Rasmussen, Amalie______137

Prados Gómez, Joaquina______162, 167, 190 Ratnayaka, Nilushi______167

Prasad, Saras______191 Rebolledo, Raquel______172, 175,

Prat, Gemma______55, 164 180, 205 Pratdesava Villanueva, Albert______184, 198 Rebolledo Carmona, Raquel______186, 195, 203 Prieto, Antonio______159 Recalde, Cristina______79, 191 Prieto Bonilla, Esperanza______102, 172 Recio Vivas, Ana María______203, 205 Probst, Charlotte______121 Redondo, Justa______102 Proskurina, T.______47, 161 Regina Noto, Ana______58 Puigdemont, Dolors______168 Rehm, Jürgen______121 Pujol, Tània______200 Reig, Gemma______99 Quijano José, Rodríguez______202 Reina González, Rocio______180, 203 Quintero Gutiérrez del Álamo, Francisco Javier______190 Renau Minguez, Bianca______181 Quiroga-Fernández, Candela______93 Rentero, David______151

Quirós López, Alicia______192, 193 Reshetovska, N.______161

244 23 - 26 March, 2017 Madrid - Spain

Restrepo, Osvaldo______120 Rodríguez-Borlado, Belen______190

Reys, Bruno______166, 197 Rodríguez-Cano, Ruben______185

Ribas Muñoz, Natàlia______198, 199 Rodríguez-Cintas, Laia______69, 167, 179, 183, 194, 205 Rincon, Camila______175 Roig, Jaume______141 Riper, Heleen______143 Rojas, Yaiza______182 Rivas, Mar______177 Rojo Vallejo, Yaiza______174 Rivera Villaverde, Álvaro______40, 198 Rollat, Camille______165 Robles, Dolores______162, 189, 191 Romac, Danica______202 Robles, María______205 Romaguera, Ana______179 Robles Martínez, María______47, 111, 183, 205 Roman, Eva______152

Robles Martínez, Ricardo______166, 172 Romero, Diana______195, 196

Rodrigues, Rosa______184 Romero, Patricia______186, 187

Rodríguez, Beatriz______152, 211 Romero, Serafín______108

Rodríguez, Estibaliz______121, 191 Romero Guillena, Samuel Leopoldo______168, 182, 189, Rodríguez, Hector______199 192, 193, 202 Rodríguez, Laia______195 Romero Rodenas, Patricia______164, 166, Rodríguez, Melania______182 176, 177

Rodríguez Cejas, María Romero Ródenas, Patricia______165 Ángeles______168 Romildo Bueno, João______158 Rodríguez Cintas, Laia______196 Romo, J.______162 Rodríguez Fernández, Roncero, Carlos______36, 62, 88, 96, 104, Francisco Luis______190 111, 121, 144, 167, Rodríguez Gómez Carreño, 179, 183, 193, 194, Carlos______162 195, 196, 205, 223

Rodríguez Hernández, Alicia______166, 172 Ros, Elena______196

Rodríguez Lara, Melania______167 Ros-Cucurull, Elena______56, 167, 179, 183, 193, 194 Rodríguez Manzano, José Antonio______165 Rosales, Juan______109

Rodríguez Martín, Irene______189 Rosca, Paola______111

Rodríguez Martos, Lola______196, 199 Rosique Díaz, Pedro Alfonso______172

Rodríguez Paz, Beatriz______163 Rossi, Gabriel______76, 143

Rodríguez Quijano, José______167 Rossi, Paola______166, 178, 201

245 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Rubio, C.______186, 190 Salmerón Ríos, Sergio______171 Rubio, Gabriel______44, 222 Salom, Caroline______87 Rubio, Iñigo______152 Salud García, Mª______44 Rubio, Laura______168, 170, 189 Salvador, A.______176 Rubio García, Ana______162, 166, 186 Salvador, Lidia______187 Rubio Rodríguez, Laura______179 Samico, Ana______79, 191 Rubio Valladolid, Gabriel______197 Samos, Pilar______178 Ruiz, Inmaculada______166 San, Luis______210 Ruiz, Manuel______194 San Martín, Juan______172 Ruiz, Miguel______168 San Narciso-Izquierdo, Gemma Isabel______192 Ruiz, Pedro______43, 96, 122 San Román Uría, Alberto______181 Ruiz Feliu, Mikel______177 Sanabria, Rebeca______188 Ruiz Idiago, Jesús Miguel______179 Sanahuja Muñoz, Clara______195 Ruiz-Veguilla, Miguel______97, 126, 160, 162, 166, 184 Sánchez, Arantxa______168, 189 Ryan, Pablo______42 Sánchez, Javier______172, 194 S. Isla, Ramiro______119 Sánchez, Mª del Mar______68, 108 Saad, Yenny______189 Sánchez, María José______102 Sabater, Gerardo______176 Sánchez, P.______186, 190 Sacristán, Eduardo______162, 182, Sánchez, Pilar______152 189, 191 Sánchez, Rafael______40 Saez Fuentes, Estela______171, 184 Sánchez Acosta, Daniela______93 Sagiv Alayoff, Moran______92 Sánchez Bahillo, Ángel______172 Sagiv-Alayoff, Moran______139 Sánchez Cerezo, Javier______175, 205 Sáiz, Héctor______174, 192, 195, 205 Sánchez de la Nieta Sáiz, Jerónimo______53, 71, 211 Aragonés, Paloma______111, 121, 179 Saiz González, María Dolores______173 Sánchez Enamorado, Marta______184 Saiz Ruiz, Jerónimo______191 Sánchez Fernández, María del Mar______111, 121, 179 Sala, Mireia______162 Sánchez Flores, Luciana______172, 181 Salas Martínez, Anna______191, 203 Sánchez González, Roberto______173 Salavert, Jose______174 Sánchez Hernández, José______194 Salazar de Pablo, Gonzalo______172, 175, 194, 205 Sánchez Lorenzo, Isabel______166

246 23 - 26 March, 2017 Madrid - Spain

Sánchez Marcos, Lucía______170 Segrec, Nusa______80

Sánchez Páez, Patricia______191 Segura, Estefania______161

Sánchez Pernas, Lucía______174, 177, Segura Escobar, Estefania______162 182, 189, 194 Sentir, Alena______164 Sánchez Quintero, Sabrina______185 Serna Torrijos, María______171 Sánchez Sánchez, Lola______199 Seron, Juan______168 Sánchez Sánchez, María Serón Luna, Juan Manuel______184 del Carmen______204 Serra, Madalena______181, 183 Sánchez Thevenet , Paula______200 Serrano, Iván______197 Sánchez-Autet, Monica______203 Serrano, Pilar______134 Sánchez-Huesca, Ricardo______140 Serrano, Silvia______187 Sandonis Vicente, Miguel______193 Serrano García, Antonio______190 Sanjuan, Fernando______99 Serrano Guerrero, Estrella______182, 189, 202 Sanjuan, Julio______103 Serrat, Rosa______162, 182, Sansores, Raul______185 189, 191 Sant’Ángelo, Rosa Patrizia______162, 191 Sevilla, Juncal______75 Santiago Isla, Ramiro______70 Sevilla, Laura______177 Santos, Adriana______156 Shalini, S.______151 Santos, Marta______198 Shen, Chanchan______48 Santos-Burguete, Marta______174 Shen Yap, Lee______168 Sarkar, Siddharth______151, 191 Sher, Leo______59, 84, Sarramea, Fernando______91, 102 122, 144

Sauras Quetcuti, Rosa______173 Shukla, Lekhansh______193

Sauras Quetcuti, Rosa Blanca______170 Shushpanova, Olga______163

Schaub, Michael______143 Shushpanova, Tamara______101, 112

Schifano, Fabrizio______105, 190 Sierra Hincapie, Gloria María______93

Schifano, Paolo______190 Signe Landheim, Anne______93

Schwartz, Marcus______166 Silva, Carla______196

Scott, Jan______161 Silva, Tânia______153, 158, 164

Secades-Villa, Roberto______48, 126 Simón Martínez, Vanesa______48

Seco-Casares, Cristina______198 Simón Rodríguez, Carmen______196

Sedano Capdevila, Alba______182 Simunovic, Constanza______199

247 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Sion, Ana______197 Taboada, Andrea______142

Skutle, Arvid______80 Taheri-Otaghsara, Seyedeh-Mohadeseh______160 Solé, Josep______112, 187 Talavera Palacios, Solerdelcoll Arimany, Mireia______169 Jessica Lorena______164, 171, 184 Solonskii, Anatoly______112 Tamarit, Claudio______166, 178, 201 Somaini, Lorenzo______80, 179, Tan, Chunzhen______215, 223 168

Sordo del Castillo, Luis______118 Tanna, Raj______198

Sorribes Puertas, Marta______111, 141, 194, Tapia, Geraldine______163 195, 196, 205 Targa, Irene______187 Sosin, Ivan______144 Tarjuelo, Blanca______160 Sotelo Borjas, María Jesús______199 Tenorio Guadalupe, Soto Laguna, Marta______162, 167, Miriam Manuela______167, 173, 176, 183, 183, 190 184, 197, 200

Sousa, Cristina______120 Terán, Antonio______216

Soutullo-Esperón, César______75, 174 Terzic, Kristina______202

Spampinato, Umberto______39 Tevez Lombardo, Hilda______150

Srivastava, Ratika______70 Thiebaut, Sylvain______86

Stankovic, Miodrag______161 Thylstrup, Birgitte______70

Starostina, Marina______101 Tiana, Thaïs______168

Stein, Dan______100 Tirado, Judit______77

Stein, Elliot______127 Tiscar Méndez Magaña, María______Sternat, Tia______65, 175 205

Stockmeier, Craig______169 Todadze,, Khatuna______80

Storbini, Viviana______162 Todd, Travis______100

Suarez Velazquez, Andres______190 Tolaguera, Xavier______162, 182, 189, 191 Suárez Viñas, Catalina______179 Toledo-Fernández, Svetozarevic, Snezana______112 Aldebarán______121

Syed, Shabbiullah______191 Tolosa, Mª Teresa______186, 187

Szerman, Néstor______36, 52, 61, 62, 96, Tolosa Gutiérrez, Leticia______203 103, 112, 145, 155, 159, 194, Tolosa Pérez, María Teresa______164, 165, 214, 216, 220 166, 176, 177

Szpindel, Isaac______175 Tomás, Carmen______55

248 23 - 26 March, 2017 Madrid - Spain

Tomic, Andrea______192 Vallecillo, Gabriel______178 Torales, Julio______140 Vallejo Auñón, Francisco Manuel______163 Tore Sælør, Knut______164 Vallejo Oñate, Silvia______182 Torija Daza, Manuel______183 Vallejo Silva, Alexie______202 Torío Ojea, Esther______197 Vallejo-Valdivielso, María______174 Torrecilla Olavarrieta, Rocío______172, 185 Vallmitjana-Soler, Anna______198 Torrens, Marta______36, 54, 59, 74, Vallvé, Marta______176 105, 159, 165, Valriberas Herrero, Isabel______170, 174, 177, 178, 179, 184, 182, 189, 194 196, 201, 217 Valverde Barea, Mercedes______190 Torres Rincón, Tania______112 van der Nagel, Joanneke______132 Torroba, José______183, 194 Vaquero Casado, Patricia______179 Tovarovic, Jelena______182 Varela, María______172, 175 Trigo, Sofia______154 Varghese, Joseph______92 Tripathi, Richa______151 Vasconcelos, Carlos______196 Trippier, Justine______115 Vázquez, Élida______78 Trujillo, Ana______189 Vázquez, José Mª______210 Trujillo Moreno, Ana Cristina______205 Vázquez Ramo, Elena______48 Trujols, Joan______168 Vázquez-Bourgon, Javier______197 Trung Nguyen, Chi______106 Vega, Pablo______112, 145 Uddin Ahmed, Masbah______58 Velásquez, Elvia______126 Ulmer, Albrecht______53 Venâncio, Ângela______79, 191 Unzeta Conde, Belen______190 Vendrell Serres, Júlia______174, 193 Urgelés, Diego______40 Vendrusculo, Taina______188 V. Lagerberg, Trine______86 Vera Varela, Constanza______182 V. Samokhvalov, Andriy______121, 132 Vergara Moragues, Valades Santos, Antonio______174 Esperanza______112, 164, 190 Valdés Valdazo, Javier______190 Verissimo Junior, Jose______166, 197 Valdivia, Francisca______102 Vicente, Isabel______172, 186, Valenti, Emanuel______135 181, 190 Valera Fernández, María Rosario______184 Vicente Cobo, Jesus______166 Valero, Sergi______200 Vicente Rivera, Daniel______191, 203 Valero Carvajal, Jaime______202 Vidal, Raquel______78

249 FIRST WORLD CONGRESS OF THE WORLD ASSOCIATION ON DUAL DISORDERS (WADD) & FIFTH INTERNATIONAL CONGRESS OF THE SPANISH SOCIETY ON DUAL DISORDERS (SEPD) DUAL DISORDERS Addictions and other Mental Disorders

Vidal Millares, María______185, 188 Weidberg, Sara______48, 126

Vieta, Eduard______62, 218 Weinstein, Aviv______45

Vilariño Besteiro, Pilar______190 Weiss, Roger______113

Vilaverde, Daniela______184 Wenger, Andreas______143

Vílchez Trigueros, Fátima______48 Whitley, Robert______196

Vilella-Carbonell, Vanessa______198, 204 Wolf, Aviva______203

Villa-Diez, Rocío______192 Wolff, Kim______185

Villahoz González, Jesus______189 Wong, Christina______58

Villalobos-Gallegos, Luis______120, 185 Woodward, Rachel______199

Villanueva Gallego, Manuel______173 Yakovenko, Igor______147

Villoria Borrego, Lucía______182 Yen, Cheng-Fang______70

Vincent Tur, Elisabet______164, 171, 184 Yetano Larrazabal, Ioritze______172

Visiers Jiménez, Laura______203 Ying, Jiangbo______168

Voevoda, Mikhail______69 Yubero, Arantza______200

Vojnović, Daniela______177 Yzuel Sanz, Manuel______191, 203

Volkow, Nora______61, 62 Zabaleta Andreu, Iraia______190, 195 Zamora Rodríguez, Voore, Peter______121, 132 Francisco Javier______203 Vorspan, Florence______69, 88, Zarate, Illargi______121, 191 95, 165 Zarco, José______41 W. Muquebil Ali Al Shaban Rodríguez, Omar______166, 169, Zarrans Herrera Oria, 173, 202 Ignacio______177 Wahba, Mourad______199 Zhuo, Chuanjun______128, 137 Walid Muquebil, Omar______168 Zoido Ramos, José MIguel______110, 174 Wang, Jiawei______48 Zubimendi, Sabina______42 Wang, Wei______48 Zun, Leslie______128, 136

250 Come To The WADD Booth On The Exhibition Area And Become Member Of The World Association On Dual Disorders (WADD)

More Information in: http://www.worlddualdisorders.org SAVE THE DATE

VI INTERNATIONAL CONGRESS DUAL disorders Addictions and other Mental Disorders

4 - 7 April, 2019 Barcelona - Spain

www.icdd-congress.com